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The work presented in this thesis explores insecticide resistance using NMR metabolomics in 
pupa, early pupa and early adult mosquitoes of both sexes. Firstly, sex differences were 
investigated in early pupa and early adult strains of Anopheles gambiae and Aedes aegypti. 
Secondly, Cyp4g16 and Cyp4g17 knock-down strains of An. gambiae were studied to further 
understand the cuticular hydrocarbon (CHC) biosynthesis mechanism. Lastly, wild type 
susceptible and resistant strains of An. gambiae and Ae. aegypti were studied to understand 
metabolic differences in resistance. A common theme in this work is the utilisation of NMR 
metabolomics, focusing on polar metabolic profiles and its application in insecticide resistant 
mosquitoes. Improvements on the analyses of the NMR data to make the identification of 
metabolites from the NMR spectra more robust was also undertaken in the course of this 
project.   
 
The vast majority of mosquito studies focus on females since only females bite. This means 
that there is often a great amount of information on male mosquitoes that is not utilised. In 
order to investigate sex differences in wild type An. gambiae (and knock-down strains) and 
Ae. aegypti, a metabolomics protocol was established. This study found that early female 
pupae and adults have higher levels of lactate and glucose compared to males, whereas, their 
pyruvate and propionate levels were found to be lower. 
 
Cuticular resistance is a relatively newly discovered mechanism, with much about it that is 
still unknown, Electron microscopy studies have shown that insecticide resistant mosquitoes 
of An. gambiae possess a thicker cuticular layer. Furthermore, the decarbonylases, Cyp4g16 
and Cyp4g17, have been found to be critical in CHC biosynthesis and are highly expressed in 
insecticide resistant strains. Although not fully characterised, these enzymes are thought to 
catalyse a decarbonylation step in CHC biosynthesis. The study here showed evidence that 
both Cyp4g16 and Cyp4g17 take part in the biosynthesis of methyl branched-alkanes. 
Additionally, these enzymes have temporal activity where Cyp4g16 activity can be observed 
in both pupa and adult stages, whereas Cyp4g17 activity is only observable in the adult stage. 
 
Using resistant and susceptible strains of both An. gambiae and Ae. aegypti, metabolic 
differences were observed. Trehalose was found consistently higher in all resistant strains 
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and so it has been proposed as a biomarker candidate. Furthermore, systems using trehalose 
were suggested as potential targets in insecticide development. 
 
In conclusion, the work in this thesis shows that it is possible to use NMR metabolomics to 
study the metabolic responses found in insect pupae and adults, to distinguish sex 
differences and the obtained development stage- dependent temporal information on the 
activity of specific enzymes. Furthermore, through the identification of elevation in trehalose 
in resistant mosquitoes, this study has proposed a potential biomarker for identification of 
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1.1 Mosquitoes and mosquito borne diseases 
Mosquitoes (Culicidae family) are one of the families described in the Diptera order [1]. The 
Culicidae family comprises approximately 3,500 two-winged species of mosquitoes. Almost 
all aquatic habitats in the world provide a breeding site for mosquitoes [2], except 
permanently frozen areas. Mosquitoes can inhabit humid tropics, warm moist climates, 
temperate and cool zones [3]. High variation in mosquito species adaptations enable them 
to inhabit temporary, permanent, highly polluted or clean water bodies [2]. 
 
Mosquitoes are mostly known for their vector role in disease transmission. As a vector, 
certain mosquitoes can host certain pathogens and take part in the pathogen’s life cycle. 
These pathogens can cause a variety of diseases such as chikungunya, dengue fever, 
lymphatic filariasis, zika, and malaria. Generally, when a mosquito hosts a pathogen, the 
mosquito is not affected by it, but rather transmits the pathogen to a secondary host, such 
as humans, that will suffer the associated disease.  
 
Although mosquitoes are not the only vectors for disease-causing pathogens, they cause the 
most damage to public health in terms of deaths caused [4]. Mosquitoes also account for the 
majority of the most closely monitored diseases. Figure 1.1-1 shows the percentage of 




Figure 1.1-1: WHO most closely monitored diseases’ vector distribution. Out of the vector borne diseases, 
mosquitoes are responsible for transmitting 42.31%. Data from WHO global vector control response 2017 – 2030 
[4]. 
 
Within the mosquito family, different mosquito species host different pathogens and hence 
cause different diseases (Table 1.1-1). Among the most notable are malaria and zika.  
 
Table 1.1-1: Most closely monitored mosquito vectors and their associated diseases [4]. 
Host genus Pathogen type Pathogen name Disease 
Aedes Parasite Filarioidea spp. Lymphatic filariasis 
 Virus Chikungunya virus Chikungunya 
  Dengue virus Dengue fever 
  Phlebovirus Rift Valley fever 
  Yellow fever virus Yellow fever 
  Zika virus Zika 
Anopheles Parasite Filarioidea spp. Lymphatic filariasis 
  Plasmodium spp. Malaria 
Culex Parasite Filarioidea spp. Lymphatic filariasis 
 Virus Japanese encephalitis virus Japanese encephalitis 
  West Nile virus West Nile fever 
 
Cumulatively, mosquito-borne diseases shown in Table 1.1-1 account for approximately one 
million deaths per year. On an economical perspective, the global direct cost of malaria alone 
is estimated around 12 billion USD per year. 
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An. gambiae and Ae. aegypti species were identified as the most influential due to the fact 
that Anopheles species account for the most deaths and Aedes species account for the 
greatest number of diseases contracted. 
 
1.1.1 Impact on population 
In developed countries, mosquitoes do not pose an endemic danger as much as they do in 
less developed countries. Approximately 17% of all infectious diseases are caused by vector 
borne diseases, causing 700,000 deaths per annum [4]. In 2016, malaria alone was estimated 
to cause 445,000 deaths [5]. Figure 1.1-2 shows countries in Africa, south Asia and south 
America with at least one malaria incident. Diseases with lesser deaths per year such as 
Chagas disease [6], leishmaniasis [7] and schistosomiasis [8] affect hundreds of millions of 
people worldwide. While there are numerous diseases of concern transmitted by Ae. 
Aegypti, none of them cause as many deaths as malaria. Figure 1.1-3 shows the current state 
of reported Ae. aegypti-borne diseases. 
 
 
Figure 1.1-2: Malaria status changes between 2000 and 2017 according to reported cases. From the map it can 




Figure 1.1-3: Map of Ae. aegypti disease reports for zika, dengue, yellow fever, chikungunya and RVF (Rift Valley 
Fever). White represents no reported cases and grey highlights the states of USA with no reported cases [9]. 
 
The burden of mosquito-borne diseases are not only measured by the deaths disabilities, and 
infections caused, but also by the serious financial impact they have on countries. For 
example, one study estimated that in Asia it would cost approximately 1,151 USD for 
treatment and related costs to treat a child infected with Japanese encephalitis [10]. To put 
this amount into context, the families in the study worked in rural areas in parts of Asia and 
had incomes of about 115 USD per month [10]. Other mosquito-borne diseases incur similar 
costs. The economic impact of West Nile virus in the United States between 1999-2012 was 
approximately 56 million USD per year [11], excluding vector control programs or money lost 
as a consequence of workforce sickness. In 2005, a West Nile virus outbreak in California was 
estimated to cost 2.98 million USD [12]; comparatively the 2002 outbreak in Louisiana, USA 
had a total cost of 20.14 million USD [13]. Furthermore, studies conducted on the cost of 
Dengue Fever from eight countries in the Americas and Asia (Brazil, El Salvador, Guatemala, 
Panama, Venezuela, Cambodia, Malaysia and Thailand) and Americas overall, estimates 
overall  direct and indirect costs between 1.8 and 2.1 billion USD each year [14] [15]. 
Considering that there are 100 million infections per year, this disease has a high impact on 
economy and health care. In the case of Rift Valley Fever virus, an additional impact to 
consider is that it affects both humans and animals. Currently, it is most prevalent in Africa. 
The outbreak in Kenya between 2006 and 2007 resulted in a financial impact of 9.3 million in 
USD due to the effect on both people and livestock [16]. Moreover, to date, Yellow Fever is 
the only disease in Table 1.1-1 for which a commercial vaccine is currently available. Between 
2011 and 2015, 330 million USD was spent on yellow fever vaccines in endemic countries 
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[17]. Other outbreaks such as the Chikungunya outbreak of 2017 in Bangladesh created a 
minimum loss of 606 USD per month per patient, caused by loss of productivity [18]. Finally, 
non-lethal malaria treatment alone can be a heavy burden on public health funds. In 2013, 
the cost of uncomplicated malaria treatments in Nigeria was 182,953.65 USD from a single 
hospital [19]. This sum accounted for 25% of the hospital’s total expenditure of 2013 [19]. 
 
1.1.2 Diseases, treatment and prevention 
Disease treatments most frequently treat the symptoms rather than the disease itself. As 
shown in Table 1.1-2 the majority of these diseases cannot be readily treated directly and do 
not have available vaccines for prevention. When a disease without a treatment is 
contracted, pathogen clearance is reliant completely on the host immune system. 
Meanwhile, only the symptoms presented, such as headaches, swelling and fever, can be 
treated. This approach is effective only in so much as the resources available in the region 
and the education level of the population in danger. Furthermore, immunosuppressed and 
vulnerable members of society such as those who are pregnant, juveniles and the elderly will 
have greater difficulties in clearing the pathogen. 
 
Table 1.1-2: List of diseases monitored by WHO. MDA, mass drug administration; NST, no specific treatment; Anb, 
antibiotics; VC, vector control; Vac, vaccination; M, million; T, thousand; PPE, personal protective equipment. 
Disease Pathogen Type Year Cases Deaths Treatment Prevention 
Lymphatic filariasis Parasite 2014 120 M - MDA MDA ,PPE & VC 
Chikungunya Virus 2006 1.4 M - NST PPE & VC 
Dengue fever Virus Per year 100 M 12,500 NST PPE & VC 
Rift Valley fever Virus   - NST PPE & VC 
Yellow fever Virus Per year 200 T 30,000 NST Vac, PPE & VC 
Zika Virus   - NST PPE & VC 
Malaria Parasite 2012 207 M 627,000 Anb PPE & VC 
 
To reduce the number of cases and the costs incurred by treatments, disease prevention 
methods play a critical role. Currently there are two widely adopted prevention methods: 
application of insecticides and use of insecticide-treated nets (ITN). Although the latter 
application mostly affects female mosquitoes, both rely on use of effective insecticides. 
Treatments for some of the more significant mosquito-borne diseases are described briefly 
below. 
 
1.1.2.1 Lymphatic filariasis treatment 
Lymphatic filariasis (also known as elephantiasis) is caused by parasites of Filarioidea species 
and can be transmitted by female mosquitoes of the species Anopheles, Aedes, Culex or 
Mansonia [20]. Lymphatic filariasis is known to be endemic in over 70 countries however 
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70% of the infected cases are in India, Nigeria, Bangladesh and Indonesia. Male to female 
ratio of infected patients is 10:1 which may be due to women's more covered attire in the 
highly endemic regions. Amongst the infected patients about 50% are between 30-50 years 
old. 
 
Lymphatic filariasis can be diagnosed through testing of blood for microfilariae presence. A 
skin biopsy may be required if the parasite is a skin dwelling type. Symptoms of lymphatic 
filariasis can be divided into three groups: asymptomatic, chronic and acute [20]. 
Approximately half of the lymphatic filariasis patients are clinically asymptomatic. This is 
despite having the parasite in their blood. Depending on patient's immune response length 
of asymptomatic period can vary. Acute and chronic filariasis manifests itself by lymph gland 
inflammation episodes and swelling of the limbs and usually accompanied by pulmonary 
eosinophilia, fever and malaise [20]. Typically, fevers caused by lymphatic filariasis is 
accompanied with headache and chills. 
 
The parasites causing Lymphatic filariasis can be eliminated from a patient’s system with 
proper treatment with antibiotics and anthelmintics. Treatment for lymphatic filariasis is 
administered in the form of prophylactic chemotherapy to the endemic population [21]. 
Patients suffering from muscle deformation caused by the disease may experience disability 
and reduced life quality [20]. While these patients can undergo surgery to improve their life 
quality, the muscle deformation will not be fully cured and will require lifelong care. There 
are no commercially available vaccines for lymphatic filariasis, although a vaccine reported 
in 2013 was found to be effective in a Rhesus macaque model although a human trial has not 
been reported yet [22]. 
 
1.1.2.2 Chikungunya treatment 
Chikungunya is a viral disease transmitted by Ae. aegypti females. Chikungunya Virus (CHIKV) 
is an Alphavirus [23]. Chikungunya was first described in 1952 in Tanzania and shortly after 
was identified in central and southern Africa as well [23]. Two outbreaks in Asia was recorded 
in 1958 and 1973 [23]. Following the 2004 outbreak in Kenya the virus spread to India and 
southeast Asia [23]. 
 
Chikungunya is diagnosed through serological tests and virus isolation for identification. The 
majority of Chikungunya patients recover fully but some may have symptoms persisting over 
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a longer time [23]. Chikungunya symptoms are fever, rash and severe aches in joints that 
usually progresses to a chronic stage [23]. More severe cases can cause extreme pain in 
hands, fingers and elbows hence debilitating patients [23]. Joint symptoms are typically 
characteristic to chronic form of the diseases [23]. Chikungunya is rarely fatal where it is 
mostly observed in elderly and new born. Approximately 50% of acute chikungunya patients 
have cutaneous manifestations in palms, soles of the feet, torso and face [23]. 
 
There is no specific treatment for Chikungunya [23]. In case of an infection, the symptoms of 
the disease are treated until it is cleared [23]. Although a commercial vaccine is not available 
there is a vaccine (MV-CHIKV) in phase II of clinical trials, started in August 2016 and expected 
to be completed by June 2018 [24]. In November 2018, Phase-II clinical trial of MV-CHIK was 
reported to be successful and Phase-III trials are currently being designed [25]. 
 
1.1.2.3 Dengue fever treatment 
Dengue virus (DENV) is a Falvivirus and Ae. aegypti females are the primary vector for it, 
although, it can be transmitted by other Aedes species as well [26]. DENV transmission can 
be found in Eastern Mediterranean, American, South east Asia Western Pacific and African 
regions [26]. Highest DENC infection is in Asian children between ages 5 and 15 followed by 
American tropics between the ages of 19-40 [26]. 
 
Dengue fever can be diagnosed through serological test and DENV can be detected in the 
blood prior to 1-2 days before the fever onset and the following 5-6 days [26]. Different 
phases of the disease can be detected through immunoglobin M (acute) and G (recovery) 
detection [26]. Typically, dengue fever lasts a week, although in this time frame the disease 
can rapidly worsen. Dengue fever can be categorised in three phases: acute febrile phase, 
critical phase and recovery phase. Symptoms manifest in the acute phase as fever, headache, 
body pain and vomiting [26]. Most patients enter the recovery phase within 5 days and the 
symptoms deteriorate [26]. Some patients, worse following the fever drop and enter the 
critical phase [26]. Patients in this phase can experience shock induced by plasma leakage. 
Symptoms of this shock includes coldness, weak pulse, tachycardia and hypotension[26]. 
Dengue fever is another disease where no specific treatment exists. All treatment methods 
are focused on relieving the symptoms.  
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About 3.9 billion people are at risk of Dengue infection [27]. The first Dengue vaccine was 
licenced in 2015 by Sanfoni Pasteur [28], [29]. The vaccine was deployed in highly endemic 
areas on conditional recommendation by 2016 [30]. In 2017, further analyses showed the 
vaccine to be highly effective only in people who had previously contracted the virus [30]. 
Moreover, and in contrast, if the vaccine was used prior to any DENV infection, the patient 
actually had a higher risk of severe Dengue fever upon DENV infection through a mosquito 
[30]. 
 
1.1.2.4 Rift Valley fever treatment 
Rift Valley fever virus (RVFV) is a Phelebovirus and transmitted primarily by Aedes females 
[31]. RVFV was first isolated in Kenya 1930 and is prevalent in Africa [32]. Recorded major 
outbreaks of RVFV were South Africa in 1950-19501, Egypt in 1977-1979, Mauritania in 1978 
and Madagascar in 1990 [31]. In year 2000 first outbreak outside of Africa was recorded in 
Arabian Peninsula [31]. Humans as a host for RVFV is considered to be dead, due to low 
amplification of virus in human hosts [31]. Hence, completing the life cycle of the virus 
through a human host is favourable. Nevertheless, humans can be infected through 
mosquitoes and cattle [31]. 
 
Similar to other diseases RVFV can be detected through serological test by means of 
Immunoglobin M and G detection although this is usually possible between 4 to 7 days after 
infection which is also the typical duration of the diseases. Rift Valley Fever can be observed 
in two forms mild and severe. Mild form being the most common, manifests symptoms of 
fever, muscle & joint pain and headache [31]. The severe form of the disease typically 
manifests 1 or more of the following 3 syndromes: eye disease (0.5-2% of patients), 
inflammation of cerebral tissue (<1% of patients) and haemorrhagic fever (<1% of patients). 
For mild forms of Rift Valley fever, no treatment is required [31]. In severe cases the 
treatment is in the form of supportive therapy where symptoms are treated while the 
immune system clears out the viral infection [31]. Rift Valley fever can also infect livestock, 
which can have a high economic impact [32]. 
 
A vaccine for humans does not exist, although, there are vaccines available for livestock. 
Since cattle is the primary host that complete the host-vector cycle, immunising cattle plays 
an important part in reducing the number mosquitoes with RVFV hence reducing the number 
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of infections in humans. Hence there is great interest in developing better vaccines for 
livestock which also help with reducing the number of infected humans [32].  
 
1.1.2.5 Yellow fever treatment & prevention 
Yellow fever virus is a Flavivirus and transmitted by Aedes and Hemagogus females [33]. 
Yellow fever endemic is endemic in South America (most notably Brazil) and central Africa 
[33]. The “Yellow” in Yellow fever refers to the jaundice caused by the liver damage [33]. 
 
Yellow fever diagnosis can be carried out by serological test by detection of Immunoglobiln 
M [33]. Yellow fever is an acute illness with symptoms; fever, nausea, vomiting, pain in torso 
[33]. Yellow fever can cause hepatitis with jaundice, renal failure, haemorrhage, shock and 
can lead to death [33]. There is no direct treatment for Yellow fever hence, only the 
symptoms are treated. It is the only disease in Table 1.1-2 for which an effective vaccine is 
available. A single dose of the vaccine can immunize a person for a lifetime [33]. 
 
1.1.2.6 Zika treatment 
Zika is caused by the Flavivirus zika virus (ZIKV) and is transmitted primarily by Ae. aegypti 
females [34]. Since it's firs known outbreak in 2007 in island of Yap, in the western Pacific, 
Zika virus was only recorded as epidemics [34]. Between 2007-2017 outbreaks were recorded 
in French Polynesia, south pacific & pacific islands, Brazil and Americas [34]. A survey 
conducted on the serological tests in French Polynesia showed 80% percent of the infections 
to be asymptomatic of which 30% were infants and 50% were adults [34]. 
 
ZIKV is diagnosed through serological tests where specific immunoglobin M antigens are used 
as a marker for the virus [34]. Due to immunoglobin M antigens not always being detectable 
complementary methods might be required for diagnosis and need to be carried out within 
the first 12 months of the infection [34]. Combination of urine analysis was shown to increase 
the detection rate ZIKV within the first week after onset of the symptoms [34]. ZIKV disease 
symptoms can appear between 3-12 days and are fever, joint pain, red eyes, headache and 
rashes [35]. There are no specific treatments available for Zika. During pregnancy, the Zika 
virus can be transmitted to the foetus which may cause birth defects such as microcephaly 
[36]. Following the relatively recent outbreak in Brazil, a reduction in Zika infections were 
observed. This is most likely due to the high media coverage the virus took in 2016, prior to 
the Olympics held in Brazil. As a consequence of the high media exposure, general public was 
 10 
more aware of and took precautions for Zika virus [37]. Currently, there are no commercially 
available vaccines for Zika. A few are in clinical trials, although the decrease in number of 
Zika infections may provide a challenge in completing the trials [38].  
 
1.1.2.7 Malaria treatment 
Malaria is caused by the parasites of the Plasmodium genus [39]. Malaria endemic regions 
can be found in Africa, Central & South America and South-East Asia. In 2016, Malaria caused 
an estimate of 445,000 deaths[5]. Within this genus severe human malaria is mainly caused 
by P. falciparum [40]. Anopheles females are the vectors for the disease.  
 
Gold standard for malaria diagnosis is investigating blood samples with light microscopy. 
Malaria disease can be categorised as uncomplicated or severe. This disease is mostly known 
for its severe cases which can be lethal; however uncomplicated malaria is treatable [41]. 
Uncomplicated malaria can be easily treated with anti-malarial drugs and manifests 
symptoms of fever, headaches, nausea and body aches [42]. The disease is mostly known for 
it severe malaria which can be lethal [42]. Severe malaria occurs when patient develops organ 
failures, blood and/or metabolic abnormalities [42]. Complications that can observed in a 
severe malaria patient are: impairment of consciousness, seizures, coma, anaemia, 
respiratory distress, low blood pressure, high acidity in the blood and low blood glucose [42]. 
 
Antimalarial drugs and treating the symptoms are the current way to deal with malarial 
infections [41]. However, resistance to antimalarial drugs is increasing [43] and so there is 
significant interest in preventing infection in the first instance. Currently there is only one 
vaccine that has shown preventative results, RTS,S/AS01 [44]–[46]. In clinical trials 
RTS,S/AS01 demonstrated an efficacy of approximately 20-45% when given four doses (up to 
6 in babies) [44]. Although there is a potential vaccine in trials there is a challenge with the 
vaccine’s receptivity. It has been reported that community engagement was inadequate due 
to lack of information about the vaccine [45]. Moreover some studies highlighted the fear of 
vaccine's side effects [45]. Additionally, inefficient delivery to children and low quality health 
service [45]. 
 
1.2 Mosquitoes An. gambiae and Ae. aegypti 
Mosquito species of the Culicidae family can be found in fresh or salt-water marshes, 
mangrove swamps, rice fields, grassy ditches, the edges of streams as well as in small 
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temporary water collections [1], [2]. Even though some species may prefer certain breeding 
sites over the others, overall most water bodies can become a breeding site for mosquitoes. 
The life cycle of the different mosquito species is well conserved. Although there are 
differences between species, all mosquitoes go through a life cycle that comprises three 
aquatic (egg, larva & pupa) and one terrestrial (adult) stage (Figure 1.2-1).  
 
 
Figure 1.2-1: Mosquito life cycle through four main stages. The first three stages are in an aquatic environment 
(egg, larvae, pupa) followed by an adult stage in the terrestrial environment. Four instar stages make up the larvae 
stage progression. Eggs are typically laid on water bodies, although some species’ eggs undergo quiescence which 
allows them to lay eggs on moist soil. Typically, eggs hatch within three days. The larval stage is a mobile stage, 
where larva swim and look for food. Through a series of moulting, larvae go through four sub-stages called instars. 
Each instar takes roughly three days. After the fourth instar, a pupa develops from each larva. The pupal stage is 
the last aquatic stage, where the pupae are still mobile in water. In this stage they do not feed, but stay close to 
the surface to breathe. Typically, in three days, adult mosquitoes emerge from the pupal casing. After a brief 
period of drying, they start to fly. Adult mosquitoes spend the rest of their life in a terrestrial environment. Upon 
successful mating, females return to a suitable breeding site to lay eggs, thus completing the life cycle. 
 
Female mosquitoes lay between 50-200 eggs per oviposition [2]. Generally, mosquito eggs 
can be divided in to two groups depending on whether they enter a quiescence or not [2]. 
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Egg quiescence is also known as embryonic desiccation resistance (EDR) and depends on a 
variety of factors such as eggshell structure & composition and metabolic activity of the 
larvae reside within the egg [47]. There are 3 layers to the egg shell critical for EDR: serosal 
cuticle (inner layer), endochorion (middle layer) and exochorion (outer layer) [47]. The 
serosal cuticle secretes a coating material under the chorion layer containing chitin which 
protects the embryo from desiccation. Additionally, changes in the abundance of the eggshell 
components such as hydrocarbons affects the water loss regulation [47]. Higher chitin 
content in eggshells increase desiccation resistance [47]. 
 
Species where eggs do not go through quiescence are laid directly on water [48]. Depending 
on the species, these eggs may be laid singly, in small groups (Figure 1.2-2), or in a raft form 
[49]. These eggs start their development immediately after oviposition, and hatch 2-7 days 
later depending on temperature. Species laying eggs who enter quiescence do not lay directly 
on water [2]. These eggs are laid singly on moist soil, which floods when water levels rise. 
During the quiescence, the eggs are protected against desiccation that may be caused by the 
arid conditions or elevated temperature [47]. 
 
 
Figure 1.2-2: Ae aegypti eggs are laid singly or in small groups. These can undergo quiescence, which makes them 
more resistant to desiccation compared to Anopheles eggs. During quiescence, the eggs wait for environmentally 
optimal conditions to start developing. This type of egg is not required to be directly laid on a water body. Picture 
taken by me. 
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Larvae hatch from the eggs and remain in the water in order to feed on algae, bacteria and 
other microorganisms. As for all insects, the larval body has three distinctive sections; head, 
thorax and abdomen. The larvae live underwater but use their respiratory siphons (except 
Anophelines) for breathing [2]. Larvae moult four times before reaching the pupal stage. Each 
one of these moulting periods is called an instar. Throughout the last instar and pupal stage, 
the adult exoskeleton develops internally. Just like egg development, larval development is 
temperature dependant and can last 6-23 days [2]. 
 
After the fourth instar, the larvae grow into pupae, with the pupal stage being the last aquatic 
stage before emerging into adult mosquitoes. Pupae possess two respiratory trumpets that 
are used for breathing and, when at rest, the pupae float with the trumpets breaking the 
water surface for respiration (Figure 1.2-3) [2]. Unlike many other insects, mosquito pupae 
are very mobile and relatively resistant to desiccation, with mosquito pupae not needing to 
feed [2]. The pupal stage usually takes 2-3 days, although this can be longer or shorter 
depending on the environmental temperature [2].  
 
 
Figure 1.2-3: Close up of an Ae. aegypti pupae, collected for transferring into emergence cage. Above the labelled 
pupa, three pupae can be seen with their trumpets breaking the water surface tension while breathing. The 
labelled pupa is resurfacing passively after a dive. Picture taken by me. 
 
During the pupal stage, metamorphosis occurs and this is where some of the key processes 
for adult formation take place. Upon metamorphosis, larval organs that are no longer 
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required are broken down by a process known as histolysis [2]. The fat body of the larva is 
transferred to the adult abdomen. The fat body is used as a source of vitellogenines 
(precursor protein of egg yolks) for autogenous egg formation. At this stage, numerous 
morphological changes take place [2]. The pupal thorax and head are united into a 
cephalothorax [2]. The chephalothorax also carries the pupal respiratory trumpets to provide 
the adult mosquito with oxygen [2]. Both male and female pupae go through these changes 
and spend the same time in the pupal stage [2]. Although morphologically different under a 
microscope, the developmental progression from pupa to adult is almost identical for males 
and females [2]. 
 
At the end of the final metamorphosis stage, an adult mosquito emerges. To emerge, the 
adult mosquito swallows air to expand its thorax. This expansion causes the pupal cuticle to 
rupture, allowing the adult mosquito to emerge [2]. Once emerged, the cuticle of the 
mosquito is still soft and starts hardening (sclerotisation) within a few minutes after 
emerging, allowing adult mosquitoes to fly [2]. Due to the difference in maturity between 
male and female adult mosquitoes, males emerge 1-2 days before females. During this time 
(typically 24-48 hours) males reach sexual maturity [2]. Post-eclosing, female mosquitoes are 
already sexually mature [2]. Although there is a difference between the adult emergence, 
both spend the same time as pupa, this means the shortening of development time takes 
place in the larva stage [2]. Between different mosquitoes species, the aquatic stages are 
quite similar, although very distinctive morphological differences can be observed in adults 
even by the naked eye. 
 
1.2.1 Anopheles gambiae adult 
Anopheles adults (Figure 1.2-4) are quite distinctive from the Aedes species. Anopheles 
species possess brown pigmentation and can be easily identified by their distinctive linear 
posture [1]. In their resting position, an Anopheline will form a declining straight line from 
the end of the abdomen to the tip of the proboscis. Anopheles females lay their eggs singly 
or in small groups and directly on water bodies and An. gambiae prefer humans for blood 




Figure 1.2-4: Close up picture of a mature adult An. gambiae male on An. gambiae eggs. The distinctive Anopheles 
resting position can be seen from the straight line from the end of the abdomen to the top of the proboscis. 
Picture taken by me. 
 
1.2.2 Aedes aegypti adult 
Aedes adults (Figure 1.2-5) are quite distinctive with their black colour and white spotted 
pattern across their bodies. Compared to the Anopheles species, in their resting position they 
form a roof rather than a straight line. Starting from the end of the abdomen to the 
scutellum, they form an inclining straight line followed by a declining line from the end of 
thorax to the tip of the proboscis. Aedes females lay their eggs singly or in small groups and 
can lay eggs on either water bodies or moist soil. Depending on species, female Aedes species 




Figure 1.2-5: Close up picture of an adult Ae. aegypti male. Distinctive Aedes pigmentation of black with white 
spots can be seen throughout the body and legs. Another distinctive Aedes feature is the body forming a roof 
shape which can be observed at the thorax. 
 
1.3 Insecticides, mechanisms and resistance 
1.3.1 Insecticides 
Insecticides are compounds used for killing insects. They are often stage-specific such as 
ovicides and larvicides, which are targeted at eggs and larvae, respectively. The majority of 
insecticides target either the peripheral nervous system (PNS) or the central nervous system 
(CNS) [50]–[52]. Table 1.3-1 shows the most common insecticide groups and their targets. 
Targeting the nervous system is a very effective way of eliminating mosquitoes due to the 
irreversible effects caused [51], [53]. 
 
One of the most well-known insecticides is the organochloride Dichloro-diphenyl-
trichloroethane (DDT). It gained popularity as a preventative treatment and has been used 
to eradicate malaria in western countries such as UK, mainland Europe and USA. However, 
its use has not been without controversy and whilst DDT was widely used between 1940-
1970s, it was eventually banned due to its negative effects on wildlife [51]. Some countries 
still use DDT, but the majority have converted to more environmentally-friendly insecticides 
such as the pyrethroids, deltamethrin and permethrin. 
 




system Target Mode of action References 
Carbamates CNS Acetylcholinesterase Inhibits acetylcholinesterase, 
causes exhaustion and tetany 
[54] 
Neonicotinoids CNS Nicotinic 
Acetylcholine 
receptors 
Activates Nicotinic acetylcholine 
receptors, cause exhaustion 
[55] 
Organochlorides PNS Sodium Channels Keeps sodium channels open 
causes seizures  
[51] 
CNS GABAA receptors Binds to GABAA receptors, 
depresses central nervous system 
[51] 
Organophosphates CNS Acetylcholinesterase Inhibits acetylcholinesterase, 
causes exhaustion and tetany 
[54] 







Binds to ryanoid receptors to lock 
calcium channels, causes calcium 
depletion and death. 
[56] 
CNS, central nervous system; PNS, peripheral nervous system 
 
Currently, the most used insecticides are pyrethroids. These are insecticides derived from 
the naturally occurring compound pyrethrum. Pyrethroids are favoured due to being less 
toxic for mammals and the environment. Insecticides of this class target the sodium channels 
in the PNS. 
 
1.3.2 Common targets, mechanisms and their usage 
Most insecticides target the nervous system and their lethal effects are due to the fact that 
the nervous system is generally irreversibly damaged. Even though an insecticide might 
target another organ, it is the nervous system that is ultimately affected. Most insecticides 
target the CNS and PNS although, in recent years, the muscular system has also been 
targeted.  
 
1.3.2.1 Central nervous system (CNS) 
CNS is a widely exploited target in insecticide development. The insect CNS is analogous to 
the mammalian CNS. Acetylcholine was established to be the neurotransmitter in insect CNS 
synapses [57], although ɣ-aminobutyric acid (GABA) [58] is also a key neurotransmitter found 
in the insect CNS. Insecticides targeting the CNS mostly inhibit the acetylcholine esterase, 
preventing the breakdown of acetylcholine. When this occurs, acetylcholine remains 
continuously active, causing exhaustion, tetany and eventually death [51]. 
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1.3.2.2 Peripheral nervous system (PNS) 
PNS is another widely exploited target for insecticidal activity. PNS comprises all the sensory 
neurons that are not bundled to the CNS. Within the PNS, the most targeted proteins are of 
the Na+ channels [51]. These channels depend on a finely tuned system of Na+ and K+ 
turnover. Insecticides interacting with the Na+ channels cause delays on the closure of the 
Na+ channels [51]. This delay changes the resting potential of the neurons. This perturbation 
demands more energy, which can often cause paralysis followed by death. 
 
1.3.2.3 Muscular system 
Insecticides affecting the muscular system are targeted towards the Ca2+ channels in the 
sarcoplasmic reticulum [59]. When affected by the insecticides, Ca2+ ions are rapidly exported 
to the cytoplasm [59]. This leads to muscle contraction and paralysis [59]. The insecticides in 
this class have near to zero toxicity to mammals, although a 1995 study revealed an 
interaction with K+ channels on mouse models with certain compounds of this class of 
insecticides [60]. 
 
1.3.3 Insecticide resistance and their mechanisms 
Insecticide resistance in adults is detected using a response-to-exposure test [61]. An 
illustration of this test is shown in Figure 1.3-1. This test is conducted using seven chambers 
(where five are used for testing and two for controls) in an insectary. Each chamber is filled 
with 20 female mosquitoes and left for an hour. After an hour, dead mosquitoes are replaced. 
Each chamber is then fitted with an insecticide impregnated paper (oil for control). After 
exposing the mosquitoes for an hour, impregnated papers are removed. Mosquitoes are 
then left for 24 hours to recover in the insectary. Post recovery, dead mosquitoes are 
recorded. The number of dead mosquitoes are summed and expressed as a percentage of all 
the mosquitoes tested (controls calculated separately). If the mortality of controls is less than 
or equal to 5%, mortality of test mosquitoes can be interpreted without correction. If control 
mortality is between 5-20%, the mortality of test mosquitoes needs to be corrected using 
Abbot’s formula [62] to account for the natural mortality rate in the mosquito strain tested. 
Control mortality higher than 20% indicates the test needs to be discarded and repeated. 
Interpretation of the test mortality is as follows: higher than or equal to 98% indicates 
susceptibility, between 97-90% indicates resistance and further tests are required and less 




Figure 1.3-1: Determination of insecticide resistance in adults via WHO protocol [61]. In an insectary, seven 
mosquito chambers are set up with 20 female mosquitoes in each. Five chambers (red) are fitted with insecticide 
impregnated paper and two chambers (blue) are fitted with oil impregnated paper as control. Mosquitoes are 
exposed to insecticides for one hour and then transferred to clean new chambers with a mesh-screen. A pad of 
cotton-wool soaked in 10% sugar water solution is then placed on each mesh-screen and the mosquitoes are left 
to recover for 24 hours. After 24 hours, the number of dead mosquitoes are recorded. The number of dead 
mosquitoes in the treated chamber are summed up and expressed as a percentage of total number of tested 
mosquitoes and the same is done for the controls. A mortality rate higher than or equal to 98% indicates 
susceptibility, between 90-97% indicates possible resistance and requires a repeat of the test and mortality less 
than 90% indicates confirmed resistance. If mortality in the controls are less than or equal to 5% the test does not 
require any correction. Between 5-20% requires correction with Abbot’s formula. Control mortality higher than 
20% requires the discarding and the repeat of the test. 
 
The response-to-exposure test informs on the resistance status. There can be multiple 
mechanisms causing the resistance, such as behavioural resistance, target site mutation, 
metabolic resistance and cuticular resistance.  
 
1.3.3.1 Behavioural resistance 
Behavioural resistance can be defined as a change in the behaviour of the mosquito affected 
by pesticides, compared to their regular behaviour [63]. These individuals show a trend to 
avoid pesticide treated areas and prefer to fly to the pesticide free zones. Thus, avoiding 
contact with pesticide treated surfaces [63]. Behavioural resistance has been recorded by 
multiple studies [63]–[66], reporting the recognition of pesticide treatment followed by 
avoidance of these zone. This has been argued to be one of the reasons for the decline of the 
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effectiveness of insecticides. However, due to the nature of behavioural studies, designing 
and executing experiments to test this hypothesis has proven to be a major challenge. 
 
1.3.3.2 Target site mutation 
Another resistance mechanism that arises through overuse of insecticides is target site 
mutation. In target site mutation resistance, a point mutation in the targeted enzyme causes 
the insecticide less favourable or impossible to bind to the targeted enzyme. This causes the 
insecticides to be excreted as waste material [67]–[71]. 
 
1.3.3.3 Metabolic resistance 
Metabolic resistance is caused by the fast metabolic breakdown of the insecticides. In this 
resistance mechanism, the insecticides taken up by the mosquito are rapidly broken down to 
non-toxic compounds and excreted. Although this may not be as efficient a mechanism as 
target site mutation (where the insecticide cannot activate the lethal mechanism it is 
designed to), with metabolic resistance the lethal concentration is not reached since the 
insecticides are rapidly broken down. Extreme dosage use can still be lethal, although, at 
these extreme doses the insecticides become toxic to other organisms where the insecticide 
applied as well [70]–[72]. 
 
1.3.3.4 Cuticular resistance 
The cuticular layer, also known as the exoskeleton, is the outermost layer of an insect. The 
majority of insecticides targeting adult mosquitoes reach their target by penetrating this 
layer. The cuticular layer is comprised of epicuticle, exocuticle and endocuticle.  
 
Epicuticle forms the outer most layer of the cuticle and is typically 1-4 µm in thickness [73]. 
A detailed composition of this layer is difficult to elucidate but it is known to contain 
sclerotized proteins, lipoproteins, lipids, waxes and a shellac-like substance (similar to resin) 
[73]. This layer forms the outer most barrier to the cuticle. Underneath epicuticle is the 
procuticle which is formed by exocuticle (top) and endo cuticle (bottom) [73]. Exocuticle is a 
hard and sclerotized layer containing chitin and proteins. Endocuticle is mainly composed of 
hydrocarbons, proteins, lipids, wax esters and free fatty acids [73]. Hydrocarbon types that 
can be observed in this layer are n-alkanes, methyl-branched alkanes and unsaturated 
hydrocarbons [72]. Endocuticle also contains chitin and proteins although due to lesser 
sclerotization it is softer and more flexible in comparison [73]. 
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Epidermis is a layer comprised of epidermal cells underlying the cuticle. Insecticides 
penetrating through this layer reaches the basal lamina which have pores facilitation access 
to haemolymph [73]. 
 
Cuticular resistance refers to the changes in thickness and/or composition of the [74], [75]. 
Figure 1.3-2 shows an illustration of how different cuticular layer structures can affect the 
uptake of insecticides.  
 
 
Figure 1.3-2: Insecticide penetration efficacy on different cuticular layers. In the susceptible cuticle, insecticide 
penetrates as intended and is absorbed through the epidermis. In the altered cuticle layers Resistant1 (thicker 
epicuticle), Resistant2 (thicker endo-cuticle and exo-cuticle) and Resistant3 (change in cuticular layer 
composition), insecticide resistance is considerably greater than the susceptible cuticle (adapted from [74]). 
 
The cuticular layer of a susceptible species is more permeable to insecticides. When the 
cuticular layer is altered by means of thickening of layers and/or alteration to the 
composition of the layers, the permeability to insecticides is reduced [76]. In this case, if a 
lethal dose insecticide was applied, only a small fraction of the insecticide penetrates the 









In current insecticide resistance research, behavioural resistance is still treated with caution. 
Showing evidence of insecticide avoidance has proved to be a major challenge. Both 
metabolic resistance and target site mutation are very well studied and characterised with a 
wide repertoire of studies covered in numerous reviews [68], [70]. Cuticular resistance is a 
more recent discovery and as such requires further investigation [75], [77]. 
 
1.4 Cuticular Hydrocarbons (CHC) 
1.4.1 CHC in mosquitoes and their functions 
Mosquito integument is formed from three elements: cuticle as the outer layer, epidermis, 
and basement membrane [1]. The integument functions both as a protective layer for the 
organs and as a rigid exoskeleton for the muscles to bind to [1]. This integument also serves 
as a barrier for water loss [78]. The outermost layer of the integument is the cuticle and it is 
first line of the mosquito’s defence against both living threats (such as fungi, bacteria and 
parasites) and non-living threats (such as insecticides). In some insects, the cuticle also serves 
an instrument of communication which facilitates the selection of mating partners [79], 
communication of caste [80], swarm [81], and autotoxicity [82]. Evidence of similar functions 
been shown in mosquitoes [83]–[85] although overall their function is known to a lesser 
extent. 
 
The outermost section of the cuticular layer comprises a variety of long chain alkanes, 
branched alkanes, alkenes, waxes and esters. Chung and Carroll [86] have shown CHCs with 
higher melting temperatures (Tm) directly correlate with waterproofing properties, whereas 





Figure 1.4-1: Examples of typical mosquito CHCs and their function in relation to Tm. CHCs are typically made of 
16-37 carbons (adapted from Chung & Carroll, 2015). 
 
1.4.2 CHC in insecticide resistance 
Adult mosquitoes can come into contact with insecticides in one of two ways. Either the 
insecticide molecules in the air land on the mosquito’s body or the mosquito lands on an 
insecticide-impregnated surface and insecticide is contacted through the tarsus (lower 
section of the leg, Figure 1.2-5). Between the two, the latter is the most common form of 
exposure to insecticides due to their application regimen. Upon interaction, insecticides 
penetrate the cuticular layer down to the epidermis and eventually make contact with the 
target proteins. In mosquitoes with cuticular resistance, this process is either slowed down 
and/or altered. 
 
A 2012 study by Qiu et al [87] investigated CHC biosynthesis in insects. In their search for a 
candidate aldehyde oxidative decarbonylase cytochrome P450 (CYP), they identified CYP4G 
subfamily as being present in every insect genome. From microarray data Cyp4g1 was 
identified as the most highly expressed of all CYP genes in D. melanogaster. Furthermore, 
they identified Cyp4g2 as the closest homologue in Musca domestica which was used to show 
the decarbonylase activity in vitro [87]. 
 
A study conducted in 2016, assessed insecticide penetration in An. gambiae using 14C 
deltamethrin [75]. The study showed that resistant species had slower uptake of 
deltamethrin. In the same study, this result was followed up by electron microscopy which 
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measured the thickness of the cuticular layer from a femur cross-section. It was found that 
the resistant species  had a significantly thicker epicuticle (2.13 ± 0.32 μm) than the 
susceptible species (1.873 ± 0.30 μm). In the same study they identified Cyp4g16 and 
Cyp4g17 as potential paralogues of Cyp4g1 and Cyp4g2 [75]. 
 
1.4.3 CHC Biosynthesis 
CHC composition varies between different insects. For example, in Drosophila CHCs differ 
between the species and within Drosophila melanogaster different CHC profiles can be seen 
between males and females [86]. Despite numerous different configurations, insect CHC 
biosynthesis is very well conserved [88]. CHCs are synthesised in the oenocytes which are 
secretory cells that are characteristic of insects. Between different species, the oenocytes 
can be found in different locations; in mosquitoes they are mostly found in the abdomen. 
Oenocytes work together with the fat body to secrete components of the cuticular layer, 
which is followed by transportation to the cuticle via lipophorins [88]. 
 
CHC synthesis is a diverse set of reactions (Figure 1.4-2) with a wide range of end products. 
Within the oenocytes, CHCs are synthesised in the endoplasmic reticulum. It has been shown 
that acetate is a common precursor of CHC biosynthesis via labelled acetate studies in D. 
melanogaster [89]. The proportion of labelled acetate derived carbons was found to be equal 




Figure 1.4-2: General CHC biosynthesis pathway in insects. In each pathway, malonyl-CoA (non-branched) and/or 
methyl malonyl-CoA (methyl branched) are used for hydrocarbon elongation. Double arrows represents omitted 
multiple steps. A) Biosynthesis of methyl-branched alkanes (purple) from valine, isoleucine, succinyl-CoA, and 
acetyl-CoA. 16-20 carbon methyl-branched fatty acyl-CoA are elongated to very long chain (VLC) methyl-branched 
fatty acetyl-CoA. Prior to producing the final product, CoA is cleaved off by a reductase and finally the carboxyl 
group is decarboxylated via CypP450. B) Shows the production of alkenes (yellow) starting with an Acetyl-CoA as 
a head group. The HC chain is elongated using malonyl-CoA and elongase with each elongation step requiring 
NADPH for the elongase to catalyse the reaction. The final product, (Z)-9-tricosane, is decarboxylased via 
CypP450. (Z)-9-Tricosane can also be used as a starting material for further alkene biosynthesis. DESAT: 
desaturase, Hyd: hydrocarbon, Al: aldehyde. C) Biosynthesis of even chain length (ECL) 2-methyl branched alkanes 
(red) ɣCH3 of valine becomes the 2-methyl branch in the final product where elongation is done by addition of 
malonyl-CoA. D) Biosynthesis of odd chain length (OCL) 2-methyl branched alkanes (blue) ΔCH3 of leucine becomes 
the 2-methyl branch in the final product where elongation is done by addition of malonyl-CoA. E) Biosynthesis of 
n-alkanes (green) acetate is used to produce appropriate length fatty acyl-CoA which are then elongated using 
malonyl-CoA. Figure adapted from (Howard & Blomquist, 2005). 
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In order to synthesise n-alkanes, appropriate length fatty acyl-CoAs are elongated using 
acetate in the form of malonyl-CoA [90]. Acetate is converted acetyl-CoA via acetyl-CoA 
synthase [91] which is then carboxylated to malonyl-CoA by acetyl-CoA carboxylase [92]. Post 
elongation, a decarbonylation step catalysed by a CYP yields the final product  which has one 
less carbon than the elongated precursor [90]. Branched alkanes are synthesised in a manner 
similar to n-alkanes. In order to create the branching, malonyl-CoA is substituted with 
branched amino acid (valine, leucine and isoleucine) derivative methylmalonyl-CoA [93]. 
Biosynthesis of even chain length 2-methylalkanes starts by converting valine to isobutyrate 
and for odd chain length leucine  to isovalerate [94]. 
 
The biosynthesis of alkenes follows the same process as that of the n-alkanes and methyl-
branched alkanes, with the addition of fatty acyl-CoA desaturases. The majority of insects 
have the enzyme ∆9-desaturase hence insect alkenes predominantly have the double bond 
at the 9-position [88]. Studies on the desaturases in D. melanogaster characterised two 
proteins, desat1 and desat2, which take part in the biosynthesis of 7,11-double bonds and 
5,9-dienes, respectively [88].  
 
Prior to the final step, HC-CoAs are reduced to HC-aldehydes via reductases. Studies on D. 
melanogaster and An. gambiae show the decarbonylation of the HC-aldehyde via CYP 
decarbonlyases [75], [86]. Decarbonylation enzymes are highly conserved between species 
and are found as paralogues [95]. Enzymes catalysing the previous steps of HC biosynthesis 
are found as multicopy and specific isoforms are expressed in oenocytes [96]. The common 
decarbonylation step in the CHC synthesis pathway is an ideal target to probe CHC production 
using metabolomics.  
 
1.5 Cytochrome P450 (CYP)  
CYPs are a heme-binding, electron transferring, superfamily of proteins. CYP contain a wide 
range of families of enzymes which take part in numerous reactions, ranging from drug 
metabolism & detoxification to fatty acid biosynthesis. CYPs can be found throughout the 
domains of archaea, eukarya, bacteria and viruses [95], [97]. Although they have a wide 
range of substrates, CYPs have an overall conserved fold which gives this superfamily its 
conserved mechanism for a wide range of reactions [95]. The majority of CYPs catalyse 
monooxygenation [97] reactions and can be generalised as: 
RH + O2 + NADPH + H+ à ROH + H2O + NADPH+ 
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In this reaction, a hydroxyl group is incorporated to R following donation of an H+ from 
NADPH to the monooxygenase enzyme. After the monooxygenation, remaining oxygen is 
reduced to H2O. CYP enzymes require a redox partner and are generally divided into two 
major classes. Class I CYPs comprise mitochondrial and bacterial P450s that use two unique 
redox partners involving an iron-sulphur protein and a flavin-containing reductase making a 
three component system [95], [98]. Class II CYPs are microsomal monooxygenases and 
partner with NADPH-cytochrome P450s oxidoreductase (POR) for supply of electrons 
required for monooxygenation, thereby creating a two-component system [97], [98]. The 
overall structure of CYPs is quite conserved. When different CYP structures compared, 
majority of the differences come from ligand binding sites. In contrast the heme-binding sites 
are highly conserved [95]. In eukaryotes, CYPs are generally bound to the endoplasmic 
reticulum membrane [95]. 
 
1.5.1 CYPs of mosquitoes  
Microarray and transcriptome studies conducted on vector insects have shown 
overexpression of CYP4, CYP6, CYP9, CYP12, CYP305, CYP307, CYP314 and CYP325 families in 
insecticide-resistant populations [99]–[105]. Genomic and transcriptomics studies on CYPs 
have shown that CYP4G genes are insect-specific [106]. In 2011, a study on the mosquito 
species Culex quinquefasciatus identified a total of four families in the completed genome: 
CYP2, CYP3, CYP4 and mitochondrial [107].  
 
The majority of the studies on resistant mosquitoes mainly focus on target site mutations 
and metabolic resistance [52]. In these studies, members of CYP6 and CYP9 families are 
usually flagged as key components of these resistance types due to their roles in 
detoxification mechanisms [108]–[111].  
 
In recent years however, there has been more interest in the cuticular resistance. Studies 
focused on genomics and transcriptomics have highlighted the importance of the CYPs 
associated with cuticular layer biosynthesis [74], [75], [87] (Section 1.4.1). 
 
The CYP4 family catalyses hydrocarbon biosynthesis and metabolism. Enzymes of this family 
mainly act as monooxygenases, but there are members that act as decarbonylases [95] 
(Figure 1.5-1). Several studies have shown overexpression of CYP4 enzymes in mosquito 
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species with cuticular resistance along with some target site mutation resistance [75], [87], 
[112]. In 2012, a study conducted on D. melanogaster and Musca domestica [87] targeted 
two CYPs active in the final step of CHC biosynthesis (~C21-C37+ length). In this study, Qiu et 
al used a Gal4-UAS system to create a Cyp4g1 knock-down line of D. melanogaster [87]. 
These knock-downs resulted in a reduction of CHCs and high mortality rates in post larval 
stages [87]. In the same study, the orthologue Cyp4g2 (M. domestica) was expressed as a 
recombinant protein in Saccharomyces cerevisiae and its decarbonylase activity was 
determined in vitro [87]. Similar results regarding the number of deaths in knock-down 
strains were recorded by other studies [113]–[115]. Qiu et al proposed the use of the CYP4 
family of enzymes as a target for insecticide resistance [87]. 
 
 
Figure 1.5-1: Generalised form of CHC production through CYP-P450, where a decarbonylation step taking place. 
The majority of CYP-P450s perform a decarboxylation (adapted from Qiu et al, 2012). 
 
1.5.2 Cyp4g16 and Cyp4g17  
Cyp4g16 and Cyp4g17 are the closest An. gambiae paralogues of the previously mentioned 
Cyp4g1 and Cyp4g2 enzymes [75]. Currently, there are no deposited structures of Cyp4g16 
and Cyp4g17. A 2016 study by Balabanidou et al has demonstrated that Cyp4g16 and 
Cyp4g17 are two critical CYPs in the CHC pathway and are found to be up-regulated in 
insecticide resistant species [75]. Both Cyp4g16 and Cyp4g17 are localised to the oenocytes, 
with immunohistochemical experiments showing Cyp4g16 to be localised to the plasma 
membrane and Cyp4g17 to around the cell nucleus, the latter suggesting an association with 
the endoplasmic reticulum [75]. 
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Studies on CHCs and their related enzymes typically take a more direct approach, such as a 
labelled trace study or expression of the enzyme to demonstrate its properties in vitro. 
However, these approaches may not be suitable for every case. For example, the expression 
of Cyp4g16 and Cyp4g17 in the work by Balabanidou et al was only successful for Cyp4g16 
[75]. The function of Cyp4g17 was predicted due to their high similarity [75]. Although 
expression of Cyp4g17 was unsuccessful, it is possible to create knock-down lines of this 
enzyme. A different approach to such a case is the metabolic profiling of these knock-down 
lines in order to investigate CHC biosynthesis precursors. Such an approach would be ideal 
with metabolomics methods. 
 
1.6 Metabolomics  
1.6.1 Metabolomics in science 
Metabolites are small biological molecules, typically less than 1500 Da which are often 
intermediates or products of biological processes [116]. Metabolites also have roles in the 
regulation of certain processes as signals and/or checkpoints [117]. By measuring metabolic 
perturbations, information on biological processes can be recorded or inferred. 
 
Metabolomics is an application of analytical chemistry. Employing analytical methods to 
determine the abundance, relative or absolute, of a molecule predates the term 
metabolomics. Emergence of the field of metabolomics coincided with advances made in 
spectroscopic, mass spectrometry and chromatographic methods, allowing samples to be 
analysed in a high sensitivity, high resolution and high throughput manner [117]. Since its 
emergence in the early 1970s, metabolomics has been applied to many areas of biological 
research including microbiology, oncology, agriculture, animal studies and insect biology. 
Taking its strength from identification and quantification of a range of metabolites 
simultaneously, metabolomics applications are varied and include diagnostics, disease 
progression, disease mechanism elucidation, biomarker discovery, personalised medicine, 
cell biology and experimental condition comparisons. 
 
1.6.2 Core concept  
Metabolomics is the study of small molecules in a system via quantification, be it relative or 
absolute. By quantifying metabolite levels, a metabolic profile (chemical phenotype) is built. 
This profile is then compared to another profile built under a different experimental 
condition [118] for example wild type v knock-down or treated v untreated. This comparison 
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allows investigation of processes governing the biological system in question. 
Complementary to other “-omics” techniques (genomic, transcriptomics and proteomics) 
(Figure 1.6-1), metabolomics focuses on the precursor and product material in biochemical 
reactions [118]. Ultimately, the metabolites reflect the bio-processes that the system has 
achieved at any time point, building upon the information from potential processes reported 
in proteins and transcripts. Furthermore, metabolomics can infer information on the most 
predominant processes, which is not possible from protein levels alone. 
 
 
Figure 1.6-1: General properties of all -omics techniques. Comparing the human coverage of each technique, 
metabolomics has a rather large set with 114,000 metabolites compared to the estimated 25,000 genes, 100,000 
transcripts and 1,000,000 proteins [117], [119]. 
 
In simple terms, genomics creates the potential map of an organism, showing all the 
pathways that could be taken in different conditions [118]. Transcriptomics uses the 
genomics data in order to identify the genomic instructions being executed [118]. The degree 
of execution is reflected in terms of the number of each transcript expressed. Transcripts 
provide the genetic code that directs production of proteins, which in turn catalyse the 
chemical reactions producing or regulating metabolites. Proteomics identifies and quantifies 
proteins in a system which yields information on active processes in the system [118]. Every 
chemical reaction starts with substrate/precursor molecules and ends with product 
molecules. Metabolomics monitors the abundance of these molecules, thereby reporting on 








































1.6.3 Approaches in metabolomics studies 
Metabolomics research typically follows one of two approaches; targeted or non-targeted 
[120]. A targeted approach is preferable for the measurement of a small and specific set of 
metabolites which are expected to change between experimental conditions. Studies of a 
targeted nature are inherently easier to quantify, although, making assumptions on the 
whole system beyond the measured metabolites is considerably harder or simply not feasible 
in some cases. Another downside of targeted metabolomics is that these studies may ‘miss’ 
the knock-on effects of seemingly disparate processes [120]. Non-targeted metabolomics, 
sometimes called “discovery” metabolomics, aims to identify and measure as many 
metabolites as possible. This approach is ideal when comparing experimental conditions 
and/or identifying metabolic changes. However, it should be noted that mapping 
metabolomics information back to biological processes is only as good as the information 
and databases available on the organism of interest [121]. 
 
The choice of approach is dependent on the research question and compromises between 
metabolite coverage and precision. A system-wide approach such as investigating all the 
metabolites in a cell culture or a urine sample will give rise to a rich and complex metabolite 
profile, but quantification will be challenging. However, looking for several specific 
metabolites would be easier to quantify but as the coverage is very narrow, certain processes 
would not be reported. 
 
1.6.4 Metabolomics workflow 
For an effective metabolomics workflow (Figure 1.6-2), careful consideration of the biological 
rationale is essential, with a clear understanding of what information metabolomics will 
generate [118]. This is followed by careful experimental design which must consider and 
mitigate specific limitations of the study, as metabolites susceptible to any change in 
experimental design which will severely effect study outcomes. Due to the statistical nature 
of the analysis, consistency is a very critical part of metabolomics studies. Following the 
biological experiments, samples are carefully collected and prepared for the required 
analytical platform. Depending on the experimental design, sample preparation might 
include a chemical extraction [118]. Following sample preparation, data is acquired using the 
appropriate platform. Data is then checked for quality; this step ensures the data was 
acquired to the desired standard and helps with identification of required repeats. Prior to 
statistical analysis, the data is checked for outliers and artefact data points. Cleaned data is 
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then subjected to robust statistical analysis. Finally, the important findings identified through 
statistical methods are contextualised biologically. Attributing metabolite changes to 
biological processes is often the most challenging part of the metabolomics workflow [116]. 
 
 
Figure 1.6-2: Typical Metabolomics workflow. Alternating dashed line represents the iterative step where samples 
failing the quality control are repeated. Uniformly dashed line represents optional routes, which might be 
required depending on the experimental design and research question. 
 
1.6.5 Techniques in metabolomics - advantages and disadvantages  
Metabolomics methods can be categorised under two general groups: analytical and 
statistical. The analytical techniques utilised in metabolomics are some of the most common 
tools used in analytical chemistry: mass spectrometry (MS) and solution nuclear magnetic 
resonance spectroscopy (NMR) [122]. Technological advancements in these analytical tools 
have allowed their usage in a high throughput manner, which is a key feature in 
metabolomics. After acquiring data with the analytical platform of choice, a final dataset 
table is generated which is then analysed via a series of statistical methods. In this section, 
the advantages and disadvantages of both analytical and statistical techniques will be 
discussed. 
 
1.6.5.1 Nuclear Magnetic Resonance 
NMR is a cornerstone analytical tool with a wide range of applications that includes 
compound quantification, purity assessment, structural elucidation, and binding constant 
calculations to name but a few. NMR spectroscopy, like any other spectroscopy, measures 
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the interactions between matter and electromagnetic radiation. NMR can be separated in to 
two main types, namely solution NMR and solid-state NMR. Both types of NMR operate 
under the same physical principles in terms of interaction of matter and electromagnetic 
radiation. Since only solution NMR was used in this project, only solution NMR will be 
explained and discussed, and any instance of NMR hereafter refers to solution NMR.  
 
NMR exploits an intrinsic property of atomic nuclei called spin [123]. Spins are an intrinsic 
nuclear angular momentum that cause the nuclei to behave like magnets. As a consequence, 
nuclei with a net spin adopt a preferred orientation when exposed to an external magnetic 
field. With any nuclei there are 3 possible ways the spin can be quantified: 
 
1) The number of neutrons and protons are both even resulting in no spin. 
2) The number of neutrons plus protons is odd resulting in half integer spin (i.e. 1/2 , 
3/2, 5/2). 
3) The number of neutrons and protons are both odd resulting in integer spin (i.e. 1, 2, 
3). 
 
The quantification of spin determines energy levels that a nucleus can take in an applied 
magnetic field [123]. This is determined by the equation 2𝐼 + 1, where 𝐼 is the net spin of 
the nuclei [123]. For example, the most typical NMR active nuclei Hydrogen (or as typically 
referred to, a proton) has a net spin of ½, which means in an applied magnetic field it has 
two energy states, high energy state (β) and low energy state (α) [123]. Nuclei with half 
integer spin other than ½ will have more than 2 energy levels and the difference between 
the energy levels is directly proportional to the strength of the magnetic field. For simplicity, 
half integer spin of ½ will be explained in this section, although the same concept is applicable 
to different numbers of energy levels [123].  
 
As previously mentioned, a proton (net spin of ½) will adopt a preferred orientation in an 
external magnetic field. This is determined by either the high or low energy state. A proton's 
preferred orientation in a magnetic field is either in the direction of the magnetic field 
(aligned, β state) or in the opposite direction (against, α state), but not parallel to the 
magnetic field [123]. However, it is important to remember that not all nuclei in a sample 
will show this behaviour in a magnetic field. In a magnetic field of 2.34 Tesla, which is the 
same as a 100 MHz NMR magnet, only 6 in every 1,000,000 nuclei are in the α state, with 
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even less nuclei populating the higher energy β state. The remaining nuclei that are not in 
either the α or β states are randomly oriented in the magnetic field [123]. When all of the 
orientations of the nuclei in a sample are summed, the randomly oriented nuclei sum up to 
zero and the net bulk magnetization is therefore given by the sum of the nuclei in the α and 
β states [123]. This low proportion of energy level difference is enough to make 
measurements, but also gives NMR its inherent low sensitivity [123]. The number of α and β 
states are directly proportional to the strength of the magnetic field, meaning a higher 
magnetic field will yield a higher energy level difference thus increasing the sensitivity of the 
measurement. 
 
The relationship between the preferred orientation of a nuclei and the energy states lays the 
ground for NMR measurements. As discussed, when a proton is in a high magnetic field, 
typically annotated as B0, it will either be in a high energy state (β) and align with the external 
magnetic field or be in a low energy state (α) where it is against the external magnetic field. 
However, this ground state of nuclei in the α and β states is not static, but rather it precesses 
at a certain frequency, also known as Larmor frequency, around the magnetic field axis. 
Furthermore, these α and β states can be manipulated by applying radio frequencies which 
then give rise to resonance energy at a frequency intrinsically unique to that atom [123]. 
 
The radio frequencies used for pulsing a sample are in the MHz range, the same frequency 
range as used for car radios. This is where the resonance in NMR is critical. Resonance can 
be defined as the amplification of a measured event due to the matching of frequencies. As 
such, when a sample is pulsed with radio frequencies for measurement, it is matched, or in 
resonance, with the Larmor frequency [123]. This burst of in resonance electromagnetic 
pulse through a coil around the sample creates a temporary magnetic field (B1), which is 
perpendicular to the static magnetic field B0. This causes the precessing nuclei to become 
aligned along the new magnetic field axis B1 [123]. Measurements in NMR are taken by the 
same coil around the sample. The signal recorded will be amplified due to the in-resonance 
pulse applied prior to the acquisition of the resonance signal.  
 
The recorded signal in NMR is a free induction decay (FID) and it is the superimposition of all 
acquired resonance signals [123]. The FID has a duration, typically up to 5 seconds depending 
on the sample, and an intensity. For the analysis of such complex signals, Fourier 
transformation is ideal. Fourier transformation is a mathematical operation where the time 
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domain is transformed to the frequency domain [123]. A Fourier transformed FID results in 
a spectrum where the x-axis is frequency and the y-axis is intensity and the signatures of all 
the detected nuclei can be observed [123]. 
 
The intrinsic resonance frequency of each atom is known as its chemical shift and is measured 
in Hz. Since the precession is directly proportional to the magnetic field, two molecules 
measured on two magnets with different magnetic fields, e.g. 600 MHz and 800 MHz, would 
not have the same chemical shift [123]. In order to make NMR spectra comparable between 
different magnetic fields, the chemical shift needs to be normalised to the magnetic field. 
For example, a signal measured at 600 Hz on a 600 MHz magnet would be 600 Hz/ 600 MHz, 
yielding 1 x 10-6 or 1 part per million (ppm). Using higher magnetic fields comes with two 
advantages, increase of sensitivity and resolution. Earlier it was mentioned how higher 
magnetic field increases the population difference observed in bulk magnetisation hence, 
increasing sensitivity [123]. Resolution enhancement can easily be explained with the ppm 
scale. Two spectra acquired at 600 MHz and 800 MHz would have the exact same ppm scale. 
Taking a portion of this scale as an example (0-1 ppm), spectra from the 600 MHz magnet 
would have points from 0-600 Hz to define 1 ppm while the 800 MHz magnet would have 
points from 0-800 [123]. An illustration of resolution enhancement with higher magnetic 
fields can be seen in Figure 1.6-3.  
 
 
Figure 1.6-3: Basic schematic of a NMR spectrometer. The NMR sample vial is placed onto the probe that resides 

















align with or against the direction of the magnetic field. Using RF pulses generated from the probe, these net 
magnetisations are manipulated. These changes are transferred by the probe to the console for digitisation of the 
data followed by transferring to a computer for analysis. 
 
The chemical shifts obtained from NMR are related to the chemical structure of the molecule 
the atom is part of [123]. A methyl group resonance which is typically 0.5-1 ppm is distinctly 
different than the resonance of an aromatic ring, typically 6.5-8 ppm. Certain molecular 
structures will cause signals to split in a systematic fashion. A split signal is called a multiplet 
and the multiplicity of the signal is given by the rule 𝑛 + 1, where 𝑛 is the number of 
neighbouring 1H environments (see the origins of the signals in  
Figure 1.6-4). Additionally, the intensity pattern also follows a systemic rule based on Pascal’s 
triangle [124]. Furthermore, the intensity of the resonance peak is proportional to the 




Figure 1.6-4: Stacked spectra of simulated 1H of ethanol under magnetic fields of 500 MHz, 600 MHz, 800 MHz 
and 1000 MHz. All spectra show the range of 1 ppm to 4 ppm where the signals from CH2 and CH3 are observed. 
Higher resolution provided by higher magnetic fields can be seen from the narrowing of the multiplet peaks as 
the magnetic field increases. Spectra were simulated using nmrdb [125]–[127]. 
 
In biological sciences, molecules of interest are typically composed of a combination of H, C 
and N atoms. All three elements have a NMR active (spin ½) isotope: 1H, 13C, and 15N. Due to 
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molecules, proton NMR, or1H NMR, is the most commonly used NMR method [123]. 
However, there is one major disadvantage with 1H NMR, its narrow ppm scale. All 1H signals 
are typically observed between 0-12 ppm. For comparison, the 13C NMR scale is typically 
between 0-200 ppm. The high numbers of 1H atoms in organic molecules, compounded with 
the narrow scale at which they resonate, means 1H NMR spectra of complex mixtures are 
often overcrowded and highly overlapped [128]. This makes the identification of metabolic 
signatures a challenge. Even though splitting and intensity patterns can be used to 
deconvolute some signals, for complicated mixtures this can be very demanding. Improving 
the resolution of signals by using high magnetic fields can be of great aid in the identification 
of molecules with very close chemical shifts. A typical NMR metabolomics experiment would 
most likely be conducted on a 600 MHz (14.04 T) magnet. A 600 MHz magnet provides 
sufficient resolution for metabolite identification and is more accessible than magnets with 
higher fields such as 800 MHz (18.72 T), 900 MHz (21.06 T) and 1 GHz (23.4 T) [129]. Higher 
field NMRs are a much more common commodity in biological research due to the much 
needed high resolution requirements of protein NMR. Unsurprisingly, metabolomics 
researchers with NMR access tend to benefit from magnetic fields of 600 MHz or above. 
 
As explained earlier, NMR is inherently low on sensitivity, but improvements in this area are 
being made. In addition to high field magnets becoming more commonplace, the latest 
developments in cryogenically cooled probes, known as cryoprobes, have enhanced NMR 
sensitivity by at least an order of magnitude although it is still below the sensitivity of MS. 
Even with the latest cryoprobes and high field magnets it is not always possible to resolve a 
1H spectra. Usually, this problem can be overcome with adding information from a 
complementary nucleus such as carbon which is achieved by detecting another range of 
frequencies [120]. The carbon frequency range is broader than hydrogen (13C range: 0-200 
ppm) and so yields more resolved resonance peaks, although the NMR active isotope of 
carbon,13C, is only abundant in nature at 1.11%. This results in longer data acquisition as only 
information from NMR active isotopes is able to be recorded [123]. 
 
The simplest NMR experiment is a single pulse for a single nucleus type prior to data 
acquisition, but they can be far more complex. A pulse sequence is a series of carefully 
designed and executed pulses to acquire specific types of information from the sample. Using 
different pulses e.g. different pulse configurations, power, and length of pulse, different 
types of information can be obtained from the sample [128]. For example, a sample 
containing both large and small molecules can be acquired using a 1D Nuclear Overhauser 
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Spectroscopy (NOESY) where all signals are observed. If the user requires to observe only the 
small or large molecules it is possible to do so without any chromatography. A Carr-Purcell-
Meiboom-Gill (CPMG) experiment would suppress the signals arising from large molecules 
[128] whereas a longitudinal encode decode (LED) experiment will do the opposite and 
suppress small molecule resonances while large molecule signals remain intact [128]. One of 
the great advantages of NMR is that it is possible to observe multiple nuclei during a single 
experiment. The most common application of this is the use of 2D NMR experiments such as 
1H-13C HSQC. Such experiments allow the deconvolution of signals utilising the chemical shifts 
on 13C. This type of experiment observes the 1H nuclei directly bonded to 13C i.e. CH, CH2 and 
CH3 groups. HSQC experiments are a great aid in the identification of metabolites with high 
confidence. The ability to detect 13C labelled materials in NMR also allows the probing of the 
fate of a site-specific labelled metabolite qualitatively and quantitatively in processes known 
as trace analysis [130] and metabolic flux analysis [131] respectively. The NMR experiments 
used for the work detailed in this thesis include 1D, NOESY, CPMG, and 13C-1H HSQC are 
covered in detail in section 2.3.4. Benefiting from high reproducibility, easier quantification 
and non-destructive nature NMR is a powerful tool to be used in metabolomics research. 
 
1.6.5.2 Mass Spectrometry 
Mass spectrometry (MS) is one of the most used analytical methods, with applications in 
compound detection and validation, purity assessment and protein sequencing, to name but 
a few [122]. As one of the two main analytical platforms (the other being NMR), MS 
dominates the field. MS is intrinsically highly sensitive in metabolite detection and 
quantitation as well as structure elucidation, within its limitation [Gowda & Djukovic]. MS is 
an analytical technique that involves interpretation of ionisation patterns of molecules in 
order to identify them [122]. A mass spectrometer is comprised of three essential 
components: an ion source, a mass analyser and a detector. These measure the mass over 
charge (m/z) of ions, with this information used to infer the identity of the metabolites, as 
well as their relative quantities. Typically, a sample is injected into the ioniser, which converts 
the metabolite into ions. These ions are then transferred to the mass analyser where ions 
are separated according to their mass over charge. Finally, a detector will capture the mass 
over charge and quantify the information before transferring it to a computer for analysis 
(Figure 1.6-5). The finer details of how MS works is beyond the scope of the work carried out 
in this thesis, but it is extensively covered in numerous publications and textbooks [122], 




Figure 1.6-5: Schematic of a basic MS. Samples can either be injected directly or can be separated through a 
chromatographical method a priori. Injected samples containing the neutral sample are converted into ions via 
the ioniser. Molecular ions are then passed through the mass analyser which separates the ions according to their 
mass over charge. The detector records the mass over charge and relative abundance which is processed by a 
computer for analysis. 
 
MS is a highly modular method and is often used in tandem with chromatography equipment 
(Figure 1.6-5) such as liquid chromatography (LC) or gas chromatography (GC). This 
functionality allows MS to be used in the analysis of biofluids, tissue samples and volatile 
compounds [134]. High performance LC-MS (HPLC-MS) requires samples to be in solution. 
HPLC separates the molecules present in the solutions according to their affinity to the 
attached column, examples of which include, C8, C18, C30 and hydrophilic interaction liquid 
chromatography (HILIC) columns. Once separated, these samples are individually sent to the 
MS for mass analysis. GC-MS requires samples and the compounds they contain to be 
volatile. In GC, samples are heated until they turn into gas where they can then be separated 
by their volatility, amongst other properties (e.g. size, polarity). Like LC-MS, once separated 
the compounds are sent in turn to a MS mass analyser. This technique is ideal for studying 
volatiles such as pheromones, although it can be used for a large range of metabolites [134]. 
The LC-MS approach is one of the most common in MS metabolomics due to its many 
benefits, but one of its biggest drawbacks is retention time drift. Using the retention time of 
molecules alongside mass over charge greatly increases the number of molecules that are 
able to be identified. However, this method is very sensitive to the experimental conditions. 





Injector Ioniser Mass analyser Detector
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a change in the retention time of a molecule. This can happen between samples, batches or 
experiments. A drift happening in a single run or between batches of an experiment would 
greatly affect the structure of the dataset as well as the identification and may require a 
repetition of the experiments. Additionally, retention time drifts make comparison or 
replication of experiments from different labs a major challenge.  
 
Ionisation is arguably the most critical stage in a MS metabolomics study. One of the 
limitations of MS is that only the detection of ionised molecules is possible. Understandably, 
the existence of a range of ionisation methods is not surprising. Electron impact (EI) and 
electrospray ionisation (ESI) are the most common ionisation methods used in MS 
metabolomics [122]. EI is a hard ionisation method where a heavy fragmentation of the 
molecule takes place and is the preferred method of GC-MS studies. In LC-MS studies, ESI is 
typically preferred. ESI is a soft ionisation method where less fragmentation of the molecule 
takes place. ESI is typically preferred due to is efficiency in ionising a wide range of small 
molecules, as well as larger molecules such as peptides and proteins. Another limitation of 
the ionisation specific to LC-MS is ion suppression. Ion suppression occurs when co-eluting 
molecules compete for the limited molecular ions. In such cases, molecules with low electron 
or proton affinity can be obscured or not detected [122].  
  
In combination with its inherent sensitivity and ability to be easily coupled to 
chromatographic methods, MS is a great tool for qualitative analyses such as metabolic 
library building for organisms. On the other hand, a major limitation with MS is the 
challenging quantitative analysis. In quantitative complex mixture analysis, comparable 
quantitation of samples is of great importance. MS can only measure ionised molecules, and 
for a reliable exact quantification a non-variable ionisation is critical. Unfortunately, 
ionisation in MS is variable and so signal intensities do not always reflect the actual quantities 
in the samples. Another commonly referred to disadvantage of MS methods is the inability 
to identify isomers [135]. Since isomers are different configurations of the same molecule 
their masses cannot be used as an identification method, although it should be noted that it 
is possible to identify isomers with tandem methods such as HPLC-MS and/or MS-MS. Some 
isomers elute at different retention times and using their elution order, different isomers can 
be identified [136]. However, this method heavily relies on the chromatographic method and 
in some cases can even be performed without the mass spectrometer via different columns 
[136]. Another approach to identify isomers is to use MS-MS. Some isomers can exhibit 
characteristic fragmentation patterns which can be recorded with MS-MS and identified 
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[137]. Although possible, MS isomer identification is not a straightforward and robust 
method. It requires a lot of user interaction and may not be feasible for a large metabolomics 
study. Due to the nature of the MS systems, cross contamination between samples is a 
common problem, which brings further issues with reproducibility and quality assurance 
(QA). In order to monitor these problems, MS metabolomics experiments require QC samples 
in the data acquisition. Typically these are a series of pooled samples to ensure the quality 
and integrity of data acquisition [138]. Furthermore, this approach compounded with a 
hyphenated technology (e.g. HPLC) means the sample amount for a metabolomics 
experiment dramatically increases. Although, even with QC sample concentration required 
are very low. 
 
1.6.5.3 Advantages and disadvantages of NMR and MS in metabolomics 
Between the two leading methods in metabolomics, NMR and MS, the latter tends to be the 
preferred choice. Besides the numerous advantages of mass spectrometers; they are 
cheaper than NMR spectrometers, more space efficient (NMR requires anti-vibration 
measures on the floor for high quality data acquisition), and mass spectrometers can be 
operated with less training than is needed for NMR. Although these are not the only reasons 
why MS is generally preferred, they do make MS more widely accessible and hence more 
widely adopted which perhaps can be considered as an advantage. As a side-effect of being 
more widely used, MS has larger curated databases aiding in metabolite identification on a 
larger scale, especially with the added dimension of retention time (acquired from 
chromatography). This, compounded with the sensitivity down to nM (pM for some 
equipment) makes MS a very versatile instrument in metabolomics research.  
 
LC-MS measurements performed on the same instrument in the same laboratory can present 
systemic variability in data collected over long periods of time [139]. These variabilities 
typically manifest themselves as changes in ionisation (co-elution of metabolites, salts, pH, 
mobile phase), drifting in retention time (degrading or replaced column), and mass 
calibration drift (temperature or circuitry configuration). Such variabilities can be observed 
over long acquisition runs or in the same set of samples acquired in 2 batches, although there 
are special measures that can be taken to deal with these issues. NMR on the other hand 
provides a framework which is more resistant to such systemic variabilities. Similar to MS, 
NMR can also be affected by temperature changes, pH variation, and salt concentration but 
in contrast they are easier to resolve. NMR samples sits on a temperature-controlled probe 
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which can be calibrated to 0.1 ˚C (see section 2.3.1) and can be monitored throughout the 
acquisition time. Variations in pH are typically seen as shifts in peaks, but can be stabilised 
using NMR compatible buffers. Although this increases the ionic strength of the solution, 
NMR pulses can be calibrated per sample for consistency of data acquisition. The ease and 
robustness of such a calibration makes NMR exceptionally reproducible and allows for 
acquiring data in batches as well as acquisition of additional experiments at a later date. 
 
There are cases in metabolomics studies where re-acquiring of data or additional data is 
required. In such cases, using the same sample is the gold standard. Excluding the 
disadvantages of reproducibility of methods, another fundamental difference between NMR 
and MS can be seen. MS is a destructive method where the sample injected is not 
recoverable, whereas NMR samples are always contained in the sample tube and can be 
stored and reused. That being said, a critical point that needs to be mentioned is the amount 
of sample 'destroyed' in a MS injection is far less than the amount required to acquire an 
NMR spectrum. Nevertheless, NMR is still the only method where the initial sample remains 
untouched. 
 
A common challenge for both methods is quantification. It is commonly referred to that NMR 
is quantitative (see section 1.6.5.1) and MS is not. This is a common oversimplification and is 
not entirely correct. It is possible to have quantitative measures, be it absolute or relative, 
with either of the techniques if proper methods are implemented. Nevertheless, this is much 
easier achieved with NMR than it is with MS. As explained in section 1.6.5.2, MS signal 
intensities can be varied due to concentration, efficiency of separation and ionisation 
conditions and so quantification requires careful calibration of the equipment, use of internal 
standards, and spiking of samples for accurate quantification. In contrast, for NMR, relative 
quantification is readily available on data acquisition and for absolute quantification the user 
can chose from: internal standard, external standard or a calibration curve. 
 
Another key detail to be aware of is the polarity of the compounds of interest. Typically, 
metabolomics studies are conducted on either water soluble (polar) or non-water soluble 
(apolar) compounds. In both LC-MS and NMR, apolar compounds are typically more straight 
forward to measure. In NMR, samples are mixed with a suitable solvent and data acquired. 
For LC-MS, chromatographic methods are well established for apolar compounds, but 
separation of polar compounds is often more challenging. When more common place 
chromatography columns (e.g. C18) are used, it is often complicated due to the poor 
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interaction of biologically relevant polar compounds with the column resulting in fast elution 
of compounds and poor separation [140]. For such applications, the relatively new HILIC 
columns can be of great help. These columns have a higher affinity to polar compounds, 
eluting compounds in order of increasing polarity thus achieving a greater overall separation 
[140]. However, they are generally costly and retention mechanisms are not well understood 
[140]. In comparison, NMR acquisition of polar compounds requires only dissolution in an 
appropriate NMR buffer before acquisition. 
 
Lastly, LC-MS platforms use a flow system for sample transportation meaning all samples are 
carried through the same tubing. Using one route for all the samples brings the possibility of 
cross-contamination of samples, prior to and during a run [138]. In comparison, NMR is a 
closed system where samples never come into contact. Although cross-contamination is a 
concern that the user should be aware of, with the use of proper pooled sample checks to 
track the status of consistency [138], and performing periodic maintenance of the equipment 
with cleaning and purging, cross-contamination can be kept in check. 
 
Often in metabolomics, a researcher will have to choose between one of these techniques. 
Ideally, they would be used in combination to provide complementary information, but this 
is rather uncommon due to financial constraints, the expertise needed to operate both 
technologies in a metabolomics appropriate manner, instrument availability and sufficient 
sample/material. In a situation like this, the strengths and weaknesses (Table 1.6-1) of both 





Table 1.6-1: Strength and weaknesses of NMR and MS. 
  NMR MS 
Sample Recovery Non-destructive analysis Destructive analysis 
 Volume Higher volumes Lower volumes 
 Large molecule filtering Non-destructive filtering Sample processing required 
Instrument Quantitation Absolute and relative Relative 
 Calibration and setup Easier Harder 
 Installation cost Expensive Cheaper 
 Maintenance & operational cost Cheaper Expensive 
 Time per sample 1D: short time 
2D: long time 
Long data acquisition when 
coupled to chromatography 
 Reproducibility Reproducible Semi-reproducible 
 Sensitivity Lower sensitivity Higher sensitivity 
 Dynamic range Larger Smaller 
Data  Metabolite identification Challenging Easier 
 Available databases Limited Several 
 Size of databases Smaller Larger 
 Analysis applications Limited Several 
 
Acknowledging that MS would be a much more sensitive choice for identification, an in-
house pilot test performed on single mosquitoes showed that certain NMR configurations 
(i.e. 700 MHz equipped with an inverse cryoprobe) are sensitive enough to acquire data to 
the complexity that allows the observation of experimental variations. Furthermore, 
considering the high reproducibility (e.g. use of external databases for identification), 
reusability of sample (i.e. for further experiments or repeats), ease of acquiring polar 
metabolite data with minimal steps, and eliminating the possibility of cross-contamination 
at the data acquisition stage, NMR was selected as the preferred analytical platform in this 
project. 
 
1.6.5.4 Metabolomics datasets and their analyses 
Once data is acquired we can proceed to the data analytic steps (Figure 1.6-6). Given that the 
metabolomics platform chosen for this project was NMR, in this section the data analysis 
steps undertaken when analysing 1H NMR spectra will be described. It should be noted that 
majority of the downstream analyses are platform independent and is stated where 
applicable. Prior to any data analysis checkpoints to assess sample quality control (QC) need 
to be in place. These QC steps typically include markers for suitable acquisition and 
assessment of overall sample variance to identify potential outliers. The later should be 
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match with experimental notes to ID any problems in current pipelines and iteratively 
improve the sample acquisition steps. 
 
 
Figure 1.6-6: Diagram representing the analytical steps taken in classic metabolomics analysis. 
 
Sample failing QC due to faulty acquisition may be acquired again with the aim of retaining 
as many samples within the overall study. Upon consistent failure (typically 3 tries) failed 
samples should be identified as problematic and removed from the study. Typically NMR QC, 
includes the assessment of the half height full width of the internal standard, overall shape 
of the baseline, wideness of the residual water peak and signal overflow. NMR QC is 
explained in detail in section 2.3.6.  
 
Generally, data acquisition is followed by metabolite identification. This is typically done by 
a combination of in-house metabolite library and/or external databases (e.g. Chenomx 
(Chenomx, CA), HMDB [119], BMRB [141]) where the spectra are compared to spectra of 
standard compounds. Details of the metabolite identification is detailed in section 2.4. 
Typically, in NMR dataset there are two choices either absolutely quantified datasets (will be 
referred to as absolute dataset) or relatively quantified dataset (will be referred to as relative 
dataset). Absolute datasets contain concentration values per metabolite per sample. As 
identification is often incomplete, these datasets contain fewer variables but are more 
powerful as results from their analysis are easier to interpret biologically. In these datasets, 
unidentified signals are removed. On the other hand, datasets of relative quantification 
(relative datasets) contain all the information acquired by all the signals independently on 
whether they are identified or not. In NMR a metabolite may have more than one signal and 
that signal might have an overlap with others, what can make interpretation more difficult. 
However, these datasets retain most information and can be key to detect relevant biological 
samples. It is important to mention that a step to assess the quality of the signals of each of 
the metabolites identified needs to be in place in order to select the best suitable marker for 
that metabolite. There are currently no standard methods to do so but I propose one in 
section 2.5.2.3.2. Best operating practice include the provision of relative datasets within any 















depth comparison of both and allows for further analyses by the community that might have 
access to wider metabolite libraries to further identify signals.  
 
Metabolomics experiments typically require the acquisition of large number of samples 
which typically cannot be processed within the same experiment. This implies the need for 
sample acquisition in batches. Variation that may be introduced from sample handling, 
pipetting errors, batch and/or data acquisition needs to be controlled. Such variations may 
mask the experimental variation of interest. The first step for unwanted variation control is 
normalisation. There are multiple normalisation methods used in NMR metabolomics, some 
of the most common include normalisation by total area, normalisation by a reference 
spectral bin, and probabilistic quotient normalisation (PQN). Total area normalisation is most 
commonly used when the suspected source of non-experimental variation is mainly due to 
dilution effects [PQN ref]. Normalisation by a reference spectral bin is typically preferred 
when a given standard has been added to the metabolite mixture prior to extraction and can 
serve as representative of the proportional changes a sample has suffered in the extraction 
and acquisition steps. It can also be a typically stable signal in particular biofluids, for example 
creatinine is widely used to normalise 1H-NMR urine spectra. PQN normalisation method can 
be used for both relative and absolute concentration datasets. This normalisation method is 
designed to calculate a normalisation factor through the quotients of median values in the 
dataset (see section 2.5.1.2 for details). Due to the use of medians instead of means in PQN, 
it is inherently resistant to the skew caused by outliers and sample with extreme cases (which 
typically may be confused with outliers). in the spectra an is applicable to both relative and 
absolute concentration datasets [PQN ref]. 
 
Normalisation methods are not always sufficient due to the high batch effects in the dataset. 
In such situations additional batch correction methods also need to be applied. Methods for 
batch correction develop for omics data analyses (i.e. multidimensional data) are based on 
analysis of covariance (ARSyN [142]), Bayesian models (ComBat [143]) or Surrogate Value 
Analysis (SVA [144]). Detailed explanations of these methods would be out of the scope of 
this project hence the reader is encouraged to read the detailed publications of methods 
themselves. All batch correction methods mentioned above use different statistical 
approaches to minimise the non-experimental variation. Some of these methods are more 
powerful than the others and all of them may introduce some bias to the dataset. For 
example, ARSyN is designed to remove any variation that is not explained by the 
experimental groups provided (for example drug treatments). This typically yields excellent 
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results separating the groups of interest but it can introduce bias by removing variation that 
might be also relevant to it (for example sample demographics such as sex or age). On the 
other hand, ComBat is a method designed to remove the variation linked solely to known 
batches. This might lead to worse outcomes but it is a safer option if we want to keep other 
possibly relevant variation within the data. Suitability of batch correction methods should be 
assessed to choose the most suitable method. Principal variance component analysis (PVCA) 
[145] is an algorithm that estimates the variation in the data based on the factors provided 
such as, experimental factors, non-experimental factors (e.g. batch), and residual variation 
(i.e. all the remaining variation in the dataset). PVCA can provide information of the variation 
reduced by a particular batch effect correction method.  
  
NMR signals represent specific nuclei in the molecule under specific magnetic environment 
they experience. Thus, a metabolite's NMR signature can be a single peak or more (see 
section 1.6.5.1 more detail). Thus, NMR data is highly multicollinear. 
 
As metabolomics datasets are multivariate, it is advisable to use multivariate methods for 
their analyses. These can be unsupervised or supervised. Unsupervised methods does not 
require the experimental-group information. Most widely-used multivariate transformation 
in omics analysis is principal component analysis (PCA) (see section 2.5.2.1). 
 
PCA is typically used as a data exploration tool where the inner structures of the data can be 
revealed. PCAs are very fast to calculate and are implemented in many statistical packages. 
When a structure cannot be appraised with PCA, supervised methods can be used. These 
methods use the information regarding the groups present in the data to maximise 
differences between groups. Examples to such methods are partial least square discriminant 
analysis (PLS-DA) or random forest (RF). These methods and their model building procedures 
are covered in detail in section 2.5.2.2. these methods build a model that uses a fingerprint 
of signals to predict the different groups. The importance of each of those signals is rated, 
thus a selection of most important metabolite signals can be subsetted and taken forward 
for more analysis. Supervised methods create models. These models are prone to overfitting. 
Overfitting is the process by which a model performs excellently to describe the data used to 
build it but is unable to predict groups from new datasets (i.e. it has fitted to noise). In order 
to avoid overfitting rigours cross-validation steps are required and are covered in section 
2.5.2.2. PLS-DA models are widely used in metabolomics and implemented in most analytical 
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steps. There are not the best performing supervised algorithms but they are most 
appropriate for multi-collinear datasets such as NMR.  
 
Once a multivariate approach has led a list of interesting features/metabolites, one can 
further the analysis by undertaking 2-sample or 2+ sample tests such as Student’s t-test or 
ANOVA test respectively. These hypothesis testing methods are evaluated by using an 
arbitrarily set threshold known as the α value and is typically set to 0.05 (or 5%). This 
threshold represents the amount of potential false positives we are willing to accept in our 
comparisons. As the names suggest univariate tests are designed to compare a single variable 
and are not designed for multiple hypothesis testing as it is. Meaning testing of multiple 
simultaneous variables from the same data. When a univariate test is used in multiple 
comparisons, it becomes increasingly more likely for at least one comparison to be different 
with statistical significance (determined by the α = 0.05 threshold). Thus, by using multiple 
comparisons the probability of making an error increases with each test made. Consequently, 
when undertaking multiple hypothesis testing we need to incorporate a step to correct for 
potential false discoveries, to avoid falsely concluding some metabolites to be important 
while they are not. Two methods can be commonly observed in metabolomics as well as 
biological sciences in general to undertake false discovery corrections. The more 
conservative method Bonferroni correction and the less conservative Benjamini-Hochberg 
method. In Bonferroni method randomly assigns alpha-new values (can be variable) to each 
test such that the sum of all alpha-new values is equal to the desired α value for the entire 
test (typically 0.05). This method is very conservative in controlling false positive discoveries, 
but the trade comes with cost of increased discovery of false negatives. The alternative 
method is the Benjamini-Hochberg (BH) method. In this method p-value are ranked in an 
increasing fashion and a new alpha threshold is calculated per comparison via & '
(
)𝑄 where 
𝑖 is the raw p-value, 𝑚 is total number of comparisons, and 𝑄 is the alpha value for the test. 
Then each raw p-value is compared agains its new threshold. This step is then followed by 
finding the highest raw p-value that is lesser than its new α threshold. Any comparison before 
this is considered significant and this process is continued until all comparisons are evaluated. 
This method controls the false discovery rate as well as the false negative rate thus, have a 
higher statistical power compared to the Bonferroni method. Note that univariate methods 
can be applied to multivariate tests but their use is not efficient providing the false discovery 
rate increases with the number of tests. Thus, although the option is available within multiple 
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statistical packages (including Metaboanalyst [146]), it is advised to undertake a multivariate 
approach followed by a univariate one. 
 
Once a robust list of relevant variables whether identify with multivariate methods or jointly 
verified with univariate methods, the next step in the pipeline is the biological 
contextualisation. In metabolomics this is typically combined with pathway analysis. Pathway 
analysis methods are one of the bottlenecks in metabolomics analyses. Most common 
implementations are based on Fisher's exact test (see section 2.5.4 for details) where the 
probability of a set of input metabolites representing another set of metabolites (i.e. 
pathways) is calculated. Such methods are typically called metabolite set enrichment analysis 
(MSEA). Users must be cautious when using MSEA methods since the results of such test are 
not definite answers and should be treated as leads to follow up un. It should be noted that 
MSEA methods do not take metabolite levels into account. Additionally, the quality of such 
tests heavily depends on the quality of pathway database used. It should be noted that there 
are implementation of MSEA where pathway rankings can be calculated through an 
‘importance’ score. These implementations typically depend on the number of connections 
the metabolites have in the pathway (usually calculated via in-betweenness centrality). 
Although it may be more informative, similar to MSEA the result of such analyses should be 
taken as a complementary metric to the results rather than definite answers. 
 
In this project a relative datasets were used to incorporate as much as information from the 
data acquired. Normalisation of choice was PQN due its high effectiveness on NMR data and 
Batch effects were assess via PVCA and multiple correction methods were tested and applied 
per dataset. Multivariate analyses PCA and PLS-DA were used to explore data and to select 
variables respectively. Selected metabolites were compared using the univariate methods t-
test and ANOVA as dictated by the number of experimental groups. Multiple comparison 
adjustments were performed using BH to have a more balance false positive and false 
negative correction. MSEA was performed by a custom implementation of Fisher’s exact test 
and the data was contextualised by correlating with the information available on 
publications. Implementations of the statistical methods are covered in detail in section 2.5. 
 
1.6.6 Metabolomics studies on insects 
Since the turn of the century there has been a total of 22,856 documents published under 
the topic ‘metabolomics’ (data from Web of Science, Clarivate Analytics; UK) with 17,488 
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(72.82%) novel research articles (Figure 1.6-7). Within the 22,856 documents, 197 (0.86%) 
were published under the topics of metabolomics and insects but, only 25 (0.11%) of these 
were published under the topics metabolomics and mosquitoes, all of which were published 
between 2004 and 2019. 
 
 
Figure 1.6-7: ‘Metabolomics’ publications between 2000-2019 data from Web of Science. A) Number of 
publications under the topic ‘metabolomics’. Percentages are of the total number of metabolomics publications 
(22,856). B) Breakdown of the published documents topic ‘metabolomics’. Due to some documents having 
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In 2015, Snart et al. published a mini review mentioning the term ‘entometabolomics’ 
(entomology + metabolomics). However, this term has not been widely used since. Currently, 
metabolomics is employed in insect research to investigate insect-bacterial interactions 
[147]–[149], insect-plant interactions [150], [151], development [152], interactions with 
commercial pesticides [153], [154] and temperature stress [155], [156]. The most published 
model to date is D. melanogaster. This is perhaps unsurprising considering the amount of 
scientific knowledge gathered using D. melanogaster [157], [158]. In terms of metabolic 
profiling, there is a keen interest in the profiling of insect biofluids, specifically the 
haemolymph. One of the most important milestones in insect metabolomics is the profiling 
of the insect haemolymph in 2008 (Phalaraksh et al, 2008). 
 
Amongst the 245 unique publications under the topics metabolomics and 
mosquitoes/insects, two studied Anopheles mosquitoes and seven investigated Aedes 
mosquitoes (Table 1.6-2). Although a metabolomics approach is adopted by many fields of 
research, it is still not common in mosquito research. 
 
Table 1.6-2: Research articles between 1900-2019 on Web of Science under topics: metabolomics and 
mosquitoes/insects which studied either Anopheles or Aedes species. CHIKV: Chikungunya virus, DENGV: Dengue 
virus, Ref: reference. 





LC-EI-MS Crowding and starvation during breeding causes 
lower levels of alanine due to high turnover to 
pyruvate. 
[159] 
Haemolymph NMR L-cysteine levels in the haemolymph are affected 
upon CHIKV and DENGV infection. 
[160] 
Whole extract GC-MS Carbohydrate metabolism is controlled by 
methoprene-tolerant receptor, after a blood meal it 
is controlled by ecdysone receptor. 
[161] 
 Ibuprofen exposure increased male mosquito life 
span and in progeny eggs metabolic resource 
internalisation is affected. 
[162] 
HPLC-MS Metabolomics of juvenile hormones synthesis 










Whole extract UHPLC-TOF Nine lipids were identified as more abundant in 
quiescence eggs and tyrosine metabolism identified 





Whole extract GC-MS Higher levels of triglycerides in populations more 






Revealed a parasitic relationship between the host 
mosquito and Mycobacterium ulcerans. 
[149] 
 
Amongst the studies published under the topics of ‘metabolomics’ and ‘insects’, desiccation 
resistance was studied by two groups. In 2018, Batz and Armbruster investigated the HC 
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composition of Ae. albopictus eggs, where they compared the changes when the eggs 
undergo quiescence [165]. In 2016, Hidalgo et al focused on the physiological adaptations to 
desiccation in distinct populations of female An. coluzzi and highlighted the mosquito 
response to desiccation through the use of metabolic processes [166]. Batz and Armbuster 
used a multiomics approach by incorporating metabolomics information into the 
transcriptomics data acquired from a previous studies. Their analytical platform of choice 
was GC-MS for lipidomics and LC-MS for polar metabolomics. Metabolite identification for 
lipidomics was performed by using an external library, whereas polar metabolites were 
identified via their in-house library. Their statistical analyses showed an accumulation of nine 
lipids and nine glycerides (two diglycerides and seven tri glycerides) in eggs that undergo 
quiescence [165]. One of the interesting results of their study was the identification of 36 
distinct metabolite that were uniquely found in quiescence eggs, but unfortunately none of 
these metabolites could be identified [165]. The study undertaken by Hidalgo et al in 2016 
investigated the desiccation in An. coluzzi [166]. Although the species of these two studies 
are different, and Anopheles eggs do not undergo quiescence, Aedes egg that undergo 
quiescence are resistant to desiccation [ref mosq book]. Aedes eggs can survive in 
considerably drier conditions and so it is not unreasonable to expect some of the desiccation 
resistance mechanisms to be similar. Hidalgo et al identified 36 metabolites, of which 29 
showed significant differences between experimental groups [166]. These metabolites were 
mainly consisted of saccharides and amino acids [166]. When the two studies are compared, 
it is evident that polar metabolic profiles of adult mosquitoes and eggs are quite dissimilar. 
Although it can be speculated that some similar metabolites are either unidentified or 
extremely low concentration of egg metabolites were not quantifiable. Nevertheless, both 
studies have identified triglycerides as being important. Hidalgo et al argued the oxidation of 
triglycerides can provide a reliable source of water, whereas Batz and Armbuster discussed 
triglycerides as a reliable energy source. It has been reported that triglycerides have a high 
calorie content and release water on oxidation [#3 in Hidalgo refs]. Triglycerides are 
synthesised by the esterifcation of a glycerol with 3 hydrocarbons. An increase in HC 
production under desiccation conditions is therefore very likely in order that they can be 
used to make triglycerides which can be oxidised to produce the water which is lacking. 
 
Another area of interest is the factors effecting the development of mosquitoes. A 2015 study 
by Price et al investigated the Ae. aegypti development using a combination of metabolomics 
and transcriptomics. In this study, one strain was bred under typical laboratory conditions, 
referred to as large mosquitoes, and another was raised under crowded and nutritionally 
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deprived condition, referred to as small mosquitoes [159]. All samples used in this 
experiment had the fat body obtained through dissection of the mosquitoes. Samples were 
then pooled to create samples for GC-MS and RNA-sequencing [159]. The obtained 
transcriptomics results indicated the vitellogenesis (egg yolk formation) process to be 
negatively affected in small mosquitoes. The transcript counts were not statistically different 
prior to a blood meal, although this was expected due to vitellogenesis being activated only 
after mating and a blood meal. In large mosquitoes there was a 1.6-2 fold increase in 
vitellogenesis transcripts [159]. The researchers interpreted these results as being due to the 
fact that in small mosquitoes all the nutrients obtained from the blood feeding were 
redirected to energy related mechanisms in order to compensate for the malnourished state 
they were in. As complementary information, Price et al also used metabolomics. An 
inconsistency observed in this publication was the vague description of the analytical 
platform used for the metabolomics. The metabolomics section mentions LC-MS, although 
the methods section describes a derivatisation procedure which is commonly used in GC-MS. 
Since the analytical platform is not explicitly detailed, extrapolating from the mentioning of 
a derivatisation procedure it is assumed that GC-MS was used. Price et al identified 138 
metabolites of which 58 were different between small and large mosquitoes after a blood 
meal and 65 were different for no blood meal [159]. They showed a particular interest in the 
amino acids and the decrease they observed between small and large mosquitoes, 
interpreting the results as the amino acids being used as energy sources rather than 
resources for protein production.  This study revealed some interesting differences between 
different breeding conditions, although the experimental design includes multiple variables 
which may not be deconvoluted. More specifically, between the large and small mosquitoes 
there is the variation of nutrition provided as well as crowding of the breeding tray. The 
majority of their conclusions are related to energy metabolism, but it is not possible to 
determine if this is related to the crowding, nutrition, or perhaps a mixture of both. A follow-
up study could possibly shed more light on the metabolomics of breeding of mosquitoes.  
 
In the same year as the Price study, Hou et al investigated the reproductive cycles of 
mosquitoes in relation to the juvenile hormone and its role in carbon metabolism in Ae. 
aegypti females using transcriptomics and metabolomics [161]. Hou et al used GC-MS 
metabolomics in addition to microarray transcriptomics for a multiomics approach. 
Transcripts of carbon metabolism after eclosion and post blood meal were compared as a 
time course study. These transcripts were found to be significantly higher in the first 24 hours 
after eclosion, decreasing afterwards until a blood meal [161]. After a blood meal these 
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transcripts were again found to be significantly elevated, followed by a decline over a period 
of 48 hours. In order to verify their results, they used GC-MS metabolomics to quantify the 
intermediary metabolites of the elevated carbon metabolism enzymes (proxied through 
transcripts). Between the two sources of data, a high correlation was observed in enzymes 
and their final product. An interesting outcome of their research was the distinct citrate cycle 
profiles between post eclosion and post blood meal [161]. Considering that in both cases 
carbon metabolism is upregulated, it is reasonable to expect the citrate cycle profiles to be 
similar. However, in their findings, citrate and maleate were found to be significantly reduced 
in the post eclosion phase, whereas they were found to be higher after a blood meal [161]. 
The juvenile hormone and its receptor, methoprene-tolerant receptor, are both key to the 
regulation of a mosquitoes reproductive cycle [161]. In order to test their role in carbon 
metabolism, the juvenile hormone and receptor were applied topically on newly eclosed 
females. The application caused a significant decrease in carbon metabolism transcripts and 
an elevation in glycogen and glucose compare to untreated mosquitoes [161]. Thus, 
indicating Methoprene-tolerant receptor controlling the carbohydrate metabolism pathways 
upon a blood meal. As revealed by Price et al, in malnourished conditions a blood meal can 
be redirected to energy metabolism rather than vitellogenesis. This 'switch' was also 
investigated by Horvath et al in 2018 by analysing Ae. aegypti fed with blood meals 
supplemented with 13C-glucose using LC-MS [164]. Mosquitoes were fed with a 3% sucrose 
solution for 3 days then were subjected to a 24 hour starvation period, followed by the 13C 
glucose supplemented blood meal [164]. The starvation step is necessary to remove the 
interference of diet, but as Price et al showed, starvation applies a pressure for the blood 
meal to be utilised in energy production which was not mentioned in the study [164]. In this 
time course study, Horvath et al traced the 13C revealing the utilisation of glucose in ammonia 
detoxification and uric acid synthesis upon blood feeding through the glycolysis and pentose 
phosphate pathway [164]. This study made a note that although the acetyl-CoA derived from 
the 13C glucose is expected to be used in fatty acid production based on literature, the 
measuring of fatty-acids was out of the scope of the study. Similarly, it would be reasonable 
to expect a positive correlation between energy mechanisms and fatty acid production. 
 
The 13C glucose trace study by Price et al revealed the role of glycolysis in ammonia 
detoxification [159]. Ammonia is a by-product of the processing of the blood meal, and it is 
not the only dangerous one. Processing of a blood meal creates a great oxidative stress on 
the mosquito. In 2018, Shrinet et al investigated the effect of this oxidative stress and how it 
is amplified when the blood is infected with arboviruses such as chikungunya virus or dengue 
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virus in Ae. aegypti using a multiomics approach with the integration of transcriptomics 
(published data), proteomics (unpublished data) and metabolomics (experimentally acquired 
NMR data) [159]. To understand the effects of the oxidative stress under arbovirus infection, 
mosquitoes infected via injections with chikungunya virus, dengue virus, and co-infections of 
these viruses were compared. NMR was performed on a 500 MHz magnet fitted with a 
cryoprobe for high sensitivity. In contrast to most studies, Shrinet et al used the haemolyph 
of the mosquitoes rather than whole extracts in this study [159]. Shrinet et al did not report 
the total number of identified metabolites, but their PLS-DA models yielded 15 metabolites 
of importance via VIP scoring [159]. Following the PLS-DA modelling, a pathway analysis was 
performed. Taurine and hypotaurin pathways were the topmost predicted pathways 
followed by pantothenate and CoA biosynthesis, however, the list of metabolites used for 
the pathway analysis was not reported [159]. Following the metabolomics analysis, an 
integration of proteomics and transcriptomics data was performed. Firstly, published 
transcriptomics data was selected from the literature and supplemented by an unpublished 
in-house proteomics dataset. These data were also analysed with pathway analysis 
individually and the results were merged in the discussion. A common pathway highlighted 
by all the methods was oxidative phosphorylation [159]. This was attributed to the virus 
modulating the bioenergetics of the mitochondria in order to optimise the viral replication 
[159]. Furthermore, L-cysteine levels were found to be lower in infected mosquitoes 
affecting the taurine and hypotaurine pathway during oxidative stress. L-cysteine is a 
precursor of glutathione which is an antioxidant and was not reported by this study [159]. 
Nevertheless, the study concluded that oxidative stress caused by the blood meal can be 
further increased by an arboviral infection on which upon Ae. aedes species can inhibit 
oxidase in order to stop the production of reactive oxidative species. 
 
Viral infection in mosquitoes does not only create oxidative stress, but can also affect the 
development of the mosquitoes. The 2015 study by Hoxmeier et al investigated An. gambiae 
mosquitoes infected with live and dead Mycobacterium ulcerans [149]. An. gambiae larvae 
were reared in water with live M. ulcerans, dead M. ulcerans (gamma irradiated), and no M. 
ulcerans [149]. Emerging adult mosquitoes were collected for metabolic profiling using LC-
MS. Upon analysis, all three groups presented distinct metabolic profiles [149]. Most notably, 
the phospholipid pathway was affected when exposed to live M. ulcerans. Di-
acylphospholipids were higher in the live M. ulcerans infected mosquitoes as well as tri-
glycerides [149]. Amongst the findings were also lower survival and pupation rates during 
development [149]. In light of the findings, a parasitic relationship between the bacteria and 
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the host rather than a communalistic relationship is implied. Unfortunately, the depth of 
disruption to the phospholipids and triglycerides was not covered in this study and it is a 
relatively unexplored area. It may be of great importance to know whether these disruptions 
go as far as altering the hydrocarbon productions as such alterations might interfere with the 
delivery of insecticides (i.e. cuticular hydrocarbon resistance). 
 
The use of metabolomics in mosquito development is relatively more common than its use 
in other mosquito research areas. A 2018 study by Prud’homme et al investigated the direct 
exposure of ibuprofen on Ae. aegypti adults and their progenies using a combination of 
metabolomics and transcriptomics [150. In their study, Prud'homme et al observed no 
phenotypic change in the parents (F0). Although the survival rate of the ibuprofen exposed 
parents’ first-generation progeny (F1), was twice as much as control under starved conditions 
[150. They have identified 134 differentially transcripted genes in the F0 larvae, whereas this 
number was 1566 in F1 larvae [150. The F0 larvae did not show any stress related transcripts 
[150. The metabolomics data was acquired via GC-MS on F0 males and females and F1 eggs 
(1-4 hours old). The F0 metabolic profiles did not show any differences between control 
samples and those exposed to ibuprofen [150. In contrast, F1 eggs showed 20 metabolites 
to be significantly lower in the ibuprofen exposed group [150. These metabolites mainly 
consisted of amino acids, carbohydrates, and polyols, thus indicating impaired resource 
internalisation during embryonic development [150. Interestingly, upon hatching these 
exposed F1 larvae showed overactivation of the ecdysone signalling pathway which 
promotes accelerated development [150. This over activation was discussed to be the reason 
for the F1 progenies high survival rate during starvation [150. It is unclear whether ibuprofen 
exposure is the reason for the high survival rate in the F1 progenies or this is simply a stress 
response. Nevertheless, it is clear, as shown by Prud'homme, that such pollutions in water 
bodies may cause more favourable survival conditions for mosquitoes, hence increasing the 
risk of vector borne diseases. 
 
Lastly, Rivera-Perez et al studied mosquito development in 2014 with a focus on reproductive 
physiology in Ae. aegypti, particularly, mevalonate and juvenile hormone synthesis pathways 
and their links to the reproductive system [163]. The juvenile hormone is synthesised through 
the mevalonate pathway [163]. Being a multipurpose pathway, it is responsible for the 
biosynthesis of essential signalling molecules used in energy homeostasis and glycosylation 
[163]. Through the use of acetyl-CoA, this pathway branches into juvenile hormone synthesis 
[163]. Using chromatography coupled with a fluorescent detector and MS, a targeted 
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metabolomics approach was utilised. Quantification was done by adding fluorescent tags to 
the metabolites of interest, such as mevalonate and acetyl-CoA, and acquiring the data by 
fluorescens detector. In order to complement the metabolomics data, published studies 
were utilised for a meta-analysis [163]. In their results, they reported a 10-fold increase in 
juvenile hormone within the first 24 hours of eclosion [163]. Given its established role in 
development, it is expected to observe an increase of this hormone. Interestingly, the 
mevalonate pathway metabolites were low while juvenile hormone was on a high indicating 
a possible feedback loop between the two processes. 
 
From the published literature covered in this section, it is clear that the majority of 
metabolomics studies on mosquitoes are in the form of a multiomics study, predominantly 
with transcriptomics. Furthermore, in metabolomics, the preferred analytical platform is GC-
MS followed by LC-MS followed by NMR. It is also interesting that the majority of the 
discussions are derived from the transcriptomics data and supplemented by metabolomics, 
suggesting an underuse of the available metabolomics data. The metabolomics analysis 
techniques in the above literature are mostly univariate comparisons, thus the strength of 
multivariate analyses is rarely exploited. Excluding the studies on blood feeding, the majority 
of the studies only focused on female mosquitoes and the utilisation of male mosquitoes in 
research is severely lacking. Furthermore, a metabolomics study between males and females 
was not found. Given the strength of metabolomics to compare profiles and identify 
differences, it is surprising that no study comparing insecticide resistant and susceptible 
strains was found. Interestingly, all of the studies covered above were either focused or 
linked to the development of mosquitoes. It is also clear that there is a lack of NMR based 
studies. Judging by the experimental designs of pooling samples for both MS and NMR 
studies, researchers might be under estimating the sensitivities of both analytical methods. 
Thus, a gap in single mosquito metabolomics is present and exploring the detection limits of 
these analytical platforms may open up opportunities in mosquito research. 
 
1.6.7 Metabolomics studies on cuticular hydrocarbons 
In the past five years, the importance of CHC in insecticide resistance has been gaining more 
attention in the entomology world. The majority of the previous research on CHC was 
conducted between 1970-1990 by Michael Locke [167]–[172]. More recent work in the field 
was led by the research group of Gary Blomquist [78], [88], [173]–[175]. They established 
that insect CHC is well conserved across insect species as well as identifying similarities of 
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their biosynthesis mechanisms. However, to date, a full characterisation of this process still 
does not exist. Although there are no research papers published on this subject under the 
topic metabolomics, between 1997 and 2018 there were 11 research articles and one review 
(data from Web of Science) using methods that are employed by the metabolomics studies 
(Table 1.6-3). 
 
Table 1.6-3: Publication search on Web of Science with the topics cuticular hydrocarbon, resistance and 
mosquitoes between years 1900 and 2019. Ref: reference 
Species Type Short summary Ref 
Ae. aegypti Research Revealed CHC of older age mosquitoes attract same sex while 
three days old mosquitoes are more attractive to opposite sex. 
[176] 
Age determination of adult mosquitoes using composition of 
CHC compositions from head and thorax. 
[177] 
Ae. albopictus Research Desiccation resistance in mosquito eggs are linked to HC 
composition on the egg shell surface. 
[178] 
An. coluzzii Research CHC abundance alone does not provide desiccation tolerance. [179] 
An. gambiae Research Cyp4g16 functions as a decarbonylase in CHC biosynthesis. [75] 
CHC composition is predetermined before adulthood and are 
altered before and after mating during adulthood. 
[180] 
An. gambiae & 
An. coluzzii 
Research Revealed simulated dry and rainy seasonal conditions does not 
effect CHC composition. 
[181] 
2La chromosomal inversion does not effect CHC composition 
and increases non-branched alkane abundance. 
[182] 
An. stephensi Research Modelled resistance and genetic background through CHC 
profiles. 
[84] 
D. melanogaster Research Decreased CHC levels in Cyp4g1 knock-down strains and 
increased mortality. 
[183] 
Multi resistance mechanisms including thicker CHC layer, 
xenobiotic metabolism and toxin excretion. 
[184] 




Literature searches on cuticular hydrocarbons and metabolomics did not yield a vast 
repertoire of publications. Of the papers found, most were either about insecticide resistance 
in relation to CH resistance or CHC composition and profiles. On the whole, most of these 
studies were in agreement with each other’s finding. 
 
A recent review by Kim et al (2018) took the RNAi approaches in insecticide resistance studies 
and focused on D. melanogaster 91-R strain (DDT resistant) [185]. Although not a study 
carried out on mosquitoes, this well understood model is a close enough relative to 
mosquitoes. Many mosquito studies are based on extrapolations from D. melanogaster 
studies to other mosquito species. In their review, Kim et al drew attention to the 
upregulation of Cyp6g1, Cyp6a2 and Cyp12d1 [185]. These CYPs are known to be involved in 
DDT metabolism although they are not the sole reason why this strain is resistant to DDT 
[185]. Additionally, Kim et al elaborated on the insecticide penetration. As discussed in 
section 1.3.3.4, this phenomenon, also known as cuticular resistance, is the result of 
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alterations in the cuticular layer causing reduced permeability to insecticides. The reviewers 
acknowledge that this mechanism is still largely unknown although they draw attention to a 
particular CYP, Cyp4g1 [185]. This enzyme catalyses a decarbonylation step in the long chain 
fatty acid biosynthesis and is critical for the production of CHCs [87], [183], [186]. 
  
A 2015 study by Gellatly et al investigated the knockdown effects of Cyp4g1 in D. 
melanogaster 91-R strain [183]. Deriving the Cyp4g1 target through literature research, 
Gellatly et al employed a UAS-RNAi knockdown model to observe the effects of Cyp4g1. The 
knock-down flies were studied by mortality bioassays and CHC analysis. From the mortality 
assays, the researchers observed a 25% increase in susceptibility to DDT on the resistant 
strains [183]. Furthermore, using a targeted GC-MS approach, four out of five HCs were found 
to be significantly lower in the knock-down strains [183]. Unfortunately, identification of the 
hydrocarbons was not given, although they were chosen from another study conducted by 
Strycharz et al [184]. A study on a similar premise was conducted in 2013 by Strycharz et al 
where 14C labelled DDT penetration was investigated in D. melanogaster 91-R [184]. The 
control flies (Canton-S strain) used showed higher contact penetration percentage compared 
to the D. melanogaster strain [184]. To supplement these findings, both 91-R and Canton-S 
strains were investigated with transmission electron microscopy, revealing the 91-R strain 
possessed a thicker cuticle [184]. Furthermore, the CHC composition was analysed via GC-
MS and no qualitative differences were found between the two strains although five HCs (9-
triacosane, triacosane, pentacosane, heptacosdiene and heptacosane) were found to be 
significantly different between the two strains [184]. 
 
In 2016, Balabanidou et al conducted a study 'translating' the Cyp4g1 decarbonylase in D. 
melanogaster into An. gambiae. Cross-referencing the over-expressed CYPs of resistant An. 
gambiae with potential An. gambiae orthologues of Cyp4g1, two enzymes were identified: 
Cyp4g16 and Cyp4g17 [75]. These enzymes were also shown to be upregulated in insecticide 
resistant species. A deltamethrin uptake experiment was performed with resistant (Tiassale 
strain) and susceptible (N'Gusso strain) strains of An. gambiae where resistant strains were 
observed to internalise deltamethrin approximately 50% slower [75]. Furthermore, when 
cross-sections of these strains femurs were compared under a transmission electron 
microscope, the resistant strains were found to be significantly thicker, similar to the D. 
melanogaster 91-R strain [75]. Overall, CHC profiles of both strains were analysed via GC-MS 
and no qualitative differences were found [75]. Furthermore, HC levels were compared as a 
total with no individual HC levels being reported. In order to further characterise these two 
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enzymes, an immunostaining assay was performed, revealing both enzymes reside within 
the oenocytes, but are sub-localised differently. Cyp4g16 was found to be associated with 
the plasma membrane on the intracellular side whereas Cyp4g17 is dispersed throughout the 
cytoplasm [75]. Balabanidou et al tried to express both of these enzymes in order to evidence 
their role in decarbonylation. Unfortunately, only Cyp4g16 could be expressed as a fusion 
protein with CYP reductase at levels high enough to test its decarbonylase activity in vitro 
[75]. Balanbanidou et al showed evidence for cuticular resistance in An. gambiae and 
identified an enzyme which can be used to further study the mechanism that can give an 
insight into the function of CHCs. 
 
It is generally known that CHCs have an important role in waterproofing mosquitoes [78], 
[86], [87]. Alterations in the CHC structure can also affect a mosquitoes resistance to 
desiccation. A 2010 study by Urbanski et al investigated the molecular physiology of Ae. 
albopictus eggs in terms of desiccation resistance [178]. Their study focused on the egg 
diapause initiated by photoperiods in temperate and tropical populations. This was 
investigated by profiling the HC composition on the surface of eggshells and quantifying a 
fatty acyl-CoA elongase which is known to be upregulated in shorter days [178]. They 
employed a GC-MS platform to quantify HCs on the eggshells although the data obtained was 
not shown. Urbanski et al reported higher surface HCs in temperate populations under 
shorter days, whereas tropical populations showed no difference [178]. None of the 
conditions showed a qualitative difference in the HC profiles [178]. Similar results were also 
reported for the fatty acyl-CoA elongase quantities [178]. This was attributed to the 
requirement for higher desiccation resistance in temperate populations due to the harsh 
winters. Interestingly, the temperate population showed a significant difference between 
shorter (higher HC) and longer (lower HC) days. Both days were lower than in tropical 
populations which showed no significant difference between shorter and longer days. 
Unfortunately, the results from temperate and tropical populations were not statistically 
compared to each other and so it is unknown if these differences are significant or not. 
Nevertheless, a clear link between HCs and desiccation is evident. As such, it was also studied 
by Arcaz et al in 2016, this time in An. coluzzi. Arcaz et al investigated the effects of thoracic 
spiracle size and CHCs on desiccation tolerance [179]. In their study, a mortality assay was 
used under dry and rainy season conditions. Each mosquito was weighed prior to the 
experiment. During the experiment, mosquitoes had no access to food or water. Dead 
mosquitoes were collected and weighed to assess water loss. Additionally, randomly selected 
dead mosquitoes were placed in a desiccation oven prior to dissection for spiracle size 
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measurement, followed by CHC analysis by GC-MS. There was no significant difference 
reported between the initial and end mass of mosquitoes [179]. Arcaz et al concluded that a 
higher total CHC abundance was not the sole determinant of desiccation tolerance, but that 
the abundance of specific CHCs played an important role in desiccation tolerance [179]. A 
caveat to this study is CHC profiling was performed on dead mosquitoes which were starved 
and not supplied with water. Under such conditions, the HC profile might have been altered 
due to extreme stress. For example, in desiccation conditions, mosquitoes can oxidise 
triglycerides to produce water [187]. 
 
Perhaps within the studies covered here, Hidalgo et al (2018) produced the most 
comprehensive study investigating differences between dry and rainy season condition in 
Anopheles species (An. gambiae and An. coluzzi). In order to probe the physiological and 
metabolic mechanism of the well-known aestivation process, Hidalgo et al used a 
combination of gas exchange measurements, gene expression analysis and HCs profiling. In 
total, three populations (two An. coluzzi, one An. Gambiae) were bred in dry and rainy season 
conditions [181]. The profiling of these mosquitoes was performed by measuring gas 
exchange (O2 and CO2), flight activity, allometric measures, gene expression and CHC 
fingerprints [181]. Due to the scope of this literature search, only the CHC profiling and its 
relation to the desiccation will be discussed. The CHC profile of each population was measure 
via GC-MS and a total of 13 compounds were identified and quantified [181]. Linear 
discriminant analysis showed a clear separation between the dry and rainy season 
populations. Although the loadings of the discriminant analysis were not discussed in detail, 
three metabolites can easily be seen from the loadings: 3-methylpentacoase, 13-
methylhexacosane, and n-heptacoase [181]. When HCs and their properties are considered, 
alkanes are classed as the compounds with the highest waterproofing properties, although 
it is interesting to see methyl branched alkanes were influential in the discriminant analysis.  
  
The remaining publications that were found during the literature search were more focused 
on the profiling of the CHCs in mosquitoes. An early study on An. stephensi in 1997 by 
Anyanwu et al used a GC approach to investigate the CHC profiles of four strains, where two 
were resistant and two were susceptible to DDT and malathion [84]. This study used GC 
chromatograms to profile CHCs and used a combination of PCA and linear discriminant 
analysis to model the differences between different experimental groups [84]. Surprisingly, 
the discriminants were not dissected further in order to determine the most influential HCs 
in the discrimination. The study successfully managed to model the resistance status by CHC 
 62 
profiles although their genetic background could not be supressed [84]. It should be noted 
that, it was reported that all four strains were obtained from a laboratory, but how long these 
strains were maintained for was not reported. This might explain the interference of genetic 
background in the analysis. This study acknowledges the genetic background was a limitation 
and the fact that there are four population where half are resistant and the other half 
susceptible could have been investigated differently. Discriminant analysis could have been 
performed to accentuate differences between resistance status giving the study more 
confidence over the result. Furthermore, investigating the discriminants themselves would 
have given an insight into the key HCs in discriminating between different populations as well 
as resistance status. 
 
A similar study was undertaken by Liebman et al in 2015, investigating the effects of diet on 
age determination in Ae. aegypti using near infrared spectroscopy (NIRS) [177]. NIRS is a lot 
less common compared to NMR and MS in metabolomics studies although typically Fourier-
transform infrared spectroscopy (FTIR) is used. Liebman et al investigated the effects of diet 
in determining the age of Ae. aegypti mosquitoes. In order to do this, measurements from 
the head and thorax were taken without extraction via NIRS which measures the CH, NH and 
OH functional groups [177]. In their study, Liebman et al focused on correctly classifying 
mosquitoes with a cut off of 7 days old. This was selected since it takes 7 days for female Ae. 
aegypti to become infected with Dengue virus after an infected blood meal [177]. Due to the 
nature of NIRS which measures the absorbance of functional groups, it is not always possible, 
if at all, to identify individual CHCs, although the cumulative absorbance recorded from the 
CHC layer can be used to create a statistical model representing the CHC layer. Statistical 
models were built by either fitting a linear or polynomial model [177]. The highest performing 
model was a polynomial model with an R2 of 0.6, which is not particularly high [177]. Liebman 
et al discussed that regardless of the poor fit of the model, the prediction results with a 7 
days old cut off was satisfactory and should be further improved by acquiring more data 
[177]. Although this may be true, the data presented in this work suggests that the prediction 
model is highly variable. For each age group, the predictions vary by approximately ± 3-4 
days. NIRS is a very portable method compared to NMR and MS and can have a great impact 
in field studies. However, the statistical approaches taken need to be revised to fully explore 
the suitability of NIRS in such applications although it is unlikely for NIRS to be a common 
application for CHC profiling on its own. 
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GC-MS is currently considered the current gold standard for CHC profiling. Two studies 
conducted in 2014 by Wagoner et al [180] and Reidenbach et al [182] both investigated 
changes in Anopheles species in dry and rainy seasons using GC-MS profiling. Wagoner et al 
focused on the water control mechanisms in these seasonal conditions whereas Reidenbach 
et al investigated the mechanisms through inversion of 2La chromosome. Wagoner et al 
hypothesised larvae maintained under dry season conditions (i.e. shorter days) would induce 
aestivation and would produce larger adults with smaller spiracle size in order to preserve 
more water [180]. In their research, Wagoner et al compared the wing size, spiracle size and 
CHC composition of larvae and adults under dry and rainy season conditions [180]. Dry and 
rainy seasons were simulated through different relative humidity as well as different length 
photoperiods. Wagoner et al reported wing size of adults in the dry season conditions were 
4.4% larger [180]. Interestingly, these mosquitoes also took a shorter time to hatch 
compared to the shorter winged rainy season mosquitoes. When the spiracle sizes were 
compared, dry season mosquitoes showed a 5% increase in size which was unexpected as 
during dry season conditions, it would be expected for spiracle size to be smaller in order to 
have better control over water loss [180]. Mosquitoes lose water through respiration which 
happens through the spiracles. It can be speculated that larger mosquitos would require 
larger spiracles in order to have enough gas exchange for their body size, even though this 
may result in more water loss. Wagoner et al (2014) used a GC-MS approach to analyse CHCs 
and did not report any qualitative differences between the two seasons. On the other hand, 
when their quantities were considered, dry season mosquitoes had significantly more CHCs 
compared to rainy season mosquitoes [180]. A total of 15 CHCs were reported with only nine 
being identified (six alkanes, two alkenes and one dimethyl-alkane) [180]. Unfortunately, the 
CHC levels were not standardised to the body size and so it is unknown if this difference is 
due to seasonal conditions. A previous study by Urbanski et al (2010) [178] reported higher 
CHCs on Aedes eggs undergoing quiescens in drier seasons and so such CHC changes are likely 
to be seasonal. Another interesting observation reported was that regardless of the rearing 
condition the young virgin females did not present any difference in their CHCs. Thus, 
Wagoner et al concluded that CHC composition is predetermined during the larval and pupal 
stages and is not affected by the seasonal conditions [180]. In spite of pupal variation, CHC 
composition is dynamically altered in adulthood, especially between virgin and mated 
mosquitoes. This is most likely for mating purposes. A caveat to this study is that in order to 
simulate the dry and rainy seasons, both humidity and day lengths were altered. Although 
this creates a better representation of the seasons, it also introduces extra variations in the 
experiment with the changes of two variables rather than one. These variations should have 
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been taken into account either in the experimental design or acknowledged in the 
discussions as a limitation. 
 
Reidenbach et al (2014) investigated the same seasonal effects on An. gambiae and An. 
coluzzi with 2La chromosomal inversion [182]. Chromosome inversion is the 180˚ rotation of 
a chromosome segment in its location and can occur naturally. By doing so, the information 
content in the original segment (2La) is unchanged, but the order of the information is 
inverted (2L+a) [182]. The segment 2La has been implicated to effect heat and desiccation 
tolerance in literature [182]. Reidenbach et al measured the water lost between the 
karyotypes 2La and 2L+a under two seasonal conditions and reported significantly higher 
water loss in 2La karyotype mosquitoes [182]. Further extrapolating on the desiccation 
resistance properties, the CHC profiles were analysed in order to reveal if any link between 
2La karyotype and CHCs is present. Reidenbach et al reported sixteen CHCs (nine alkane, two 
alkene, four methyl-branched alkanes, and an unidentified) with no qualitative difference 
between karyotypes or seasonal conditions [182]. In arid conditions, unbranched alkanes 
were preferred over branched alkanes in either karyotype. Additionally, in the inversion 
karyotype (2L+a), a greater abundance of unbranched saturated alkanes was observed [182]. 
The 2L+a karyotype showed a higher abundance of alkanes compared to the 2La karyotype, 
irrespective of seasonal conditions [182]. Reidenbach concluded that the inverted 2L+a 
karyotype gives higher waterproofing properties to the mosquito. Reidenbach also noted 
that this inversion is rare in desiccation resistant species suggesting water control 
mechanisms might be more complex and have multiple compensation mechanisms 
associated with them. 
 
The last study on CHC profiling found in the literature search was the 2016 study by Hamid 
et al investigating the behavioural response to CHCs in Ae. aegypti. Using GC-MS, Hamid et 
al identified n-heptacoase as the major constituent of the CHC extract via hexane [176]. 
Within this extract, all reported compounds were long chain alkanes. In this behavioural 
study, mosquitoes' attraction to CHCs of different ages were tested [176]. The experimental 
design tested male and female hexane extract on the same sex and the opposite sex. Hamid 
et al reported that both males and females were more attracted to the older members of 
their own sex, while for the opposite sex, both were most attracted to three day old members 
[176]. An interesting result of this study is that previously alkanes were typically not referred 
to as compounds with communication properties [Chung and caroll] and so it suggests that 
perhaps long-chain alkanes could be used in communication as well as waterproofing in 
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mosquitoes. If so, given their more stable nature compared to pheromones, n-alkanes might 
be used in the communication of more static information such as age, sex, and maturity 
rather than information of a more dynamic nature such as surroundings and potential 
danger. Another explanation might be that the minor constituents of the hexane extract 
contain semiochemicals used in communication which are very potent or more simply that 
long chain alkanes have more than one property which has not been fully characterised yet. 
 
From the studies covered in this section, there is a clear link between CHCs and their role in 
resistance via reducing the insecticide penetration. Furthermore, there is strong evidence in 
the Cyp4g family, especially Cyp4g16, for their role in hydrocarbon production as 
decarbonylases. Several studies showed strong evidence of a higher abundance of total CHCs 
in desiccation and/or insecticide resistant species, particularly the alkanes and methyl 
branched alkanes. Interestingly, no study investigated the precursor of these mechanism, 
thus creating a knowledge gap. 
 
Considering the studies covered in section 1.6.6 and here, three topics stood out as areas for 
further investigation. 
 
1) The lack of metabolomic studies between males and females in mosquitoes should be 
addressed. Establishing the metabolic differences between sexes can yield important 
information on how experiments should be designed (e.g. pooling of males and females). 
2) A metabolomics polar approach into increasing the understanding of the relationship 
between CHCs and the Cyp4g16 and Cyp4g17 enzymes. 
3) A comparison study of the polar metabolites of resistant and susceptible species. 
 
The work presented in this thesis will try to fill these knowledge gaps. 
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1.7 Aims and objectives 
The overall objective of this work was to use NMR metabolomics to bring further knowledge 
on insecticide resistance and differences in metabolism between the sexes in mosquitoes. 
More specifically, Cyp4g16, and Cyp4g17-related mechanisms thought to be involved in 
cuticular resistance through pupal and adult life stages were investigated. Furthermore, wild 
type resistant and susceptible mosquito strains were compared in order to deepen the 
understanding on resistance in wild type mosquitoes. This project is based on the hypotheses 
that (i) the different life stages of mosquitoes have distinct metabolic needs, and (ii) the 
development of resistance through enzymatic alterations will manifest changes in metabolic 
pathways that can be characterised through NMR metabolomics. This entirely novel research 
investigation is carried out in close collaboration with Dr. Gareth Lycett at the Liverpool 
School of Tropical Medicine. 
 
Anopheles and Aedes species are vectors of 31% of the closely monitored diseases by WHO. 
Anopheles species account for the highest mortality, and the Aedes species account for the 
greatest number of diseases contracted. Within these genera, An. gambiae and Ae. aegypti 
have been identified as the most important vectors and as such were selected for this project. 
Furthermore, in order to explore CHC involvement in resistance, the effects of Cyp4g16 and 
Cyp4g17 KDs were selected as paralogues of Cyp4g1 found in D. melanogaster. In this project, 
NMR was selected as the primary analytical technique as mosquitoes typically weigh around 
1-2 mg providing enough material for measurment, with NMR providing a very robust and 
reproducible pipeline where the majority of the data acquisition can be automated which 
aids with consistency.  
 
The outline of the following chapters are: 
 
In chapter 2, the methods employed in the metabolomics framework that was developed are 
explained in detail, covering mosquito rearing to data analysis. 
 
In chapter 3, metabolic differences between sexes in An. gambiae and Ae. aegypti species 
across pupal and adult stages will be determined. In order to accomplish this, a metabolomics 
framework will be built based on previous methods published on metabolite extraction, data 
acquisition and data analysis. This is a novel study and as such a considerable amount of time 
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was spent on optimising the sample preparation, data acquisition and specifically data 
analysis protocols. 
 
In chapter 4, mosquitoes carrying individual gene knock-downs of Cyp4g16 and Cyp4g17 
from pupal and adult stages will be compared using the metabolomics framework 
established. Both Cyp4g16 and Cyp4g17 are thought to catalyse the same decarbonylation 
step, although both enzymes have distinct secondary structures and exhibit different 
temporal expression profiles at early larval stages. This chapter aims to increase the 
understanding of the differential function of these genes through analysis of metabolite 
disruption in the mutant mosquitoes and the relevant metabolic pathways affected. 
 
In chapter 5, wild type mosquito strains resistant to insecticides are compared to susceptible 
strains in both sexes using the metabolomics framework. The strains tested are An. gambiae 
VK7 (resistant) and N’Gusso (susceptible) and Ae. aegypti Cayman (Grand Cayman; resistant) 
and New Orleans (USA; susceptible). A caveat to these studies is that these strains do not 
have close intraspecies genetic backgrounds which may interfere with creating a more 
complex analysis. The analysis is performed at pupal and adult stage to probe the resistance 
profile of wild type mosquitoes. 
 
In chapter 6, a discussion of the results obtained in chapters 3-5 will be carried out in relation 
to the literature and overall conclusions are drawn. Additionally, further improvements, 
future work and applications of the findings are discussed. Finally, this work has been 
critiqued in terms of assumptions, limitation, and disadvantages. 
  
 68 
Chapter 2  
2 Materials and methods 
2.1 Mosquito rearing 
All mosquitoes were reared in the Liverpool School of Tropical Medicine (LSTM) under the 
supervision of Dr Gareth Lycett. For all rearing the following conditions were used: 
temperature: 27 ˚C, humidity: 75%, 12:12 hour:hour night and day cycle with dusk and dawn 
simulations (30 min each). All mosquitoes were reared from established colonies (100% 
clonal adaptation). 
 
2.1.1 Floating eggs  
Eggs were laid by female mosquitoes on a filter paper (Whatman, UK) after a blood meal (An. 
gambiae: fresh blood donated by Dr Gareth Lycett, Ae. aegypti: 50% red blood cells in blood 
plasma (National blood service, Liverpool) with Haemotek membrane feeding system: 
SP4W2 (Haemotek; Blackburn, UK). These eggs were floated on trays with tonic salt water 
(TSW). To prepare TSW, Pond Guardian Tonic Salt (Interpet; Surrey, UK) was dissolved in 
reverse osmosis (RO) water (1 gL-1). A plastic tray (7.5 x 25 x 25 cm) was filled with TSW up 
to 1 cm in height. Filter paper containing the eggs was then washed with TSW using a wash 
bottle over the tray and the filter paper left floating on the tray. To prevent contamination, 
the tray was covered with a net. Eggs and the filter papers were washed twice a day with 
TSW using a wash bottle until the eggs hatched. 
 
2.1.2 Larval stage 
When eggs hatched, the filter paper was removed from the trays. The trays were washed 
daily with TSW and all the larvae were fed. An. gambiae larvae were fed with TetraMin fish 
food (Tetra; Melle, Germany) and Ae. aegypti larvae were fed with 300 mg of brewers yeast 
(Natures Aid; Huddersfield, UK). Trays containing more than 200 larvae were split into two 
trays. This process was repeated until all larvae hatch into pupae. 
 
2.1.3 Pupal stage 
 All pupae samples were collected within 12 hours of pupating. Pupae samples were collected 
and placed in bowls containing fresh TSW. The collected samples were sex classified and 
screened (if required) under a microscope (Figure 2.1-1). Each pupa was then transferred 
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into a new Eppendorf with 500 µL of TSW to wash off the dirty water from the larvae tray. 
After this washing step, the TSW was removed and samples were flash frozen in liquid 
nitrogen. Collected samples were stored at -80˚C until extraction.  
 
 
Figure 2.1-1: Comparison of male (left) and female (right) pupa illustrations. Sexing pupa can easily be achieved 
by comparing genitals (red circles) by the anterior fins. 
 
To rear adults, pupae were collected within 12 hours of hatching and placed in bowls with 
fresh TSW. These bowls are then placed in buckets and covered with netting. Damp cotton 
wool soaked in 10% sucrose (Tate and Lyle, UK) dissolved in TSW was placed in the bucket; 
this provided the feed for the maturing mosquitoes. 
 
2.1.4 Adult stage  
Mosquitoes that emerged were collected via standard mouth aspirator within 12 hours of 
emergence. After collection with the aspirator, mosquitoes were anesthetised using CO2 (5 
Lmin-1 flow rate). Anesthetised mosquitoes were sexed visually and placed in individual 
Eppendorf tubes via fine point forceps. Upon waking (typically 5 minuntes after aesthesia), 
mosquitoes were checked prior to collection. Only mosquitoes that were intact and capable 
of flying were collected for analysis. Collected samples were flash frozen in liquid nitrogen 
and stored at -80 ˚C until extraction. 
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2.1.5 An. gambiae knock-down crossing and Gal4/UAS screening 
The generation of the Gal4/UAS (Figure 2.1-2-A) transgenic mosquito lines was performed by 
Dr Gareth Lycett and a detailed explanation of the procedure can be found in Lynd et al 2019 
[188]. Briefly, an oenocyte specific Gal4 driver line was created by insertion of a promoterless 
Gal4 gene into the An. gambiae genome close to a suspected oenocyte enhancer. The Gal4 
construct was marked with a red fluorescent protein gene. Suitable UAS vectors to induce 
RNAi of each gene were also constructed, in this case using an eYFP (yellow fluorescent 
protein) marker gene. In order to create the Cyp4g16 and Cyp4g17 knock-down constructs, 
fragments of the respective An. gambiae genes from a G3 strain were cloned. These 
fragments were placed as two copies in opposite orientations, separated by their native 
introns to create templates that would be transcribed and spliced to produce hairpin RNA 
interference (RNAi) constructs. These hairpin fragments were cloned downstream of the UAS 




Figure 2.1-2: A) Gal4/UAS system requires a line with a driver and a line with a responder. Upon breeding, some 
progenies will have both the driver and responder lines. When they are present together, the driver line promotes 
production of Gal4 (red fluorescens) which is recognized by the UAS system (yellow red fluorescens). The 
activated UAS system will promote the expression of the gene on the responder line. This can be a gene to 
overexpress a protein or knock-down a gene, such as RNA interference (RNAi) for knock-downs. B) Crossing of 
Gal4 driver and UAS responder lines to produce mosquito eggs with knock-down mosquitoes. 
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A PhiC31 vector was used to transform two different docking strains of An. gambiae embryos 
to generate the driver and responder lines. For Gal4 driver lines, early embryos from 
transgenic attP docking line A14, in which the docking site was under the transcriptional 
influence of an oenocyte enhancer, were co-injected with the Gal4 donor plasmid and PhiC31 
helper plasmid [188]. Similarly, for generation of cyp4g16-RNAi and cyp4g17-RNAi, the 
respective UAS plasmids were co-injected with helper plasmid into embryos from A11 line 
[188]. Following the injections, mosquitoes were reared under standard conditions and 
mated to wild type mosquitoes, as explained in section 2.1. Larval progeny from these 
matings were screened for the fluorescent eye markers to identify individuals carrying stably 
inherited driver (red fluoresence) and responder (yellow fluoresence) constructs. These were 
interbred to create populations of each of the transgenic driver and responder lines. 
  
In order to activate the knock-downs of Cyp4g16 and Cyp4g17, pupae were collected from 
the established transgenic lines for sexing, screening and crossing. Sexing and screening for 
the Gal4 driver (RFP) and UAS responder (YFP) was performed using a Leica MZFLIII 
microscope. Figure 2.1 2 shows the crossing performed in order to knock-down Cyp4g16 and 
Cyp4g17. Upon sexing and screening, up to 50 pupae from each of following sexed strains 
were selected: male Gal4, female Gal4, male Cyp4g17 responder and female Cyp4g16 
responder, and crossed to produce progeny that expressed the respective RNAi hairpins in 
an oenocytes specific manner (Figure 2.1-2-B). 
 
2.2 Metabolite extraction  
All extractions were performed on samples retrieved from -80 ̊ C storage. Due to the residual 
water in pupae samples, thawing of the residual ice was performed over ice ensuring a 
uniform interaction of the solvent with the sample. To keep the extraction protocol 
consistent adult samples were thawed over ice prior to extraction in the same manner. All 
solvents used in the extraction procedure were ice-cold. Except for the different solvent 
composition, both polar and non-polar extraction procedure follows that same protocol 




Figure 2.2-1: A typical extraction method starting from a fresh/stored sample. Addition of the extraction required 
solvent (polar or non-polar) followed by an incubation over ice ensured solvent penetration through the sample. 
Homogenisation was critical for the separation of protein and small molecules. Homogenised samples were 
centrifuged to separate the debris and precipitants (this allowed the solution of metabolites to be extracted). The 
supernatant was lyophilized and metabolites either stored or prepared for analysis. Dry pellets were mixed with 
the appropriate buffer depending on the technique (Mass spectrometry or NMR) to be used. In this illustration 
the technique was NMR.  
 
Extraction method of polar metabolites was adapted from Beckonert et al [189]. For polar 
metabolite extraction, a 50% acetonitrile (HPLC grade Fisher scientific) solution in RO water 
was used. Each sample was mixed with 500 µL of 50% acetonitrile and incubated on ice for 
10 minutes. Samples were then homogenised using a sonicator (MSE Soniprep 150 plus) 
fitted with an exponential probe operating at a frequency of 23 KHz and amplitude of 10 µm. 
Each sample was sonicated with 3 x 30 s pulses and 30 s breaks in between pulses over an 
ice bath. Homogenised samples were then centrifuged at 21,000g for 10 minutes at 4 ˚C to 
separate the non-soluble material. Aliquots from the centrifuged samples were transferred 
to a fresh microtube. Each was flash frozen in liquid nitrogen prior to lyophilisation. Frozen 
samples were lyophilised (Thermo Scientific, Power dry CL 3000) at -56 ˚C for 16 h. 
Lyophilised samples were stored at -80 ˚C until NMR sample preparation. 
 
Sample retrieved from -80 ˚C storage were mixed with an NMR buffer solution comprised of 
100 mM sodium phosphate buffer (Sigma-Aldrich), 0.1 mM 3-(Trimethylsilyl)propionic-
2,2,3,3-d4 acid sodium salt (TSP) (Sigma-Aldrich), 1.2 mM sodium azide (Sigma-Aldrich) in 
2H2O (Sigma-Aldrich) was used. Lyophilised samples were mixed with 200 µL of the NMR 
Buffer. Each sample was then vortexed and centrifuged at 12,100g for 2 minutes. Samples 
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were then transferred to NMR tubes (diameter: 3 mm, length: 103.5 mm & Borosilicate 
glass). 
 
2.3 NMR setup and data acquisition 
All samples were acquired using a Bruker Ascend 700 MHz spectrometer fitted with a 5 mm 
TCI Cryoprobe, Avance III HD console and a SampleJet automated sample changer with a 
chiller set to 4 ˚C. 
 
2.3.1 Temperature calibration 
NMR data is sensitive to temperature fluctuations. Although the temperature can be kept 
stable in the magnet, environmental temperature can cause an offset in the temperature 
setting process. To minimise environmental temperature fluctuations, NMR spectrometers 
are kept in a temperature controlled environment set to 21 ˚C.  
 
Changes in temperature causes systematic shift in an NMR spectrum. These shifts are on a 
linear scale by nature hence can be exploited to measure the actual sample temperature 
once it is inserted into the probe [190]. By measuring the distance between two peaks in a 
99.8% Methanol-d4 sample (Bruker, product code: Z10627) the actual sample temperature 
sitting on the probe was calibrated with an accuracy of ±0.1 ˚C [190]. 
 
2.3.2 Shimming 
NMR data acquisition requires a homogenous magnetic field in the three-dimensional space. 
When a sample is inserted into the magnet, it interferes with the homogeneity of the 
magnetic field. Between samples of similar nature, the magnetic field on the Z-axis distorts 
the most, whereas X and Y axes fields are more stable. Prior to each dataset, magnetic field 
homogeneity was calibrated using a standard sample comprised of 2 mM Sucrose, 0.5 mM 
4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS), 2 mM sodium azide in 90% 1H2O and 10% 
2H2O with 40 mm filling height (Bruker, product code: Z10902). Following calibration, the TSP 
signal was used to assess the homogeneity of the magnetic field. Overall peak shape and half 
height full width (HHFW) was checked (less than 1 Hz). 
 
2.3.3 Water suppression 
Water is the most common solvent for NMR in biological samples. Due to the high abundance 
of 1H isotope using water gives a very intense signal that saturates the receiver hence, 
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masking signals coming from metabolites with low concentrations. In order to overcome this 
problem all samples were dissolved in NMR buffer prepared in 99.9% 2H2O. Even though 2H 
is not detected by NMR, exchange with 1H and trace amounts of 1H2O can still cause signal 
overflow and/or distortions around water region (approximately 4.7 ppm). This was resolved 
by using NMR solvent suppression methods. Two most commonly used were used 
presaturation and excitation sculpting were used for 1D and 2D experiments respectively. 
 
2.3.3.1 Presaturation 
Presaturation suppression is applied by irradiating the solvent resonance with long low-
powered selective pulse before the experimental pulse sequence is initiated. By applying this 
selective pulse, the water spins are flipped on to the X-Y plane while the spins arising from 
metabolites are still on Z-axis. By applying the first hard 90˚ pulse of the experiment, all 
metabolite spins are flipped on to the X-Y plane where acquisition can take place. This first 
hard 90˚ pulse also flips the water spins which were on the X-Y plane to Z-axis where no 
acquisition occurs. Therefore, supressing the signals originated by the 1H in water. In this 
project the presaturation was applied with a power level of 49.98 dB for 20 µs. 
 
2.3.4 NMR data acquisition 
Throughout this project 4 NMR experiments were used to generate data. 1D-Nuclear 
Overhauser spectroscopy (NOESY) were used for checking the shims and water suppression 
per sample during data acquisition. Carr-Purcell-Meiboom-Gill (CPMG) experiment was used 
to measure metabolites for statistical analysis. 1H-1H total correlation spectroscopy (1H-1H 
TOCSY) and 13C-1H-heteronuclear single quantum coherence (13C-1H HSQC) for 
complementary information on metabolite identification. 
 
2.3.4.1 1D-Nuclear Overhauser spectroscopy (1D-NOESY) 
1D-NOESY experiment is a 1H experiment where both large and small molecules can be 
observed. It is based on a 2D experiment where coupling between 1H-1H is observed through 
space. The 1D implementation of this experiments uses presaturation and gradient pulses to 
achieve water suppression. In this project this experiment was utilised as a quality check 
during data acquisition as well as a critical part of the automation process for high-
throughput. The automation program integrated to the 1D-NOESY experiment was used to 
save common experimental parameters to be transferred to the subsequent experiments 
such as: CPMG, 1H-1H TOCSY and 13C-1H HSQC. 
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2.3.4.2 Carr-Purcell-Meiboom-Gill (CPMG) 
CPMG is a 1D 1H experiment where larger molecules are filtered out by exploiting the 
relaxation properties of molecules. When excited with a pulse, over time molecules will 
‘relax’ (T1 relaxation) and recover their pre-excited state on the Z-axis (along the magnetic 
field). Relaxation time and molecule has an inverse relationship, where larger molecules relax 
faster, and smaller molecules relax slower. In a CPMG experiment using carefully timed 
pulses, molecules are ‘locked’ on the X-Y plane (also known as spin echo lock) for a 
predefined time. While ‘locked’ relaxation takes place and larger molecules relax quicker 
than smaller ones. When the signal acquisition starts larger molecules are effectively filtered 
out while smaller molecules remain. 
 
In this project CPMG experiment was used as the main source of data for statistical tests. It 
was preferred over 1D-NOSEY due to the residual large molecules that could not be 
separated via physical methods (i.e. extraction and centrifugation). 
 
2.3.4.3 1H-1H Total correlation spectroscopy (1H-1H TOCSY) 
TOCSY is a homonuclear experiment where correlations within an unbroken chain of coupled 
spins are observed. TOCSY is an extension of the experiment correlation spectroscopy (COSY) 
where the coupling between 1H-1H through 3 bonds is observed. Unlike COSY, TOCSY can 
observe couplings four of more covalent bonds away. For example, if 1H-A is coupled to 1H-B 
and 1H-B to 1H-C while 1H-A is not directly coupled to 1H-C, TOCSY would show a correlation 
both from 1H-A to 1H-B and 1H-A to 1H-C. In TOCSY experiments, the covalent bond coverage 
depends on a parameter called 'mixing time' where longer time is required for higher number 
of bond correlations. The trade of is that higher mixing time results in longer acquisition time 
and a reduction in sensitivity due to relaxation of the molecules. 1H-1H TOCSY experiments 
were used to resolve ambiguity in 1D-NMR identification due to overlapping. For all TOCSY 
experiments a mixing time of 80 ms were used. 
 
2.3.4.4 13C-1H Heteronuclear single quantum coherence (13C-1H HSQC) 
HSQC is a heteronuclear correlation experiment typically in between 13C-1H or 15N-1H. HSQC 
achieves heteronuclear correlation through transferring of polarisation from highly abundant 
NMR active nuclei (typically 1H) to lower abundant NMR active nuclei (e.g. 13C). This is called 
insensitive nuclei enhanced by polarisation transfer (INEPT). Following the transfer of 
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polarisation from 1H to 13C, the sensitivity enhance polarisation is transferred back to 1H for 
direct measurement. By doing so chemical shifts of 13C are indirectly recorded on the directly 
measured 1H dimension. An 13C-1H HSQC shows chemical shifts of protons and carbon that 
are directly bonded. Benefiting from the large chemical shift scale of 13C (0-200 ppm), 
overlaps observed in 1H spectra (due to low chemical shift range of 0-12 ppm) can be resolved 
further. 
 
2.3.4.5 NMR experiment parameters 
NMR experiments were acquired as following: 1H 1D-NOESY (48 K complex points, 32 scans, 
4 dummy scans) and 1D with 1H 1D-CPMG pulse (48 K complex points, 128 scans, 4 dummy 
scans) experiments were acquired for each sample. Further details of the experiments are 
shown in Table 2.3-1. 
 
Table 2.3-1: Acquisition parameters for NMR experiments. 
Experiment 1D-NOSEY CPMG 1H-1H TOCSY 13C-1H HSQC 
Pulse program noesygppr1d cpmgpr1d dipsi2esgpph hsqcetgpsisp.2 
Complex points(a) 1H = 48 K 1H = 48 K 1H = 2048 1H = 1024 
   1H = 512 13C = 512 
Number of scans 128 128 16 32 
Dummy scans 4 4 32 16 
Temperature [˚C] 25 25 25 25 
Acquisition time [s] 2.7262 2.7262 1H = 0.1218 1H = 0.0731 
   1H = 0.0304 13C = 0.0121 
Spectral width [ppm] 25.75 25.75 1H = 12.0018 1H = 10.0015 
   1H = 12.0018 13C = 119.8242 
Receiver gain [rel] 79.66 79.66 169.84 169.84 
Dwell time [µs] 27.73 27.73 59.5 71.4 
Relaxation delay [s] 4 4 2 1.5 
Mixing time [ms] 10 NA 80 NA 
 (a)K is equal to 1024. 
 
2.3.5 NMR spectra processing 
Acquired spectra were processed using standard automation routines for consistency. 
Spectra were first zero filled 128 K data point (K = 1024), followed by standard Bruker phase 
correction method apk0.noe where an exponential window function with 0.3 Hz line 
broadening is applied prior to Fourier transformation. Lastly, spectral referencing set as such 
that TSP signal is at 0 ppm. No baseline correction was applied during processing. 
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2.3.6 NMR spectra quality control and binning  
Spectra were individually checked for quality control (QC). During QC, spectra were checked 
for overall flat baseline, width of the water residue (less than 0.25 ppm), half height full width 
of TSP peak (less than 1 Hz), presence of TSP 29Si satellite peaks and overall shape of TSP 




Figure 2.3-1: Proton NMR spectrum from a knock-down An. gambiae pupa satisfying the QC criteria. The spectrum 
demonstrates an overall flat baseline, symmetrical TSP (0 ppm) signal with a HHFW less than 1 Hz with satellite 
peaks arising from 29Si in TSP and finally a water residue (4.5-5 ppm) less than 0.25 ppm. 
 
In an NMR spectrum, the area under the peak is directly proportional to the concentration 
of the compound. In order to convert NMR spectra into a dataset that can be analysed with 
statistical methods, the peaks in the spectra are integrated. This process is called spectral 
binning and can be performed either by a set interval (incremental binning) or by manual 
selection (variable sized binning). In this project, manual selection was used in spectral 
binning. Each bin was defined by their chemical shift boundaries (in ppm), non-overlapping 
multiplet signals were binned together. Spectra were integrated using the defined 
boundaries via AMIX (Bruker, Coventry). Following peak integration, each peak was divided 
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by the peak region. During the binning process the water region (around 4.7 ppm) was 
excluded. 
 
2.4 Metabolite assignment 
Metabolite assignment is one of the critical processes in metabolomics as it is essential to 
know metabolite identities in order to find biomarkers and perform pathway analyses. The 
current acknowledged metabolite assignment standard is set by the metabolomics standards 
initiative (MSI) [191]. Although this method works well with MS techniques, it does not 
capture some of the intrinsic features of NMR. Table 2.4-1 shows an adaptation of the MSI 
scoring system in order to reflect NMR features. 
 
Table 2.4-1: MSI assignment confidence levels adapted for NMR metabolomics. 
Confidence level Description 
Level 1 Identified metabolites. This level requires two or more orthogonal properties 
of a standard compound to be analysed in the same laboratory where the 
experiment was conducted. 
Level 2a* Identified metabolites. This level requires matching one property of a 
standard compound analysed in the same laboratory where the experiment 
was conducted. 
Level 2b* Putatively identified metabolites. In contrast to identification, level 2a does 
not require the standard information to originate from the same laboratory. 
Level 3 Putatively characterised compound classes. Same as level 2 annotation, it is 
used when the molecule can only be annotated as a particular class rather 
than a specific metabolite. 
Level 4 Unknowns. Peaks that can be reproducibly detected and quantified. 
*: Only for metabolites with NMR signature comprised of multiple signals. 
 
Acquired spectra were assigned to individual metabolites using of the Chenomx software 
(Chenomx, CA) and an in-house library of metabolite spectra. Chenomx-identified 
metabolites were checked with in-house 1D standards (where available) to improve 
assignment confidence. Metabolite identification was also carried out by using 2D in-house 
spectra (1H-1H TOCSY and 1H-13C HSQC). Confidence scoring was performed according to the 
MSI scoring system where level 2a and level 2b are assignments done by internal and external 
databases respectively. Level 1 is standards acquired using the same equipment and further 
confirmed by an orthologous method (1H and 13C nuclei of NMR spectrum). 
 
2.4.1 Level 1 assignment 
Use of only 1H information cannot yield a level 1 identification. For a metabolite to be 
identified with level 1 confidence, 1H information needs to be complemented by a secondary 
orthologous method that annotates the same compound. In the context of NMR, use of 13C 
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spectral information supplies the secondary orthologous information. NMR experiments 
such as 1H-13C HSQC (Figure 2.4-1), provides assignment information for both 1H and 13C 
nuclei hence yielding an identification. Unfortunately, due to the technical limitation of 13C 
NMR, this information may not be possible to acquire for all concentration ranges. 
 
 
Figure 2.4-1: Identification of trehalose via 1H-13C HSQC. Using HSQC, both peaks arising from the hydrogen and 
carbon chemical groups the metabolite can be assigned hence providing further confidence in the assignment. 
 
2.4.2 Level 2 assignment 
Level 2a and 2b assignment is done by matching 1D-1H NMR spectrum of a standard to the 
experimental spectrum (Figure 2.4-2). This process is done in two steps. The first step is the 
use of in-house metabolite libraries. These libraries are generated by acquiring the NMR 
spectrum of the metabolites on the same instrument where the experimental data was 
acquired. This type of annotation yields a MSI level 2a annotation. The second step is 
performed by Chenomx software (Chenomx, CA) which is designed to match 1D-1H NMR 
spectrum of metabolite standards to an experimental spectrum using various matching 
algorithms. Assignment done via Chenomx yields a level 2b assignment, due to the use of 
external libraries.  
 









































Figure 2.4-2:Matching of valine peaks from an in-house standard (red spectrum) with peaks on the mosquito 
extract experimental data (blue spectrum). Sample: Female KD16 pupa using in-house compounds yielding a level 
2a annotation. 
 
Compounds for the in-house libraries comprise of a mix of compounds classed as amino 
acids, sugars, purine and pyrimidines and carboxylic acids. Chenomx comes with a pre-built 
metabolite library for a range of magnetic fields (including 700 MHz). The Chenomx 
compound matching algorithm was designed to work with sample pH ranging from 4 to 9 
and experiments acquired at 25 ˚C. 
 
2.5 Statistical analysis 
A flowchart of the statistical analysis is shown in Figure 2.5-1. Prior to the analysis, each NMR 
spectrum was subjected to quality control (QC) as explained in section 2.3.5. Any sample 
failing QC was feedback into the acquisition pipeline to acquire a new spectrum to a 
maximum of three times per sample, when failed samples were discarded from further 
analyses. This was done with the aim of retaining as many high-quality samples as possible.  
After QC, spectra were collated into a dataset for analysis. All further analytical steps were 
undertaken using a combination of published and custom-made scripts in R [192], [193] 
(Table 2.5-1). Statistical analysis was performed using R statistical package [192], [193]. Batch 
variation was assessed using principle vector component analysis (PVCA) [145]. The dataset 
was then normalised using probabilistic quotient normalisation (see section 2.5.1.2). Batch 
1H [ppm] 1.2  1.1  1.0  0.9 
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effect correction was then applied as appropriate and data was scaled by standard deviation 
(autoscaling). The scaled dataset was subjected to multivariate analysis using a combination 
of principle component analysis (PCA) and partial least square – discriminant analysis (PLS-
DA) (see section 2.5.2). Variable importance of the projection (VIP) was used to select 
important features from the PLS-DA models. Representative bins for the selected features 
were identified via correlation reliability score, (CRS, see further description in section 
2.5.2.3.2). Verification PCA and PLS-DA models were built with the selected metabolites in 
order to demonstrate the information retained with the selected metabolites was 
informative of the groups to discriminate. Selected metabolites and differences between 
groups were used in suitable univariate tests (t-test/ANOVA-Tukey’s HSD depending on 
number of groups to contrast). Finally, pathway analysis was performed via metabolite set 




Figure 2.5-1: Metabolomics statistical analysis flowchart. Green rounded rectangles show start and end points. 
Purple rectangles show processes. Blue diamonds represent decision points. Red documents represent curated 
dataset. 
 
All the data processing and statistical analysis was performed using R and Python statistical 
package [192], [193] with various packages and scripts. Table 2.5-1 includes all the scripts 
and packages used in this project. The custom scripts written by me are available at. 
‘https://github.com/RGmetab/Thesis_Scripts’. 
  













































Table 2.5-1: List of packages and scripts used in statistical analyses.  
Name Function References 
cowplot R package, extension for producing complex plots. [194] 
ggplot2 R package, for producing plots. [195] 
mixOmics R package, set of tools for metabolomics analysis. [196] 
NMRMetab_norm_scale.R In-house script, performs normalization and scaling for 
metabolomics data. Written by Dr Arturas Grauslys 
 
Pathway_Fisher.R In-house script, performs Pathway analysis via Fisher’s exact 
test. Written by me. 
 
PathTabforFisher.py In-house script, generates pathway table from KEGG database 
to be used in Fisher’s exact test. Written by me. 
 
pvca R package, set of tools for variance estimation. [145] 
readBruker.R Published script, reads in NMR spectrum in bruker format. 
Written by Dr Jie Hao. 
[197] 
reshape2 R package, arranges data frames for ggplot functions. [198] 
sourceARSyN.R Published script, loads the required functions for ARSyN batch 
correction. 
[142] 
sva R package, set of tools for batch correction. [199] 
 
2.5.1 Data processing  
2.5.1.1 Data cleaning  
Spectra that did not pass the QC (as described in section 2.3.6) were contrasted with lab book 
records to link the poor sample quality to known possible sources of variation. When 
suspected contamination, a comparison between spectral signals of the sample to spectral 
signals from the pooled data was done. Contamination signals were defined as peaks present 
in the question sample but not present in 99% of the total data. These spectra were deemed 
unsuitable to analyse and removed before analysis. 
 
2.5.1.2 Data normalisation  
Normalisation is an essential step in omics analysis and corrects fluctuations on sample 
preparation that result in a level of inter sample error. Probabilistic quotient normalization 
(PQN, [200]) is a widely used method in the NMR community and our chosen method.  This 
method   normalises each spectrum by a reference one, in this case we chose the median 
spectrum. These are the steps implemented in the PQN normalisation function: 
1. Create a reference spectrum by calculating the median spectrum from the whole 
dataset (through bins). 
2. To create the quotients, divide all spectra by the reference spectrum. 
3. Calculate the median of the quotients to give the normalisation factor. 
4. Divide the raw data by the normalisation factor. 
 85 
 
2.5.1.3 Batch effect assessment and correction 
The number of samples acquired in this project required the experimental design to include 
several batches for acquisition and preparation. All batches were designed such that a batch 
of any experiment contained all the experimental groups for even representation across 
batches. Under the assumption that batches will be inherently different due to experimental 
fluctuations, batch effect contribution was assessed using PVCA [145]. PVCA utilises PCA and 
variance component analysis in order to estimate the proportion of different factors in the 
dataset. Using PVCA the batch correction methods were also assessed in order to determine 
which method to use in case it was needed. Methods tested were; ASCA [ANOVA 
simultaneous component analysis] removal of systemic noise (ARSyN) [142], surrogate 
variable analysis (SVA) [199], and combining batches (ComBat) [143].  
 
2.5.1.4 Data scaling and centring 
Data was scaled to avoid magnitude-bias in variable selection when undertaken multivariate 
modelling. The chosen method was autoscaling. Autoscaling calculates the mean and 
standard deviation of each variable (bins). Then it subtracts the mean value from all 
individual points and divides by the standard deviation. 
 
2.5.2 Multivariate Analyses  
Univariate analyses test differences of one variable in a number of groups. Each test result 
has a probability of being a false positive or a false negative. Thus when multiple testing it is 
critical to perform false positive corrections. When looking at multivariate data having large 
number of variables to compare and not only wanting to know how if each individual one 
presents a significant difference between our groups of study but also whether there is an 
interaction between any of them and whether the overall fingerprint can be considered 
different from others. Furthermore, applying false positive correction methods in a very large 
number of tests usually results in an underpower analysis (see Figure 2.5-2). Thus, for 
multivariate data multivariate analysis are more suited. Below there is a description of the 




Figure 2.5-2: Increase of false positive rate during multiple hypothesis testing with significance level of α=0.05. 
Without p-value adjustment for multiple testing; at 14 tests false positive rate is higher than 50%, at 28 tests 
higher than 75% and at 45 tests higher than 90%. 
 
2.5.2.1 Principal component analysis (PCA)  
Principal component analysis (PCA) is an orthogonal data transformation that returns 
unobserved (latent) variables named principal components (PC). Each PC is the linear 
combination of the original variables in such a way that the first PC explains the most variance 
in the data. The second components explaining the most variance unexplained by the first 
PC and is orthogonal and uncorrelated to the first PC. Subsequent PCs follow the same 
procedure. This transformation results in a dataset where the original variables are replaced 
by uncorrelated PCs. In this new dataset of PCs only the first few (typically) PCs are required 
to explain majority of the variance in the dataset hence reducing the high number of starting 
variables with minimal information loss. 
 
In this project PCA was preferred as a data exploration tool to reveal and observed the hidden 
structures in the data. on a PCA scores plot, each point represents a sample and can gives 
information about the similarities between samples. This is elucidated from the distances 
between points on the scores plot. Furthermore, we can link observed structures in the PCs 
to the original variables/metabolites. This is typically represented in loading plots although, 
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2.5.2.2 Partial least square discriminant analysis (PLS-DA) 
Partial least square - discriminant analysis (PLS-DA) is a variation of partial least square (PLS) 
regression. PLS is a supervised statistical model applied to multivariate datasets in order to 
make predictive models between two matrices. A PLS model requires a matrix of input data 
(predictors) and a secondary matrix called (response) where the output of the model is 
recorded. PLS projects both of these matrices (predictors and response) into two new 
matrices where the covariance between the two are minimised. PLS and PCA show some 
similarity in terms of creating latent (unobserved) variables, using of projections to new 
spaces although. While PCA projects maximum variance in latent variables called PCs, PLS 
projects predicted and observable variables using a linear regression model in latent 
variables called variates. PLS-DA variation uses a nominal vector as response which allows 
the building of models for classification problems. PLS models are particularly suitable for 
data with multicollinearity in predictors such as, NMR data where a single metabolite can be 
represented by multiple peaks depending on its molecular structure. 
 
One critical step of statistical modelling is to check for overfitting and underfitting. 
Supervised statistical models requires the model to be trained on data prior to prediction. 
Models depending on creation of latent variables (not exclusively) such as PLS-DA can be 
heavily affected by this process. When the number of latent variables to be used in model 
set very high, usually to achieve high accuracy. By doing so, the model starts to train on how 
to recognise the noise in the data that is very specific to the training dataset. This 
phenomenon is also known as overfitting, as can be easily spotted by making predictions on 
new data. Since, experimental noise is random, an overfitted model will have poor prediction 
accuracy on new data. On the opposite side of the scale the models can be underfitted. This 
is when too few latent variables a chosen and the model does not perform well due to not 
being able to describe the data in selected number of latent variables. This also results in 
poor prediction accuracy. In both cases any further analysis (e.g. variable selection) would be 
unreliable. This can be avoided by tracing the training of the model by making prediction on 
a new dataset which the model is never exposed to during training. The ideal model building 
process would require 3 dataset one for training, another for validation of the trained model 
and a final one for testing. Although this is the best way to build a model, this is not always 
possible (especially in metabolomics studies). For such cases a method called cross-validation 
can be used. In cross-validation, data is randomly split into training set and test set (typically 
90% to 10% respectively). Following the split the model is trained on training set followed by 
prediction on the test set. After prediction, the model is typically assessed by prediction 
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accuracy. This process is repeated, multiple times (between 100-150 is a good rule of thumb) 
and for different numbers of latent variables. Typically model with the best predictive 
accuracy is selected. 
 
In this project PLS-DA was used to build predictive models between experimental groups. 
PLS-DA model’s performance was assessed by dividing the data into 70% and 30% training 
and validation sets respectively. The training set was then 5-fold cross-validated over 250 
repetitions. Classification errors were used to determine the optimal model complexity 
parameter. The refined model was then used to predict the validation set to obtain model 
performance. Model performance was assessed by calculating accuracy, precision, recall and 
F-score as describe in Sokolova and Lapalme [201]. R2 and Q2 score were not preferred in 
model performance assessment since they require the response matrix to be on a ratio scale 
rather than nominal. Using the refined model parameters, a model was built using both 
training and validation sets, yielding a generalised model of the dataset. These final models 
were then used in bin (representing metabolites) selection to reveal key metabolites driving 
the differences between experimental groups. 
 
2.5.2.3 Bin selection 
2.5.2.3.1 Variable importance of the projection (VIP) 
Bin (variable) selection from a statistical model is critical step for most metabolomics studies 
in order to extract biologically relevant information. PLS-DA and its derivative methods are 
designed to transform the data and make predictions. However, variable (bin) selection is 
not integrated into the model building process. Variable importance of the projection (VIP) 
scores is such a method that is often preferred with datasets with multicollinearity. VIP 
scores in essence are weighted sum of squares of PLS weights (calculated during PLS-DA 
model building) which also take explained variance in PLS variates. This method is designed 
to be used for multivariate datasets where there is correlation between variables as well as 
a higher number of variables than samples. 
 
Once the VIP scores are calculated a cutoff needs to be defined in order to include or exclude 
variables. VIP scores are calculated as such that average of all VIP scores squared is 1 [202]. 
Hence a cutoff of 1 was used to select important variables. Due to the nature of VIP scores 
calculation, after excluding variables via VIP scores, a refined PLS-DA model built after will 
have VIP scores less than 1 for previously passing variables. 
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Due to the nature of NMR data, metabolites with multiple signals presented multiple entries 
in VIP scores. We then included an extra step to select the most representative bin per 
metabolite to take forward on the analysis pipeline. 
 
2.5.2.3.2 Correlation Reliability Score (CRS) 
To address the problem of selecting appropriate representative bins from VIP scores a 
correlation-based scoring method was developed. Depending on the molecular structure 
some metabolites have multiple NMR signals. These multiple signals arising from a 
metabolite will increase/decrease as the concentration increases/decreases, yielding a high 
correlation score between multiple signals belonging to the same metabolite. However, 
some areas of the spectra are populated by peaks belonging to multiple metabolites, thus 
some bins might be more reliable markers for a metabolite than other. Correlated bins 
(assigned to the same metabolite) were scored to determine their reliability to report on the 
assigned metabolite, a specific challenge given the severe overlap of peaks in certain bins of 
the NMR datasets. This score is referred to as the correlation reliability score (CRS) that 
shows the performance of a bin as a representative of the metabolite through its correlation 
with other bins of the same metabolite. This score is determined via the following algorithm: 
1. Calculate Pearson correlation matrix for all the identified bins per metabolite. 
2. For each unique metabolite extract individual bin correlation values. 
3. Calculate the mean for each individual bin of the unique metabolite. 
4. Multiply each score by 100 to present the percentage. 
 
It should be noted that algorithm above is designed to select a representative bin from a 
metabolite with multiple NMR signals. Hence it is not suitable for metabolites with single 
NMR peak. When the algorithm is used on metabolites with single NMR peaks a score of 
100% would be calculated due to self-correlation. When tabulated these signals were noted 
as not applicable (NA). In order to separate the candidate bins from non-candidate bins, a 
passing score was then calculated using the previously calculated CRS scores via the following 
algorithm: 
1. Exclude all bins with a 100% CRS. 
2. Calculate median and standard deviation with the remaining scores. 
3. CRSpass = median – standard deviation 
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A CRS above the threshold represents a high correlation of the bin to the rest of the signals 
of the same metabolite. For final selection, highest CRS scores of non-overlapping bins 
(where applicable) were preferred yielding a dataset consisting of one variable per 
metabolite to be used in univariate and pathway analyses. Prior to further analysis the 
efficacy of the selection was assess by PCA scores plot and PLS-DA model predictions with 
the dataset of selected metabolites. 
 
2.5.3 Univariate analyses  
Univariate analyses were performed using Welch’s t-test and analysis of variance (ANOVA) 
where appropriate in order to compare the means of selected metabolites. To account for 
type-I errors arisen from multiple hypothesis testing, P-values were corrected via Benjamini 
& Hochberg (BH) [203] method unless otherwise stated. To visualise the significant changes 
in metabolites between experimental groups, boxplots (Figure 2.5-3) were plotted. 
 
 
Figure 2.5-3: Break down of a boxplot. Outlier limits were calculated as Q1 - 1.5*IQR for lower and Q3 + 1.5*IQR 
for higher, where IQR is Q3-Q1. 
 
2.5.3.1 Welch’s t-test 
Following metabolite selection, for further insight metabolites were compared between 
experimental groups. Welch’s t-test was used to compared the means where only 2 
experimental groups were present. Welch’s t-test [204] is an adaptation of Student’s t-test 












the null hypothesis where there is no difference between the means of the groups being 
tested. A t-score is calculated and compared against a t-distribution probability table for 
analysis. The p-value shows the probability of obtaining such results in the following tests 
given that the null hypothesis is true. An arbitrary significance level of α=0.05 was used to 
either accept or reject the null hypothesis. It should be noted when conducting multiple t-
tests, the chance of finding false positives increase. To avoid drawing conclusions from false 
positives, p-values were adjusted with BH method for false discovery rate (FDR). 
 
2.5.3.2 Analysis of variance (ANOVA) & Tukey’s honest significant difference (HSD) 
ANOVA was used where Welch’s t-test was not applicable due to the number of groups 
present. ANOVA compares the means of multiple groups while operating under the null 
hypothesis that there is no difference between the means of the groups being tested. 
Determination of significance was done by the assessment of p-values of an arbitrary 
significance level of α=0.05. ANOVA does not perform pairwise comparisons; results reported 
to be significant mean there is at least one group that is different from at least one other 
group. Pairwise comparisons need to be performed by a post-hoc test such as Tukey’s honest 
significance difference (HSD). 
 
Tukey’s HSD is a pairwise comparison, where means of all the groups are compared to every 
other group. The difference is deemed significant via p-value with the widely adopted 
significance level of α=0.05. Tukey’s HSD performs p-value adjustment for multiple 
comparisons built into the comparison. 
 
2.5.4 Metabolite set enrichment analysis (MSEA) and interpretation 
Upon the selection of metabolites, through PLS-DA modelling a qualitative metabolic set 
enrichment analysis (MSEA) was used based on a Fisher’s exact test. MSEA provides a 
probability measure for a set of metabolites likelihood of representing a pathway in a system. 
Given both the qualitative nature of this analysis and metabolomics showing 'metabolic 
snapshot', it is not possible to annotate a pathway as being increased/decreased or up-
regulated/down-regulated. MSEA's sole purpose is to provide possible leads on pathways 




In this project pathway analysis was performed using a number of metabolite sets (one per 
pathway) generated from the KEGG database (accessed on 26/03/2019). The metabolite set 
for An. gambiae and Ae. aegypti were curated from KEGG [206] using a custom scripts written 
by me (available at ‘https://github.com/RGmetab/Thesis_Scripts‘). The curated An. gambiae 
metabolite set included 4270 (of which 2770 were non-repeating) metabolites and 135 
pathways. The Ae. aegypti metabolite set comprised 129 pathways with 3991 metabolites of 
which 2697 were non-repeating. Identified metabolite names were converted to KEGG 
compound codes which were then used to calculate the probability of individual pathways 
via a one-sided Fisher’s exact test with Expression Analysis Systematic Explorer (EASE) scoring 
as applied in DAVID [207]. EASE applies more stringent rules on this calculation by using a 
penalty (number of hits - 1) on the calculation. This penalty also ensures any pathway found 
with only one metabolite is excluded. Resulting p-values were adjusted for Type I errors with 
BH, with pathways with p-values less than 0.05 presented as significant and discussed further 





3 Investigation of sex-specific metabolic differences in mosquito species 
of An. gambiae knock-down (Cyp4g16 & Cyp4g17), wild type An. 
gambiae and wild type Ae. aegypti 
 
3.1 Introduction, chapter aims and objectives 
In mosquito research, sex has always been a key factor in dictating the research focus. A great 
deal of mosquito research is on female mosquitoes due to them being the vector capable of 
pathogen transmission with great efficiency. Unless there is a particular interest in males, 
they are discarded. This extensive focus on females has generated a larger amount of 
knowledge for one sex than the other. Currently, there are a wide range of publications and 
books about the anatomical differences between males and females. Unfortunately, this is 
not the case for sex-related metabolic differences. Further exploration of these differences 
can shape how non-female specific experiments (e.g. blood meals and oviposition) are 
designed. 
 
In the mosquito life cycle from eggs to pupae, males and females do not show many 
morphological differences. They behave and act very similar. Even in the pupal stage where 
the most morphological differences are observed, it is only possible to distinguish between 
males and females under a microscope. A study investigating diapause in moths (Antheraea 
mylitta) performed a comparison between males and females fed on different crops and 
found that the amino acid (except one crop) and protein content were not significantly 
different [208]. Although this study was on moth’s, metamorphosis is relatively well 
conserved in insects and so can be expected to be similar in mosquitoes [209]. Thus, strong 
differences in the metabolic profiles of males and females are not expected. On the other 
hand, female adults are required to find a blood source for oviposition, which may require 
the mosquito to maintain flight for a longer time. Therefore, a metabolic profile comparison 
of energy storage mechanisms and related metabolites would be expected to be higher in 
females compared to males.  
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This chapter aims to explore whether metabolic sex-specific differences can be detected 
using NMR metabolomics and if so, what effect sex has on the metabolic profile of pupa and 
adult mosquitoes across species and strains. These points will be explored under three main 
male and female comparisons. 
1) Cyp4g16 and Cyp4g17 knockdowns of An. gambiae 
2) 2) Wild type An. gambiae 
3) 3) Wild type Ae. aegypti. 
 
To achieve this, PCA scores plots of metabolite bins will be used to determine the major 
contributors in variance. If sex is not one of these major contributors, a statistical modelling 
approach will be applied to determine to what extent sex differences are observable via polar 
NMR metabolomics. 
 
It is known that mosquitoes use certain hydrocarbons (HC) for communication purposes, 
such as pheromones, multiple branched alkanes and alkenes. Cuticular hydrocarbons (CHC) 
are utilised for waterproofing and physical protection properties, such as alkanes and single 
branched alkanes and they are not known to differ in variety between males and females 
[78], [86]. The biosynthesis of CHCs mainly takes place in the pupal stage and early adult 
stage. CHC biosynthesis is a culmination of several complex pathways and a wide variety of 
final products can be synthesised [78], [172]. The majority of CHCs can be grouped into 
families 
 
The enzyme Cyp4g16 has been shown in vitro to catalyse the decarbonylation of such CHCs 
and the enzyme Cyp4g17 has been hypothesised to also carry out this reaction [75]. 
Performing a metabolomics analysis of such knock-downs to investigate the changes in the 
precursors without exploring the difference between males and females may lead to false 
conclusions confounding with sex differences. Prior to investigation of CHC biosynthesis 
precursors, a comparison between males and females was first carried out. 
 
3.2 Experimental Design 
All samples used in this project were field collected and are generations of the same lineage. 
All mosquito breeding was done in the Liverpool School of Tropical Medicine insectary. Table 
3.2-1 shows the history of the species used in this project. 
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Table 3.2-1: Metadata of samples used in this project. 
Species Genotype Pyrethroid Strain Origin Since 
An. gambiae Knock-down Susceptible Gal4 Lab 2011 
Susceptible RNAi16 Lab 2014 
Susceptible RNAi17 Lab 2014 
Wild type Resistant VK7 Burkina Faso >5 years 
Susceptible N’Gusso Cameroon >5 years 
Ae. aegypti Wild type Resistant Cayman Cayman Islands >8 years 
Susceptible New Orleans USA >8 years 
 
In order to establish whether sex influenced metabolic profiles in each strain, samples were 
grouped as male and female. All samples were collected as biological triplicates and sample 
numbers post QC are shown in Table 3.2-2.  
 
Table 3.2-2: Sample numbers for sex testing post QC. Criteria used for QC were: overall flat baseline, TSP HHFW 
≤ 1 Hz, water residue ≤ 0.25 ppm and no presence of contaminants. 
Samples collected 
 An. gambiae knock-down An. gambiae wild type Ae. aegypti wild type 
 KD16 KD17 Control Susceptible Resistant Susceptible Resistant 
Gender ♂ ♀ ♂ ♀ ♂ ♀ ♂ ♀ ♂ ♀ ♂ ♀ ♂ ♀ 
Pupa 15 15 15 15 15 15 15 15 15 15 15 15 15 15 
Adult 15 15 15 15 30 30 15 15 15 15 15 15 15 15 
Spectra acquired 
 An. gambiae knock-down An. gambiae wild type Ae. aegypti wild type 
 KD16 KD17 Control Susceptible Resistant Susceptible Resistant 
Gender ♂ ♀ ♂ ♀ ♂ ♀ ♂ ♀ ♂ ♀ ♂ ♀ ♂ ♀ 
Pupa 7 10 9 11 10 10 15 15 15 15 15 15 15 15 
Adult 15 15 15 15 30 30 15 15 15 15 15 15 15 15 
Quality control passed 
 An. gambiae knock-down An. gambiae wild type Ae. aegypti wild type 
 KD16 KD17 Control Susceptible Resistant Susceptible Resistant 
Gender ♂ ♀ ♂ ♀ ♂ ♀ ♂ ♀ ♂ ♀ ♂ ♀ ♂ ♀ 
Pupa 4 7 7 8 5 7 12 15 11 9 15 12 14 14 
Adult 12 15 14 15 28 28 13 14 15 14 9 11 10 11 
♂: Male; ♀: Female; KD16: Cyp4g16 knock-down; KD17: Cyp4g17 knock-down 
 
3.3 Spectral binning and metabolite identification 
For statistical analysis, all peaks were manually selected to create a list of chemical shift 
regions. These regions were collated in a pattern file. Metabolites were assigned using a 
combination of 1D & 2D in-house libraries and Chenomx software by matching chemical 
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shifts, intensity ratios between groups of peaks and peak multiplicity. Assigned metabolites 
were then associated with their specific chemical shifts in the pattern file created 
(Appendix 1). Representative 2D assignments for An.gambiae knock-down, An. gambiae 
wild type and Ae. aegypti wild type can be found in Appendix 2, Appendix 3 and Appendix 4 
respectively. Assigned pattern files were verified by highlighting the chemical shift regions 
on a representative spectra (Figure 3.3-1 & Figure 3.3-2). A total of 496 chemical shift 
regions were selected in the binning process. For An. gambiae data, out of 496 bins 107 
(21.57%) were associated with 21 metabolites. For Ae. aegypti data, 111 bins out of 517 
(21.47%) were associated with 21 metabolites. Throughout the statistical analyses, 
unidentified bins were included until metabolite selection. In all data sets, the annotated 
metabolites were identical and are shown in   
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Table 3.3-1. The annotation table shows the list of assigned metabolites with their confidence 




Figure 3.3-1: NMR spectrum of an An. gambiae knock-down pupa control. The y-axis represents peak intensity 
relative to water peak (purple). A) NMR spectrum highlighted by typical regions of interest. Spectrum shown is 
between 0-9 ppm where signals were observed. Only the water residue and TSP signals were truncated. During 
the binning process, a total of 496 bins were selected. B) Aliphatic region of NMR spectrum typically between 0-
6.5 ppm, total number of bins in this region is 447. C) Aromatic region of NMR spectrum typically between 6.5-9 




Figure 3.3-2: NMR spectrum of an Ae. aegypti pupa. The y-axis represents peak intensity relative to water peak 
(purple). A) NMR spectrum highlighted by typical regions of interest. Spectrum shown is between 0-9 ppm where 
signals were observed. Only the water residue and TSP signals were truncated. During the binning process a total 
of 513 bins were selected. B) Aliphatic region of NMR spectrum typically between 0-6.5 ppm, total number of bins 
in this region is 461. C) Aromatic region of NMR spectrum typically between 6.5-9 ppm, total number of bins in 
this region is 52. In figures B and C, grey boxes represent manually selected bins. 
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Table 3.3-1: Metabolite assignment table, with MSI level [191], KEGG compound code and classifications. See 







code Unique Overlap Total 
Alcohols Methanol Level 1 1 0 1 C00132 
Amino acids Alanine Level 1 2 3 5 C00041 
Glutamate Level 1 7 3 10 C00025 
Glutamine Level 1 2 3 5 C00064 
Glycine Level 1 1 0 1 C00037 
Isoleucine Level 1 3 0 3 C00407 
Threonine Level 1 4 0 4 C00188 
Tryptophan Level 1 12 3 15 C00078 
Tyrosine Level 1 12 2 14 C00082 
Valine Level 1 5 0 5 C00183 
Carboxylic 
acids 
Acetate Level 1 1 0 1 C00033 
Formate Level 2a 1 0 1 C00058 
Fumarate Level 2a 1 0 1 C00122 
Lactate Level 1 4 0 4 C00186 
Propionate Level 2b 6 0 6 C00163 
Pyruvate Level 1 1 0 1 C00022 
Succinate Level 1 1 0 1 C00042 
Purines Oxypurinol Level 2b 1 0 1 C07599 
Xanthine Level 2b 1 0 1 C00385 
Saccharides Glucose Level 1 24 8 32 C00031 
Trehalose Level 1 10 7 17 C01083 
 
Representative raw 1H-NMR spectra showing male and female comparisons that can be 
found in Appendices are: An. gambiae knock-down pupae (Appendix 5), An. gambiae knock-
down adult (Appendix 6), An. gambiae wild type pupae (Appendix 7), An. gambiae wild type 
adult (Appendix 8), Ae. aegypti wild type pupae (Appendix 9) and Ae. aegypti wild type adult 
(Appendix 10). 
 
3.4 Sex-specific differences in metabolic profiles of An. gambiae knock-down 
(Cyp4g16 & Cyp4g17) pupa and adult 
3.4.1 Sex differences in mosquito pupae 
3.4.1.1 Statistical analysis 
Prior to statistical analysis, the contribution of batch effect was estimated using PVCA. 
Experiments of this scale require the experimentation to be performed in batches. Although 
most environmental factors are controlled, such as temperature, day and night cycle, 
humidity and feeding, variation between batches can still be observable. These variations 
can arise due to other factors such as activity of sample in their environment, their feeding 
habits, and their natural developmental synchronicity, which can cause unwanted clustering 
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in the data. Sometimes, this clustering behaviour in data can interfere and/or mask the 
signals arising from experimental effects. In order to prevent such an effect, variance in the 
data can be estimated and batch correction methods can be applied if necessary. Figure 3.4-1 
shows the high batch effects, present in the raw pupa data. In the raw data (red bars), batch 
effects were found to be accounting for 81.20% of the variance in the data. Upon applying 
different correction methods, ComBat (blue bars) was found to be the most effective in 
reducing the batch variation to 1.42%, and was used in all subsequent analyses. 
 
 
Figure 3.4-1: Estimation of batch, sex and strain variances via PVCA in knock-down An. gambiae pupae. Colons in 
the x-axis denote the combined effects of two sources of variance and, Residual denotes all remaining variation 
in the data (residual). ComBat outperformed other methods with the lowest batch variance. Correction methods 
applied: None, no correction; PQN.Auto, probabilistic quotient normalization and autoscaling; ARSyN, ASCA 
[ANOVA simultaneous component analysis] removal of systematic noise; ComBat, Combining batches and SVA, 
surrogate variable analysis. 
 
It is important to establish the major variances in the data before further analysis. Sex in 
these samples is one of the major concerns that may affect the results. To resolve this, PCA 
(Figure 3.4-2-A) was used to observe the sources of the major variance in the data. The plot 
displays PC1 (18.43%) against PC2 (12.34%), with no clear distinction between male and 
female species. The first two components account for 30.77% of the explained variance in 
the metabolic profiles and a total of 25 components were required to explain the 95% 
variance in the data. This is consistent with the theory that the overall metabolic profile of 
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Figure 3.4-2: A) PCA scores of all knock-down An. gambiae pupae coloured by sex (nmale = 16 and nfemale = 22). 
Brackets report the variance explained by the PC. Twenty-five PCs were required to achieve 95% explained 
variance. Only PC1 (18.43%) and PC2 (12.34%) are shown in the Figure for simplicity. Clear clustering according 
to sex is not observed suggesting the metabolic differences between males and females very high variations in 
the dataset. Sex difference was not observed in the density plots of the other PCs. Ellipses represent 95% 
confidence region. B) PLS-DA scores of pupae knock-down of An. gambiae discriminated by sex (nmale = 16 and 
nfemale = 22). Model complexity of three variates was optimised via cross-validation with 45.45% accuracy. Two 
clusters can be easily seen in the scores plot indicating the discrimination capabilities of the model. Ellipses 
represent 95% confidence region. 
 
In order to probe deeper, a statistical model can help to bring out the sex effects masked by 
other components of the data. A cross-validated PLS-DA model was performed on the same 
dataset to establish whether any metabolic differences could be attributed to the sex 
differences in pupa. A three-variate PLS-DA model (Figure 3.4-2-B) was determined to be 
optimal to discriminate between females and males with 45.45% accuracy (Appendix 11 for 
further metrics) discriminating between females and males. Nearly half the sample were 
correctly classified by the model. Using VIP scoring as a criterion, metabolites influential in 
such discrimination can be extracted. 
 
3.4.1.2 Key metabolites between males and females 
VIP scores were calculated from the model in order to select spectral features influencing 
the separation between males and females. A passing one was applied to VIP scores of 
variate-1 and variate-2 where separation between males and females was observed. A total 
of 103 bins scored above the passing score where only 24 (23.30%) were identified. Figure 
3.4-3 shows the 24 identified bins representing 10 unique metabolites. In order to assess 
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Figure 3.4-3: VIP scores of PLS-DA model built on sex discrimination of KD An. gambiae pupae. Identified bins 
scoring higher than 1 on variate-1 and variate-2 were selected from the PLS-DA model. Black line represents VIP 
score of 1. 
 
As a secondary criterion, CRS was used to select representative bins for a metabolite. CRS 
(Table 3.4-1) was calculated for all identified bins and filtered to show bins selected by VIP 
scoring. CRS threshold score of 27.11% was calculated using all the CRS scores.  
 
Table 3.4-1: CRS scores of VIP selected bins from the knock-down An. gambiae pupa PLS-DA model for sex 
discrimination. Rep: representative bin. 
Metabolite Bin CRS [%] CRS > 27.11% Rep Metabolite Bin CRS [%] CRS > 27.11% Rep 
Acetate 102 Singlet NA 102 Tryptophan 476 49.88 ✓ 476 
Formate 497 Singlet NA 497  478 47.22 ✓  
Glucose 267 64.41 ✓ 267  462 44.70 ✓  
 356 58.19 ✓ 
 
 466 38.40 ✓  
 420 57.84 ✓ 
 
 248 37.52 ✓  
 323 54.35 ✓ 
 
 460* 32.65 ✓  
Glutamate 336 -5.75 ✕ -  286 31.08 ✓  
Glycine 295 Singlet NA 295 Tyrosine 214 97.76 ✓ 214 
Methanol 260 Singlet NA 260  460* 97.64 ✓  
Oxypurinol 493 Singlet NA 493  212 97.49 ✓  
Propionate 17 39.48 ✓ 17  227 97.03 ✓  
 15 36.46 ✓ 
 
 461 94.27 ✓  
      207 92.61 ✓  
*, overlapping peak; NA, correlation score for singlet were not calculated. 
 
Only non-overlapping (where applicable) bins scoring higher than the CRS threshold were 
considered as a representative of the metabolite. Table 3.4-2 shows the list of selected 
Variate 1 (13.27%) Variate 2 (9.70%)
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metabolites and their representative bins, chemical shift of the bin and the metabolite’s 
KEGG code. From the 10 metabolites identified via VIP scores, only nine were selected from 
CRS. Glutamate was excluded due to the low CRS. CRS selected metabolites comprised of five 
metabolite classes; alcohols, amino acids, carboxylic acids, purines and saccharides. 
 
Table 3.4-2: List of selected metabolites via CRS and their representative bins. 
Class Metabolite Bin Chemical shift [ppm] KEGG code 
Alcohols Methanol 260 3.36 C00132 
Amino acids Glycine 295 3.57 C00037 
Tryptophan 476 7.55 C00078 
Tyrosine 214 3.08 C00082 
Carboxylic acids Acetate 102 1.92 C00033 
Formate 497 8.46 C00058 
Propionate 17 1.07 C00163 
Purines Oxypurinol 493 8.27 C07599 
Saccharides Glucose 267 3.41 C00031 
 
The metabolites selected were used in PCA and PLS-DA to verify their discriminatory 
properties exclusively. The PCA scores (Figure 3.4-4-A) plot of PC1 (44.78%) against PC2 
(16.14%) exhibits a separation of the majority of the data points representing 60.92% 
variance in the data. In Figure 3.4-4-A four female samples on the left (two KD16 and two 
KD17), and four male samples (two CONT and two KD 17) did not cluster with their groups. 
 
 
Figure 3.4-4: A) PCA scores of selected metabolites of An. gambiae pupae coloured by sex (nMale = 16 and nFemale 
= 22). Clustering of sex can be observed along PC1 (44.78%). PC2 (16.14%) does not explain the sex difference in 
the metabolic profiles. A total of 25 components were required to achieve 95% explained variance. Ellipses 
represent 95% confidence region. B) PLS-DA density plot to verify metabolite selection in pupa knock-down of 
An. gambiae discriminated by sex (nMale = 16 and nFemale = 22). Model complexity of one variate (44.11% explained 
variance) was optimised using a cross-validation with 63.64% accuracy. Ticks under the density plot represents 










































































To assess sex discriminatory performance of the selected metabolites, a PLS-DA model was 
built using their representative bins. A single-variate PLS-DA (Figure 3.4-4-B) model was built 
with 63.65% predictive accuracy (Appendix 11 for further metrics) on unseen data at 
discriminating between males and females. 
 
In order to gain metabolite level understanding on sex differences, metabolite levels were 
compared via BH adjusted t-test (for detailed statistics see Appendix 12) and shown by 
boxplots (Figure 3.4-5). A total of nine metabolites were selected from the PLS-DA model, 
although none were found to be significantly different in BH adjusted t-tests when 
considered in isolation. In the boxplots of three metabolites tryptophan, oxypurinol, and 
format sub-populations can be seen. These sub-populations are not consistent across all 
metabolites. Furthermore, the sample within the sub-populations do not follow a trend. 
Within these sub-populations clustering of KD17 & CONT, KD16 &KD17, and all three can be 




Figure 3.4-5: Boxplots of selected metabolites from An. gambiae pupae PLS-DA model on sex discrimination (nMale 
= 16 and nFemale = 22). No significance differences were observed. 
 
3.4.2 Sex-specific differences in adult mosquitoes 
3.4.2.1 Statistical analysis 
The same approach as was performed on pupae was taken to assess batch effect and the 
major source variance in the adult samples for the knock-down An. gambiae. PVCA plot 
(Figure 3.4-6) shows how much batch effect accounts for the variation in adult knock-down 
An. gambiae. Raw data (red bar) showed batch to be accounting for 00.03% in the data hence 
no batch correction was applied to the data. Through PVCA, it was also found that when PQN 
normalisation and auto-scaling (yellow bar) were applied, the proportion of the batch 





























































































































































































































































Tryptophan [476] Oxypurinol [493] Formate [497]
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Figure 3.4-6: Estimation of batch, sex and strain variance via PVCA in knock-down An. gambiae adults. Colon 
denotes the combined effects of two sources of variance and Residual denotes all the remaining variation in the 
dataset (residual). PVCA shows batch effect is minimal and masked by the effects caused by sex and strain. 
Correction methods applied: None, no correction; PQN.Auto, probabilistic quotient normalization and 
autoscaling; ARSyN, ASCA [ANOVA simultaneous component analysis] removal of systematic noise; ComBat, 
Combining batches and SVA, surrogate variable analysis. 
 
Upon establishing the negligible batch effect in adult mosquito samples, PCA was performed 
on the dataset (Figure 3.4-7-A) to observe major variances in the data and if sex was 
represented by these variances. A total of 48 components were required to explain 95% of 
variance in the data. The first two components, PC1 (30.11%) and PC2 (14.02%), explained a 
cumulative variance of 44.13%. This does not distinguish sex as a major source of variance in 
these samples as this was also observed in pupae data. Therefore, a discriminant PLS-DA 
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Figure 3.4-7: A) PCA scores of all knock-down An. gambiae adult coloured by sex (nmale = 54 and nfemale = 58). 
Brackets report the variance explained by the PC. Forty-eight PCs were required to achieve 95% explained 
variance. Only PC1 and PC2 are show in the Figure for simplicity. Sex separation was not observed in the density 
plots of the remaining PCs. Ellipses represent 95% confidence region. B) PLS-DA scores of adult knock-down of 
An. gambiae discriminated by sex (nmale = 54 and nfemale = 58). Model complexity of two variates was optimised 
using a cross-validation with 94.12% accuracy. Percentage reported in the brackets report the variance explained 
by the variate of the model. Ellipses represent 95% confidence region. 
 
Using a cross validated PLS-DA model, sex differences were accentuated as shown in Figure 
3.4-7-B. A two-variate PLS-DA model was found to be the optimal complexity with 94.12% 
accuracy (Appendix 11 for further metrics). As the Figure shows, males and females 
differentiate clearly along a diagonal of variate-1 and variate-2. The PLS-DA plot also exhibits 
some samples clustering with the opposite sex. These samples could be the extreme cases 
of their own groups and were misclassified by the model. This occurrence demonstrates the 
limitations of the model. Nevertheless, given the low numbers of misclassifications it does 
not greatly impact the model’s success in discriminating between males and females. In order 
to extract the metabolites the most influential in this discrimination, VIP scores were 
calculated. 
 
3.4.2.2 Key metabolites between male and female 
In order to generate a metabolite list from the PLS-DA model, first spectral features most 
influential in the discrimination needed to be identified. This was performed by calculating 
VIP scores from the PLS-DA model. Using a passing score of 1 on variate-1 and variate-2, bins 
influential in the discrimination between males and females were identified. A total of 109 
bins scored higher than the VIP score threshold. Of the 109 bins, only 20 (18.35%) were 
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accepting these metabolites, CRS were calculated. CRS were used to report on a bin 
representative strength over its metabolite. 
 
 
Figure 3.4-8: VIP scores of PLS-DA model built on sex discrimination of adult KD An. gambiae. A lower threshold 
of 1 was used on variates one and two to select metabolites from the model. Black line represents VIP score of 1. 
 
Prior to selecting a metabolite, CRS for all identified bins were calculated in order to ensure 
the selected bin is a reliable representative of the metabolite. From the CRS calculated from 
identified bins, a passing score of 29.14% was determined. For the selection process, only 
bins scoring above the passing score were considered. Only the highest scoring, non-
overlapping (where applicable) bins were selected. Table 3.4-3 shows the CRS for the VIP 
selected bins. 
  
Variate 1 (21.36%) Variate 2 (15.84%)

























Table 3.4-3: CRS for adult knock-down An. gambiae, representing the influential bins from PLS-DA model on sex 
differences. 
Metabolite Bin CRS [%] 
CRS > 
29.14% Rep Metabolite Bin CRS [%] 
CRS > 
29.14% Rep 
Lactate 386 49.82 ✓ 386 Tyrosine 452 70.05 ✓ 452 
 384 35.70 ✓ 
 
 458* 69.82 ✓  
Oxypurinol 493 Singlet NA 493  460* 69.69 ✓  
Propionate 12 52.57 ✓ 12  459 69.45 ✓  
Trehalose 424 35.66 ✓ 424  214 69.21 ✓  
Tryptophan 460* 24.00 ✕ -  457 67.13 ✓  
 458* 23.97 ✕ 
 
 212 66.66 ✓  
 478 20.65 ✕ 
 
 461 57.10 ✓  
 466 20.09 ✕ 
 
 227 22.37 ✕  
 476 17.66 ✕ 
 
 360 -13.88 ✕  
     Valine 304 -12.94 ✕ - 
     Xanthine 482 Singlet NA 482 
*: Overlapping bin; NA: Singlet self-correlation. 
 
After applying CRS analysis, the list of selected metabolites was shortened to six metabolites 
(Table 3.4-4). Omitted metabolites were tryptophan and valine. The list of selected 
metabolites comprised of 4 metabolite classes; amino acids, carboxylic acids, purines and 
saccharides. 
 
Table 3.4-4: Most influential metabolite list of PLS-DA model for discriminating adult knock-down An. gambiae 
females against males. 
Class Metabolite Bin Chemical shift [ppm] KEGG code 
Amino acids Tyrosine 452 6.90 C00082 
Carboxylic acids Lactate 386 4.13 C00186 
Propionate 12 1.05 C00163 
Purines Oxypurinol 493 8.27 C07599 
Xanthine 482 7.89 C00385 
Saccharides Trehalose 424 5.20 C01083 
 
In order to observe the sex variance represented by the selected metabolites, PCA (Figure 
3.4-9-A) was performed on the filtered data to include only the selected metabolites. The 
PCA scores plot of PC1 (43.81%) against PC3 (15.31%) shows two tightly clustering groups 
accounting for a cumulative explained variance of 59.12%. A total of 5 components were 
required to explain 95% variance in the data. The plot exhibits sex-specific variation largely 
represented by PC1. The intersection of the data clusters shows the limitation of these 
metabolites in sex discrimination, although, a great portion of the data is clearly separated 




Figure 3.4-9: A) PCA scores for selected metabolites of adult knock-down of An. gambiae selected PCA. PC1 
(43.81%) and PC3 (15.31%) account for 59.12% cumulative explained variance. A total of 5 components were 
required to explain 95% variance in the data. Ellipses represent 95% confidence region. B) PLS-DA scores to verify 
metabolite selection in adult knock-down of An. gambiae discriminated by sex (nmale = 54 and nfemale = 58). Model 
complexity of two-variates explaining 43.47% of the variance was optimised using cross-validation with 94.12% 
accuracy. Ellipses represent 95% confidence region. 
 
Shortlisted metabolites were used to build a PLS-DA model in order to verify the 
discriminatory strength of the metabolite used. Cross validated PLS-DA model optimal 
complexity was determined to be two-variates, with 94.12% accuracy (Appendix 11 for 
further metrics). The resulting model (Figure 3.4-9-B) shows discrimination to be better than 
sex differences represented in the previous PCA plot (Figure 3.4-9-A). 
 
Upon metabolite selection of sex-specific differences, metabolite levels were compared via 
BH adjusted t-test (for detailed statistics see Appendix 12) to gain metabolite level 
information on sex differences. The differences were shown in boxplots (Figure 3.4-10). From 
the metabolite level comparison, the carboxylic acid propionate was found to be significantly 
higher in males while lactate was significantly higher in females. The amino acid tyrosine was 
significantly higher in males as well as the saccharide trehalose. Lastly, the purines xanthine 
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Figure 3.4-10: Boxplots for selected metabolites from adult knock-down An. gambiae. ** and *** denotes p-
values less than 0.01 and 0.0001 respectively. 
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Table 3.4-5 shows selected metabolite levels of female species compared to males. Pupa 
metabolites were not found to be significantly different between sexes. All adult measured 
metabolites were significantly different in univariate testing, resulting in a metabolic sex 
profile easier to discriminate in PLS-DA models. In order to understand these changes on a 
pathway level, MSEA was performed on the elected metabolites.  
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Table 3.4-5: Metabolite shortlist comprising metabolites selected from the PLS-DA models discriminating females 
against males for both pupae and adults. Arrows represent significant changes, NS (arrow) denotes non-significant 
change with mean abundance level, and square brackets report the BH-adjusted p-value. 
 Pupa Adult 
Metabolite class Female compared to male 
Alcohols Methanol NS (↑) [3.12 x 10-1]   
Amino acids Glycine NS (↓) [3.12 x 10-1]   
Tryptophan NS (↓) [3.93 x 10-1]   
Tyrosine NS (↑) [8.93 x 10-1] ↓ [4.14 x 10-6] Tyrosine 
Carboxylic acids Acetate NS (↓) [2.43 x 10-1]   
Formate NS (↓) [3.12 x 10-1]   
  ↑ [1.25 x 10-21] Lactate 
Propionate NS (↓) [3.61 x 10-1] ↓ [7.98 x 10-5] Propionate 
Purines Oxypurinol NS (↓) [8.93 x 10-1] ↓ [1.23 x 10-6] Oxypurinol 
  ↑ [3.12 x 10-1] Xanthine 
Sugars Glucose NS (↑) [8.93 x 10-1]   
  ↓ [1.30 x 10-3] Trehalose 
 
Selected metabolites were used in MSEA (Figure 3.4-11). Due to the low number of 
metabolites, only pupae metabolites produced a significantly over-represented pathway (  
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Table 3.4-6). It should be noted that if the unadjusted raw p-values are considered, the adult 
metabolite list’s only over-represented pathway was propanoate metabolism. 
 
 








Table 3.4-6: MSEA result details for KD An. gambiae, reporting; stage, raw & BH adjusted p-values, number of hits 






p-value Hits/total (%) Metabolites 
Carbon 
metabolism 




Pupa 0.0014 0.0222 3/48 (6.25%) Acetate, methanol, propanoate 
 
Following metabolite selection both in pupa and adult stages, a different set of metabolites 
were shown to be important in differentiating the sexes metabolically. In pupa, nine 
metabolites were sufficient to explain the differences between sexes in the selected 
metabolite PCA and PLS-DA model. Whereas, in adults, only five metabolites were required 
to show differences both in PCA and PLS-DA model. Interestingly, metabolites selected for 
the pupa model were not found to be significantly different, whereas the lesser numbers of 
selected metabolites in adults, were all significantly different (lowest being p-value < 0.01). 
When these were used in MSEA, both pupa (BH-adjusted p-value) and adult (raw p-value) 
stages over-represented propanoate metabolism. 
 
To summarise, sex-specific differences in knock-down An. gambiae species exhibit limited 
metabolic variance in the data. Although not the major variance, these differences can still 
be extracted through robust statistical modelling methods. As evidenced by the data, 
metabolic sex profiles are more similar in pupae compared to in adults. In adults, five 
metabolites were needed to differentiate between sexes and they were found to be 
significantly different in the univariate test. Finally, on a pathway level, sex differences are 
represented by the same pathway both in pupa and adults. This suggests that these sex 
effects, however minor, can be overcome by employing the same method both in pupae and 
adults. 
 
3.5 Sex-specific differences in wild type An. gambiae pupa and adult 
metabolic profile 
3.5.1 Sex-specific differences in mosquito pupae 
3.5.1.1 Statistical analysis 
Statistical analysis was started with the assessment of batch effect in the samples. Figure 
3.5-1 shows the calculated variance estimation of the data via PVCA. For the raw pupa (red 
bars) dataset, PVCA calculations estimated batch effect to account for 3.55% of the variance. 
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In comparison to other batch effect correction methods ComBat, (blue bar) performed best 
in reducing the batch effect variance in the pupa dataset to 0.00%. 
 
 
Figure 3.5-1: Estimation of batch, sex and strain variances via PVCA in wild type An. gambiae pupae. Colon denotes 
the combined effects of two sources of variance and Residual denotes the total remaining (residual) variation in 
the data. ComBat outperformed other methods with the lowest batch variance. Correction methods applied: 
None, no correction; PQN.Auto, probabilistic quotient normalization and autoscaling; ARSyN, ASCA [ANOVA 
simultaneous component analysis] removal of systematic noise; ComBat, Combining batches and SVA, surrogate 
variable analysis. 
 
As established in the knock-down analysis, the sex difference for all the comparisons should 
be considered. To establish possible effects of the knock-down on sexes, wild type 
mosquitoes were also analysed for sex variation. PCA (Figure 3.5-2-A) was performed to 
observe the major variances in the data. PCA scores plot of PC1 (22.16%) against PC2 
(20.75%) showing weak clustering of sex in terms of separation. PC1 and PC2 explains a 
cumulative variance of 42.91%. Meanwhile a total of 27 components were required to 
explain the 95% variance in the data. When the overall metabolic profile of pupae is 
considered, males are clustered tighter compared to females on PC1 and PC2. This suggests 
the male population have less variation compared to females. When the largest contributors 
for the variation is considered, sex is less likely to be one of them. However, the weak 










































Correction None PQN.Auto ARSyN ComBat SVA
PVCA estimation for pupa data
 117 
 
Figure 3.5-2 A) PCA scores plot of wild type An. gambiae showing the major variances in the dataset (nFemale=24, 
nMale=33). A total of 27 components were required to explain 95% of the variation in the data. Sex separation was 
not observed in the density plots of the first 27 components. Ellipses represent 95% confidence region. B) PLS-DA 
model on sex in wild type An. gambiae pupa. The model (nFemale=24, nMale=33) was built with four variates and 
was cross validated with 71.43% accuracy. Brackets represent the explained variance percentage got the given 
variate. Ellipses represent 95% confidence region. 
 
Although it does not clearly separate males and females, Figure 3.5-2 shows some clustering 
of the data in terms of sex. This underlying chemical phenotype can be accentuted by the aid 
of a cross validated PLS-DA model. A cross-validated PLS-DA (Figure 3.5-2-B) model 
discriminating between females and males was built with four variates achieving 71.43% 
accuracy (Appendix 11 for further metrics). The PLS-DA scores plot demonstrates the 
underlying chemical phenotype mentioned in the PCA scores plot. From the scores plot of 
the PLS-DA model, a separation between males and females can be seen along a diagonal on 
variate-1 and variate-2. To delve into the metabolite level information, VIP scores of the PLS-
DA model were calculated. 
 
3.5.1.2 Key metabolites between males and females 
To extract the metabolite level information from the model, VIP scores were calculated. In 
order to select bins to represent metabolites, only identified bins scoring a VIP score higher 
than 1 on both variate-1 and variate-2 were selected (Figure 3.5-3). A total of 135 bins scored 
higher than the threshold. From the 135 bins, only 53 bins (31.26%) were identified and were 
assigned to 14 unique metabolites. Furthermore, CRS were calculated to assess the reliability 
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Figure 3.5-3: VIP scores of PLS-DA model built on sex discrimination of wild type An. gambiae pupae. A lower 
threshold of 1 was used on variates one and two to select metabolites from the model. Black line represents VIP 
score of 1. 
 
Using CRS, bins selected by the VIP criteria were assessed on their reliability on reporting 
their attributed metabolites. Prior to bin selection, a threshold was calculated using CRS 
from all identified bins.   
Variate−1 (20.82%) Variate−2 (6.35%)
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Table 3.5-1 shows the CRS calculated for bins selected by the VIP scoring. Only non-
overlapping (where applicable) bins scoring higher than the threshold of 31.74% were 
accepted. Using the CRS table highest scores, non-overlapping (where applicable) bins were 
selected as the representative of their respective metabolites. 
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Table 3.5-1: CRS for wild type An. gambiae pupae. Only showing CRS for VIP selected bins. Rep: representative 
bin. 
Metabolite Bin CRS [%] 
CRS > 
31.74% Rep  Metabolite Bin CRS [%] 
CRS > 
31.74% Rep  
Acetate 102 Singlet NA 102 Glutamate 138 43.40 ✓ 138 
Alanine 337* 81.37 ✓ 342  140 40.04 ✓  
 342 80.89 ✓   142 35.01 ✓  
 340* 78.94 ✓   135 19.68 ✕  
 58 72.74 ✓   336 17.15 ✕  
Formate 497 Singlet NA 497 Glutamine 333* 38.12 ✓ 333 
Fumarate 450 Singlet NA 450  128 27.39 ✕  
Glucose 270 66.52 ✓ 270 Lactate 384 90.00 ✓ 384 
 329 65.92 ✓   51 87.32 ✓  
 281 65.86 ✓   49 85.74 ✓  
 267 65.76 ✓   386 77.89 ✓  
 282* 65.72 ✓  Propionate 129 64.35 ✓ 129 
 279 65.60 ✓   15 60.78 ✓  
 283 65.35 ✓   17 55.79 ✓  
 323 63.40 ✓   127 53.79 ✓  
 264 62.99 ✓  Pyruvate 139 Singlet NA 139 
 425 62.43 ✓  Threonine 299 13.82 ✕ - 
 337* 62.39 ✓  Trehalose 346* 66.76 ✓ 346 
 327 62.26 ✓   333* 56.12 ✓  
 285 59.13 ✓   340* 20.26 ✕  
 287 58.87 ✓  Tryptophan 248 25.60 ✕ - 
 347 57.66 ✓   282* 17.52 ✕  
 354 56.79 ✓   286 -6.70 ✕  
 420 56.77 ✓  Valine 304 34.01 ✓ 304 
 292 56.62 ✓  
     
 356 56.51 ✓  
     
 346* 55.19 ✓  
     
 291 54.31 ✓  
     
 276 53.20 ✓  
     
 289 52.71 ✓  
     
 239 48.43 ✓  
     
 274 46.49 ✓  
     
 236 24.04 ✕  
     
 
From the 14 unique metabolites shortlisted via VIP scoring, 12 bins were selected to 
represent their metabolites (Table 3.5-2). Meanwhile, two metabolites, threonine and 
tryptophan, were excluded from the final metabolite shortlist due to their low CRS. 
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Table 3.5-2: Influential metabolites of the PLS-DA model for sex discrimination in wild type An. gambiae pupa. 
Class Metabolite Bin Chemical shift [ppm] KEGG code 
Amino acids Alanine 342 3.80 C00041 
 Glutamate 138 2.35 C00025 
 Glutamine 333* 3.77 C00064 
 Valine 304 3.61 C00183 
Carboxylic acids Acetate 102 1.92 C00033 
 Formate 497 8.46 C00058 
 Fumarate 450 6.52 C00122 
 Lactate 384 4.11 C00186 
 Propionate 129 2.18 C00163 
 Pyruvate 139 2.37 C00022 
Sugars Glucose 270 3.42 C00031 
 Trehalose 346* 3.83 C01083 
*: Overlapping bin. 
 
Prior to MSEA, the discriminatory properties of these 12 metabolite bins were investigated. 
Figure 3.5-4-A shows PCA scores plot of PC1 (61.77%) against PC2 (15.82%) for pupae. PC1 
and PC2 explain a total of 77.59% of the explained variance, meanwhile, 95% of the variance 
was explained with six components. In the PCA scores plot, a clear separation of males and 
females was not observed. Although, along PC1, males and female clusters can be seen 
suggesting an underlying structure in the data. Applying a cross-validated PLS-DA, the 
performance of the selected metabolites in discriminating between sexes was assessed. 
 
 
Figure 3.5-4: A) PCA of shortlisted metabolites for wild type An. gambiae pupa (nFemale=24, nMale=33). PC1 (61.77%) 
and PC2 (15.82%) account for a cumulative explained variance of (77.59%). A total of six components were 
required in order to explain 95% of the explained variance. Ellipses represent 95% confidence region. B) PLS-DA 
scores from selected metabolites discriminating wild type An. gambiae pupa by sex (nFemale=24, nMale=33). Two-
variate model complexity was optimised using cross-validation with 71.43% accuracy. Brackets report the 
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A PLS-DA model (Figure 3.5-4-B) to discriminate between males and females was built. 
Through cross-validation, optimal model complexity was determined to be a two-variate 
model with 71.43% accuracy (Appendix 11 for further metrics). PLS-DA scores plot show a 
greater degree of separation compared to the PCA scores plot. Discrimination of females 
against males can be seen along a diagonal of variate-1 and variate-2. Intersecting data points 
demonstrate the similarities between males and females as well as the limitation of the 
model in discriminating between males and females. To obtain metabolite level information, 
BH adjusted t-test (for detailed statistics see Appendix 12) was used to compare the 
metabolite levels. These comparisons were demonstrated with boxplots (Figure 3.5-5). 
 
 
Figure 3.5-5: Selected metabolite boxplots of male (nMale=33) and female (nFemale=24) wild type An. gambiae 
pupae. *, ** and *** represent p-value less than 0.05, 0.01 and 0.001 respectively. * in the boxplot title represent 
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Univariate analysis revealed selected metabolites representing the sex differences to be 
significantly different between sexes. Within the selected metabolites, representative bins 
for glutamine and trehalose were of overlapping peaks. In the comparison of selected 
metabolites, all the amino acids (valine, glutamine and alanine) were found to be significantly 
higher in females except glutamate where it was higher in males. All carboxylic acids (acetate, 
propionate, pyruvate, fumarate and formate) were significantly higher in males except 
lactate where it was higher in females. Lastly, all saccharides (glucose and trehalose) were 
higher in females. 
 
3.5.2 Sex-specific differences in adult mosquitoes 
3.5.2.1 Statistical analysis 
Prior to the statistical analysis of sex differences, variation types in the data were estimated 
using PVCA. Figure 3.5-6 shows the variation estimation in the data. As the figure shows, 
there is no batch effect seen in the adult dataset. Therefore, the data was not treated with a 
batch correction method and was PQN normalised followed by auto scaling prior to statistical 
analysis. It should be noted that the PQN normalisation and auto scaling increases the batch 
effect contribution to 0.45% but, compared to the 18.64% sex effect, it is negligible.  
 
Figure 3.5-6: Estimation of batch, sex and strain variances via PVCA in wild type An. gambiae adult. Colon denotes 
the combined effects of two sources of variance and Residual denotes the total remaining variation in the dataset 
(residua). Data shows no batch effect. Correction methods applied: None, no correction; PQN.Auto, probabilistic 
quotient normalization and autoscaling; ARSyN, ASCA [ANOVA simultaneous component analysis] removal of 
systematic noise; ComBat, Combining batches and SVA, surrogate variable analysis. 
 
Following the variation estimate, PCA was performed to observe the major variances in the 
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PVCA estimation for adult data
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and females. Although a clear separation was not observed along PC1 (38.67%), male 
samples are clustered tighter compared to females, suggesting a higher degree of variability 
within female species. In contrast, sex difference was observed with better resolution along 
PC3 (8.63%). PC1 and PC3 accounted for a total variance of 47.30% and 29 components were 
required to explain the 95% cumulative variance. Along PC1, a female sub-population can be 
observed, although, given the metadata this could not be attributed to any known factor of 
batch and sex. Upon the observation of the loadings of PC1 (Appendix 13), glucose 
demonstrates a high influence in the separation observed. This is most likely due to the 
feeding habits of the mosquitoes. This underlying structure for sex differences, especially 
exhibited on PC3, can be further used in a supervised PLS-DA for further enhancement of the 
sex differences and identification of the metabolite differences observed. 
 
 
Figure 3.5-7: A) PCA scores plot of adult wild type An. gambiae coloured by sex (nFemale=25, nMale=28). A total of 
29 components were required for 95% explained variance. PC1 (38.91%) shows a higher degree of variation within 
females. Meanwhile, the most pronounced sex separation was observed on PC3 (8.56%). Ellipses represent 95% 
confidence region. B) PLS-DA scores of adult wild type An. gambiae discriminated by sex (nFemale=25, nMale=28). 
Model complexity of two variates was optimised using cross-validation with 87.50% accuracy. Ellipses represent 
95% confidence region. 
 
A cross-validated PLS-DA model (Figure 3.5-7-B) was built, which was then used for 
metabolite selection. Through the cross-validation, a two-variate model with 87.50% 
accuracy (Appendix 11 for further metrics) was found to be the optimal complexity for sex 
discrimination for adult wild type An. gambiae. PLS-DA scores plot retained the sub-
populations observed in the PCA scores plot (Figure 3.5-7-A), which could not be attributed 
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were used to discriminate between the two female sub-populations and males. Using VIP 
scores, this discrimination can be probed further for metabolite level information. 
 
3.5.2.2 Key metabolites of the comparison 
VIP scores were calculated for all the bins in the model. In order to select metabolites 
influential in discriminating between males and females, identified bins scoring higher than 
1 were selected. A total of 179 bins out of 496 (36.09%) scored above the VIP score threshold 
of one. From the 179 bins, only 58 (32.40%) were identified and were attributed to 14 unique 
metabolites (Figure 3.5-8). In order to select metabolites, these selections from VIP scoring 
needed to be further checked for their representative quality for their respective 
metabolites, which was performed by CRS. 
 
 
Figure 3.5-8: VIP scores of wild type An. gambiae adult PLS-DA model discriminating between males and females. 
A total of 58 bins out of 496 (11.69%) were selected representing 14 unique metabolites. Black line represents 
VIP score of 1. 
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CRS was calculated for all identified metabolites. A passing threshold of 35.82% was 
calculated using all the CRS. Each score for the VIP selected bins were compared to the 
threshold (Table 3.5-3). Passing bins were taken into consideration for representing their 
respective metabolites. Out of the passing scores, the highest non-overlapping (where 




Table 3.5-3: CRS for wild type adult An. gambiae. A passing score of 35.82% is required for a bin to be considered 
as a representative of a metabolite. 
Metabolite Bin CRS [%] 
CRS > 
35.82% Rep Metabolite Bin CRS [%] 
CRS > 
35.82% Rep 
Acetate 102 Singlet NA 102 Glutamate 334* 13.97 ✕ - 
Alanine 337* 79.78 ✓ 342  331 12.37 ✕  
342 79.58 ✓ 
 
 332* 10.95 ✕  
334* 77.28 ✓ 
 
 336 6.80 ✕  
340* 75.69 ✓ 
 
Glutamine 333* 22.20 ✕ - 
Glucose 354 98.00 ✓ 354  335* 21.83 ✕  
356 97.97 ✓ 
 
Glycine 295 Singlet NA 295 
283 97.78 ✓ 
 
Lactate 386 46.84 ✓ 386 
292 97.71 ✓ 
 
 384 30.28 ✕  
285 97.61 ✓ 
 
Oxypurinol 493 Singlet NA 493 
329 97.47 ✓ 
 
Propionate 12 58.17 ✓ 12 
291 97.38 ✓ 
 
 15 54.93 ✓  
425 97.35 ✓ 
 
 17 54.58 ✓  
270 97.26 ✓ 
 
Threonine 299 -0.23 ✕ - 
420 97.24 ✓ 
 
Trehalose 351 90.94 ✓ 351 
279 97.24 ✓ 
 
 335* 90.73 ✓  
289 97.22 ✓ 
 
 278* 90.53 ✓  
287 97.19 ✓ 
 
 348 90.24 ✓  
264 97.16 ✓ 
 
 280* 90.19 ✓  
267 97.15 ✓ 
 
 333* 88.77 ✓  
239 97.10 ✓ 
 
 349* 88.61 ✓  
327 97.08 ✓ 
 
 346* 86.56 ✓  
323 97.01 ✓ 
 
 340* 85.34 ✓  
281 96.92 ✓ 
 
 344 84.14 ✓  
236 96.89 ✓ 
 
 345 82.82 ✓  
332* 96.69 ✓ 
 
Tryptophan 476 21.85 ✕ - 
280* 96.65 ✓ 
 
 463 21.12 ✕  
347 96.64 ✓ 
 
 478 20.41 ✕  
337* 96.58 ✓ 
 
 466 19.98 ✕  
282* 96.47 ✓ 
 
 284 -2.07 ✕  
338 96.02 ✓ 
 
 282* -2.26 ✕  
278* 95.72 ✓ 
 
 383 -2.86 ✕  
276 95.35 ✓ 
 
Tyrosine 360 -7.91 ✕ - 
346* 94.43 ✓ 
 
Valine 304 -14.50 ✕ - 
349* 91.76 ✓ 
 
     
334* 90.44 ✓ 
 
     
* Overlapping bin 
 
VIP scoring shortlisted 14 unique metabolites. When CRS was applied, this list was further 
shortened to 8 metabolites. Excluded metabolites included threonine, tryptophan, tyrosine 
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and valine. Table 3.5-4 shows the metabolites shortlisted from VIP scoring and CRS. The 
metabolite shortlist comprises four metabolite classes: amino acids (alanine and glycine), 
carboxylic acids (acetate, lactate and propionate), purines (oxypurinol) and saccharides 
(glucose and trehalose). 
 
Table 3.5-4: Selected metabolites of PLS-DA model discriminating between males and females in wild type adult 
An. gambiae. 
Class Metabolite Bin Chemical shift [ppm] KEGG code 
Amino acids Alanine  342 3.80 C00041 
Glycine  299 3.57 C00037 
Carboxylic acids Acetate  102 1.92 C00033 
Lactate 386 4.13 C00186 
Propionate 12 1.05 C00163 
Purines Oxypurinol 493 8.27 C07599 
Saccharides Glucose  354 3.89 C00031 
Trehalose  351 3.87 C01083 
 
Prior to performing MSEA, discriminatory properties of only the selected metabolites were 
assessed. This was performed by filtering the data to include only the representative bins of 
the selected metabolites, then applying PCA. Using the filtered data, PCA scores plots (Figure 
3.5-9-A) show separation between males and females along PC2 (16.02%) which is 
augmented by PC1 (67.06%). The same female sub-population can still be observed along 
PC1 and the large variance explained by this component suggest it is caused by the observed 
female sub-population. PC1 and PC2 accounted for a cumulative variance of 83.08%, 
meanwhile four components were required to explain the 95% variance in the filtered data. 
A supervised PLS-DA model was also built in order to determine the performance of these 




Figure 3.5-9: A) PCA scores plot PC1 against PC2 of wild type adult An. gambiae from selected metabolites 
(nFemale=25, nMale=28). PC1 and PC2 accounts for a cumulative explained variance of 83.08%. Meanwhile, four 
components were required to explain the 95% variance. Ellipses represent 95% confidence region. B) PLS-DA 
scores of adult wild type An. gambiae discriminated by sex (nFemale=25, nMale=28). Model complexity of three 
variates was optimised using cross-validation with 93.75% accuracy. Brackets report the explained variance for 
the variate. Ellipses represent 95% confidence region. 
 
Selected metabolites were also used to build a PLS-DA model in order to assess their 
performance on discrimination models exclusively. A cross-validated model was built where 
a two-variate model was determined to be optimal with 93.75% accuracy (Appendix 11 for 
further metrics). PLS-DA scores plot (Figure 3.5-9-B) shows a separation between sexes along 
a diagonal of variate-1 and variate-2. Although there are some classification errors which are 
easily recognised by data point clustering with the opposite sex, the majority could be classed 
correctly. Metabolite comparison was carried out in order to gain metabolite level insight on 
the divergent pathways between males and females. 
 
Metabolite levels were shown via boxplots (Figure 3.5-10) and significance were calculated 
using BH adjusted t-test (for detailed statistics see Appendix 12). All selected metabolites 
were found to be significantly different between males and females. More specifically, 
selected amino acids and sugars were all found to be significantly higher in females. The only 
purine selected was oxypurinol and it was found to be significantly higher in males. In 
carboxylic acids, while acetate and propionate were found to be significantly higher in males, 
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Figure 3.5-10: Boxplots of selected metabolites from PLS-DA model discriminating between females and males in 
adult wild type An. gambiae (nFemale=25, nMale=28). ** and *** represents p-values less than 0.01 and 0.001 
respectively. 
 
3.5.3 Sex-specific differences across stages 
Metabolite level differences were summarised in Table 3.5-5. The table clearly shows 
metabolite selection yielded 12 metabolites in pupa compared to the 8 metabolites in adults. 
It should be noted that overlapping metabolites both in pupa and adults follow the same 
trend across stages. PLS-DA scores plots have shown the metabolic profiles regarding sexes 
could be discriminated more successfully in adults. Interestingly, adults required a smaller 
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Table 3.5-5: Metabolite changes summary for wild type An. gambiae pupae and adults. Arrows represent 
significant metabolite level differences when females were compared to males, and square brackets report BH-
adjusted p-values. 
 Pupa Adult 
Class Female compared to male 
Amino acids Alanine ↑ [4.00x10-5] ↑ [2.74x10-3] Alanine 
Glutamate ↓ [1.82x10-3]   
Glutamine ↑ [1.09x10-2]   
  ↑ [4.38x10-3] Glycine 
Valine ↑ [3.43x10-4]   
Carboxylic acids Acetate ↓ [1.82x10-3] ↓ [3.04x10-5] Acetate 
Formate ↓ [2.09x10-3]   
Fumarate ↓ [3.57x10-2]   
Lactate ↑ [3.43x10-4] ↑ [3.63x10-10] Lactate 
Propionate ↓ [2.53x10-4] ↓ [1.08x10-3] Propionate 
Pyruvate ↓ [2.17x10-2]   
Purines   ↓ [3.46x10-6] Oxypurinol 
Sugars Glucose ↑ [4.00x10-5] ↑ [4.38x10-3] Glucose 
Trehalose ↑ [2.82x10-3] ↑ [4.38x10-3] Trehalose 
 
Using the selected metabolites for both pupae and adults, a MSEA was performed (Figure 
3.5-11). High numbers of selected metabolites from the pupae resulted in a longer list of 
over-represented pathways (Table 3.5-6). In contrast, adult metabolite selection produces a 
much more concise list of pathways over-represented. Considering the more successful 
discrimination achieved in adult mosquitoes, glycolysis/gluconeogenesis and propanoate 
metabolism may be a better representative for sex separation in both pupae and adults. It 
should be noted that if the unadjusted raw p-values are considered, propanoate metabolism 




Figure 3.5-11: MSEA from selected metabolites in wild type An. gambiae pupae and adults. Black line represents 
p-value of 0.05. 
  
Pupa Adult
0.0 2.5 5.0 7.5 10.0 12.50.0 2.5 5.0 7.5 10.0 12.5
2−Oxocarboxylic acid metabolism
ABC transporters
Alanine, aspartate and glutamate metabolism
Aminoacyl−tRNA biosynthesis
Arginine biosynthesis




Glyoxylate and dicarboxylate metabolism




Taurine and hypotaurine metabolism
−log10(BH adjusted p−value)
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Table 3.5-6: MSEA result details for wild type An. gambiae, reporting; stage, raw & BH adjusted p-values, number 





p-value Hits/total (%) Metabolites 
2-Oxocarboxylic acid 
metabolism 
Pupa 6.0 x 10-6 5.5 x 10-5 3/134 (2.24%) Pyruvate, glutamate, valine 
ABC transporters Pupa 3.9 x 10-14 8.9 x 10-13 6/182 (3.30%) Glutamate, glucose, alanine, 
glutamine, valine, trehalose 
Adult 5.0 x 10-5 1.5 x 10-3 4/182 (2.20%) Glucose, glycine, alanine, 
trehalose 
Alanine, aspartate and 
glutamate metabolism 




Pupa 1.3 x 10-8 1.5 x 10-7 4/52 (7.69%) Glutamate, alanine, 
glutamine, valine 
Arginine biosynthesis Pupa 6.1 x 10-3 2.0 x 10-2 3/23 (13.04%) Glutamate, glutamine, 
fumarate 
Biosynthesis of amino 
acids 
Pupa 2.4 x 10-11 3.6 x 10-10 5/128 (3.91%) Pyruvate, glutamate, alanine, 
glutamine, valine 
Butanoate metabolism Pupa 3.8 x 10-3 1.5 x 10-2 3/42 (7.14%) Pyruvate, glutamate, 
fumarate 
Carbon metabolism Pupa 3.9 x 10-14 8.9 x 10-13 6/112 (5.36%) Pyruvate, glutamate, acetate, 
alanine, formate, fumarate 
Adult 3.2 x 10-3 3.2 x 10-2 3/112 (2.68%) Acetate, glycine, alanine 
Glycolysis / 
Gluconeogenesis 
Pupa 7.0 x 10-5 4.5 x 10-4 4/31 (12.90%) Pyruvate, glucose, acetate, 
lactate  









Pupa 1.6 x 10-3 6.7 x 10-3 3/55 (5.45%) Pyruvate, fumarate, 
propanoate 
Nitrogen metabolism Pupa 5.3 x 10-3 1.9 x 10-2 3/43 (6.98%) Glutamate, formate, 
glutamine 
Propanoate metabolism Adult 5.6 x 10-3 4.1 x 10-2 3/48 (6.25%) Acetate, propanoate, lactate 





Pupa 5.8 x 10-4 3.0 x 10-3 4/22 (18.18%) Pyruvate, glutamate, acetate, 
alanine 
 
The analyses showed the sex differences in pupae although present, are not a major variation 
in the dataset. By means of statistical modelling and variable selection, these differences can 
be extracted and further used for different purposes. These differences are more 
pronounced in adults and some precaution should be taken. When sex differences were 
being probed, pupal metabolic profiles of males and females were found to be more similar 
compared to the adult profiles. Both in PCA and PLS-DA approaches, sex differences in pupae 
were less pronounced and harder to discriminate. In PCA scores plots, neither pupae or 
adults achieved a clear separation of sexes but nevertheless, adult scores plots showed 
tighter sex clustering. Additionally, in adults, all dataset PLS-DA models required two variates 
to achieve 87.50% accuracy whereas pupae PLS-DA model scored 71.43% accuracy with two 
variates, demonstrating the challenges in discriminating chemical phenotypes of pupae 
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compared to adults. When a metabolite selection approach was employed, adults required 
less metabolites to achieve good discrimination compared to pupae. During the univariate 
comparison, common metabolites selected in pupae and adults followed the same 
abundance levels across stages (Table 3.5-5), suggesting sex differences can be further 
refined to a specific set of common metabolites. 
 
3.6 Sex-specific differences in wild type Ae. aegypti pupae and adult metabolic 
profile 
3.6.1 Sex-specific differences in mosquito pupae 
3.6.1.1 Statistical analysis 
Prior to assessing sex differences batch variation in pupal data was assessed using a PVCA 
estimation (Figure 3.6-1). Variation estimations show batch effects account for 0.64% of the 
variance in the data, contributing more than the threshold of 0.5%. However, the batch 
effects could not be fully removed by normalisation and scaling. Therefore, the batch 
correction method of ComBat was selected reducing the batch contribution to 1.47 x 10-19%, 
ensuring the variation in the data was not affected by batch variation. Following this 
assessment, the PCA was performed in order to observe the major variances in the data. 
 
 
Figure 3.6-1: PVCA of wild type Ae. aegypti pupa (nFemale=26, nMale=29). Each bar colour represents a different data 
treatment method. Each batch correction method was normalised before correction and scaled after with PQN 
normalisation and auto scaling respectively. Where effects of two factors were estimated ‘:’ was used to show it. 
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In order to observe the major variance in the data, PCA was performed. The PCA scores plot 
(Figure 3.6-2-A) of PC1 (33.39%) against PC2 (14.82%) accounted for 48.21% variance in the 
data. A total of 29 components were required in order to explain the 95% variance in the 
data. The results shows a clear separation between males and females, except one male 
sample. This is most likely an extreme case sample, since this sample was not classed as an 
outlier given the sample passed all QC criteria. Within the plot, two sub groups can be seen 
in male and female which perfectly match with the resistance status of the mosquitoes. To 
minimise these differences and accentuate the difference between males and females, a 
cross-validated PLS-DA model was used. This allowed metabolite selection representing the 
differences between the two sexes. 
 
 
Figure 3.6-2: A) PCA scores plot of wild type Ae. aegypti pupa coloured by sexes (nFemale=26, nMale=29). PC1 
(33.39%) against PC2 (14.82%) accounting for a cumulative varinace of 48.21%. A total of 29 componenets were 
required in order to explain 95% of variance in the data. Ellipses represent the 95% confidence region. B) PLS-DA 
density plot showing discrimination of females against males (nFemale=26, nMale=29). Each tick represents a sample 
coloured by its group. Classification accuracy of the PLS-DA model is 93.75%. Brackets report the explained 
variance for the variate. 
 
A PLS-DA model with cross-validation was built in order to discriminate between male and 
female mosquitoes (Figure 3.6-2-B). Cross-validation results show the optimal complexity to 
be a single-variate model with 93.75% accuracy (Appendix 11 for further metrics). In order 





















































































3.6.1.2 Key metabolites of the comparison 
VIP scores were calculated to select the bins that are most influential on the discrimination 
between males and females. VIP scores were calculated for all the bins and only identified 
bins that scored higher than the threshold of 1 were selected. A total of 209 out of 513 bins 
scored above the VIP threshold of 1. Out of the 209, only 60 (28.71%) were identified and 
attributed to 15 metabolites (Figure 3.6-3). In order to generate a list of metabolites, the 
reliability of the bins in terms of representing its metabolite was evaluated by calculating 
CRS. 
 
Figure 3.6-3: VIP scores from PLS-DA model of wild type Ae. aeypti pupae discirminating between males and 
females. Only 60 identified bins scored higher than the threshold of 1 out of 513 bins. Selected bins represent a 
total of 15 metabolites. Black line represents the VIP score of 1. 
 
CRS (Table 3.6-1) was calculated for all the bins in order to establish the threshold score. 
Threshold score of 42.82% was calculated from all the scores. This threshold was applied to 
the bins selected from VIP scores. Only non-overlapping (where applicable) bins scoring 
higher than this threshold were considered as a possible representative of the metabolite. 
Only the highest scoring bins were selected amongst the bins meeting the scoring criteria.  
Variate−1 (27.85%)
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Table 3.6-1: CRS for Ae. aegypti pupa. Rep: representative bin. 
Metabolite Bin CRS [%] 
CRS > 
42.82% Rep Metabolite Bin CRS [%] 
CRS > 
42.82% Rep 
Acetate 114 Singlet NA 114 Lactate 398 90.09 ✓ 398 
Alanine 351* 79.77 ✓ 356  400 78.49 ✓  
 354* 77.51 ✓ 
 
Propionate 141 83.75 ✓ 141 
 356 55.79 ✓ 
 
 17 80.36 ✓  
Formate 514 Singlet NA 514  15 80.01 ✓  
Glucose 284 87.41 ✓ 284  139 76.63 ✓  
 368 87.30 ✓ 
 
 12 75.20 ✓  
 370 87.13 ✓ 
 
 142 66.26 ✓  
 303 86.41 ✓ 
 
Threonine 313 18.17 ✕ - 
 278 86.35 ✓ 
 
Trehalose 362 70.75 ✓ 362 
 439 86.32 ✓ 
 
 360* 67.07 ✓  
 360* 86.18 ✓ 
 
 349* 66.61 ✓  
 343 85.92 ✓ 
 
 347* 57.38 ✓  
 341 85.75 ✓ 
 
 354* 45.27 ✓  
 337 85.74 ✓ 
 
 291 42.94 ✓  
 434 85.66 ✓ 
 
 438 35.35 ✕  
 301 85.53 ✓ 
 
Tryptophan 262 31.91 ✕ - 
 297 85.46 ✓ 
 
 397 29.19 ✕  
 351* 85.04 ✓ 
 
 300 20.56 ✕  
 352 83.53 ✓ 
 
 476* 8.23 ✕  
 361 81.85 ✓ 
 
 474* 6.57 ✕  
 290 81.32 ✓ 
 
Tyrosine 474* 95.51 ✓ 466 
 288 80.75 ✓ 
 
 466 95.49 ✓  
 250 62.90 ✓ 
 
 228 95.42 ✓  
 346* 56.47 ✓ 
 
 476* 95.36 ✓  
Glutamate 150 36.59 ✕ -  226 95.16 ✓  
 346* 13.77 ✕ 
 
 475 94.47 ✓  
 130 3.41 ✕ 
 
 241 94.17 ✓  
 350 -8.84 ✕ 
 
 244 94.09 ✓  
Glutamine 349* 9.41 ✕ -  224 93.99 ✓  
 347* 9.07 ✕ 
 
 221 93.62 ✓  
 140 -0.28 ✕ 
 
 473 92.34 ✓  
Glycine 309 Singlet NA 309  477 92.01 ✓  
Isoleucine 4 87.01 ✓ 4 Valine 318 18.56 ✕ - 
*: Overlapping bins 
 
Post CRS selection, only eight out of 15 metabolites remained in the shortlist. Amongst the 
excluded metabolites were; glutamate, glutamine, threonine, tryptophan and valine. The 




Table 3.6-2: Selected representative metabolites for Ae. aegypti pupa, representing the differences between 





[ppm] KEGG code 
Amino acids Alanine 356 3.80 C00041 
Glycine 309 3.57 C00037 
Isoleucine 4 0.94 C00407 
Tyrosine 466 6.90 C00082 
Carboxylic acids Acetate 114 1.92 C00033 
Formate 514 8.46 C00058 
Lactate 398 4.11 C00186 
Propionate 141 2.18 C00163 
Saccharides Glucose 284 3.42 C00031 
Trehalose 362 3.85 C01083 
 
Prior to MSEA, data was filtered with the selected bins to represent the metabolites of 
interest and to establish the discriminatory properties of selected metabolites exclusively. 
PCA (Figure 3.6-4-A) was performed on the new dataset consisting only of selected 
metabolites. PCA scores of PC1 (60.24%) and PC2 (14.86%) showed the most variation 
representing the difference between males and females. PC1 and PC2 cumulatively explained 
75.10% of the variance. A total of six components were required to explain the 95% of the 
variance in the data. A cross-validated supervised PLS-DA model was made to accentuate 




Figure 3.6-4: A) PCA on selected metabolite for wild type Ae. aegypti pupae, coloured by the sexes (nFemale=26, 
nMale=29). A total of six components were required to explain the 95% variance in the data. Ellipses represent the 
95% confidence region. B) PLS-DA density plot showing discrimination of females against males (nFemale=26, 
nMale=29) in wild type Ae. aegypti pupae. Each tick represents a sample from groups. Variate-1 explains 59.78% of 
the variance in the data. The model accuracy was measured as 100%. 
 
PLS-DA model performance was optimised to a single-variate model complexity with 100% 
accuracy (Appendix 11 for further metrics). The density plot shows the models capability of 
discriminating between males and females. To understand the metabolite level differences, 
a BH adjusted t-test method was performed. 
 
To further understand the changes between resistant and susceptible pupae strains, 
metabolite levels were compared via BH adjusted t-test (for detailed statistics see Appendix 
12). Compared metabolites were then visualised by boxplots (Figure 3.6-5). Out of the 10 
selected metabolites, all were significantly different between male and female species. These 
10 metabolites were then analysed by MSEA to compare the pathways affected by sex in 






























































































Figure 3.6-5: Boxplot of metabolites selected from Ae. aegypti pupae (nFemale=26, nMale=29). Metabolites were 
compared via BH adjusted t-test. ** and *** denotes p-values less than 0.01 and 0.0001 respectively. 
 
3.6.2 Sex-specific differences in adult mosquitoes 
3.6.2.1 Statistical analysis 
In order to obtain comparable results, the approach taken in pupal analysis was applied to 
the adult dataset. Prior to statistical analyses, batch variation in the data was estimated via 
PVCA. Batch variation contribution in the raw data was revealed to be 0.86%. When the 
dataset was PQN normalised and auto-scaled, batch contribution was increased to 3.34%. 
When compared to other batch correction methods, ComBat was able to correct the batch 
effectively by reducing its contribution to 0.00%. Prior to further analysis, data was PQN 
normalised, ComBat corrected and auto-scaled in the given order. Following the batch 
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Figure 3.6-6: PVCA estimation of Ae. aegypti adult data (nFemale=22, nMale=19). Each bar colour represents a 
different data treatment method. Each batch correction method was normalised before correction and scaled 
after with PQN normalisation and auto scaling respectively. Where effects of two factors were estimated ‘:’ was 
used to show it. Residual, total remaining (residual) variation in the data; PQN.Auto, PQN normalisation and Auto 
scaling. 
 
PCA (Figure 3.6-7-A) was performed to observe the major variances in the data. Variances 
representing the sexes were found along a diagonal of PC1 (29.14%) and PC2 (13.17%). PC1 
and PC2 accounted for 42.31% of the variance in the data. In order to explain the 95% 
variance in the data, a total of 25 components were required. Overall, the plot shows a 
variance structure based on sex difference, some samples are not as clearly separated as the 
others. Similar to the pupae data a sub-population due to the resistance status can be seen. 
By accentuating differences between males and females with a PLS-DA model, metabolites 
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Figure 3.6-7: A) PCA for wild type Ae. aegypti adult showing PC1 (29.14%) against PC2 (13.17%) (nFemale=22, 
nMale=19). PC1 and PC2 account for a cumulative explained variance of 42.31%. A total of 25 components were 
required to explain the 95% variance in the data. Ellipses represent 95% confidence region. B) PLS-DA scores plot 
of variate-1 (28.10%) against variate-2 (12.34%) discriminating between males and females of adult wild type Ae. 
aegypti (nFemale=22, nMale=19). Model complexity of two-variate was determined through cross-validation with 
100% accuracy. Brackets report the explained variance for the variate. Ellipses represent 95% confidence region 
for each group. 
 
Discrimination between male and female samples were performed via PLS-DA modelling. 
Using a cross-validation, PLS-DA model was optimised to a two-variate model with 100% 
accuracy (Appendix 11 for further metrics). The PLS-DA (Figure 3.6-7-B) model could clearly 
separate males and females, except for one sample. This is a misclassification of the model, 
representing the limitations of the model on very extreme samples. VIP scores were 
calculated from the PLS-DA model in order to select metabolites for MSEA. 
 
3.6.2.2 Key metabolites of the comparison 
VIP scores were calculated for all the bins of the model. In order to create a list of selected 
metabolites, the most influential bins of the separation needed to be identified. To achieve 
this, only identified metabolites scoring higher than the threshold of one on variate-1 and 
variate-2 were considered (Figure 3.6-8). From the 513 VIP scores calculated, 196 bins scored 
above the threshold on both variate-1 and variate-2. Within the 196 bins, only 34 (17.35%) 
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Figure 3.6-8: VIP scores for wild type adult Ae. aegypti. PLS-DA model discriminating between males and females. 
A total of 34 identified bins scored higher than 1, representing 14 metabolites. Black line represents VIP score of 
1. 
 
In order to generate a list of selected metabolites, a selection of bins representing each 
metabolite was required. Prior to this selection, bins were assessed on how well they 
represented each metabolite by CRS. A threshold was set to 41.68%, calculated from all the 
CRS. From the VIP-selected bins, the highest, non-overlapping (where applicable) scoring bins 
above the threshold were selected as the representative of its metabolite (Table 3.6-3).  
 
Table 3.6-3: CRS for wild type Ae. Aegypti adults. A passing score of 41.68% was calculated using all identified bin 
CRS. Res: representative bin. 
Metabolite Bin CRS [%] 
CRS > 
41.68% Rep Metabolite Bin CRS [%] 
CRS > 
41.68% Rep 
Acetate 114 Singlet NA 114 Isoleucine 9 72.60 ✓ 9 
Formate 514 Singlet NA 514 Lactate 398 76.56 ✓ 398 
Glucose 434 78.44 ✓ 434  400 62.34 ✓  
 370 78.20 ✓ 
 
Methanol 274 Singlet NA 274 
 303 78.00 ✓ 
 
Propionate 15 77.02 ✓ 15 
Variate−1 (28.10%) Variate−2 (12.34%)



































Variable importance of the projection
 144 
 343 77.45 ✓ 
 
 141 76.87 ✓  
 352 69.21 ✓ 
 
 17 75.59 ✓  
 250 67.47 ✓ 
 
 139 66.64 ✓  
 290 61.42 ✓ 
 
Pyruvate 151 Singlet NA 151 
 346* 57.16 ✓ 
 
Threonine 412 23.29 ✕ - 
Glutamate 150 33.86 ✕ - Trehalose 438 47.62 ✓ 438 
 152 32.90 ✕ 
 
 349* 44.36 ✓  
 154 31.45 ✕ 
 
Tryptophan 483 53.41 ✓ 483 
 130 30.09 ✕ 
 
 397 38.11 ✕  
 346* 1.24 ✕ 
 
Valine 8 68.31 ✓ 8 
Glutamine 140 23.93 ✕ -  13 67.87 ✓  
 349* 15.96 ✕ 
 
 10 67.74 ✓  
 143 -0.58 ✕ 
 
 318 61.64 ✓  
* Denotes overlapping bin. 
 
Using the VIP scoring, 14 unique metabolites were listed. Post CRS, three metabolites were 
excluded from this shortlist due to low CRS. The excluded metabolites were glutamate, 
glutamine and threonine. The remaining n11 metabolites (Table 3.6-4) comprised of four 
metabolite classes; alcohols, amino acids, carboxylic acids and saccharides. 
 
Table 3.6-4: List of selected metabolites from the PLS-DA model discriminating between sexes of adult Ae. aegypti. 
Class Metabolite Representative bin Chemical shift [ppm] KEGG code 
Alcohols Methanol 274 3.36 C00132 
Amino acids Isoleucine 9 1.02 C00407 
Tryptophan 483 7.33 C00078 
Valine 8 1.00 C00183 
Carboxylic acids Acetate 114 1.92 C00033 
Formate 514 8.46 C00058 
Lactate 398 4.11 C00186 
Propionate 15 1.10 C00163 
Pyruvate 151 2.37 C00022 
Sugars Glucose 434 4.65 C00031 
Trehalose 438 5.20 C01083 
 
Prior to MSEA, the discriminatory properties of these metabolites were exclusively probed 
using PCA (Figure 3.6-9-A). PCA scores plot of PC1 (60.19%) against PC2 (13.47%) show a clear 
separation between males and females. A wider spread in the male cluster suggests a larger 
variation in male population compared to the females. These two components account for a 
cumulative variance of 73.66%. A total of six components were required to explain 95% 
variance in the data. A cross validated PLS-DA model was also built in order to determine the 




Figure 3.6-9: A) PCA of selected metabolites in adult wild type Ae. aegypti (nFemale=22, nMale=19). PC1 (60.19%) and 
PC2 (13.47%) account for a cumulative variance of 73.66% while six components were required to explain the 
95% variance in the data. Ellipses represent the 95% confidence region. B) PLS-DA density plot of adult wild type 
Ae. aegypti discriminated by sex (nFemale=22, nMale=19). Single-variates model (59.89% explained variance) 
complexity was optimised using a cross-validation with 100% accuracy. Ticks represent samples from each group. 
 
A cross-validated PLS-DA model was built in order to discriminate between males and 
females using the selected metabolites Figure 3.6-9-B. A single variate model with 100% 
accuracy (Appendix 11 for further metrics) was shown to be the optimal complexity for sex 
discrimination. Males could be discriminated from females on variate-1. Metabolite 
comparison was carried out in order to gain metabolite level insight on the changes between 
males and females. 
 
Metabolite levels were shown via boxplot (Figure 3.6-10) and statistical significance was 
calculated using BH adjusted t-test (for detailed statistics see Appendix 12). All selected 
metabolites were found to be significantly different between males and females. More 
specifically, selected amino acids (valine, isoleucine and tryptophan) were all significantly 
higher in females, whereas all carboxylic acids (propionate, acetate, pyruvate and formate) 
except lactate were higher in males. This was also observed in both knock-down and wild 
type An. gambiae. In the saccharides, glucose was higher in females, meanwhile, trehalose 
















































































Figure 3.6-10: Boxplots of selected metabolites from PLS-DA model discriminating between females and males in 
adult wild type Ae. aegypti (nFemale=22, nMale=19). ** and *** represents p-values less than 0.01 and 0.001 
respectively. 
 
3.6.3 Sex-specific differences across stages 
Metabolite differences in pupae and adults were summarised in Table 3.6-5. The total 
number of metabolites selected from the pupae model was 10 compared to the 11 
metabolites from the adult model. Overlapping carboxylic acids follow the same trend both 
in pupae and adults. In the amino acids, only isoleucine metabolite is shared and it lower in 
female pupae while higher in female adults. This could be due to the development of the 
pupae. From the sugars, only glucose was found to be higher in both adult and pupae 






















































































































































































































































































































































































Trehalose [438] Tryptophan [483] Formate [514]
Pyruvate [151] Methanol [274] Lactate [398] Glucose [434]
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Table 3.6-5: Metabolite changes summary for wild type Ae. aegypti pupae and adults. Arrows represent significant 
metabolite level differences when were females compared to males, and square brackets report BH-adjusted p-
values. 
 Pupa Adult 
Class Female compared to male 
Alcohols   ↓ [4.61 x10-3] Methanol 
Amino acids Alanine ↑ [2.82x10-5]   
 Glycine ↑ [4.38 x10-7]   
 Isoleucine ↓ [1.59 x10-5] ↑ [1.59 x10-5] Isoleucine 
   ↑ [5.92 x10-4] Tryptophan 
 Tyrosine ↓ [2.53 x10-5]   
   ↑ [1.25 x10-9] Valine 
Carboxylic acids Acetate ↓ [1.05 x10-11] ↓ [5.92 x10-11] Acetate 
 Formate ↓ [2.75 x10-11] ↓ [6.63 x10-11] Formate 
 Lactate ↑ [2.53 x10-11] ↑ [3.63 x10-6] Lactate 
 Propionate ↓ [1.23 x10-11] ↓ [3.28 x10-12] Propionate 
   ↓ [3.85 x10-3] Pyruvate 
Sugars Glucose ↑ [1.10 x10-4] ↑ [5.92 x10-4] Glucose 
 Trehalose ↑ [3.99 x10-4] ↓ [1.17 x10-3] Trehalose 
 
When MSEA (Figure 3.6-11) was performed on selected metabolites, seven pathways were 
significantly over-represented. Out of the seven, two were uniquely significant for adults and 
the remaining five were commonly significant (Table 3.6-6). 
 
 
Figure 3.6-11: MSEA from selected metabolites in wild type Ae. aegypti pupae and adults. Black line represents 
p-value of 0.05. 
Pupa Adult
0 1 2 3 0 1 2 3
2−Oxocarboxylic acid metabolism
Aminoacyl−tRNA biosynthesis








Table 3.6-6: MSEA result details for wild type Ae. aegypti, reporting; stage, raw & BH adjusted p-values, number 






p-value Metabolites Hits/total (%) 
2-Oxocarboxylic acid 
metabolism 




Pupa 0.00005 0.00060 4/52 (7.69%) Glycine, Alanine, 
Tyrosine, Isoleucine 




Pupa 0.00003 0.00060 4/128 (3.13%) Glycine, Alanine, 
Tyrosine, Isoleucine 
Adult 0.00028 0.00198 4/128 (3.13%) Pyruvate, Tryptophan, 
Valine, Isoleucine 
Carbon metabolism Pupa 0.00002 0.00060 4/112 (3.57%) Acetate, Glycine, 
Alanine, Formate 




Pupa 0.00229 0.02063 3/31 (9.68%) Glucose, Acetate, Lactate 




Adult 0.00083 0.00501 4/48 (8.33%) Acetate, Methanol, 
Propionate, Lactate 
Pyruvate metabolism Pupa 0.00521 0.03753 3/31 (9.68%) Acetate, Formate, 
Lactate 
Adult 0.00022 0.00198 4/31 (12.9%) Pyruvate, Acetate, 
Formate, Lactate 
 
Following the analyses of sex-specific metabolic signatures of wild type strains (An. gambiae 
and Ae. aegypti), it is evident that the metabolite differences between sexes are greater in 
the wild type Ae. aegypti compared to the An. gambiae samples. In Ae. aegypti these 
differences were much heightened in pupae compared to adults. Two sub-populations can 
clearly be seen in Ae. aegypti pupae, whereas in adults these sub-population cannot be seen. 
Interestingly, when Ae. aegypti sex differences were analysed via supervised PLS-DA, both 
pupae and adult models required a higher number of metabolites. A lower number of 
metabolites was expected, as observed in An. gambiae analyses. When the analyses of pupal 
and adult sex differences are compared, there are five metabolites (acetate, formate, lactate, 
propionate and glucose) significantly different between males and females while their levels 
are similar across stages within each sex (Table 3.6-5). Additionally, between pupae and 
adults, the pathways pyruvate metabolism, glycolysis/gluconeogenesis, carbon metabolism, 
biosynthesis of amino acids, and aminoacyl-tRNA biosynthesis were significantly over-
represented as pathways altering between males and females. Therefore, the precautions 
taken in further analyses to mitigate sex differences in the next chapters can be applied both 
to pupal and adult datasets enabling the increase of sample size. 
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3.7 Chapter results summary 
This chapter aimed to explore the sex differences in the metabolome of knock-down An. 
gambiae, wild type An. gambiae, and wild type Ae. aegypti. Each dataset was analysed in two 
parts as pupae and adults while using both unsupervised and supervised multivariate 
methods. Sex differences were less pronounced in knock-down An. gambiae compared to 
wild type An. gambiae and Ae. aegypti. Pupae separations were more complex than adults, 
as revealed by the PLS-DA model scores (Table 3.7-1). The wild type Ae. aegypti pupal model 
(selected metabolites) and adult models (all and selected metabolites) were the most robust 
(100% accuracy), whereas knock-down An. gambiae pupa model for all data was the poorest 
(45.45% accuracy). Overall, adult models were more robust in discriminating between males 
and females. 
 
Table 3.7-1: PLS-DA model details for discrimination between males and females. 









Knock-down Pupa All data 3 45.45% 24 (23.30%) 9 
Adult 2 94.12% 20 (18.35%) 6 
Pupa Selected 1 63.64% NA NA 
Adult 2 94.12% NA NA 
Wild type Pupa All data 2 71.43% 53 (31.26%) 12 
Adult 2 87.50% 58 (32.40%) 8 
Pupa Selected 2 71.43% NA NA 
Adult 2 93.75% NA NA 
Ae. aegypti Wild type Pupa All data 1 93.75% 60 (28.71%) 10 
Adult 2 100.00% 34 (17.35%) 11 
Pupa Selected 1 100.00% NA NA 
Adult 1 100.00% NA NA 
 
Metabolite selection was carried out from the cross-validated PLS-DA models and metabolite 
levels were compared using BH-adjusted t-test. Table 3.7-2 collates all the changes across 
species and stages. The changes shown in the table are most concentrated in the metabolites 
belonging to the carboxylic acids class (acetate, formate, lactate, and propionate). Out of all 
the selected metabolites, carboxylic acids are the most consistent in terms of metabolite 
level between males and females.  
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Table 3.7-2: Metabolite level comparisons between sexes for knock-down An. gambiae, wild type An. gambiae 
and wild type Ae. aegypti. Arrows represent significant changes, NS (arrow) denotes non-significant change with 
mean abundance level, square brackets report the BH-adjusted p-value, and ‘-‘ represents metabolite not 







  Females compared to males 
Class Metabolite Pupa Adult Pupa Adult Pupa Adult 
Alcohols Methanol NS (↑) 
[3.12x10-1] 











Glutamate - - ↓ 
[1.82x10-3] 
- - - 
Glutamine - - ↑ 
[1.09x10-2] 
- - - 
Glycine NS (↓) 
[3.12x10-1] 









Tryptophan NS (↓) 
[3.93x10-1] 
- - - - ↑ 
[5.92 x10-4] 




- - ↓ 
[2.53 x10-5] 
- 
Valine - - ↑ 
[3.43x10-4] 
- - ↑ [1.25 x10-9] 
Carboxylic 
acids 



















Fumarate - - ↓ 
[3.57x10-2] 
- - - 






















Pyruvate - - ↓ 
[2.17x10-2] 
- - ↓ 
[3.85 x10-3] 








Xanthine - ↑ 
[3.12x10-1] 
- - - - 





















Over-represented pathway comparisons are summarised in Table 3.7-3. In knock-down An. 
gambiae pupae, carbon metabolism and propanoate metabolism were found to be the only 
over-represented pathways between males and females. The wild type An. gambiae 
comparison identified the highest number of pathways with 15 pathways. Amongst the 15 
pathways, alanine, aspartate and glutamate metabolism, aminoacyl-tRNA biosynthesis, 
arginine biosynthesis, biosynthesis of amino acids, butanoate metabolism, glyoxylate and 
dicarboxylate metabolism, nicotinate and nicotinamide metabolism and nitrogen 
metabolism were specific to pupae. Meanwhile, only ABC transporters, carbon metabolism 
and glycolysis/gluconeogenesis were common between pupae and adults. Only propanoate 
metabolism was found differing in adults. In wild type Ae. aegypti, common pathways to both 
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pupae and adults were aminoacyl-tRNA biosynthesis, biosynthesis of amino acids, carbon 
metabolism, glycolysis/gluconeogenesis, and pyruvate metabolism. Meanwhile, 2-
oxocarboxylic acid metabolism and propanoate metabolism were identified as differing in 
adults. 
 

























































A: only in adults, C: common for pupae and adults, P: only in pupae. 
 
3.8 Chapter Discussion 
The work presented in this chapter evaluated the metabolic differences between male and 
female pupal and adult stage mosquitoes. NMR metabolomics highlighted sex differences 
that could be attributed to an energy-related mechanism due to the female mosquitoes’ role 
in reproduction. In order to complete oviposition, female mosquitoes require a blood meal 
which may necessitate longer flight time in order to find a suitable source. Hence, females 
may be expected to be able to process and store energy more efficiently than males. Both 
An. gambiae (knock-down and wild type) and Ae. aegypti presented different degrees of 
metabolite differences between male and female at both pupa and adult stages. Ae. aegypti 
strains exhibited a more distinct metabolic profile between males and females than An. 
gambiae; this difference could be observed both in pupal and adult datasets via unsupervised 
methods (i.e. PCA). Additionally, sub-populations were observed both in An. gambiae and 
Ae. aegypti. These were attributed to their resistance status. Interestingly, wild type An. 
gambiae (pupae and adults) demonstrated more subtle distinctions between metabolite 
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profiles of males and females, yet they were still distinguishable via PCA. Surprisingly, in spite 
of observable physical differences, the distinction between males and females was less clear 
in the knock-down mosquitoes of An. gambiae. This suggests that the effects of the knock-
down are not just to the CHC profile but also in the general metabolic characteristics of the 
mosquitoes. When males and females were compared, the CONT groups were also included. 
CONT did not form a sub-population or show any clustering in terms of sex in the PCA scores 
plot (Appendix 14). The commonality between the KD16, KD17 and CONT is the presences of 
the Gal4 driver, suggesting that the Gal4 driver expression might be affecting the sex 
characteristics observable via NMR metabolomics. 
 
In terms of batch variation, knock-down pupae showed the most variation. Although it could 
be thought that this is the output of poorer signal to noise ratio (SNR), sample verification 
showed that there were no significant SNR variations between any of the samples (Appendix 
23) and that no group had a distinctly different SNR (either pupae or adults) which could 
explain the batch variation observed. One explanation could be linked to one of the caveats 
of the Gal4/UAS knock-down system: the levels of knock-down varies between individuals 
depending on the Gal4 expression. Also, due to the critical nature of these knock-downs to 
survival, it is thought that only the low-level knock-down pupae emerge and survive as adults. 
Hence, adults bearing the knock-down are more likely to be similar between batches. In 
contrast, during the pupal stage, all different levels of knock-downs are alive during sample 
collection (with no selection based on fluorescence possible), thus increasing the likelihood 
of a higher degree of batch variation in pupae samples. 
 
In this chapter, sex-related differences were investigated, with a particular focus on 
understanding how strong these differences are compared to the experimental differences. 
This was accomplished by gathering all samples of a single experiment, including controls, be 
it comparison of resistant and susceptible strains or knock-down models and dividing them 
into males and females. The main goal in doing so was to answer the question 'Would sex-
related differences be so strong that it would mask all the experimental differences?' During 
this process, groupings on experimental conditions were used as visual cues, but not in 
statistical analyses. Alternatively, this could have been done with smaller groups such as 
males vs females in only KD16 knock-downs or resistant and susceptible strains of Ae. 
aegypti. This would have resulted in very specific sex-related differences, if they were 
observed, and considering the number of comparisons, joining these results would have been 
more challenging. The approach that was taken in this project was to show a more 
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generalised result for the sex-differences. The expected confounding differences that would 
have manifested themselves in the PCA scores plots were the experimental groups (i.e. 
knock-down status or resistance status) which were visually highlighted. 
 
Feeding habit is a factor that could not be fully controlled in this study, although food source 
was consistent throughout. All adult mosquitoes were supplied with a 10% sucrose solution 
as food source, however the amount ingested and timing relative to collection could not be 
controlled. The PCA scores plot of wild type adult An. gambiae exhibited a sub-population in 
females. When further investigated via PCA, this sub-population was heavily influenced by 
glucose (Appendix 13), a strong indication that the nutritional state of some mosquitoes was 
captured in the metabolomics of these samples.  
 
Similar sub-population separation can also be observed in wild type of Ae. aegypti, although 
the sub-populations exhibited in both males and females were attributable to resistance 
status from the metadata. Differences between males and females were most pronounced 
in Ae. aegypti species compared to An. gambiae, as revealed by the separation in the PCA 
scores plot as well as the higher number of significantly different metabolites. This is thought 
to be mostly due to the females being larger than males. Ideally males and females would be 
normalised to dry body mass. Unfortunately, the drying and weighing process would have 
affected the metabolome. It is possible arrest the metabolic state with liquid nitrogen and 
dry the mosquitoes with lyophilisation. Although, from previous experience this application 
causes the lyophilised mosquito to be brittle and fragile making the handling of the mosquito 
challenging and therefore this step was skipped. In order to control for this source of 
variance, equal numbers of males and females were maintained in all experiments 
throughout the study and data was normalised using probabilistic quotient normalisation 
(PQN). 
 
When PLS-DA models were used to discriminate between males and females, the key 
metabolites identified across species and stages that were attributable to sex include; 
glucose, trehalose, propionate, lactate, acetate. These metabolites are mainly involved in 
energy and energy storage mechanisms. Glucose is the main energy source [210] and it is 
converted into trehalose for short-term storage [210]. Trehalose reserves are kept constant 
and any excess is stored as glycogen [210]. Furthermore, the metabolites propionate, lactate 
and acetate are key metabolites found in pathways downstream of glycolysis such as TCA 
cycle and propionate metabolism. TCA continues the energy production mechanism started 
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by glycolysis. On the other hand propionate metabolism is an important pathway in 
synthesising the precursors for fatty acid biosynthesis such as malonyl-CoA and methyl-
malonyl-CoA [78], [90]. Observing the over-representation of these pathways further 
supports the hypothesis that the main difference demonstrated here via metabolic profiles 
originates from the higher energy demand of females compared to the males in An. gambiae 
and Ae. aegypti. Over representation of propionate metabolism, and the similar male and 
female profiles in KD mosquito strains suggest that loss of observable sex characteristics in 
the metabolome could be a consequence of disturbance of normal fatty acid pathway caused 
by knocking-down of enzymes critical in HC production. Although, when the CONT group was 
investigated via PCA for sex difference, males and females could not be separated (Appendix 
14). This suggests the more plausible explanation is the common presence of the Gal4 driver 
line effecting the observable sex characteristics. 
 
In this chapter, sex differences to varying degrees in different species (An. gambiae & Ae. 
aegypti) and strains (KD16, KD17, CONT, resistant & susceptible) of mosquitoes were shown. 
For knock-down An. gambiae, these differences were found to be the least pronounced 
compared to the wild type mosquitoes, as shown by lesser separation observed via PCA and 
the lowest number of significantly different metabolites out of all comparisons (pupa: 0 and 
adult: 6). Comparing the results obtained from each species’ pupa and adult analyses, 
metabolic profiles were similar in each species in terms of over-represented pathways and 
selected metabolites. Furthermore, the limited sex difference in knock-downs may be traced 
to the pathways affected by the reduction of Cyp4g16 & Cyp4g17. Due to the overall 
differences observed between sexes, the following experiments were designed with a 
balanced 50-50% sex separation to avoid unwanted biases. 
 
The study explained in this chapter is a novel work that compares the male and female 
metabolic profiles of pupal and adult mosquitoes. Through statistical methods, metabolic 
differences between sexes has been identified to glucose, trehalose, lactate, acetate and 
propionate. Furthermore, evidence has been shown suggesting that knocking-down Cyp4g16 
and Cyp4g17 can indirectly affect the fatty acid biosynthesis. 
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Chapter 4  
4 Analysis of Cyp4g16 and Cyp4g17 knock-downs in An. gambiae 
4.1 Introduction, chapter aims & objectives  
The rise in insecticide resistance requires the exploration of alternative methods to keep 
vector borne diseases at bay. Thus, investigation of cuticular resistance is of great 
importance. Several studies have reported the high abundance of cuticular hydrocarbons 
(CHCs) in resistant species. The studies further reported the particularly high abundances of 
alkanes and methyl-branched alkanes in the CHC profiles of resistant species. The CHC 
biosynthesis pathway is relatively unexplored compared to the depth and breadth of 
knowledge that has been amassed for other known pathways (e.g. glycolysis, citrate cycle). 
The majority of the information on the CHC biosynthesis pathway is a culmination of 
information gathered from a variety of insects, obtained through labelled tracer studies [78], 
[171]. Although this approach can show the conversion of metabolites, the complete picture 
requires the identification and verification of the enzymes that carry out these conversions. 
 
As explained in section 1.4.3, alkane and methyl branched CHC biosynthesis (Figure 4.1-1) 
 begins with the precursors acetyl-CoA, valine and leucine. Acetyl-CoA is elongated using 
malonyl-CoA for alkanes. Valine and leucine are elongated with malonyl-CoA and 
methylmalonyl-CoA if more methyl branching is needed. These elongation steps are 
catalysed by an elongase and at each step the HC is attached to a CoA. These CoAs are cleaved 
by a reductase leaving an aldehyde group. The terminal carbonyl needs to be removed in 
order to produce the final product hydrocarbon (HC) which then gets transported to the 
cuticular layer via lipophorins [96]. This final decarbonylation step is catalysed by a CYP 
decarbonylase. 
 
Studies conducted on Drosophila melanogaster revealed two An. gambiae cytochrome p450 
(CYP) enzymes (Cyp4g16 and Cyp4g17) catalysing the decarbonylation step in CHC 
biosynthesis [75]. Balabanidou et al further found that these enzymes are highly abundant in 
insecticide resistant An. gambiae strains [75]. Furthermore, they are highly expressed in the 
abdomen where oenocytes (hydrocarbon synthesising cells) reside [75]. Previous studies 
have shown that oenocytes express high quantities of cytochrome P450 reductase (CPR), a 
redox partner which CYP enzymes require [211]. 
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To verify the decarbonylase activity of Cyp4g16 and Cyp4g17, Balabanidou et al expressed 
both enzymes as fusion proteins with CPR. While Cyp4g16-CPR was successfully expressed, 
Cyp4g17-CPR could not be expressed at similar concentrations. Using an in vitro assay, 
Cyp4g16-CPR was successfully shown to convert n-octacosane aldehyde to n-heptacosane 
revealing its function as a decarbonylase. As a result of the low expression of Cyp4g17-CPR, 
the activity could not be validated. Due to the high sequence identity, as well as the similar 
expression profiles of Cyp4g17 to Cyp4g16, it is hypothesized that the two enzymes catalyse 
the same reaction (personal conversation with Dr Gareth Lycett). Even though high 
expression of Cyp4g17-CPR could not be achieved, a knock-down model could be utilised to 
show evidence of its function by correlating to Cyp4g16 activity. 
 
By using a Gal4/UAS knock-down of the Cyp4g16 or Cyp4g17, metabolic differences related 
to precursor metabolites are expected to be determined. More specifically, it is hypothesised 
that an accumulation of precursor metabolites (valine, leucine, isoleucine and acetate [as a 
proxy of acetyl-CoA]) in the KD insects compared to the Gal4 controls will be observed due 




Figure 4.1-1: Simplified schematic of cuticular hydrocarbon production through Cyp P450 decarbonylases. 
Precursors (white box) are converted in to fatty acyl-CoA through a series of elongation and desaturation 
reactions. Fatty acyl-CoAs (light grey box) are then reduced to aldehydes (dark grey box) during which the CoAs 
are cleaved. Decarbonylation of aldehydes is facilitated by Cyp P450 decarbonylase (green box), yielding the final 
products (orange boxes). 
 
4.2 Experimental design 
In this chapter, Cyp4g16 and Cyp4g17 knock-down (KD16 and KD17) lines of An. gambiae 
were generated using a Gal4/UAS system by Dr Gareth Lycett of LSTM [188]. Gal4 
homozygous progenies produces during breeding were used as controls (CONT) to the knock-
downs strains. During the breeding of knock-down mosquitoes, the effects of the enzymes 
could be observed clearly, as shown in Figure 4.2-1. When control pupa bowls were 
compared to knock-down bowls, dead pupa and failed adult emergence where not more 
than 10%. The Cyp4g16 knock-down pupa bowl has a higher ratio of dead early pupa 
(approximately 60%) which sink to the bottom of the water, compared to Cyp4g17 and 
controls. On the other hand, the Cyp4g17 pupae bowl has a higher ratio of old pupa/eclosing 
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adults stuck in case and adults failing to emerge (approximately 90%) compared to Cyp4g16 
knock-downs and controls. Mortality rates were found to be consistent with literature [188]. 
 
 
Figure 4.2-1: Phenotypic effects of Cyp4g16 (left) and Cyp4g17 (right) knock-downs from one breeding. In this 
breeding, Cyp4g16 knock-downs have high mortality rates during the pupal stage at 52% whereas Cyp4g17 knock-
downs have extreme mortality rates in emergence at 92%. In following breeding cycles mortality rates were 
assessed visually (approximately 60% for KD16 pupae, 90% for KD17 adults and 10% for pupa and adult CONT) 
and were consistent with literature [188]. 
 
In order to collect the required number of samples for NMR metabolomics for polar 
metabolites, mosquito breeding was scaled up. Table 4.2-1 shows the sample counts for the 
data analysis per group in this chapter. Batch correction was applied as explained in Chapter 
3. 
 
Table 4.2-1: Sample Numbers used in KD16, KD17 and control (CONT) comparison. 
 Collected samples Spectra acquired Quality control passed 
 KD16 KD17 CONT KD16 KD17 CONT KD16 KD17 CONT 
Pupa 30 30 30 17 20 20 11 15 12 
Adult 30 30 30 30 30 60 27 29 56 
 
4.3 Metabolite assignment 
Bin tables for the pupal and adult stages were identical and consisted of a total of 496 bins. 
Post identification, 114 bins were assigned (22.98%) to 21 unique metabolites (Table 4.3-1). 
Amongst the identified bins, overlapping bins totalled up to 15 (13.16%). Unidentified bins 
accounted for 77.02% with 382 bins. Metabolite assignment confidence were scored using 
an adapted version of the metabolite standards initiative’s (MSI) scoring system. As a result 
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of this adapted MSI scoring, 16 metabolites were identified at Level 1 and five metabolites 
were identified at Level 2. Representative 1H-NMR spectra for An. gambiae knock-downs 
grouped by experimental groups can be found in Appendix 15 (pupa) and Appendix 16 
(adult). 
 




(MSI) Unique Overlap Total 
KEGG 
code 
Alcohols Methanol Level 1 1 0 1 C00132 
Amino acids 
 
Alanine Level 1 2 3 5 C00041 
Glutamate Level 1 7 3 10 C00025 
Glutamine Level 1 2 3 5 C00064 
Glycine Level 1 1 0 1 C00037 
Isoleucine Level 1 3 0 3 C00407 
Threonine Level 1 4 0 4 C00188 
Tryptophan Level 1 12 3 15 C00078 
Tyrosine Level 1 12 2 14 C00082 
Valine Level 1 5 0 5 C00183 
Carboxylic 
acids 
Acetate Level 1 1 0 1 C00033 
Formate Level 2a 1 0 1 C00058 
Fumarate Level 2a 1 0 1 C00122 
Lactate Level 1 4 0 4 C00186 
Propionate Level 2b 6 0 6 C00163 
Pyruvate Level 1 1 0 1 C00022 
Succinate Level 1 1 0 1 C00042 
Purines Oxypurinol Level 2b 1 0 1 C07599 
Xanthine Level 2b 1 0 1 C00385 
Saccharides Glucose Level 1 24 8 32 C00031 
Trehalose Level 1 10 7 17 C01083 
 
4.4 Analysis of metabolic profiles of knock-downs 
It is hypothesised that Cyp4g16 and Cyp4g17 catalyse the same reaction, although their 
location in the oenocytes are different [75]. Additionally, it is hypothesised that Cyp4g16 
enzymes are active earlier in mosquito development, in the early larval stages, and remain 
active throughout adulthood, whereas Cyp4g17 transcription dramatically increases in 4th 
instar larvae and remains expressed throughout the later stages of life. Hence, it is expected 
that differences in KD16, KD17 and CONT. More specifically, KD16 is expected to exhibit more 
pronounced differences in pupae compared KD17 and CONT. Additionally a higher degree of 
similarity between KD16 and KD17 is expected in the adult stage but different to CONT. 
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4.4.1 Analysis of pupae metabolic profile 
4.4.1.1 Statistical analysis of pupae 
To establish the major variance in the data prior to further analysis, PCA was applied to the 
metabolic profiles. Figure 4.4-1-A shows a PCA scores plot of metabolic profile from Control 
(CONT), Cyp4g16 knock-down (KD16) and Cyp4g17 knock-down (KD17) with PC1 (18.43%) 
against PC4 (7.40%) with a cumulative variance of 25.83%. In order to explain 95% of the 
variance in the data, a total of 25 components were required. PC1 and PC4 are PCs showing 
the highest distance between all three groups compared to other PCs. Each group shows a 
similar degree of variation within the group as can be seen from the spread of the points in 
the scores plot. When comparing the metabolic profiles, the PCA scores plot demonstrates a 
higher degree of similarity between CONT and KD17. This similarity is shown by the majority 
of the data points being overlapping and spread along the same line in the Figure. In contrast, 
KD16 samples have less data points overlapping with the rest of the samples and spread 
along a different axis. Employing a supervised PLS-DA method, metabolites responsible for 
the metabolic profile differences can be extracted. 
 
 
Figure 4.4-1: A) PCA Scores of PC1 (18.43%) against PC4 (7.40%) from Cyp knock-down pupae of An. gambiae 
(nKD16=11, nKD17=15, nCONT=12). A total of 25 PC was used to achieve 95% explained variance. Ellipses represent 
95% confidence region. B) Variates one and two of PLS-DA model for knock-down pupae grouped by knock-down 
status KD16, KD17 and CONT (nKD16=11, nKD17=15, nCONT=12). A higher degree of similarity between KD17 & CONT 
than to CONT as expected. A three-variate model was determined to be the optimal model complexity via cross 
validation. PLS-DA model average accuracy was calculated as 75.76%. Ellipses represent 95% confidence region. 
 
In order to identify differences in the metabolic profiles, the differences between groups 
were enhanced using a cross-validated PLS-DA model. Optimal model complexity was found 
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metrics). Figure 4.4-1-B shows the scores of this model with variate-1 plotted against variate-
2 for simplicity. Compared to the PCA plot (Figure 4.4-1-A), a tighter clustering of groups can 
be observed. A clear separation of KD16 samples from the remaining groups can be seen 
along a diagonal of variate-1 and variate-2. It was expected for KD16’s metabolic profile to 
be more different than KD17 & CONT. The PLS-DA model achieved a better separation 
between KD17 and CONT group, although, these groups are not fully decoupled from each 
other as expected, indicating the higher degree of similarity between the two than to KD16. 
 
4.4.1.2 Key metabolites of pupae 
Following a PLS-DA model, metabolites of interest were extracted. In order to accomplish 
this, VIP scores were calculated for all the bins in the model (Figure 4.4-2). VIP scores for 
variate-1 and variate-2 were checked for bins scoring higher than the selection threshold of 




Figure 4.4-2: VIP scores for identified bins calculated from knock-down pupae PLS-DA model discriminating 
between experimental groups. Bins scoring more than 1 on both variate-1 and variate-2 were selected. Black line 
represents a VIP score of 1. 
 
CRS was calculated for all identified bins for further shortlisting of metabolite bins. A passing 
score of 27.52% was calculated using all CRS. VIP selected bins scoring higher than the passing 
score were considered as a potential representative of its metabolite. Amongst the bins 
scoring above 27.52%, only non-overlapping (where applicable) bins with the highest score 
were selected to represent its metabolite. Table 4.4-1 shows the CRS values of VIP selected 
bins. 
  
Variate−1 (12.13%) Variate−2 (11.76%)
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Table 4.4-1: CRS for VIP selected bins in PLS-DA model of Cyp knock-down pupae. CRS thresholds were calculated 
by median(CRS)-SD(CRS). Representative bins were selected according to the highest scoring bin. In the case of 
an overlapping bin, non-overlapped alternatives were selected where available. Rep: representative bin. 
Metabolite  Bin CRS [%]  CRS > 27.10% Rep  Metabolite  Bin CRS [%]  CRS > 27.10% Rep  
Alanine 334* 45.45 ✓ 334 Tryptophan 476 49.88 ✓ 476 
Glucose 425 57.35 ✓ 425  478 47.22 ✓  
346* 49.52 ✓  462 44.70 ✓  
236 42.72 ✓  251 39.85 ✓  
334* 36.05 ✓  252 38.82 ✓  
349* 11.81 ✕  248 37.52 ✓  
280* 6.42 ✕  463 35.29 ✓  
278* -3.42 ✕  383 30.91 ✓  
329 -5.51 ✕  284 25.34 ✕  
Glutamate 334* 28.32 ✓ 334 Tyrosine 207 92.61 ✓ 207 
126* 0.01 ✕ Valine 8 68.26 ✓ 8 
Glutamine 335* 26.08 ✕ -  13 67.81 ✓  
126* 25.91 ✕  10 67.21 ✓  
131 5.99 ✕      
Propionate 17 39.48 ✓ 17      
12 38.63 ✓      
Trehalose 349* 69.92 ✓ 351      
351 69.52 ✓      
335* 64.05 ✓      
280* 61.42 ✓      
313 60.94 ✓      
278* 58.56 ✓      
277 55.57 ✓      
424 54.28 ✓      
346* 51.80 ✓      
* Denotes overlapping bin. 
 
Applying the CRS scoring threshold on VIP selected bins, eight bins were selected 
representing eight metabolites. Alanine was only represented with a bin that overlaps with 
glucose and glutamate. Additionally, the bin representing the methyl group of alanine was 
not selected, which further indicates that alanine as a metabolite is not a discriminating 
factor. Hence, alanine was removed from the selected metabolites. Bins representing 
glutamine did not achieve CRS above 27.10% and so were excluded from further analyses. 
The selected metabolites (Table 4.4-2) cover three distinct groups of metabolites: amino 
acids, carboxylic acids and saccharides. In order to verify the discriminatory properties of 
these metabolites exclusively, metabolomics data was filtered to only include the selected 
metabolites represented by their respective bins. This selection of metabolites was then 











shift [ppm] MSI level KEGG code 
Amino acids Glutamate 334* 3.77 Level 1 C00025 
Tryptophan 476 7.55 Level 1 C00078 
Tyrosine 207 3.05 Level 1 C00082 
Valine 8 1.00 Level 1 C00183 
Carboxylic 
acids 
Propionate 17 1.07 Level 2 C00163 
Saccharides Glucose 425 5.24 Level 1 C00031 
Trehalose 351 3.87 Level 1 C01083 
* Denotes overlapping bin. 
 
Using the selected metabolites, PCA was performed (Figure 4.4-3-A). PCA scores of PC1 
(33.47%) against PC2 (23.11%) account for a total of 56.58% of the explained variance. A total 
of six components were required in order to explain 95% cumulative variance. The scores 
plot shows similar results to those obtained in Figure 4.4-1. Some resolution in the group 
clusters are lost, which indicates there are unidentified metabolites which can discriminate 
between the experimental groups further. Nevertheless, KD17 and CONT show a higher 
degree of similarity, with KD16 exhibiting fewer overlapping samples with the spread of the 
data in the opposite direction on PC2. In order to assess the discriminatory properties of the 




Figure 4.4-3: A) PCA scores plot of selected metabolites for knock-down An. gambiae species pupa (nKD16=11, 
nKD17=15, nCONT=12). A total of 6 components were used to explain 95% variance. Ellipses were drawn using the 
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DA model complexity was optimised via cross-validation, yielding a two-variate model with 69.70% average 
accuracy. Brackets report on explained variance in its variate. Ellipses represent 95% confidence region. 
 
A cross-validated PLS-DA model was built using the selected metabolites (Figure 4.4-3-B). 
Optimal model complexity was determined to be a two-variate model via cross-validation 
with 69.79% average accuracy (Appendix 11 for further metrics). PLS-DA scores do not fully 
separate the three groups, with overlapping clusters similar to the unsupervised PCA (Figure 
4.4-3-A). The majority of KD17 and CONT samples were clustered together corresponding to 
the similarities in their metabolome. Meanwhile, KD16 shows a more unique profile as its 
clusters are more distinct from the other clusters. In order to probe the selected metabolites 
further, levels were compared using a BH-adjusted ANOVA followed by a Tukey’s HSD 
pairwise test and shown via boxplots. 
 
Metabolite levels were compared via univariate ANOVA with BH p-value adjustment (for 
detailed test statistics see Appendix 17). Metabolites with adjusted p-values less than 0.05 
were further analysed by Tukey’s HSD test for pairwise comparisons. Figure 4.4-4 shows 
boxplots of all metabolites selected from the PLS-DA model via VIP and CRS scoring. From 
the selected metabolites only valine, propionate, trehalose and tryptophan were found to be 
significantly different. More specifically, valine, propionate and trehalose were found to be 
significantly higher in KD17 than both KD16 and CONT. Finally, tryptophan was significantly 
higher in KD16 and KD17 compared to CONT. It should be noted that tryptophan presented 
a sub-population for the KD17 group the sub-population is consisted of four females. 
Nevertheless, this sub-population is not consistent neither in tryptophan nor other selected 
metabolites. It is clear that even with the four females clustering, the rest of the data is a mix 




Figure 4.4-4: Boxplots of selected metabolites, square brackets indicates the representative bin used for the 
metabolite. Significant difference between pairs are denoted by the following symbols: †, KD16 and CONT; &, 
KD17 and CONT; #, KD16 and KD17. 
 
4.4.2 Analysis of adults metabolic profile 
4.4.2.1 Statistical analysis of adults 
The analytical approach taken in section 4.4.1 was applied to the adult data as well. The 
unsupervised analysis via PCA was performed in order to determine the existence of 
underlying structure corresponding to the knock-downs in the data. The PCA scores (Figure 
4.4-5-A) plot shows PC1 (30.11%) against PC2 (14.02%) which demonstrates the most 
variance between groups accounting for a cumulative variance of 44.13%. PCA 
transformation of the adult data achieved 95% explained variance with 48 components. The 
PCA plot shows a higher degree of metabolic profile similarity between CONT and KD16 
revealed by the overlapping of data points as well as the similar spread along PC1. KD17 are 
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exhibit less overlap than KD16 and CONT samples. Similar to the pupae data sub-population 
can be seen, interestingly to a lesser degree. 
 
 
Figure 4.4-5: A) PCA scores plot for the knock-down An. gambiae adults (nCONT=56, nKD16=27, nKD17=29). A total of 
48 components were required to account for 95% of the explained variance in the data. Ellipses were drawn using 
the 95% confidence interval of each group. B) PLS-DA model for knock-down An. gambiae adults (nCONT=56, 
nKD16=27, nKD17=29). Model was built with 2 variates, chosen by cross-validation with 82.35% average accuracy. 
Brackets report its variates explained variance. Ellipses were drawn using the 95% confidence interval of each 
group. 
 
To explore the variation in metabolic profiles further, a supervised PLS-DA model was built 
with cross-validation. Figure 4.4-5-B shows the PLS-DA model discriminating between the 
KD16, KD17 and CONT groups. A two-variate model was selected to be the optimal model 
through cross-validation with 82.35% average accuracy (Appendix 11 for further metrics). 
PLS-DA scores plot (Figure 4.4-5-B) showed closer clustering of KD17 samples compared to 
KD16 and CONT groups, suggesting variation to a lesser degree out of all the experimental 
groups. This was expected due to the high activity of Cyp4g17 in adults. In terms of metabolic 
profile similarities, the clusters are tighter compared to what was observed in the PCA plot 
(Figure 4.4-5-A). Even after the PLS-DA model a sub-population can still be observed, 
suggesting the cause of this variation is strong. To probe the metabolites most influential on 
this discrimination, VIP scores were calculated. 
 
4.4.2.2 Key metabolites of adults 
Metabolite selection is critical for understanding the underlying processes of the knock-
downs. In order to achieve this, most influential spectral features representing the 
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ranked via VIP scores. A threshold for selection was applied, where only bins scoring higher 
than 1 were selected. Since this model’s discriminative features were expressed on variate-
1 and variate-2, bins were required to score higher than 1 on both variates. Figure 4.4-6 
shows the bins satisfying the criteria mentioned above. Only 100 bins out of 496 (20.16%) 
scored higher than the threshold. Out of the 100, only 11 (11.00%) were identified 
representing seven unique metabolites. Due to the nature and complexity of NMR, prior to 
metabolite selection, each bin needs to be ensured of it its representative quality. This was 
performed via CRS. 
 
 
Figure 4.4-6: VIP scores for knock-down An. gambiae adults with an applied threshold of 1. Bins scoring more 
than 1 on variate-1 and variate-2 were selected for further verification. A total of 11 (identified only) out of 496 
(2.22%) bins were selected. Black line represents a VIP score of 1. 
 
CRS provides a reliability measure using the correlation values of the NMR spectra. A CRS 
passing score of 29.14% was calculated using all CRS calculated from the identified bins. The 
adult dataset yielded a shorter list of 11 bins compared to the pupa VIP list of 33 bins. Using 
CRS (Table 4.4-3), 10 bins selected from VIP scoring bins were assessed for their metabolite 
representation quality. The highest scoring, non-overlapping (where available) bins above 
the passing score were selected.  
  
Variate 1 (28.07%) Variate 2 (11.10%)
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Table 4.4-3: CRS scores of VIP selected bins. Threshold of 29.14% was calculated by median(CRS)-SD(CRS). Rep: 
representative bin. 
Metabolite Bin CRS [%] CRS > 29.14% Rep Metabolite Bin CRS [%] CRS > 29.14% Rep 
Alanine 340* 67.47 ✓ 340 Tyrosine 207 59.30 ✓ 207 
Glucose 329 90.23 ✓ 329  210 59.05 ✓  
425 88.96 ✓ Valine 10 46.98 ✓ 10 
Glutamate 126* -6.16 ✕ -  13 46.54 ✓  
Glutamine 126* 7.94 ✕ -  304 12.94 ✕  
Trehalose 340* 61.45 ✓ 311      
311 52.89 ✓      
* Denotes overlapping bin. 
 
Following the CRS, the metabolites glutamate and glutamine failed to score above the 
passing score of 29.14% and so these metabolites were excluded from the list of selected 
metabolites (Table 4.4-4). PCA was performed on the selected representative bins in order 
to determine the influence of these metabolites in relation to the profiles of the experimental 
groups. 
 











Amino acids Alanine 340* 3.79 Level 1 C00041 
Tyrosine 207 3.05 Level 1 C00082 
Valine 10 1.04 Level 1 C00183 
Saccharides Glucose 329 3.74 Level 1 C00031 
Trehalose 311 3.65 Level 1 C01083 
* Denotes overlapping bin. 
 
Using the dataset including only the metabolites represented by their selected bins, PCA was 
performed. Figure 4.4-7-A shows the PCA scores plot of PC1 (60.29%) against PC2 (18.87%) 
explaining a cumulative variance of 79.16%. The scores plot shows a tighter clustering of 
KD17 samples compared to KD16 and CONT samples. KD17 samples do not show high overlap 
with KD16 and CONT samples suggesting a differing metabolic profile; this is consistent with 
the previous PCA  performed with the entire data set (Figure 4.4-5-A). KD16 and CONT 
samples possess higher numbers of overlapping samples and similar variation spread which 
are also consistent with the previously observed PCA plot (Figure 4.4-5-A). Interestingly, 
KD16 and CONT share the same variance spread along PC1 but, their spread on PC2 are 
opposite suggesting minor differences between the two metabolic profiles. Interestingly the 
sub-population in KD16 is retained. Given the high variation observed in Figure 4.4-5-A, it is 
not surprising, what is not expected is the model could not minimize the within group 
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variation as expected. Further discriminatory properties of these metabolites were 
demonstrated via supervised PLS-DA. 
 
 
Figure 4.4-7: A) PCA scores plot of selected metabolites of knock-down An gambiae adult (nCONT=56, nKD16=27, 
nKD17=29). Only selected bins were used as for the PCA. A total of four components were used to explain 95% 
variance. Ellipses represent the 95% confidence region. B) PLS-DA model for knock-down An. gambiae adults 
(nCONT=56, nKD16=27, nKD17=29). Model was built with two variates, chosen by cross-validation. Model average 
accuracy was calculated as 76.74%. Variate’s explained variance are reported in the brackets. Ellipses represent 
95% confidence region. 
 
Using the selected metabolite bins a cross-validated PLS-DA model (Figure 4.4-7-A) was built. 
The result of optimistaion is a two-variate model with 76.74% aveage accuracy (Appendix 11 
for further metrics). PLS-DA scores plot exhibits a similar clustering pattern to that observed 
in the previous PCA and PLS-DA plots (Figure 4.4-5-A, Figure 4.4-5-B, Figure 4.4-7-A). As 
observed previously, KD17 samples clustered tighter and were positioned in a more 
separated manner compared to KD16 and CONT groups. In order to reveal molecular level 
information on exhibited differences, metabolite levels were compared using BH adjusted 
ANOVA followed by Tukey’s HSD test for pairwise comparison (for detailed test statistics see 
Appendix 17). 
 
From the selected metabolites, CHC biosynthesis precursor valine was found significantly 
higher in both KD16 and KD17 compared to CONT. Similarly, Tyrosine was also significantly 
higher in KD17 compared to both KD16 and CONT. The amino acid alanine was found 
significantly lower compared to both KD16 and CONT. The remaining selected metabolites 
were the saccharides glucose and trehalose, and both were significantly lower in KD17 
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observed in the PCA (Figure 4.4-5-A ) and PLS-DA plots (Figure 4.4-5-B). Glucose and alanine 
shows a very strong formations of sub-population not attributed to sex. When compared to 
the spectra (Appendix 16) a distinctly high signal intensities can be observed in the region 
where glucose signals arise for the KD16 group. Similarly the selected alanine signal is an 
overlapping one although, it scored a passing CRS score it might be suffering from the 
variation caused by the overlapping signal or the signals around it. 
 
Figure 4.4-8: Boxplots of metabolite selected by VIP and CRS scores (nCONT=56, nKD16=27, nKD17=29). CONT, control; 
KD16, knock-down of Cyp4g16; KD17, knock-down of Cyp4g17. Significant difference between pairs are denoted 
by the following symbols: †, KD16 and CONT; &, KD17 and CONT; #, KD16 and KD17. 
 
4.4.3 Metabolite set enrichment analysis 
Selected metabolites for both stages in knock-down An. gambiae were subjected to 
metabolite set enrichment analysis (MSEA) to extract further metabolic pathway level 
information from both stages. Table 4.4-5 summarises the metabolites selected for both 
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Table 4.4-5: Summary of selected metabolites of knock-down An. gambiae in pupae and adults. Levels are shown 
qualitatively for simplicity, although metabolites were compared quantitatively via Tukey’s HSD. ↑, significantly 
higher; ↓, significantly lower, NS (arrow) denotes non-significant change with mean abundance level, and square 
brackets represent BH-adjusted p-values. 
Metabolite 
class Pupa 
Levels compared to Control 
Adult KD16 KD17 KD16 KD17 
Amino 
acids 









   




   
























   



















MSEA was performed on selected metabolites using a database curated from the KEGG 
pathways (An. gambiae PEST strain [KEGG organism code: aga]). MSEA was performed 
using Fisher’s exact test with EASE correction and BH p-value adjustment for multiple 
testing (  
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Table 4.4-6). Pathways significantly over-represented via MSEA (Figure 4.4-9) are 
biosynthesis of amino acids, aminoacyl-tRNA biosynthesis and ABC transporters. 
 
 
Figure 4.4-9: MSEA showing over-represented pathways from the selected metabolites influencing the 
discrimination between KD16, KD17 and CONT groups. Black line represents p-value of 0.05. 
  
Pupa Adult




Biosynthesis of amino acids
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p-value Hit/total (%) Matches 
2-Oxocarboxylic 
acid metabolism 
Pupa 0.000014 0.000148 4/134 (2.99%) Glutamate, Tryptophan, 
Tyrosine, Valine 
ABC transporters Pupa 0.000003 0.000122 4/182 (2.2%) Glutamate, Glucose, 
Valine, Trehalose 




Pupa 0.000108 0.000945 4/52 (7.69%) Glutamate, Tryptophan, 
Tyrosine, Valine 
Adult 0.001643 0.013692 3/52 (5.77%) Alanine, Tyrosine, Valine 
Biosynthesis of 
amino acids 
Pupa 0.000010 0.000148 4/128 (3.13%) Glutamate, Tryptophan, 
Tyrosine, Valine 
Adult 0.001423 0.013692 3/128 (2.34%) Alanine, Tyrosine, Valine 
 
4.5 Analysis of specificity of Cyp4g16 and Cyp4g17 knock-down by metabolic 
profiling 
Following the metabolic profile comparisons of KD16, KD17 and CONT groups, it was found 
that both knock-down groups differ from the CONT particularly at different life stages. 
A temporal difference between KD16 and KD17 was expected as it was observed during 
breeding and as reported by Lynd et al [188]. In section 4.4.1 it was observed that KD16 
pupae’s metabolic profile is different in comparison to pupae of KD17 and CONT which was 
attributed to the early expression of Cyp4g16 in pupal development. Similarly, a difference 
was observed in KD17 adults, which was attributed to the Cyp4g17 expression being 
predominant in late pupa/adult stages. This section focuses on exploring the differences 
between knock-downs of Cyp4g16 and Cyp4g17. A pairwise comparison of KD16 and KD17 
aims to understand how Cyp4g16 and Cyp4g17 affect the pupal development differently. A 
comparison of KD16 and KD17 will be made both for pupa and adult stages. Resulting 
metabolites will be used in a MSEA and the results will be compared. 
 
4.5.1 Analysis of specificity in pupae  
4.5.1.1 Statistical analysis 
In order to observe major variances between KD16 and KD17, PCA (Figure 4.5-1-A) was 
performed. PC1 (19.86%) and PC4 (8.75%) show the differences between KD16 and KD17 
metabolic profiles clearest compared to other PCs. A total of 18 components were required 
to explain the 95% variance in the data, with PC1 and PC4 accounting for a cumulative 
variance of 28.61%. The difference between KD16 and KD17 metabolic profiles were most 




Figure 4.5-1: A) PCA scores plot for knock-down pupae KD16 vs KD17, PC1 against PC4 (nKD16=11, nKD17=15). A total 
of 18 components were required to explain 95% of the variance in the data. Ellipses represent 95% confidence 
region of each group. B) PLS-DA density plot of Variate-1, discriminating between KD16 and KD17 pupae (nKD16=11, 
nKD17=15). Single-variate (9.21% explained variance) model complexity (75.00% accuracy) was optimised with 
cross-validation. Each tick represents a sample from KD16 (green) or KD17 (blue) and tick type represents sex 
straight for male and dashed for female. 
 
The PCA scores plot suggest KD16 and KD17 metabolic profiles are similar and their 
differences are represented by a small proportion of the variance in the data (i.e. PC4 8.75%). 
Using a PLS-DA model, the variation within groups can be suppressed while accentuating the 
variation between groups, hence highlighting subtle differences between KD16 and KD17. In 
order to build the PLS-DA model, optimisation was performed via cross-validation. A single 
variate model was identified as the optimal model complexity with 75.00% accuracy 
(Appendix 11 for further metrics). Figure 4.5-1-B shows the density plot of the PLS-DA model. 
The ticks shown under the density plots show a clear separation of the KD16 and KD17 
groups. In order to probe the metabolites most influential on the discrimination between 
KD16 and KD17, VIP scores were calculated. 
 
4.5.1.2 Key metabolites of the comparison 
VIP scores were calculated for all bins from the PLS-DA model. A passing threshold of one 
was applied to all scores. Out of 496 bins, only 170 (34.27%) bins scored higher than the 
threshold. From the 170 bins, only 41 (24.12%) were identified. Figure 4.5-2 shows the 41 
identified bins scoring higher than the passing threshold which represent 11 unique 
metabolites. To achieve robust metabolite selection, CRS were calculated for the identified 


































































Figure 4.5-2:VIP scores of identified bins scoring higher than one from the PLS-DA model build for discriminating 
between KD16 and KD17 pupae. The list contains 41 bins representing 11 unique metabolites. The total number 
of bins in the model was 496, of which 170 scored higher than one. Black line represents VIP score of 1. 
 
CRS was calculated from the correlations of all the identified bins (114 bins in total), and a 
passing score of 25.77% was calculated from all the CRS (Table 4.5-1). Amongst the bins 
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Table 4.5-1:CRS of selected bins via VIP for KD16 vs KD17 pupae. A minimum of 25.77% (median(CRS)-sd(CRS)) 
was required for a bin to be considered as representative. Unique (non-overlapping) peaks were selected where 
available. 
Metabolite Bin CRS [%] CRS > 25.77% Rep Metabolite Bin CRS [%] 
CRS > 
25.77% Rep 
Alanine 334* 41.75 ✓ 334 Trehalose 351 71.12 ✓ 351 
Formate 497 Singlet NA 497  349* 71.01 ✓  
Glucose 354 66.41 ✓ 354  344 68.05 ✓  
 279 65.49 ✓ 
 
 345 67.79 ✓  
 281 63.69 ✓ 
 
 335* 63.78 ✓  
 287 63.20 ✓ 
 
 280* 63.29 ✓  
 289 62.42 ✓ 
 
 278* 61.90 ✓  
 347 52.46 ✓ 
 
 313 59.92 ✓  
 346* 45.27 ✓ 
 
 348 59.81 ✓  
 236 42.51 ✓ 
 
 277 59.47 ✓  
 334* 38.35 ✓ 
 
 424 59.27 ✓  
 338 31.21 ✓ 
 
 346* 52.14 ✓  
 280* 3.09 ✕ 
 
Tryptophan 476 56.17 ✓ 476 
 349* 3.08 ✕ 
 
 478 54.52 ✓  
 329 -5.08 ✕ 
 
 251 49.51 ✓  
 278* -5.79 ✕ 
 
 252 42.36 ✓  
Glutamate 331 48.15 ✓ 331  463 40.72 ✓  
 118 31.82 ✓ 
 
 383 38.15 ✓  
 334* 28.32 ✓ 
 
 284 30.45 ✓  
 126* 0.07 ✕ 
 
Valine 13 65.77 ✓ 13 
Glutamine 126* 28.58 ✓ 126  10 65.10 ✓  
 335* 27.14 ✓ 
 
 8 64.80 ✓  
 131 4.71 ✕ 
 
Xanthine 482 Singlet NA 482 
Propionate 17 45.62 ✓ 17      
 12 39.94 ✓ 
 
     
Pyruvate 139 Singlet NA 139      
*: Overlapping bin 
 
Following CRS, 11 bins were selected as representatives for individual metabolites with 
alanine and glutamine representatives being the only overlapping bins. Within the 
overlapping bins, each were represented in the list only once. Selected metabolites covered 
four classes: amino acids (alanine, glutamate, glutamine, tryptophan and valine), carboxylic 




Table 4.5-2: Bins selected to represent metabolites influencing the difference between KD16 and KD17 pupae in 
the PLS-DA model.  
Class Metabolite Bin Chemical shift [ppm] KEGG code 
Amino acids Alanine 334* 3.77 C00041 
 Glutamate 331 3.76 C00025 
 Glutamine 126* 2.14 C00064 
 Tryptophan 476 7.55 C00078 
 Valine 13 1.05 C00183 
Carboxylic acids Formate 497 8.46 C00058 
 Propionate 17 1.07 C00163 
 Pyruvate 139 2.37 C00022 
Purines Xanthine 482 7.89 C00385 
Saccharides Glucose 354 3.89 C00031 
 Trehalose 351 3.87 C01083 
 
Prior to pathway analysis and biological contextualisation, raw data was filtered to include 
only the representative bins. PCA was performed on the filtered data to observe the major 
variances and their correspondence to KD16 and KD17 profiles. PCA scores (Figure 4.5-3-A) 
of PC1 (33.77%) against PC3 (17.09%) show the metabolic profile differences between KD16 
and KD17 best. A total of 8 components were required to explain 95% of the variance 
between KD16 and KD17 with, PC1 and PC3 accounting for 50.86% of this variance. In order 
to elucidate the influence of selected metabolites over the discrimination of the groups 
individually, unsupervised PLS-DA was applied. 
 
Figure 4.5-3: A) PCA scores plot selected PCA of knock-down An. gambiae pupae (nKD16=11, nKD17=15). Only 
selected bins were used as for the PCA. A total of eight components to explain 95% of the variance. Ellipses 
represent 95% confidence region for each group. B) PLS-DA model built with only representative bins 
discriminating between KD16 and KD17 pupae (nKD16=11, nKD17=15). Model complexity was determined to be two-
variates via cross validation with 75.00% accuracy. Explained variance for each variate are reported in the 













































































Sex F MFemale Male Groups KD16 KD17
 179 
 
A PLS-DA model of the filtered dataset (Figure 4.5-3-B) was built with cross-validation, 
optimised to a two-variate model with 75.00% accuracy (Appendix 11 for further metrics). 
PLS-DA scores plot shows separation for the majority of the data points between KD16 and 
KD17 along a diagonal of variate-1 and variate-2. In order to probe the metabolite levels 
responsible for the differences between KD16 and KD17, metabolite levels were compared 
using BH adjusted t-tests. 
 
The levels of selected metabolites between KD16 and KD17 were visualised using boxplots 
(Figure 4.5-4). The boxplots of KD16 and KD17 shows clearer picture on forming sub-
populations. Although it is evident that these sub-populations are on certain metabolites and 
not the others. It is consistently more pronounced in KD16 samples than KD17. In order to 
compare the levels of selected metabolites between KD16 and KD17, a BH p-adjusted t-test 
was applied (for detailed test statistics see Appendix 17). Differences in metabolites valine, 
propionate, glutamine, glutamate, trehalose and xanthine were observed, although none 




Figure 4.5-4: Boxplots from pupa samples showing the levels of selected metabolites from the PLS-DA model 
(nKD16=11, nKD17=15). Metabolite levels were compared using a BH adjusted t-test. * by the metabolite name 
denotes overlapping bin. 
 
4.5.2 Analysis of specificity in adults 
4.5.2.1 Statistical analysis 
The adult dataset analysis was performed with the same approach as for the pupal analysis. 
PCA was performed on the adult data to observe the major variances in the data and how 
they correspond. Figure 4.5-5-A shows PC1 (35.33%) and PC4 (6.01%) accounting for a 
cumulative variance of 41.34%. To explain the 95% variance in the data, a total of 30 
components were required. PC1 and PC4 were found to be the components representing 
greatest metabolic difference between KD16 and KD17. The KD17 group exhibits a close 
clustering both on PC1 and PC4. In comparison, KD16 is more variant in both PC1 and PC4. 
Due to the comparatively variance of the KD16 samples. Although KD17 demonstrates a 
tightly clustered cohort, two samples were found far away from their clusters. These two 
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extreme cases of their group. According to the available information on the samples, these 
differences could not be attributed to sex, batch, or controlled environmental factors such 
as light cycle, humidity and temperature. 
 
 
Figure 4.5-5: A) PCA scores plot for knock-down adults KD16 vs KD17. Plotted as PC4 (6.01%) against PC1 (35.33%) 
showing the metabolic difference between KD16 and KD17 accounting for a cumulative variance of 41.34%. A 
total of 30 components were needed to explain 95% variance in the data. Ellipses represent the 95% confidence 
region of each group. B) PLS-DA model of adult knock-down An. gambiae (nKD16=27, nKD17=29). Cross-validation 
was used to determine the two-variate complexity of the model with 100% accuracy. Variate-1 (34.64%) and 
variate-2 (7.89%) cumulative variance is 42.53%. Ellipses represent 95% confidence region. 
 
As shown by the PCA plot, metabolic differences between KD16 and KD17 could be attributed 
to the 41.34% of the variance in the data. Using a cross validated PLS-DA model, metabolic 
differences between KD16 and KD17 can be accentuated further allowing the selection of 
the most influential spectral features discriminating the two groups. A cross-validated PLS-
DA model was built (Figure 4.5-5-B) using cross-validation resulting in a two-variate model 
complexity with 100% accuracy (Appendix 11 for further metrics). The model shows a clear 
separation between KD16 and KD17 along a diagonal of variate-1 and variate-2 of the scores 
plot. The KD17 group exhibited a tighter clustering compared to KD16, as was observed in 
the previous PCA scores plot (Figure 4.5-5-A). To obtain metabolite level information from 
the model, VIP scores were calculated. 
 
4.5.2.2 Key metabolites of comparison 
The importance of each bin projection from the PLS-DA model was calculated to select the 
most influential spectral features in the model. Only identified bins scoring higher than 1 on 
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of 189 bins scored higher than the VIP score threshold of 1. Amongst the selected bins, only 
54 were identified (28.57%) out of the 189, representing 14 unique metabolites (Figure 




Figure 4.5-6: VIP scores from PLS-DA model of adult knock-down An. gambiae discriminating KD16 from KD17. 
Only identified bins scoring greater than one on both variate-1 and variate-2 were selected, totalling to 54 bins 
and representing 14 unique metabolites. Black line represents VIP score of 1. 
 
CRS was used to calculate the passing score to be used as selection criterion. In order for a 
bin to be considered as a representative bin candidate, a score greater than 35.03% was 
required. CRS for the VIP selected bins were tabulated in Table 4.5-3, with representative 
bins selected as the highest scoring, non-overlapping (where applicable) bin. 
  
Variate−1 [34.64%] Variate−2 [7.89%]
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Table 4.5-3: CRS for metabolites selected by VIP for KD16 and KD17. A minimum score of 35.03% was required 
for a bin to be considered as a representative of a particular metabolite. Non-overlapping peaks were selected 
where available. 
Metabolite Bin CRS [%] CRS > 35.03% Rep Metabolite Bin CRS [%] 
CRS > 
35.03% Rep 
Acetate 102 Singlet NA 102 Glutamine 335* 30.05 ✕ - 
Alanine 342 80.43 ✓ 342  333* 28.91 ✕  
 337* 79.80 ✓ 
 
 126* 10.00 ✕  
 340* 78.22 ✓ 
 
 131 7.90 ✕  
Glucose 285 96.89 ✓ 285 Glycine 295 Singlet NA 295 
 291 96.82 ✓ 
 
Lactate 384 33.64 ✕ - 
 279 96.81 ✓ 
 
Propionate 15 73.98 ✓ 15 
 270 96.76 ✓ 
 
 17 73.12 ✓  
 283 96.75 ✓ 
 
 12 70.28 ✓  
 267 96.73 ✓ 
 
 129 68.09 ✓  
 264 96.70 ✓ 
 
 127 66.78 ✓  
 289 96.69 ✓ 
 
 130 52.54 ✓  
 281 96.64 ✓ 
 
Succinate 144 Singlet NA 144 
 420 96.62 ✓ 
 
Threonine 299 2.13 ✕ - 
 329 96.58 ✓ 
 
Trehalose 313 84.51 ✓ 313 
 287 96.57 ✓ 
 
 280* 83.97 ✓  
 354 96.56 ✓ 
 
 348 83.94 ✓  
 425 96.45 ✓ 
 
 335* 82.37 ✓  
 282* 96.42 ✓ 
 
 333* 81.50 ✓  
 356 96.27 ✓ 
 
 346* 77.77 ✓  
 292 96.22 ✓ 
 
 340* 70.96 ✓  
 347 96.21 ✓ 
 
 344 70.93 ✓  
 327 96.16 ✓ 
 
 311 63.05 ✓  
 239 96.07 ✓ 
 
Tryptophan 463 15.31 ✕ - 
 323 95.56 ✓ 
 
 248 8.97 ✕  
 337* 95.09 ✓ 
 
 286 3.94 ✕  
 276 94.76 ✓ 
 
 284 2.58 ✕  
 338 94.66 ✓ 
 
 282* 0.99 ✕  
 332* 94.60 ✓ 
 
Tyrosine 212 65.44 ✓ 212 
 346* 94.47 ✓ 
 
 210 56.71 ✓  
 280* 93.35 ✓ 
 
 207 56.14 ✓  
 274 87.95 ✓ 
 
 360 -9.52 ✕  
Glutamate 140 22.39 ✕ - Valine 304 -4.43 ✕ - 
 138 22.16 ✕       
 135 19.58 ✕       
 331 5.93 ✕       
 332* 3.43 ✕       
 336 -5.40 ✕       
 126* -6.23 ✕       
*: Overlapping bins 
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A shortlist of metabolites selected via CRS analysis are shown in Table 4.5-4. After the 
selection, the number of metabolites decreased from 14 to 8. Amongst the metabolites not 
selected were glutamate, glutamine, lactate, threonine, tryptophan and valine. The final list 
discriminating between KD16 and KD17 adults comprised amino acids (alanine, glycine and 
tyrosine); carboxylic acids (acetate, propionate and succinate), and saccharides (glucose and 
trehalose). Prior to MSEA, the influence of the selected metabolites in the differences 
between KD16 and KD17 were assessed. 
 
Table 4.5-4: List of selected bins representing the metabolites influencing the metabolic differences between 
KD16 and KD17. 
Class Metabolite Bin Chemical shift [ppm] KEGG code 
Amino acids Alanine 342 3.80 C00041 
 Glycine 295 3.57 C00037 
 Tyrosine 212 3.07 C00082 
Carboxylic acids Acetate 102 1.92 C00033 
Propionate 15 1.06 C00163 
Succinate 144 2.41 C00042 
Saccharides Glucose 285 3.49 C00031 
 Trehalose 313 3.66 C01083 
 
To observe the influence of the selected metabolites exclusively, raw data was filtered to 
include only the selected bins. PCA was then performed on the filtered dataset (Figure 4.5-7-
A). PCA scores plot shows PC1 (50.16%) against PC3 (14.84%) accounting for a cumulative 
variance of 65.00%. A total of four components were required to explain the 95% variance in 
the data. Metabolic profiles of KD16 and KD17 explained by the selected metabolites show a 
difference along PC1 with minor augmentations on PC3, albeit with two samples distinct from 
the rest. The remaining samples could be easily separated. In order to assess the influences 




Figure 4.5-7: A) PCA scores plot (nKD16=27, nKD17=29) of knock-down adult data, showing PC1 (50.16%) and PC3 
(14.84%) accounting for a total of 65.00% variance. A total of four components were required to explain 95% of 
the variance in the data. The ellipses represent 95% confidence region for each group. B) PLS-DA density plot of 
filtered adult knock-down An. gambiae data (nKD16=27, nKD17=29). Cross-validation was used to determine the 
single-variate (55.85% explained variance) complexity with 90.00% accuracy for the model. Each tick represents 
the samples from their respective group and each individual’s sex. 
 
A cross-validated PLS-DA model was built using the same filtered dataset optimised to a 
single-variate model with 90.00% accuracy (Appendix 11 for further metrics). The density 
plot (Figure 4.5-7-B) of the model shows a higher degree of variation in the KD16 samples 
compared to KD17 revealed by the broader features exhibited by KD16. A single KD17 sample 
is located within the KD16 group, showing the limitation and errors of the PLS-DA. 
 
To further understand the differences between KD16 and KD17, metabolite levels were 
compared using a BH adjusted t-test (for detailed test statistics see Appendix 17) and were 
visualised by boxplots (Figure 4.5-8). In contrast to the pupae, all adult selected metabolites 
were significantly different between KD16 and KD17 post BH adjustment. The carboxylic 
acids propionate and acetate were found significantly higher in KD17, whereas succinate was 
significantly higher in KD16. Both saccharides (glucose and trehalose) were significantly 
higher in KD16. The amino acids (alanine and glycine) were also significantly higher in KD16, 
whereas tyrosine was significantly higher in KD17. These metabolites were subsequently 




























































































Figure 4.5-8: Boxplots of selected metabolites for knock-down An. gambiae adults (nKD16=27, nKD17=29). KD16, 
knock-down of Cyp4g16; KD17, knock-down of Cyp4g17. ** and *** denotes p-values less than 0.01 and 0.0001 
respectively. 
 
4.5.3 Metabolite set enrichment analysis 
Selected metabolites from pupa and adult stages are summarised in Table 4.5-5, showing the 
metabolite levels of KD16 compared to KD17. A total of 11 metabolites were selected from 
the pupa PLS-DA model, whereas, only eight were selected from the adult PLS-DA model. 
From the selected metabolites in pupa, none were found to be significantly different. Within 
the selected metabolites, the CHC biosynthesis precursor valine was found to be lower in 
abundance compared to KD16 pupae. Although this difference was not statistically 
significant, it suggests KD17 exhibits a similar response to KD16, albeit to a lesser extent. 
 
Table 4.5-5: Summary of selected metabolites of knock-down An. gambiae in pupa and adult. Levels are shown 
qualitatively for simplicity, although metabolites were compared quantitatively via t-test with BH p-value 
adjustment HSD. ↑, significantly higher; ↓, significantly lower, NS(↑); non-significantly higher, NS(↓); non-
























































































































































































































































































Trehalose [313] Alanine [342]
Tyrosine [212] Glucose [285] Glycine [295]
Propionate [15] Acetate [102] Succinate [144]
KD16 KD17 KD16 KD17
KD16 KD17 KD16 KD17 KD16 KD17











































Sex F MFemale Male Groups KD16 KD17
 187 
 
KD16 compared to KD17 
 Pupa selected Adult selected 
Class Metabolite Level Level Metabolite 
Amino acids Alanine NS (↓) [5.25 x10-1] ↑ [1.37 x10-4] Alanine 
Glutamate NS (↑) [3.81 x10-1] 
 
 
Glutamine NS (↑) [1.12 x10-1] 
 
   
↑ [5.97 x10-7] Glycine 
Tryptophan NS (↑) [5.25 x10-1] 
 
   
↓ [1.97 x10-4] Tyrosine 





↓ [1.81 x10-7] Acetate 
Formate NS (↑) [4.53 x10-1] 
 
 
Propionate NS (↑) [1.12 x10-1] ↓ [5.59 x10-4] Propionate 
Pyruvate NS (↓) [5.25 x10-1] 
 
   
↑ [1.70 x10-4] Succinate 
Purines Xanthine NS (↓) [1.12 x10-1] 
 
 
Saccharides Glucose NS (↑) [4.58 x10-1] ↑ [2.91 x10-4] Glucose 
Trehalose NS (↑) [1.45 x10-1] ↑ [4.58 x10-4] Trehalose 
 
Although some of these metabolites were not uniquely significant by univariate analysis, they 
were identified by PLS-DA as discriminating. Hence, these selected metabolites were used in 
MSEA with a pathway database curated from KEGG pathways (organism code: aga) using in-
house scripts. Figure 4.5-9 shows the results of the MSEA for both pupae and adults. Both 
biosynthesis of amino acids and carbon metabolism are significantly over-represented 
pathways in knock-downs of both pupa and adults. Both of these pathways are over-
represented in pupae with higher scores, caused by the higher number of amino acids in the 
pupal models (Table 4.5-6). The ABC transporters were also over-represented both in pupae 
and adults. Pathways over-represented uniquely include taurine & hypotaurine metabolism, 
nitrogen metabolism, glyoxylate and dicarboxylate metabolism, aminoacyl-tRNA 





Figure 4.5-9: MSEA of KD16 and KD17 for pupae and adults. Black line represents p-value of 0.05. Pathways shown 
on the Figure are the most likely pathways to be altered between KD16 and KD17. 
  
Pupa Adult
0 2 4 6 0 2 4 6
2−Oxocarboxylic acid metabolism
ABC transporters
Alanine, aspartate and glutamate metabolism
Aminoacyl−tRNA biosynthesis
Biosynthesis of amino acids
Carbon metabolism
Glyoxylate and dicarboxylate metabolism
Nitrogen metabolism
Propanoate metabolism
Taurine and hypotaurine metabolism
−log10(BH adjusted p−value)
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Table 4.5-6: Match table for identified MSEA pathways for two-way comparison of KD An. gambiae reporting; 





p-value Hit/total (%) Matches 
2-Oxocarboxylic 
acid metabolism 
Pupa 1.7 x 10-4 1.3 x 10-3 4/134 (2.99%) Pyruvate, Glutamate, 
Tryptophan, Valine 
ABC transporters Pupa 3.0 x 10-9 1.4 x 10-7 6/182 (3.30%) Glutamate, Glucose, Alanine, 
Glutamine, Valine, Trehalose 














Pupa 1.4 x 10-7 3.2 x 10-8 6/128 (4.69%) Pyruvate, Glutamate, 
Alanine, Glutamine, 
Tryptophan, Valine 
Adult 6.2 x 10-4 6.3 x 10-3 3/128 (2.34%) Glycine, Alanine, Tyrosine 
Carbon metabolism Pupa 8.7 x 10-5 1.0 x 10-3 4/112 (3.57%) Pyruvate, Glutamate, 
Alanine, Formate 


















Pupa 5.7 x 10-3 3.3 x 10-2 3/22 (13.64%) Pyruvate, Glutamate, Alanine 
 
4.6 Chapter results summary 
This chapter aimed to probe the metabolic differences exhibited by knock-downs of Cyp4g16 
and Cyp4g17 species of An. gambiae. Cyp4g16 was shown to catalyse a critical step in the 
CHC biosynthesis and Cyp4g17 is hypothesised to catalyse the same reaction in a different 
location in oenocytes where both Cyp4g16 and Cyp4g17 enzymes reside [75]. Post 
metabolite selection, all models showed an approximate accuracy decrease of 5-10% hence, 
selected metabolites were less robust (Table 4.6-1). This indicates that some of the 
metabolites influential in the clustering is an unknown. Amongst the models, the worst 
performance was exhibited by the selected metabolite model for the pupal dataset, 
discriminating between all three groups with 69.70% accuracy. Overall, adult models 
outperformed pupa models. 
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Table 4.6-1: PLS-DA model variates, accuracy, VIP selection and selected metabolites. 







KD16, KD17 and 
CONT 
Pupa All data 3 *75.76% 33 (25.78%) 8 
Adult 2 *82.35% 11 (11.00%) 6 
Pupa Selected 
metabolites 
2 *69.70% NA NA 
Adult 2 *76.47% NA NA 
KD16 and KD17 Pupa All data 1 75.00% 41 (24.12%) 11 
Adult 2 100.00% 54 (28.57%) 8 
Pupa Selected 
metabolites 
2 75.00% NA NA 
Adult 1 90.00% NA NA 
* denotes average accuracy for a three-way model. 
 
Selected metabolite comparisons from the three-way (KD16, KD17 & CONT) and two-way 
(KD16 & KD17) models comprised of amino acids, carboxylic acids, purines and saccharides 
(Table 4.6-2). In amino acids, glycine was higher in KD16 adults selected by the two-way 
model. Tryptophan was identified by all pupae models and was consistently higher than 
CONT. Valine was identified by the three-way model and was consistently higher than CONT 
in all comparisons. In the two-way comparison model, KD16 pupa showed higher levels of 
valine, but it was not statistically significant. In carboxylic acids, both acetate and succinate 
were selected from the two-way adult model and were higher in KD17 and KD16 respectively. 
Formate and pyruvate were selected by the two-way pupae model, and were higher in KD16 
and KD17 pupae respectively, although, not significantly. For purines, xanthine was only 
selected from the two-way pupal model and showed elevated levels in KD17 albeit 
statistically significant. Lastly in saccharides, both glucose and trehalose were selected by all 
models. In the three-way comparison, glucose was significantly lower in KD17 adults 
compared to CONT. Meanwhile, in the two-way comparison, KD16 glucose levels were 
significantly higher in adults. This was also observed in trehalose levels with the addition of 
significantly higher levels in KD16 pupae and adults compared to CONT in three-way 
comparisons, but not in KD17. 
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Table 4.6-2: Metabolite level comparisons for knock-down comparisons in knock-down An. gambiae. Three-way 
comparison was made between KD16, KD17 and CONT and two-way comparison was made between KD16 and 
KD17. Arrows represent significant changes, NS (arrow) denotes non-significant change with mean abundance 
level, and square brackets report the BH-adjusted p-value. 




Compared to CONT 
KD16 compared to KD17 














Glutamate NS (↑) 
[2.85x10-1] 
- NS (↑) 
[5.23x10-2] 
- NS (↑) 
[3.81 x10-1] 
- 
Glutamine - - - - NS (↑) 
[1.12 x10-1] 
- 




- ↑  
[2.85 x10-3] 
- NS (↑) 
[5.25 x10-1] 
- 























Acetate - - - - - ↓ 
[1.81 x10-7] 





- NS (↑) 
[9.91x10-1] 




Pyruvate - - - - NS (↓) 
[5.25 x10-1] 
- 
Succinate - - - - - ↑ 
[1.70 x10-4] 
Purines Xanthine - - - - NS (↓) 
[1.12 x10-1] 
- 

























MSEA results were summarised in Table 4.6-3. Propionate metabolism was the only differing 
pathway unique to adults. MSEA inferred differences in ABC transporters, carbon 
metabolism and biosynthesis of amino acids for both pupa and adult metabolic profiles in 
three-way comparison (KD16, KD17 and CONT). In the three-way comparison, 2-
oxocarboxylic acid metabolism was only differing in pupae. MSEA comparing KD16 and KD17 
identified ABC transporters, biosynthesis of amino acids and carbon metabolism differing 
both in pupae and adults. In the same comparison, pupae unique pathways were 2-
oxocarboxylic acid metabolism, alanine, aspartate and glutamate metabolism, aminoacyl-
tRNA biosynthesis, glyoxylate and dicarboxylate metabolism, nitrogen metabolism, and 
taurine & hypotaurine metabolism. Propionate metabolism was the only differing pathway 
unique to adults. 
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Table 4.6-3: MSEA summary for knock-down comparisons. 
Over-represented pathways KD16, KD17 & CONT KD16 & KD17 
2-oxocarboxylic acid metabolism P P 
ABC transporters C C 
Alanine, aspartate and glutamate metabolism  P 
Aminoacyl-tRNA biosynthesis C P 
Biosynthesis of amino acids C C 
Carbon metabolism  C 
Glyoxylate and dicarboxylate metabolism  P 
Nitrogen metabolism  P 
Propionate metabolism  A 
Taurine and hypotaurine metabolism  P 
A: unique to adults, C: common for both pupae and adults, P: unique to pupae. 
 
4.7 Chapter discussion 
Chapter 4 investigated the metabolite profile changes in the knock-downs of Cyp4g16 (KD16) 
and Cyp4g17 (KD17) in relation to their Gal4 homozygous controls (CONT), followed by a 
direct comparison of the two knock-downs (KD16 to KD17). Utilising a GAL4/UAS system in 
combination with NMR metabolomics allowed investigation of CHC biosynthesis through its 
precursor metabolites (valine, isoleucine and acetyl-CoA). Even though there has been 
extensive research performed on different aspects of CHC biosynthesis (done on different 
species), the metabolomics aspect remains unexplored. The knock-downs were hypothesised 
to increase the amount of the precursor metabolites to the CHC biosynthesis including valine, 
leucine, isoleucine and acetate as a proxy of the precursor acetyl-CoA.  
 
A temporal expression of Cyp4g16 and Cyp4g17 was previously shown through 
transcriptomics by Balabanidou et al [75]. High mortality observed in KD16 pupae and KD17 
adults during breeding in this project (Figure 4.2-1) are in line with the observations made by 
Lynd et al [188]. This further led to the expectation that KD16 (Cyp4g16 expressed highly in 
pupa) would demonstrate more differences compared to KD17 (Cyp4g17 expressed highly in 
adults). Upon knocking-down of Cyp4g16 and Cyp4g17, it was expected to create a shortage 
of final product HCs which is expected to create a build up of precursor metabolites.  
 
In the analysis, valine was observed to be significantly higher in KD16 (pupae and adults) and 
in KD17 (adults) with respect to CONT. Although enzymes of Cyp4g16 and Cyp4g17 are 
thought to catalyse a similar reaction, they appear active at different developmental stages 
[188]. Significantly higher levels of valine indicate the activity of Cyp4g16 to be higher in 
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pupal stage (KD16:CONT = 1.33) and carries on to the early adult stage, whereas, Cyp4g17 
shows greatest (as presented by valine level; KD17:CONT = 1.20) activity during early adult 
stage with respect to pupa. This is further supported by the similarities observed in the 
unsupervised multivariate analysis of pupal and adult datasets. The PCA scores plot highlights 
greater differences in KD17 compared to KD16 and CONT in adults. However, KD16 displays 
greater separation in pupae than CONT and KD17. The metabolites measured in this study 
do not separate according to sex. This indicates the affected HC biosynthesis pathways are 
not limited to sex characteristics specifically (e.g. specially leading to pheromone 
production). This further reveals the capability of both Cyp4g16 and Cyp4g17 in non-
pheromone-specific HC production, specifically in the biosynthesis of n-alkanes, methyl-
branched alkanes and 2-methyl-branched alkanes that partly form the cuticular layer.  
 
Intriguingly, both precursors isoleucine and acetyl-CoA (acetate was used as a proxy) were 
neither identified as discriminating via PLS-DA nor found to be significantly higher compared 
to CONT. This further suggests that Cyp4g16 and Cyp4g17 are likely to have substrate 
specificity or higher preference for valine as the precursor rather than isoleucine, which 
synthesises HCs such as even chain length 2-methylalkanes [78], [86], [90] and methyl-
branched alkanes [78], [86], [90]. The D. melanogaster homologue, Cyp4g1 (only 
decarbonylase) catalyses all decarbonylation of HCs. Interestingly, in the adult comparison, 
valine levels were significantly higher than CONT both in KD16 and KD17. The activity 
difference of Cyp4g16 and Cyp4g17 were observed phenotypically during mosquito rearing 
(Figure 4.2-1), although this is the first time this was shown with metabolite levels evidence 
from mosquito extracts. This metabolite level evidence supports the temporal activity of 
Cyp4g16 and Cyp4g17 shown by Lynd et al [212]. 
 
A recent study [186] has shown Cyp4g17 favours the decarbonylation of long chain methyl-
branched alkanes (such as Me-hentriacontane) which utilise valine, leucine and isoleucine as 
precursors. Intriguingly, from the two-way PLS-DA models of KD16 & KD17, these precursors 
were not selected nor were they significantly different. In the metabolomics analysis of KD16 
& KD17, valine levels were not different in the adults. Kefi et al created a D. melanogaster 
mutant where Cyp4g1 is knocked down and recovery was observed via introduction of 
Cyp4g16, Cyp4g17 and Cyp4g16/Cyp4g17 [186]. They have shown that decarbonylases 
Cyp4g1, Cyp4g16 and Cyp4g17 share a wide variety of common HC products. Furthermore, 
dimethyl-C45, dimethyl-C46 and dimethyl-C47 were only found in strains with Cyp4g16 
and/or Cyp4g17 further supporting the specificity of these enzymes on methyl branched HCs. 
 194 
Additionally, Kefi et al showed introduction of either Cyp4g16 or Cyp4g16/Cyp4g17 resulted 
in higher amounts of total CHC compared to Cyp4g17 introduced strains [186]. Taking into 
account, the rise in valine levels in early adults compounded with Kefti et al findings on 
preferences over methyl-branched HCs [186], further suggests Cyp4g16 has higher specificity 
for branched HCs which can be used for communication compared to Cyp4g17 where the 
majority HCs decarbonylated are more critical for waterproofing. 
 
Since Cyp4g1 in D. melanogaster decarbonylates all of the HCs that Cyp4g16 and Cyp4g17 
work on, it is entirely possible to speculate that, if both enzymes work on the same substrates 
there might be a competition between Cyp4g16 and Cyp4g17. The competition between 
Cyp4g16 and Cyp4g17 is in line with the findings of Kafi et al where reintroducing only 
Cyp4g16 or Cyp4g17 exclusively increased the HC biosynthesis [186]. Furthermore, the total 
CHC measured from the introductions of the Cyp4g16 and Cyp4g17 demonstrates that higher 
quantities of Cyp4g17 enzyme is required to decarbonylate the same amount of CHC as 
Cyp4g16 [186]. 
 
MSEA performed on the three-way comparison showed a consistent over-representation of 
the biosynthesis of amino acids, aminoacyl-tRNA biosynthesis and ABC transporters in the 
knock-down of Cyp4g16 and Cyp4g17. Biosynthesis of amino acids is consistent with the 
increased demand for valine to produce more CHC. Similarly, aminoacyl-tRNA biosynthesis is 
a downstream pathway of valine, leucine and isoleucine biosynthesis. Moreover, ABC 
transporters are used activating transportation of lipids (amongst other compounds) [112]. 
 
Acknowledging that the metabolomics work was done on early pupae and one day old adults, 
more apparent differences are potentially likely to be observed in older adults (3-5 days old). 
Early pupae and adults were chosen due to the lethal effects of knocking-down Cyp4g16 and 
Cyp4g17. KD16 pupae demonstrated high mortality in later pupae stages, whereas, KD17 
demonstrated high mortality during and after emergence. For an appropriately comparable 
data, early pupa and adult samples were chosen. In order to increase the power of statistical 
modelling, higher numbers of samples could have been used although obtaining the 
necessary number of samples for such an experiment would require mosquito breeding on a 
very large scale. If such an experiment were to be carried out, I would further hypothesise 
KD17 adults would have complications in mating compared to CONT due to the reduced 
branched CHCs. Since branched CHCs can be used in communication a reduction in this type 
of CHC would lead to impairing of the communication between individuals hence effecting 
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mating. Alternatively, dead pupa could be investigated in order to understand the effects of 
these enzymes. Unfortunately, though, deconvolution of the metabolic changes contributed 
by death would be near impossible. It should also be noted that collected pupae would have 
a faulty CHC layer which would eventually cause them to drown and die. It is entirely possible 
that the current metabolism might be affected by the stress this has caused. In conclusion, 
through observation of valine levels in KD16 and KD17 supporting evidence was shown for 





5 Understanding Pyrethroid Resistance using NMR Metabolomics 
5.1 Introduction, chapter aims & objectives 
Insecticide resistance is most commonly split into three types; knock-down resistance, 
metabolic resistance, and cuticular resistance [67]–[73]. Each one of these resistance types 
has been studies by various research groups using a variety of methods such as genomics, 
transcriptomics, and proteomics, but metabolomics studies of these comparisons are 
relatively lesser compared to the rest. Within the metabolomics studies, the most common 
focus is on the cuticular hydrocarbon (CHC) layer and even then, the data analysis does not 
usually make use of the multivariate statistical methods typically applied in metabolomics. 
 
As covered in section 1.6.7, studies typically focus on the profiling of the CHC via GC-MS 
which has consistently showed the importance of n-alkanes (the most abundant constituent) 
and methyl-branched alkanes (second most abundant constituent) [84], [165], [166]. 
Although these studies are of great value, investigations into the metabolic comparison of 
resistant and susceptible strains with a focus on polar metabolites are lacking. 
 
Any of these resistance mechanisms would produce a different response after coming into 
contact with an insecticide. Similarly, hypothesising these response mechanisms to have 
characteristic fingerprints on the metabolism in the absence of the insecticides would be 
logical. Hence, it is hypothesised that a resistance strain's metabolome would be distinctly 
different than that of a susceptible strain. By comparing the metabolic profiles of resistant 
and susceptible strains of An. gambiae and Ae. aegypti, these differences can be teased out. 
By doing so, externally known mechanisms or new undetected aspects of insecticide 
resistance can be attributed and explored. 
 
5.2 Experimental Design 
In this experiment, wild type mosquitoes were compared to obtain metabolic profiles of 
resistant and susceptible strains for An. gambiae and Ae. aegypti. All mosquitoes have been 
bred continuously in the LSTM insectary since their collection or acquisition from other 
laboratories. The resistant An. gambiae strain VK7 was collected from Burkina Faso and the 
susceptible An. gambiae strain N’Gusso was collected from Cameroon. Both strains have 
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been continuously bred for more than five years. For the Ae. aegypti comparisons, the 
resistant strain was collected from the Cayman Islands and the susceptible strain was 
collected from New Orleans. Both of these strains have also been continuously bred, in this 
instance for more than eight years. Table 5.2-1 shows the number of samples collected from 
the mosquitoes bred, successful NMR acquisitions, and spectra passing QC. 
 
Table 5.2-1: Sample numbers used in statistical analysis post collection and QC. SUS: susceptible strain and RES: 
resistant strain. 
 Samples collected Spectra acquired Quality control passed 
 An. gambiae Ae. aegypti An. gambiae Ae. aegypti An. gambiae Ae. aegypti 
 SUS RES SUS RES SUS RES SUS RES SUS RES SUS RES 
Pupa 30 30 30 30 30 30 30 30 27 20 27 28 
Adult 30 30 30 30 30 30 30 30 27 29 20 21 
 
5.3 Metabolic profiling of wild type An. gambiae species VK7 (resistant) and 
N’gusso (susceptible) 
5.3.1 Metabolite assignment 
The bin tables for both pupa and adult An. gambiae were identical and consisted of a total 
of 496 bins. Out of the 496 bins, 114 where assigned to specific metabolites accounting for 
22.98% of all bins, leaving 382 bins unidentified. Within the 114 assigned bins, 15 (13.16%) 
are overlapping bins. All 114 bins were attributed to a total of 21 unique metabolites (Table 
5.3-1). The confidence levels of the metabolite assignments were scored according to the 
metabolite identification level (MSI). From the 21 metabolites, 16 (76.19%) were identified 
with MSI level 1, and 5 (23.81%) were identified with MSI level 2. Representative 1H-NMR 




Table 5.3-1: Metabolite assignment table, with MSI level, KEGG compound code and classifications. See Appendix 




level (MSI) Unique Overlap Total KEGG code 
Alcohols Methanol Level 1 1 0 1 C00132 
Amino acids Alanine Level 1 2 3 5 C00041 
Glutamate Level 1 7 3 10 C00025 
Glutamine Level 1 2 3 5 C00064 
Glycine Level 1 1 0 1 C00037 
Isoleucine Level 1 3 0 3 C00407 
Threonine Level 1 4 0 4 C00188 
Tryptophan Level 1 12 3 15 C00078 
Tyrosine Level 1 12 2 14 C00082 
Valine Level 1 5 0 5 C00183 
Carboxylic 
acids 
Acetate Level 1 1 0 1 C00033 
Formate Level 2a 1 0 1 C00058 
Fumarate Level 2a 1 0 1 C00122 
Lactate Level 1 4 0 4 C00186 
Propionate Level 2b 6 0 6 C00163 
Pyruvate Level 1 1 0 1 C00022 
Succinate Level 1 1 0 1 C00042 
Purines Oxypurinol Level 2b 1 0 1 C07599 
Xanthine Level 2b 1 0 1 C00385 
Saccharides Glucose Level 1 24 8 32 C00031 
Trehalose Level 1 10 7 17 C01083 
 
5.3.2 Metabolic profiling of pupae 
5.3.2.1 Statistical analysis 
In order to explore the major variances, PCA was performed. Figure 5.3-1-A shows PC1 
(22.16%) against PC2 (20.75%) accounting for a total of 42.91% explained variance. In the 
PCA transformation, a total of 27 components were required to explain the 95% variance in 
the data. The variation spread along PC1 is similar between resistant and susceptible strains. 
The PCA scores plot shows a separation of resistant and susceptible strains along PC2. Using 
a supervised PLS-DA model, the metabolic profile observed on PC2 can be enhanced further, 
enabling metabolite selection in relation to the resistance status. 
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Figure 5.3-1: A) PCA scores plot of PC1(22.16%) and PC2 (20.75%) for wild type An. gambiae pupae demonstrating 
the overall similarity of the metabolic profiles of resistant and susceptible strains. Closer clusters indicate a higher 
degree of similarity. PC1 and PC2 accounts for a cumulative explained variance of 42.91%. A total of 27 
components were required to explain 95% of the variance. Ellipses represent 95% confidence region of the groups 
individually. B) PLS-DA density plot of variate-1 discriminating between resistant and wild type An. gambiae pupae 
(nResistant=20, nSusceptible=27). Model complexity of one-variate (20.75% explained variance) with accuracy of 64.29% 
was determined via cross-validation. Ticks represent samples from their respective groups. 
 
A PLS-DA model (Figure 5.3-1-B) was built using cross-validation, optimal model complexity 
to be a single-variate model with 64.29% accuracy (Appendix 11 for further metrics). In order 
to probe the key metabolites of this discrimination, VIP scores were used. 
 
5.3.2.2 Key metabolites 
VIP scores were calculated for all 496 bins, including both identified and unidentified, using 
a passing threshold of 1 for bin filtering. Only 182 bins (identified and unidentified) scored 
greater than the VIP score of 1. Within the 182 bins, there were 52 identified bins 
representing a total of 18 metabolites (Figure 5.3-2 ). In order to select metabolites through 















































































Figure 5.3-2: VIP scores of identified bins from the wild type pupae of An. gambiae. A total of 52 identified bins 
scored higher than the VIP threshold of one, representing 18 unique metabolites. Black line represents VIP score 
of one. 
 
CRS was calculated for all 114 identified bins and filtered to show only the bins which scored 
higher than one on VIP scoring (Table 5.3-2). Using all CRS calculated, a passing score of 
31.74% was set in order to accept a bin as a representative candidate. Only non-overlapping 
bins (where available) with the highest score amongst the candidates were selected. 
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Pupa
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Table 5.3-2: CRS for VIP selected bins from the wild type pupae An. gambiae PLS-DA model discriminating 
between resistant and susceptible strains. A passing score of 31.74% was calculated from the CRS scores of all 
114 identified bins. Rep: representative bin. 
Metabolite Bin CRS [%] 
CRS > 





Acetate 102 Singlet NA 102 Glutamate 331 45.48 ✓ 331 
Alanine 342 80.89 ✓ 342  138 43.40 ✓  
340* 78.94 ✓  140 40.04 ✓  
58 72.74 ✓ Glutamine 128 27.39 ✕ - 
Formate 497 Singlet NA 497 Glycine 295 Singlet NA 295 
Fumarate 450 Singlet NA 450 Isoleucine 4 82.87 ✓ 4 
Glucose 270 66.52 ✓ 270 Lactate 384 90.00 ✓ 384 
329 65.92 ✓  51 87.32 ✓  
281 65.86 ✓  49 85.74 ✓  
267 65.76 ✓  386 77.89 ✓  
282* 65.72 ✓ Methanol 260 Singlet NA 260 
279 65.60 ✓ Oxypurinol 493 Singlet NA 493 
283 65.35 ✓ Propionate 129 64.35 ✓ 129 
323 63.40 ✓ Pyruvate 139 Singlet NA 139 
264 62.99 ✓ Threonine 299 13.82 ✕ 299 
425 62.43 ✓ Trehalose 275 75.96 ✓ 275 
327 62.26 ✓  278* 70.47 ✓  
285 59.13 ✓  280* 70.36 ✓  
287 58.87 ✓  277 63.26 ✓  
354 56.79 ✓  424 61.46 ✓  
420 56.77 ✓  340* 20.26 ✕  
292 56.62 ✓ Tryptophan 252 36.00 ✓ 252 
356 56.51 ✓  255 24.13 ✕  
291 54.31 ✓  282* 17.52 ✕  
289 52.71 ✓ Valine 304 34.01 ✕ - 
280* 5.16 ✕      
278* 1.66 ✕      
*: Overlapping bins 
 
Through VIP scoring, a total of 18 metabolites were selected out of 21 identified metabolites. 
VIP selected list was further shortened to 16 metabolites after applying CRS criteria (Table 
5.3-3). Amongst the metabolites excluded from the selection were glutamine and valine. The 
16 selected metabolites were comprised of five metabolite classes: alcohols, amino acids, 
carboxylic acids, purines and saccharides. 
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Table 5.3-3: Selected metabolites of PLS-DA model discriminating between wild type pupae of An. gambiae 





[ppm] KEGG code 
Alcohol Methanol 260 3.36 C00132 
Amino acids Alanine 342 3.80 C00041 
Glutamate 331 3.76 C00025 
Glycine 295 3.57 C00037 
Isoleucine 4 0.94 C00407 
Threonine 299 3.59 C00188 
Tryptophan 252 3.32 C00078 
Carboxylic acids Acetate 102 1.92 C00033 
Formate 497 8.46 C00058 
Fumarate 450 6.52 C00122 
Lactate 384 4.11 C00186 
Propionate 129 2.18 C00163 
Pyruvate 139 2.37 C00022 
Purines Oxypurinol 493 8.27 C07599 
Saccharides Glucose 270 3.42 C00031 
Trehalose 275 3.44 C01083 
 
In order to determine the influence of these selected metabolites on discrimination of the 
groups, PCA was performed (Figure 5.3-3). PC1 (49.00%) and PC2 (14.82%) show a cumulative 
explained variance of 63.82%. A total of nine components were required to explain the 95% 
variance in the data. From the plot, it can be seen that the majority of the variation attributed 
to the differences between resistant and susceptible strains can be explained by PC1. PC2 
shows a similar variation spread for both resistant and susceptible strains, with minor 




Figure 5.3-3: A) PCA scores plot of selected representative bins of An. gambiae pupae between resistant and 
susceptible groups (nResistant=20, nSusceptible=27). A total of nine components were required to explain the 95% 
variance in the data. Ellipses represent the 95% confidence region. B) PLS-DA density plot of variate-1 
discriminating between resistant and wild type An. gambiae pupae (nResistant=20, nSusceptible=27) for selected 
representative bins. Single-variate (48.81% explained variance) model complexity was determined via cross-
validation with 85.71% accuracy. Each tick under the density plot represents a sample. 
 
A cross-validated PLS-DA model was built to discriminate between resistant and susceptible 
strains in order to determine the discriminative properties of the selected metabolites 
exclusively. Single-variate model complexity was determined through cross-validation and 
accuracy was calculated at 85.71% (Appendix 11 for further metrics). The resulting PLS-DA 
density plot shows the discrimination between two groups with only two resistant samples 
overlapping with susceptible samples. 
 
Following the assessment of the selected metabolites’ discriminatory properties, metabolite 
levels were compared in order to probe the metabolic phenotype of the resistant and 
susceptible groups. Metabolite levels were compared using a BH adjusted t-test (see 
Appendix 22 for detailed test statistics) and were presented in boxplots (Figure 5.3-4). All 
selected metabolites were significantly different between resistant and susceptible groups. 
More specifically, all carboxylic acids except lactate were significantly higher in resistant 
pupae. Significant carboxylic acids comprised of acetate, formate, fumarate, propionate and 
pyruvate. The only alcohol identified was methanol and it was found to be significantly higher 
in the resistant group. Within the amino acids, alanine, glycine, isoleucine and threonine 
were significantly lower in the resistant group, whereas glutamate and tryptophan were 





















































































Figure 5.3-4: Boxplots for selected metabolites between wild type resistant and susceptible An. gambiae pupa. *, 
** and *** denotes p-values less than 0.05, 0.01 and 0.0001 respectively. 
 
5.3.3 Metabolic profiling of adults 
5.3.3.1 Statistical analysis 
The same approach that was taken for the pupae sample analysis was applied to the adult 
sample analysis in order to obtain a list of key metabolites representing the differences 
between resistant and susceptible strains. PCA (Figure 5.3-5-A) was performed on the adult 
data in order to observe the major variances. Differences between resistant and susceptible 
strains were explained clearest on PC2 (14.69%) and further enhanced by PC4 (4.25%). PC2 
and PC4 accounted for a cumulative explained variance of 18.94%. Meanwhile, a total of 30 
components were required in order to explain the 95% variance in the data. The majority of 
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the resistant group compared to the susceptible group. PC4 enhances the metabolic profile 
difference observed on PC2, giving a clearer separation between two metabolic profiles. 




Figure 5.3-5: A) PCA scores plot of adult wild type An. gambiae (nResistant=29, nSusceptible=27) showing PC2 (14.69%) 
and PC4 (4.25%) accounting for a total of 18.94% explained variance. A total of 30 components were required to 
account for 95% of the explained variance. Ellipses represent the 95% confidence region. B) PLS-DA scores plot 
discriminating between resistant and wild type An. gambiae adult (nResistant=29, nSusceptible=24) along variate-1 and 
variate-2. Model complexity of two-variates was selected via cross-validation over 250 repetitions with 87.50% 
accuracy. Explained variance of each variate is reported in the brackets. Ellipses represent 95% confidence region. 
 
A cross-validated PLS-DA model was built, accentuating the differences between resistant 
and susceptible strains. The optimal PLS-DA model complexity was determined to be a two-
variate model with 87.50% accuracy (Appendix 11 for further metrics). The PLS-DA scores 
plot (Figure 5.3-5-B) shows a clear difference between profiles of resistant and susceptible 
species along the diagonal of variate-1 (14.35%) and variate-2 (20.27%). From the plot it is 
apparent that variate-1 accounts for the majority of the differences between the two 
metabolic profiles and variate-2 augments the observed difference. 
 
5.3.3.2 Key metabolites 
VIP scores were calculated for all 496 bins used in the model, including both identified and 
unidentified bins. A passing score threshold of 1 was applied on both variate-1 and variate-2 
scores for VIP selection. Out of the 496 bins, only 157 bins (31.65%) scored higher than the 
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higher than the threshold, only 30 bins were identified, representing 13 metabolites (Figure 
5.3-6). The resulting list of bins was then used to select metabolites of influence in 
discriminating between resistant and susceptible strains. In order to generate this list, the 
representative qualities of the bins were assessed using CRS. 
 
 
Figure 5.3-6: VIP scores from the PLS-DA model discriminating between resistant and susceptible adult An. 
gambiae. A total of 30 identified bins were selected representing 13 metabolites. Black line represent VIP score 
of 1. 
 
The CRS was calculated for all identified bins and then used to calculate a passing score. The 
threshold for the adult An. gambiae dataset was 39.23%. Table 5.3-4 shows the CRS of 30 
bins selected by VIP scoring criteria corresponding to 13 metabolites. In order to assess the 
representative properties of VIP selected bins, only bins scoring higher than CRS threshold 
were considered. Amongst the bins with sufficient score, only the highest scoring, non-
overlapping (where applicable) were selected as metabolite representatives. 
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Table 5.3-4: CRS of bins selected from via VIP scores for adult An. gambiae. Only the highest scoring, non-
overlapping bins (where applicable) over the CRS threshold were considered as representative bins. Rep: 
representative bin. * denotes overlapping bin. 
Metabolites Bin CRS [%] 
CRS > 





Glutamate 140 21.34 ✕ - Pyruvate 139 Singlet NA 139 
118 20.98 ✕ Succinate 144 Singlet NA 144 
138 20.69 ✕ Threonine 398 53.43 ✓ 398 
142 16.26 ✕ Trehalose 315 90.40 ✓ 315 
126* -13.47 ✕  277 86.75 ✓  
Glutamine 126* 26.62 ✕ -  311 79.26 ✓  
128 19.04 ✕  424 49.24 ✓  
131 -8.92 ✕ Tryptophan 248 16.79 ✕ - 
Lactate 49 44.79 ✓ 49  255 14.18 ✕  
51 43.94 ✓  460* 13.76 ✕  
Methanol 260 Singlet NA 260  458* 13.39 ✕  
Oxypurinol 493 Singlet NA 493 Tyrosine 458* 77.21 ✓ 452 
Propionate 129 59.25 ✓ 129  452 76.93 ✓  
127 48.26 ✓  460* 76.90 ✓  
130 20.47 ✕ Valine 132 21.03 ✕ - 
 
A metabolite shortlist (Table 5.3-5) was generated by selecting non-overlapping bins (where 
available) scoring higher than the 39.23% threshold. From the 13 metabolites identified by 
VIP, only nine were selected post-CRS. The four metabolites removed from the metabolite 
shortlist were: glutamate, glutamine, tryptophan, and valine. In order to determine the 
discriminative properties of these metabolites exclusively, adult data was filtered to only 
contain the selected bins representing their corresponding metabolites. These were then 
used in PCA to observe the major variance represented by the selected metabolites. 
 






shift [ppm] KEGG code 
Alcohols Methanol 260 3.36 C00132 
Amino acids Threonine 398 4.26 C00188 
Tyrosine 452 6.90 C00082 
Carboxylic 
acids 
Lactate 49 1.33 C00186 
Propionate 129 2.18 C00163 
Pyruvate 139 2.37 C00022 
Succinate 144 2.41 C00042 
Purines Oxypurinol 493 8.27 C07599 
Saccharides Trehalose 315 3.66 C01083 
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PCA (Figure 5.3-7-A) was performed on the filtered data to observe the major variances in 
the dataset when it only includes the selected metabolites. The PCA scores plot shows PC1 
(34.87%) against PC3 (12.12%), accounting for a cumulative explained variance of 46.99%. A 
total of seven components were required to explain 95% of the variance. Although full 
separation of the profiles was not observed, an underlying structure is exhibited, suggesting 
the capability of selected metabolites in showing the differences between resistant and 
susceptible mosquitoes. A PLS-DA model was also built in order to determine the 
discriminatory properties of the selected metabolites represented by the bins. 
 
  
Figure 5.3-7: A) PCA of selected metabolites from the adult wild type An. gambiae PLS-DA model, discriminating 
between resistant and susceptible groups (nResistant=29, nSusceptible=27). PC1 (34.87%) and PC3 (12.12%) account for 
a cumulative explained variance of 46.99%, while a total of seven components were required to explain the 95% 
variance in the data. Ellipses represent 95% confidence region. B) PLS-DA scores plot discriminating between 
resistant and wild type An. gambiae adult (nResistant=29, nSusceptible=27) for selected representative bins. Model 
complexity of two variates was determined via cross-validation with 93.75% accuracy. Variate’s explained 
variance is reported in the bracket. Ellipses represent 95% confidence region. 
 
Discriminatory properties of the selected metabolites were assessed by a cross-validated 
PLS-DA model. Two-variate model complexity was determined via cross-validation with 
93.75% accuracy (Appendix 11 for further metrics). Figure 5.3-7-B shows the PLS-DA scores 
plot for the filtered adult data. A separation of the resistant and susceptible groups can be 
seen along a diagonal of variate-1 and variate-2. 
 
After establishing the discriminative properties of the selected metabolites, their levels were 
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applied (see Appendix 22 for detailed test statistics). Figure 5.3-8 shows that all selected 
metabolites were found to be significantly different (p-value < 0.05). 
 
 
Figure 5.3-8: Boxplots for selected metabolites from adult wild type An. gambiae. * denotes p-value < 0.05, ** 
denotes p-value < 0.01 and *** denotes p-value < 0.0001. 
 
5.3.4 Metabolite set enrichment analysis of pupal and adult stages 
To summarise the key metabolite selection via statistical analyses, selected metabolites and 
their comparison to susceptible species were tabulated (Table 5.3-6). Selected metabolites 
were then used in MSEA to generate a list of pathways to represent the changes in resistant 
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Succinate [144] Methanol [260] Trehalose [315]





















































Sex F MFemale Male Group Resistant Susceptible
Adult
 210 
Table 5.3-6: Selected metabolite level comparison summary of pupa and adult wild type An. gambiae. Arrows 
represent significant changes, and square brackets represent BH-adjusted p-values. 
 Pupa Adult 
Metabolite class Resistant : Susceptible 
Alcohol Methanol ↑ [8.17x10-9] ↓ [1.90 x10-4] Methanol 
Amino acids Alanine ↓ [2.23 x10-4]   
Glutamate ↑ [7.22 x10-4]   
Glycine ↓ [1.25 x10-3]   
Isoleucine ↓ [2.89 x10-3]   
Threonine ↓ [1.48 x10-4] ↓ [1.67 x10-3] Threonine 
Tryptophan ↑ [1.67 x10-3]   
  ↓ [4.28 x10-2] Tyrosine 
Carboxylic acids Acetate ↑ [7.73 x10-3]   
Formate ↑ [2.72 x10-3]   
Fumarate ↑ [4.05 x10-8]   
Lactate ↓ [6.12 x10-5] ↓ [1.07 x10-2] Lactate 
Propionate ↑ [9.64 x10-3] ↑ [9.19 x10-3] Propionate 
Pyruvate ↓ [3.79 x10-10] ↓ [9.50 x10-6] Pyruvate 
  ↑ [1.03 x10-3] Succinate 
Purines Oxypurinol ↑ [1.19 x10-3] ↑ [1.10 x10-4] Oxypurinol 
Sugar Glucose ↓ [1.48 x10-4]   
Trehalose ↑ [1.95 x10-3] ↑ [9.19 x10-3] Trehalose 
 
MSEA was perform on the selected metabolites of both pupae and adult wild type An. 
gambiae (Figure 5.3-9). MSEA was performed on selected metabolites and p-values were 
corrected with BH for multiple testing, resulting in a list of 15 unique pathways for pupae, 
two unique pathways for adult and five pathways in common for both pupae and adults 




Figure 5.3-9: MSEA of selected metabolites of pupae and adults, showing over-represented pathways. Selected 
metabolites were derived from the PLS-DA models of pupae and adults discriminating between resistant and 
susceptible strains of An. gambiae. Pupae identified 20 significantly over-represented pathways and adults 
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2−Oxocarboxylic acid metabolism
ABC transporters
Alanine, aspartate and glutamate metabolism
Aminoacyl−tRNA biosynthesis




Glycine, serine and threonine metabolism
Glycolysis / Gluconeogenesis
Glyoxylate and dicarboxylate metabolism
Neuroactive ligand−receptor interaction
Nicotinate and nicotinamide metabolism
Nitrogen metabolism
Phenylalanine metabolism
Phosphonate and phosphinate metabolism
Porphyrin and chlorophyll metabolism
Propanoate metabolism
Pyruvate metabolism
Taurine and hypotaurine metabolism
Tyrosine metabolism
Valine, leucine and isoleucine biosynthesis
−log10(BH adjusted p−value)
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Table 5.3-7: Wild type An. gambiae MSEA result details reporting Fisher’s exact test raw & BH adjusted p-values, 






p-value Hit/total (%) Matches 
2-Oxocarboxylic 
acid metabolism 
Pupa 3.5 x 10-8 4.2 x 10-7 4/134 (2.99%) Pyruvate, Glutamate, Tryptophan, 
Isoleucine 
ABC transporters Pupa 5.8 x 10-16 1.4 x 10-14 7/182 (3.85%) Glutamate, Glucose, Glycine, Alanine, 








Pupa 2.5 x 10-13 4.0 x 10-12 6/52 (11.54%) Glutamate, Glycine, Alanine, 
Tryptophan, Threonine, Isoleucine 
Biosynthesis of 
amino acids 
Pupa 2.0 x 10-6 1.9 x 10-5 7/128 (5.47%) Pyruvate, Glutamate, Glycine, 
Alanine, Tryptophan, Threonine, 
Isoleucine 
Adult 5.0 x 10-3 2.8 x 10-2 3/128 (2.34%) Pyruvate, Tyrosine, Threonine 
Butanoate 
metabolism 
Pupa 3.0 x 10-3 9.9 x 10-3 3/42 (7.14%) Pyruvate, Glutamate, Fumarate 
Carbon metabolism Pupa 1.2 x 10-18 5.9 x 10-17 8/112 (7.14%) Pyruvate, Glutamate, Acetate, 
Glycine, Alanine, Formate, Fumarate, 
Methanol 
Adult 1.7 x 10-3 1.4 x 10-2 3/112 (2.68%) Pyruvate, Succinate, Methanol 
FoxO signaling 
pathway 
Pupa 3.5 x 10-3 9.9 x 10-3 2/5 (40%) Glutamate, Glucose 
Glycine, serine and 
threonine 
metabolism 
















Pupa 4.7 x 10-3 1.3 x 10-2 3/55 (5.45%) Pyruvate, Fumarate, Propionate 
Adult 8.8 x 10-3 4.3 x 10-2 3/55 (5.45%) Pyruvate, Succinate, Propionate 
Nitrogen 
metabolism 
Pupa 3.5 x 10-3 9.9 x 10-3 2/43 (4.65%) Glutamate, Formate 
Phenylalanine 
metabolism 








Pupa 9.9 x 10-3 2.5 x 10-2 3/141 (2.13%) Glutamate, Glycine, Threonine 
Propanoate 
metabolism 
Pupa 2.1 x 10-4 1.0 x 10-3 4/48 (8.33%) Acetate, Methanol, Propionate, 
Lactate 




Pupa 1.7 x 10-4 1.0 x 10-3 5/31 (16.13%) Pyruvate, Acetate, Formate, 
Fumarate, Lactate 








Adult 1.1 x 10-3 1.3 x 10-2 3/79 (3.8%) Pyruvate, Succinate, Tyrosine 
Valine, leucine and 
isoleucine 
biosynthesis 
Pupa 3.3 x 10-3 9.9 x 10-3 3/23 (13.04%) Pyruvate, Threonine, Isoleucine 
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In the comparison of resistant and susceptible mosquitoes of An. gambiae, metabolic profile 
differences between resistant and susceptible strains were observed. From a metabolic 
profile point of view, these differences were much more pronounced in pupae compared to 
adults. PCA scores plots for pupae exhibited the resistance differences more clearly than 
those of adults. In addition, PCs demonstrating these differences also accounted for a higher 
cumulative explained variance in pupae (50.47%) compared to adults (18.94%). PLS-DA 
models also exhibited a similar performance: pupa model discriminated with a single-variate 
with 10.23% error, whereas the adult model required a 2-variate model to discriminate with 
8.81% error rate. Upon performing MSEA, some common pathways were over-represented 
both in pupae and adult datasets. These were pyruvate metabolism, propanoate 
metabolism, nicotinate and nicotinamide metabolism, carbon metabolism and biosynthesis 
of amino acids. Furthermore, changes between resistant and susceptible strains were more 
pronounced in pupae than adults. Post-CRS metabolite selection yielded 16 metabolites for 
pupae while only nine metabolites were selected for adults. Although metabolic differences 
between resistant and susceptible strains were more pronounced in pupae, metabolite 
selection of adults has proved to be more informative. This was demonstrated by the 
performance of cross-validated PLS-DA models built with selected metabolites. In these 
models, pupae scored 85.71% accuracy. In comparison, the adult PLS-DA model scored 
93.75% accuracy. This suggests that both models have similar performance in discriminating 
between resistant and susceptible species. Furthermore, it would appear that the adult 
model, which was built with fewer metabolites, could predict with higher accuracy. From the 
comparison of the metabolite levels it was found that levels of threonine (↓), propionate 
(↑), pyruvate (↓), oxypurinol (↑) and trehalose (↑) show significant changes and in the 
same direction for the pupae and adult dataset. On the contrary, methanol is the only 
metabolite which is significant in opposite directions between pupae (↑) and adults (↓). 
 
5.4 Metabolic profiling of wild type Ae. aegypti species New Orleans 
(susceptible) and Cayman (resistant) 
5.4.1 Metabolite assignment 
Ae. aegypti metabolite assignment was consistent between pupae and adults comprising 513 
bins in total (compared to 496 bins in An. gambiae). A total of 114 bins (same number as An. 
gambiae) were assigned out of 513, accounting for 22.22% of all bins, leaving 399 bins 
unidentified. The difference between An. gambiae and Ae. aegypti datasets were 17 
unidentified bins. The metabolite assignment was identical for both resistant and susceptible 
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strains. From the 114 assigned bins, 15 (13.16%) were overlapping bins. A total of 21 unique 
metabolites were assigned from the 114 assigned bins (Table 5.4-1). From the 21 
metabolites, 12 (57.14%) were identified with MSI level 1 and 9 were assigned (42.86%) with 
MSI level 2. Representative 1H-NMR spectra for pupae and adults are shown in Appendix 20 
and Appendix 21 respectively. 
 
Table 5.4-1: Metabolite assignment table, with MSI level, KEGG compound code and classifications. See Appendix 




level (MSI) Unique Overlap Total KEGG code 
Alcohols Methanol Level 1 1 0 1 C00132 
Amino acids Alanine Level 1 2 3 5 C00041 
Glutamate Level 1 7 3 10 C00025 
Glutamine Level 1 2 3 5 C00064 
Glycine Level 1 1 0 1 C00037 
Isoleucine Level 1 3 0 3 C00407 
Threonine Level 2 4 0 4 C00188 
Tryptophan Level 1 12 3 15 C00078 
Tyrosine Level 1 12 2 14 C00082 
Valine Level 1 5 0 5 C00183 
Carboxylic 
acids 
Acetate Level 1 1 0 1 C00033 
Formate Level 2a 1 0 1 C00058 
Fumarate Level 2a 1 0 1 C00122 
Lactate Level 1 4 0 4 C00186 
Propionate Level 2b 6 0 6 C00163 
Pyruvate Level 1 1 0 1 C00022 
Succinate Level 1 1 0 1 C00042 
Purines Oxypurinol Level 2b 1 0 1 C07599 
Xanthine Level 2b 1 0 1 C00385 
Saccharides Glucose Level 1 24 8 32 C00031 
Trehalose Level 1 10 7 17 C01083 
 
5.4.2 Metabolic profiling of pupae 
5.4.2.1 Statistical analysis 
Major variances in the dataset were explored using PCA (Figure 5.4-1-A). PCA scores plot of 
PC1 (33.39%) against PC2 (14.82%) accounting for a cumulative variance of 48.21%. A total 
of 29 components were required in order to explain 95% variance in the data. The PCA plot 
shows a clear separation of resistant and susceptible species along a diagonal of PC1 and 
PC2. Observations on the plot also show subpopulations in each group which were attributed 
to sex. Using a cross-validated PLS-DA, differences between groups can be accentuated 




Figure 5.4-1: A) PCA scores plot PC1 (33.39%) against PC2 (14.82%) for wild type Ae. aegypti pupae (nResistnat=28, 
nSusceptible=27) accounting for a cumulative variance of 48.21%. A high degree of metabolic profile difference is 
demonstrated by the two distinct clusters of resistant and susceptible groups. A total of 29 components were 
required to explain the 95% variance. The ellipses represent 95% confidence region. B) PLS-DA density plot for 
wild type Ae. aegypti pupae (nResistnat=28, nSusceptible=27) PLSDA. Single-variate model (32.13% explained variance) 
complexity was determined using cross-validation and model accuracy was calculated at 100%. Each tick 
represents a sample from its respective group and its sex. 
 
Using a cross-validated PLS-DA model (Figure 5.4-1-B), sex variance observed in the PCA were 
supressed and the differences between resistant and susceptible species were enhanced. 
Single-variate optimal model complexity was determined through cross-validation with 100% 
accuracy (Appendix 11 for further metrics). PLS-DA density plot of variate-1 shows clear 
discrimination of the two groups. In order to identify metabolites influencing the 
discrimination in the model, VIP scores were calculated for the bins. 
 
5.4.2.2 Key metabolites 
VIP scores were calculated to identify the bins most influential in discriminating between 
resistant and susceptible strains of Ae. aegypti pupae. A total of 513 VIP scores were 
calculated including both identified and unidentified bins. A VIP score threshold of 1 was 
applied for selection, where 245 bins scored above. Within the 245 bins, only 60 were 
identified and these were attributed to 15 unique metabolites. Therefore, in order to select 




















































































Figure 5.4-2: Identified bins scoring higher than 1 on VIP scoring from PLS-DA model discriminating between 
pupae of wild type Ae. aegypti resistant and susceptible strains. Black line represents VIP score of 1. 
 
Using all CRS calculated from identified bins (114), a passing score of 42.82% was calculated. 
CRS scores of bins selected from VIP were checked against the passing score (Table 5.4-2). A 
selection amongst bins scoring higher than the passing score was made. Only the highest 
scoring, non-overlapping bins (where applicable) were selected. 
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Table 5.4-2: CRS of bins selected from via VIP scores for Ae. aegypti pupae. Only the highest scoring, non-
overlapping bins (where applicable) over the CRS threshold of 42.82% were considered as representative bins. 
Metabolite Bin CRS [%] 
CRS > 
42.82% Rep Metabolite Bin CRS [%] 
CRS > 
42.82% Rep 
Alanine 351* 79.77 ✓ 58 Glutamine 349* 9.41 ✕ - 
 354* 77.51 ✓   347* 9.07 ✕  
 348* 73.04 ✓ 
 
 143 8.08 ✕  
 58 66.19 ✓ 
 
 138* 0.92 ✕  
Glucose 284 87.41 ✓ 284  140 -0.28 ✕  
 368 87.30 ✓ 
 
Glycine 309 Singlet NA 309 
 370 87.13 ✓ 
 
Lactate 398 90.09 ✓ 398 
 281 86.53 ✓ 
 
 49 86.54 ✓  
 303 86.41 ✓ 
 
 51 85.31 ✓  
 296* 86.39 ✓ 
 
 400 78.49 ✓  
 278 86.35 ✓ 
 
Methanol 274 Singlet NA 274 
 439 86.32 ✓ 
 
Oxypurinol 510 Singlet NA 510 
 360* 86.18 ✓ 
 
Pyruvate 151 Singlet NA 151 
 306 86.09 ✓ 
 
Threonine 313 18.17 ✕ - 
 299 85.98 ✓ 
 
 412 -4.46 ✕  
 253 85.94 ✓ 
 
Trehalose 365 79.92 ✓ 365 
 343 85.92 ✓ 
 
 325 79.42 ✓  
 341 85.75 ✓ 
 
 327 73.52 ✓  
 337 85.74 ✓ 
 
 362 70.75 ✓  
 305 85.71 ✓ 
 
 360* 67.07 ✓  
 434 85.66 ✓ 
 
 349* 66.61 ✓  
 295 85.56 ✓ 
 
 347* 57.38 ✓  
 301 85.53 ✓ 
 
 354* 45.27 ✕  
 297 85.46 ✓ 
 
Tryptophan 483 29.31 ✕ - 
 293 85.12 ✓ 
 
 298 21.71 ✕  
 351* 85.04 ✓ 
 
 300 20.56 ✕  
 352 83.53 ✓ 
 
 266 20.18 ✕  
 361 81.85 ✓ 
 
 296* 13.09 ✕  
 290 81.32 ✓ 
 
 269 7.95 ✕  
 288 80.75 ✓ 
 
Tyrosine 374 62.67 ✓ 374 
 348* 68.48 ✓ 
 
Valine 318 18.56 ✕ - 
Glutamate 150 36.59 ✕ - Xanthine 499 Singlet NA 499 
 152 36.27 ✕ 
 
     
 147 35.36 ✕ 
 
     
 154 33.75 ✕ 
 
     
 138* 22.55 ✕ 
 
     
 348* -0.98 ✕ 
 
     
*: Overlapping bin 
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A metabolite shortlist was tabulated from the selected bins from CRS. Prior to CRS, 15 
metabolites were selected via VIP. Using CRS, the metabolites glutamine, glutamate, 
threonine, tryptophan and valine were excluded, resulting in a list of 10 metabolites. Selected 
metabolites were comprised of five classes: alcohols, amino acids, carboxylic acids, purines 
and saccharides. 
 
Table 5.4-3: Metabolite shortlist for wild type pupae of Ae. aegypti discrimination between susceptible and 
resistant strains. 
Class Metabolite Representative bin Chemical shift [ppm] KEGG code 
Alcohols Methanol 274 3.36 C00132 
Amino acids Alanine 58 1.48 C00041 
Glycine 309 3.57 C00037 
Tyrosine 374 3.94 C00082 
Carboxylic acids Lactate 398 4.11 C00186 
Pyruvate 151 2.37 C00022 
Purines Oxypurinol 510 8.27 C07599 
Xanthine 499 7.89 C00385 
Saccharides Glucose 284 3.42 C00031 
Trehalose 365 3.87 C01083 
 
Prior to MSEA, the major variances represented by the selected metabolites were evaluated 
using PCA. NMR data was filtered to include only the selected metabolites to perform PCA 
(Figure 5.4-3-A). PC1 (56.55%) against PC2 (15.17%) explains a cumulative variance of 71.72% 
and a total of 7 components were required to explain the 95% variation in the metabolic 
profile of resistant and susceptible species. Separation between resistant and susceptible 
species with no overlap can be observed along PC1. Both groups exhibit similar internal group 
variation demonstrated by the spread along PC1. Further discriminatory properties of the 




Figure 5.4-3: A) PCA scores plot of PC1 (56.55%) against PC2 (15.17%) for wild type Ae. aegypti pupae (nResistant=28, 
nSusceptible=27). PC1 and PC2 explain a cumulative variance of 71.72% in the metabolic profile between resistant 
and susceptible species. A total of seven components were required to explain 95% variation in the data. Ellipses 
represent the 95% confidence region. B) PLS-DA density plot for wild type Ae. aegypti pupae (nResistant=28, 
nSusceptible=27) for selected representative bins. Single variate (56.46% explained variance) model complexity was 
determined by cross-validation with 87.50% accuracy. Each tick represents a sample and its sex from their groups. 
 
A cross-validated PLS-DA model was built to discriminate between resistant and susceptible 
strains. Optimal model complexity was determined to be a single-variate model with 87.50% 
accuracy (Appendix 11 for further metrics). The PLS-DA density plot (Figure 5.4-3-B) shows 
clear discrimination between resistant and susceptible strains. To further probe the 
metabolite level changes, selected metabolites were investigated. 
 
Using a BH adjusted t-test, selected metabolites were compared between resistant and 
susceptible strains (see Appendix 22 for detailed test statistics). Metabolite levels were 
visualised via boxplots (Figure 5.4-4). Upon BH adjustment, all metabolites were significantly 
different between resistant and susceptible strains. In the case of alcohols, methanol was 
found to be lower in resistant strains. For the amino acids, alanine, glycine and tyrosine were 
significantly higher in resistant strains. For carboxylic acids, resistant species exhibited higher 
levels of lactate while showing lower levels of pyruvate. In purines, lower levels of oxypurinol 
were observed in resistant species while xanthine levels were higher. Finally, for saccharides, 




























































































Figure 5.4-4: Boxplots of selected metabolites between wild type resistant and susceptible Ae. aegypti. *, ** and 
*** denotes p-value less than 0.05, 0.01 and 0.0001 respectively. 
 
5.4.3 Metabolic profiling of adults 
5.4.3.1 Statistical analysis 
In order to compare the pupal and adult phases, the adult data was analysed with the same 
approach as the pupal analysis. Using PCA (Figure 5.4-5-A), major variances in the adult 
dataset were observed. Resistant and susceptible strains of adult Ae. aegypti were clearly 
separated along a diagonal on PC1 (29.14%) and PC2 (13.17%) accounting for a cumulative 
explained variance of 42.31%. A total of 25 components were required to explain the 95% 
variance in the data. In order to select metabolites of interest between resistant and 
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Figure 5.4-5: A) PCA scores plot for wild type Ae. aegypti adult (nResistant=21, nSusceptible=20). PC1 (29.14%) and PC2 
(13.17%) account for a cumulative variance of 42.31%, meanwhile, 25 components were required to explain 95% 
of the variance. Ellipses represent the 95% confidence region. B) PLS-DA density plot discriminating between 
resistant and susceptible strains of wild type Ae. aegypti adult (nResistant=21, nSusceptible=20). Single variate model 
(22.14% explained variance) complexity was determined via cross-validation 100% accuracy. Two subpopulations 
in each group can be observed due to sex as shown by the different line types of the tick marks. Ticks represent 
samples from the experimental groups and their sex. 
 
Discrimination between resistant and susceptible strains was accomplished via cross-
validated PLS-DA modelling. The optimal model was determined to be a single-variate model 
with 100% accuracy (Appendix 11 for further metrics). The density plot (Figure 5.4-5-B) shows 
a good discrimination between resistant and susceptible strains. A subpopulation in both 
resistant and susceptible strains can be observed. These subpopulations are due to sex 
differences in adult Ae. aegypti species (Section 3.6). In order to probe these differences 
further and obtain metabolite level information, VIP scores were analysed for metabolite 
selection. 
 
5.4.3.2 Key metabolites 
VIP scores were calculated for all 513 bins used in the PLS-DA model. A passing threshold of 
1 was applied in order to identify the most influential bins from the PLS-DA model. From the 
513 bins, a total of 197 bins containing both identified and unidentified bins, scored above 
the threshold. Amongst the 197 bins, only 51 were identified (9.96% of whole dataset) and 














































































metabolites. In order to select metabolites from the model, bins with the highest 
representative properties were determined via CRS. 
 
Figure 5.4-6: PLS-DA VIP scores of wild type Ae. aegypti adult bins. Only identified bins scoring higher than one 
are shown. A total of 51 identified bins out of 513 bins (9.94%) scored higher than 1, representing 14 metabolites. 
The black line represents the VIP score of 1. 
 
In order to assess the representative properties of each bin corresponding to their 
metabolites, CRS were calculated for all identified bins. Using all CRS calculated, a passing 
threshold of 41.68% was determined. Only bins scoring higher than this threshold were 
considered as potential representatives for selected metabolites (Table 5.4-4). To create the 
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Table 5.4-4: CRS of bins selected from via VIP scores for adult Ae. aegypti. Only the highest scoring, non-
overlapping bins (where applicable) over the CRS threshold of 41.68% were considered as representative bins. 
Rep: representative bin. 





Alanine 351* 72.68 ✓ 351 Glutamate 150 33.86 ✕ - 
 354* 70.72 ✓ 
 
 147 33.69 ✕  
 348* 70.52 ✓ 
 
 152 32.90 ✕  
Glucose 360* 79.83 ✓ 368  154 31.45 ✕  
 296* 79.40 ✓ 
 
 130 30.09 ✕  
 368 79.09 ✓ 
 
 348* 6.11 ✕  
 278 78.92 ✓ 
 
 138* 3.04 ✕  
 305 78.82 ✓ 
 
Glutamine 138* 28.64 ✕ - 
 301 78.79 ✓ 
 
 140 23.93 ✕  
 299 78.61 ✓ 
 
 347* 17.44 ✕  
 306 78.44 ✓ 
 
 349* 15.96 ✕  
 434 78.44 ✓ 
 
Methanol 274 Singlet NA 274 
 370 78.20 ✓ 
 
Oxypurinol 510 Singlet NA 510 
 295 78.05 ✓ 
 
Propionate 139 66.64 ✓ 139 
 303 78.00 ✓ 
 
 142 43.57 ✓  
 293 77.97 ✓ 
 
Pyruvate 151 Singlet NA 151 
 284 77.54 ✓ 
 
Succinate 156 Singlet NA 156 
 343 77.45 ✓ 
 
Threonine 313 38.86 ✕ - 
 439 77.10 ✓ 
 
Trehalose 362 61.51 ✓ 362 
 297 76.57 ✓ 
 
 360* 49.73 ✓  
 341 76.45 ✓ 
 
 438 47.62 ✓  
 281 75.74 ✓ 
 
 349* 44.36 ✓  
 253 74.02 ✓ 
 
 347* 39.49 ✕  
 361 73.56 ✓ 
 
 354* 5.44 ✕  
 337 71.71 ✓ 
 
Tryptophan 493 60.87 ✓ 493 
 352 69.21 ✓ 
 
 298 39.68 ✕  
 250 67.47 ✓ 
 
 296* 27.40 ✕  
 351* 66.73 ✓ 
 
 269 11.23 ✕  
 290 61.42 ✓ 
 
Tyrosine 374 69.59 ✓ 374 
 348* 41.86 ✓ 
 
Valine 318 61.64 ✓ 318 
*: Overlapping bin 
 
Prior to the application of the CRS passing threshold, 15 metabolites were selected via VIP 
scores. Following CRS, the metabolites glutamate, glutamine and threonine were excluded 
from the metabolite shortlist. Table 5.4-5 shows the metabolites selected from the PLS-DA 
model discriminating between resistant and susceptible strains yielding 11 metabolites from 
classes of alcohols, amino acids, carboxylic acids, purines, and saccharides. 
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[ppm] KEGG code 
Alcohols Methanol 274 3.36 C00132 
Amino acids Alanine 351* 3.78 C00041 
Tryptophan 493 7.55 C00078 
Tyrosine 374 3.94 C00082 
Valine 318 3.16 C00183 
Carboxylic acids Propionate 139 2.17 C00163 
Pyruvate 151 2.37 C00022 
Succinate 156 2.41 C00042 
Purines Oxypurinol 510 8.27 C07599 
Saccharides Glucose 368 3.89 C00031 
Trehalose 362 3.85 C01083 
*, denotes overlapping bin. 
 
In order to demonstrate the variation represented by the selected metabolites, PCA was 
performed on only the bins representing the selected metabolites. Differences attributed to 
species can be seen in the PCA scores plot (Figure 5.4-7-A) along PC1 (55.46%). A total of 7 
components were required in order to explain the 95% variance in the data. Along PC1, 
overlap can be observed between resistant and susceptible strains. Nevertheless, the 
clustering exhibited by both groups suggests through supervised modelling methods, 
discrimination between resistant and susceptible species can be achieved. 
 
 
Figure 5.4-7: A) PCA scores of PC1 (55.46%) against PC2 (17.46%) for adult wild type Ae. aegypti (nResistant=21, 
nSusceptible=20). A total of seven components were required to explain the 95% variance in the data. Ellipses 
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resistant and susceptible strains of adult Ae. aegypti (nResistant=21, nSusceptible=20). Two-variate model complexity 
was determined using cross-validation with 91.67% accuracy. Brackets report variate’s explained variance. 
Ellipses represent 95% confidence region. 
 
PLS-DA (Figure 5.4-7-B) on the selected metabolites was built with cross-validation revealed 
a two-variate model as the optimum PLS-DA model complexity for the selected metabolite 
data with an accuracy of 91.67% (Appendix 11 for further metrics). The discrimination of 
resistant species against susceptible species can be observed along a diagonal of variate-1 
and variate-2. 
 
Following the demonstration of the selected metabolites’ performance on discriminating 
between resistant and susceptible strains, metabolite levels were compared in order to gain 
metabolite level information. Boxplots (Figure 5.4-8) were used to visualise metabolite levels, 
while BH-adjusted t-tests were used for comparison (see Appendix 22 for detailed test 
statistics). Metabolite level comparisons showed 11 metabolites to be significantly different 
between resistant and susceptible strains. More specifically, in alcohols, methanol was found 
to be lower in the resistant group. Of the amino acids, alanine, tryptophan, tyrosine and 
valine were also higher in the resistant strains. For the carboxylic acids, propionate, pyruvate 
and succinate were found to be higher in the susceptible group. The only purine selected was 
oxypurinol, which was found to be lower in the resistant group. Finally, for saccharides, both 




Figure 5.4-8: Boxplots for selected metabolites from the adult wild type Ae. aegypti (nResistant=21, nSusceptible=20). 
*, ** and *** denotes p-values less than 0.05, 0.01 and 0.0001 respectively. * by the metabolite name denotes 
overlapping bin. 
 
5.4.4 Metabolite set enrichment analysis 
Selected metabolites from pupal and adult models were tabulated (Table 5.4-6) to 
summarise significant changes between resistant and susceptible strains. When the resistant 
strain was compared to the susceptible strain, the following metabolites exhibited similar 
changes across phases: methanol, pyruvate and oxypurinol were lower; alanine, tyrosine, 



























































































































































































































































































































































































Tyrosine [374] Tryptophan [493] Oxypurinol [510]
Valine [318] Alanine [351*] Trehalose [362] Glucose [368]
Propionate [139] Pyruvate [151] Succinate [156] Methanol [274]
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Table 5.4-6: Summary of significant metabolite level changes between resistant and susceptible strains across 
pupa and adult phases. Arrows represent significant changes, and square brackets represent BH-adjusted p-
values. 
 Pupa Adult 
Metabolite class Resistant compared to susceptible 
Alcohols Methanol ↓ [1.09x10-7] ↓ [6.65 x10-4] Methanol 
Amino acids Alanine ↑ [4.70 x10-10] ↑ [1.30 x10-7] Alanine  
Glycine ↑ [1.87 x10-8]   
   ↑ [1.12 x10-2] Tryptophan 
 Tyrosine ↑ [5.22 x10-5] ↑ [2.67 x10-3] Tyrosine  
  ↑ [3.80 x10
-3] Valine 
Carboxylic acids Lactate ↑ [5.11 x10-6]   
  ↓ [3.82 x10-3] Propionate 
Pyruvate ↓ [4.66 x10-8] ↓ [4.10 x10-4] Pyruvate 
 
 
↓ [4.10 x10-4] Succinate 
Purines Oxypurinol ↓ [5.11 x10-6] ↓ [4.20 x10-5] Oxypurinol 
 Xanthine ↑ [2.08 x10-7]   
Saccharides Glucose ↑ [4.63 x10-12] ↑ [1.77 x10-4] Glucose  
Trehalose ↑ [5.22 x10-5] ↑ [1.71 x10-3] Trehalose 
 
MSEA (Figure 5.4-9) was performed with EASE correction and BH adjustment for the p-values 
in order to generate a list of pathways which represent the differences between resistant 
and susceptible species on a metabolic pathway level (Table 5.4-7). A total of 11 pathways 
were over-represented between adult and pupae, of which three were unique to pupae, four 




Figure 5.4-9: Selected metabolites analysed via MSEA from both pupal and adult phases. Resulting p-values were 
adjusted with BH for multiple testing. Black line represents p-value 0.05. 
 
Table 5.4-7: Details of the MSEA for wild type Ae. aegypti reporting stage, raw & BH adjusted p-values for Fisher’s 





p-value Hit/total (%) Matches 
2-Oxocarboxylic 
acid metabolism 
Pupa 2.3 x 10-3 2.3 x 10-2 2/134 (1.49%) Pyruvate, Tyrosine 






Adult 5.7 x 10-3 2.7 x 10-2 3/29 (10.34%) Pyruvate, Alanine, Succinate 
Aminoacyl-tRNA 
biosynthesis 
Pupa 4.1 x 10-3 2.7 x 10-2 3/52 (5.77%) Glycine, Alanine, Tyrosine 




Pupa 7.9 x 10-9 3.2 x 10-7 4/128 (3.12%) Pyruvate, Glycine, Alanine, Tyrosine 




Pupa 1.9 x 10-4 3.9 x 10-3 4/112 (3.57%) Pyruvate, Glycine, Alanine, 
Methanol 








Adult 3.6 x 10-3 1.9 x 10-2 3/55 (5.45%) Pyruvate, Succinate, Propanoate 
Phenylalanine 
metabolism 
Adult 1.6 x 10-3 1.2 x 10-2 3/74 (4.05%) Pyruvate, Succinate, Tyrosine 
Thiamine 
metabolism 
Pupa 2.9 x 10-3 2.3 x 10-2 3/32 (9.38%) Pyruvate, Glycine, Tyrosine 
Tyrosine 
metabolism 
Adult 2.1 x 10-3 1.3 x 10-2 3/79 (3.8%) Pyruvate, Succinate, Tyrosine 
 
Pupa Adult
0.0 2.5 5.0 7.5 0.0 2.5 5.0 7.5
2−Oxocarboxylic acid metabolism
Alanine, aspartate and glutamate metabolism
Aminoacyl−tRNA biosynthesis
Biosynthesis of amino acids
Carbon metabolism
Glycolysis / Gluconeogenesis






5.5 Chapter results summary 
In this chapter, wild type resistant and susceptible strains of An. gambiae and Ae. aegypti 
species were compared using NMR metabolomics. Overall, wild type PLS-DA models 
demonstrated higher discriminatory properties (Table 5.5-1) between resistant and 
susceptible strains when wild type models. All models were found to be robust, exhibiting 
high accuracy (highest: Ae. aegypti pupae and adult full dataset with 100%, lowest: Ae. 
aegypti adult selected with 64.29%). The An. gambiae pupal model, built with the full 
dataset, yielded a list of 16 selected metabolites compared to the adult model where only 
nine were selected. In the Ae. aegypti full dataset models, pupae selected 10 and adults 
selected 11 metabolites. 
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Table 5.5-1: Summary of cross-validated PLS-DA model performance and following metabolite selections. VIP 
selected bins show the number of identified bins selected by VIP scoring. Brackets show the percentage of 
identified bins amongst all VIP selected bins. NA: not applicable. 











Pupa Full dataset 1 64.29% 52 (28.57%) 16 
Adult 2 87.50% 30 (19.11%) 9 
Pupa Selected 
metabolites 
1 85.71% NA NA 
Adult 2 93.75% NA NA 
Ae. 
aegypti 
Pupa Full dataset 1 100.00% 60 (24.49%) 10 
Adult 1 100.00% 51 (25.89%) 11 
Pupa Selected 
metabolites 
1 87.50% NA NA 
Adult 2 91.67% NA NA 
 
Overall, the metabolite selection performed on pupal models yielded more metabolites 
compared to the adult models. This indicates that in both species the differences between 
resistant and susceptible strains were more pronounced in pupae. 
 
Interestingly, the selected metabolites which are common between both strains of An. 
gambiae and Ae. aegypti, all show a reverse trend between species (Table 5.5-2). Uniquely 
significant metabolites were only identified in pupae of An. gambiae. These were glutamate, 
isoleucine, threonine, acetate, formate and fumarate.  
 
Table 5.5-2: Summary table for significant metabolite level changes represented as arrows between species of 
An. gambiae and Ae. aegypti. Comparisons represented as levels in resistant strains compared to susceptible 
strains for pupae and adults. Square brackets represent BH-adjusted p-values. 
  An. gambiae Ae. aegypti 
  Resistant : Susceptible 
Class Metabolite Pupa Adult Pupa Adult 
Alcohols Methanol ↑ [8.17x10-9] ↓ [1.90 x10-4] ↓ [1.09x10-7] ↓ [6.65 x10-4] 
Amino acids Alanine ↓ [2.23 x10-4]  ↑ [4.70 x10-10] ↑ [1.30 x10-7] 
Glutamate ↑ [7.22 x10-4]    
Glycine ↓ [1.25 x10-3]  ↑ [1.87 x10-8] 
 
Isoleucine ↓ [2.89 x10-3]    
Threonine ↓ [1.48 x10-4] ↓ [1.67 x10-3]   
Tryptophan ↑ [1.67 x10-3] 
  
↑ [1.12 x10-2] 
Tyrosine 
 
↓ [4.28 x10-2] ↑ [5.22 x10-5] ↑ [2.67 x10-3] 
Valine 
 
  ↑ [3.80 x10-3] 
Carboxylic acids Acetate ↑ [7.73 x10-3]    
Formate ↑ [2.72 x10-3]    
Fumarate ↑ [4.05 x10-8]    
Lactate ↓ [6.12 x10-5] ↓ [1.07 x10-2] ↑ [5.11 x10-6]  
Propionate ↑ [9.64 x10-3] ↑ [9.19 x10-3] 
 
↓ [3.82 x10-3] 
Pyruvate ↓ [3.79 x10-10] ↓ [9.50 x10-6] ↓ [4.66 x10-8] ↓ [4.10 x10-4] 
Succinate 
 
↑ [1.03 x10-3] 
 
↓ [4.10 x10-4] 
Purines Oxypurinol ↑ [1.19 x10-3] ↑ [1.10 x10-4] ↓ [5.11 x10-6] ↓ [4.20 x10-5] 
Xanthine 
 
 ↑ [2.08 x10-7] 
 
Sugars Glucose ↓ [1.48 x10-4]  ↑ [4.63 x10-12] ↑ [1.77 x10-4] 
Trehalose ↑ [1.95 x10-3] ↑ [9.19 x10-3] ↑ [5.22 x10-5] ↑ [1.71 x10-3] 
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A summary of MSEA analyses are tabulated in Table 5.5-3. The following pathways were 
found to be commonly over-represented in all the groups studied: carbon metabolism, 
biosynthesis of amino acids, aminoacyl-tRNA biosynthesis, and 2-oxocarboxylic acids 
metabolism. In An. gambiae, pupae-specific pathways are: 2-Oxocarboxylic acid metabolism, 
ABC transporters, alanine, aspartate & glutamate metabolism, aminoacyl-tRNA biosynthesis, 
butanoate metabolism, FoxO signalling pathway, glycine, serine & threonine metabolism, 
glycolysis / gluconeogenesis, glyoxylate & dicarboxylate metabolism, neuroactive ligand-
receptor interaction, nitrogen metabolism, phosphonate & phosphinate metabolism, taurine 
& hypotaurine metabolism, and valine, leucine & isoleucine biosynthesis. In comparison, only 
phenylalanine metabolism was unique to adults. Meanwhile, nicotinate & nicotinamide 
metabolism, propanoate metabolism, and pyruvate metabolism were common for both 
pupae and adults. In Ae. aegypti, common pathways between pupae and adults are: 2-
Oxocarboxylic acid metabolism and aminoacyl-tRNA biosynthesis. Pupae specific pathways 
of Ae. aegypti are: glycolysis / gluconeogenesis, glycine, serine & threonine metabolism and 
thiamine metabolism. Adult specific pathways are: alanine, aspartate & glutamate 
metabolism, nicotinate and nicotinamide metabolism, phenylalanine metabolism and 
tyrosine metabolism. 
 
Table 5.5-3: Summary of MSEA analyses showing pathways identified differing between resistant and susceptible 
strains of An. gambiae and Ae. aegypti. 
Pathway An. gambiae Ae. aegypti 
2-Oxocarboxylic acid metabolism P C 
ABC transporters P  
Alanine, aspartate and glutamate metabolism P A 
Aminoacyl-tRNA biosynthesis P C 
Biosynthesis of amino acids C C 
Butanoate metabolism P  
Carbon metabolism C C 
FoxO signalling pathway P  
Glycine, serine and threonine metabolism P P 
Glycolysis / Gluconeogenesis P P 
Glyoxylate and dicarboxylate metabolism P  
Neuroactive ligand-receptor interaction P  
Nicotinate and nicotinamide metabolism C A 
Nitrogen metabolism P  
Phenylalanine metabolism A A 
Phosphonate and phosphinate metabolism P  
Porphyrin and chlorophyll metabolism P  
Propanoate metabolism C  
Pyruvate metabolism C  
Taurine and hypotaurine metabolism P  
Thiamine metabolism  P 
Tyrosine metabolism A A 
Valine, leucine and isoleucine biosynthesis P  
A: only in adults, C: common for both pupae and adults, P only in pupae. 
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5.6 Chapter discussion 
Employing an NMR metabolomics approach, metabolite profiles of the wild type An. gambiae 
and Ae. aegypti were observed for early pupae and early adults. Surprisingly, there is no 
metabolic profiling of resistant and susceptible strains of wild type mosquitoes to date. 
Current publications on mosquito metabolomics usually target a specific case, such as blood 
digestion [164] or pathogen infection [149]. Using an NMR metabolomics approach to 
explore the metabolite profiles of wild type resistant and susceptible strains, differences 
between distinct profiles and a potential resistance biomarker was proposed. 
 
This study was based on the assumption that the different resistance statuses would 
manifest different metabolic signatures. Identified pathways characteristic to resistance 
status were correlated to pathways demonstrated by KD16 and KD17 datasets. Each dataset 
presented metabolic profile differences observable via NMR on a single pupa/mosquito 
scale. Between the pupa and adult datasets, metabolic profile separation through PCA 
attributable to resistance status was more apparent in pupae compared to adults. The VK7 
strain of An. gambiae has been shown to have cuticular resistance as well as metabolic and 
target site resistance via several studies [213], [214]. If only MSEA results are considered, 
common identified pathways between the KD strains and the wild type strains of An. 
gambiae, supports the presence or these resistance types. Although, it should be noted that 
this link cannot be directly established through metabolite levels since the metabolite levels 
of a knock-down state would not be representative of a wild type profile. Nevertheless, both 
in knock-down and wild type resistance states, similar pathways would be active and over-
represented. 
 
In this chapter, metabolic profiles of resistant and susceptible wild type An. gambiae and Ae. 
aegypti were compared during pupal and adult stages. For both pupal and adult 
comparisons, the metabolic differences between resistant and susceptible strains were 
observable through NMR metabolomics. In both An. gambiae and Ae. aegypti datasets, 
metabolic profile differences attributable to resistance status in PCA scores were more 
noticeable in pupae than in adults. In Ae. aegypti, cluster separation attributable to 
resistance status corresponded to 48.21% explained cumulative variance in pupae, while in 
adults this was 42.31%. Such high explained variation indicates a robust PLS-DA model with 
high accuracy. All data wild type models scored accuracy ranging from 64.29%-100%, 
whereas models built on selected metabolites scored a narrower range of 85.71%-93.75% 
 233 
showing the selection of metabolites captured the differences between resistant and 
susceptible strains. Using the metabolites selected from the PLS-DA models of pupae and 
adults, MSEA was performed in order to gain insight on the differences between resistant 
and susceptible strains at a pathway level. Common pathways over-represented between 
pupae and adults were: carbon metabolism, biosynthesis of amino acids, aminoacyl-tRNA 
biosynthesis, and 2-oxocarboxylic acids metabolism. In Chapter 4, the same set of pathways 
were identified in the comparison between knock-down and control strains. These pathways 
were attributed to the production of CHC in the knock-down An. gambiae (Section 4.6). 
Identification of these pathways in the MSEA comparison of resistant and susceptible strains 
of wild type An. gambiae might suggest the presence of CHC resistance in An. gambiae and 
in the VK7 strain of Ae. aegypti, which was suggested through transcriptomics studies [213], 
[214]. 
 
Compared to the previous section in this thesis wild type An. gambiae and Ae. aegypti 
showed great agreement between the pupae and adults of the same species. In An. gambiae 
threonine and lactate was significantly lower in resistant pupae and adults. Meanwhile 
propionate, oxypurinol, and trehalose was significantly higher in resistant pupae and adults. 
Surprisingly in Ae. aegypti the same list of agreeing metabolites is quite different with 
methanol, pyruvate, and oxypurinol is significantly lower while alanine, tyrosine, glucose, and 
trehalose is significantly higher. Between An. gambiae and Ae. aegypti xanthine levels are 
significantly higher and lower respectively. Although, MSEA result did not show any pathways 
related xanthine. It is possible that metabolites found together with xanthine might be some 
of the unidentified metabolites in the dataset. Interestingly, regardless of the dissimilar list 
of metabolites, MSEA resulted with pathways that are over-represented between resistant 
and susceptible strains of both species. Glycolysis/gluconeogenesis and its vicinity pathways 
glycine, serine and threonine metabolism; and 2-oxocarboxylic acid degradation were 
significantly over-represented between resistant and susceptible strains of pupal An. 
gambiae and Ae. aegypti. For adults MSEA results were more clustered around amino acids. 
The pathways over-represented in adults were tyrosine metabolism, amino acid 
biosynthesis, and phenylalanine metabolism. Although, the metabolite list may not have high 
agreement between the species, there are clear structure in them. This kind of data is 
typically amenable to statistical modelling. Unfortunately, these two datasets do not have 
identical set of bins. Thus, creating a merged dataset with proper verification of would be 
better suited for future work. Nevertheless, the data suggest that between resistant 
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susceptible strains of these species, trehalose an important metabolite for energy generation 
and protection against desiccation is the only constantly changing metabolite. 
 
Trehalose being significantly higher in resistant strains (pupae and adult) of An. gambiae and 
Ae. aegypti, which may be instrumental in identifying resistant and susceptible species in the 
wild type populations. In An. gambiae, the mean relative intensities recorded for the selected 
trehalose bins ranged from 2.98 x 108 to 3.59 x 108 in pupae and in adults from 6.21 x 108 to 
8.68 x 108 between susceptible and resistant strains. Values recorded for the Ae. gambiae 
strains were from 8.99 x 108 to 10.3 x 108 in pupae and from 11.0 x 108 to 12.8 x 108 in adults. 
When univariate tests were performed, these mean values were found to be significantly 
higher in resistant species, even after multiple test adjustments. This shows that regardless 
of how close these values might be, the variation within the strains is narrow enough to be 
statistically significant, thus indicating trehalose as a putative biomarker for identification of 
resistant strains. It should be noted that, although the mean values of trehalose are always 
higher in resistant strains, there isn't a consistency between the range they are higher. This 
means that a classifier threshold of 3.25 x 108 might yield a high accuracy in identification of 
resistant An. gambiae pupae, but the very same value is most likely to class all the adult 
strains as resistant. In order to avoid such cases, one or two or even a combination of 
preventative steps should be taken. These steps could include the use of specific threshold 
levels unique to different species/strains/stages or normalisation of the trehalose 
measurement to another metabolite. Using different thresholds for identification would 
require more testing and the establishment of this level for a variety of different cases, 
although once established this would make the measurements simpler as it would involve 
the measuring of one metabolite instead of multiple. On the other hand, using another 
metabolite for normalisation might make the optimal resistance identification threshold 
more applicable to a variety of species and/or stages. Although using a single value for 
identification is practically easier, more than one metabolite needs to be measured which 
creates an additional step to the method. Furthermore, such a metabolite needs to be similar 
to the trehalose profile in the species/stage it's being normalised in. Hence, any candidate 
metabolite for normalisation ideally should follow the same trend across all strains/stage 
(e.g. all non-significant or all significantly higher/lower but not alternating levels) and have 
similar variation. 
 
Significantly high levels of trehalose may play a critical role in resistant strains from wild type 
populations. Numerous studies [215]–[217] have linked trehalose to a role in desiccation and 
 235 
stress response. As trehalose is the primary sugar in the haemolymph and the main source 
of energy, it is kept at a constant level [210]. When in excess, trehalose is converted to 
glycogen for storage [210]. For this balance to be maintained, trehalose needs to be 
efficiently transported between cells and the haemolymph. This is performed by members 
of the ABC transporter family. From the significantly over-represented MSEA pathways 
between resistant and susceptible strains only one result included trehalose, which is the 
ABC transporters. In this family, trehalose can be transported via four possible transporters 
TreS, TreT, TreU and TreV. Amongst these, TreT type transporters are commonly observed in 
insects. TreT-1 was previously observed in Drosophila melanogaster [218] and in An. gambiae 
[219]. In Ae. aegypti, TreT-1 was inferred from uptake assays [220]. TreT-1 is transmembrane 
transporter and was shown to be activated depending on the H+ levels in a cell or 
haemolymph [221]. It should be noted that this transporter family was only identified for the 
An. gambiae pupae. This is most likely due to the fact that the ABC transporter family is a 
collection of metabolites and transporters. Selected metabolites for the other datasets are 
not comprised of enough metabolites that are members of the ABC transporter ‘pathways’ 
to yield a significant BH adjusted p-value. 
 
Using Tret-1 as an insecticide target may be an efficient approach to develop the next 
generation of insecticides. Targeting Tret-1 is a favourable approach due to its importance in 
mosquitoes and its relative unimportance in vertebrates. Hence, insecticides targeting Tret-
1 potentially could be less or near negligibly toxic for vertebrates. Although, given the 
importance of trehalose in mosquitoes [222], downstream metabolism of trehalose may be 
a more suitable target. After trehalose is exported to the haemolymph, it is broken down in 
to glucose which is then taken up by the cell for energy. Metabolism of trehalose is facilitated 
by one of two trehalase enzymes Tre-1 and Tre-2 [222]. Both of these enzymes hydrolyse 
trehalose into ⍺-D-glucose and a β-D-glucose [222]. The main differences between these two 
enzymes is Tre-1 is the soluble form where it has been identified in haemolymph [223], and 
Tre-2 is a membrane-bound enzyme where it is found on the extracellular side of trehalose 
utilising cells such as flight muscle cells [210]. It has been hypothesised that trehalase activity 
is at least partly regulated by hormones such as the set of hormones collectively called 
‘juvenile hormones’ [224].  
 
An advantage of using trehalose-related insecticides is that trehalose does not play as critical 
a role in vertebrates as it does in insects, hence overcoming toxicity in mammals [225]. 
However, trehalose has been shown to play important roles in plants as well (e.g. protection 
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against desiccation [226] and increased yield [227]), although mechanisms are not fully 
characterised to date. Validoxylamine [228] is an efficient inhibitor of trehalases [229] but 
finding delivery methods for it have proven to be challenging. Due to its polar nature, delivery 
of the inhibitor through the CHC layer made the drug inefficient in applications. Alternatively, 
shifting the focus from mosquitoes to plant-feeding pests; trehalose-related insecticides can 
be delivered systemically. In this way, the drug would be delivered through ingestion, where 




6 General Conclusions 
The main objective of this investigation was to employ nuclear magnetic resonance (NMR) 
metabolomics to advance the field of mosquito metabolomics by increasing understanding 
of insecticide resistance. In order to achieve this, I first established a robust method to 
consistently monitor and compare metabolic profiles in individual mosquitoes (pupae and 
adult). I subsequently compared metabolite profiles of knock-down and control An. gambiae 
probing the cuticular hydrocarbon (CHC) production which plays a critical role in insecticide 
penetration and delivery. Metabolic profiles of wild type An. gambiae and Ae. aegypti with 
pyrethroid resistance were then compared to explore whether conserved pathways were 
affected. 
 
Prior to this work, there was very little known about the metabolite profiles of CHC 
biosynthesis and pyrethroid resistant species (An. gambiae and Ae. aegypti). A great deal of 
work has been undertaken in various insects in order to characterise the mechanism of CHC 
biosynthesis (covered extensively in [78]). Alterations in the cuticular layer of mosquitoes is 
an area that has been gaining more attention due its link to insecticide resistance [74]. 
Mosquito-specific cytochrome P450s, Cyp4g16 and Cyp4g17, have recently been shown to 
play a critical role in CHC biosynthesis pathway [75]. The link between CHC biosynthesis and 
the metabolome has not been studied to date. The need to understand this mechanism in 
greater detail, as well as providing an explanation for other potential (nuanced) contributors 
to insecticide resistance, led to the natural progression of this study to a global approach on 
individual insects at different life stages via NMR metabolomics. 
 
6.1 Summary of thesis findings 
6.1.1 Sex-specific differences vary amongst the mosquito species 
As a part of the data exploration in this project sex-specific differences in mosquitoes were 
investigated. Unexpectedly, these differences were attenuated in the knock-down groups. 
This was interpreted as either an effect of the Gal4/UAS system or an indirect effect on fatty 
acid biosynthesis. On the contrary, in wild type Ae. aegypti these differences were 
accentuated. Unfortunately, the experimental design for this study is not capable to answer 
this question. Furthermore, four metabolites were found to be consistently significantly 
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different between males and females across all comparisons. These metabolites acetate 
(higher in males), lactate (higher in females), propionate (higher in males), and glucose 
(higher in females). These metabolites are mostly known for their roles in energy generation 
and storage. High levels of glucose in females was interpreted as higher potential of both 
energy generation (through glycolysis) and storage (through generation of glycogen). 
Similarly, high lactate is a typical indicator of anaerobic respiration and is converted from 
acetate thus high energy demand. Propanoate metabolism synthesis a wide range of fatty 
acid precursor, thus fluctuations in propionate can be speculated to be an indicator of HCs 
synthesis differences, although this would require a different experimental setup to test.  
 
6.1.2 Cyp4g16 and Cyp4g17 are temporally active decarbonylases with potential specificity 
for branched hydrocarbons 
Supporting evidence of decarbonylase function of Cyp4g16 and Cyp4g17 was shown through 
a GAL4/UAS knock-down model in An. gambiae. By monitoring the precursors metabolites 
of CHC biosynthesis valine, leucine, isoleucine, and acetate activities of Cyp4g16 and Cyp4g17 
were observed. By impairing the CHC production accumulation of precursor metabolites 
were expected. Amongst the precursors, sole accumulation of valine (a branched amino 
acid), showed evidence of both Cyp4g16’s (experimentally shown [75]) and Cyp4g17’s 
(hypothesised) activity as decarbonylases. Furthermore, through the investigation of these 
knock-down strains in pupal and adult stages, their temporal activity was observed. Higher 
valine levels were observed in Cyp4g16 knock-downs of pupae and adults supporting 
evidence for Cyp4g16’s higher activity in pupae [75]. Similarly, an accumulation of valine was 
observed only in the Cyp4g17 adults proposing a higher activity in adults. 
 
6.1.3 Pyrethroid resistant mosquito species have distinct metabolic profiles compared to 
susceptible species 
Lastly, to explore the polar metabolic profiles of resistant strains of An. gambiae and Ae. 
aegypti were investigated. This novel work aimed to give insight on the neglected polar 
metabolic aspect of resistance. By using the pipeline developed in this project. Resistant and 
susceptible strains of An. gambiae and Ae. aegypti were studied as pupae and adults. Both 
species showed great performance in statistical model building allowing for effective 
metabolite selection. It was expected to see relatively similar metabolic profiles between two 
species due to the consistent growth conditions and being bred in the laboratory for many 
years. Although, this was not the case. Interestingly the metabolic profiles between different 
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stages of the same species were very close. This was not observed in the previous 
comparisons (Sex or Cyp4g knock-down). Upon performing MSEA a set of pathways similar 
to Cyp4g knock-downs was obtained. It is known that An. gambiae resistant strain (VK7) 
possessed cuticular resistance. It was expected to see similar set of pathways such as amino 
acid biosynthesis, carbon metabolism, and valine, leucine and isoleucine biosynthesis. This 
observation suggested the presence of cuticular carbon resistance on the Ae. aegypti 
Cayman strain although this requires verification. Perhaps, the most interesting outcome of 
this section is trehalose. This metabolite was found significantly higher across all comparisons 
and were selected by all statistical models. This study proposes trehalose as a potential 
biomarker for identification of resistance. 
 
6.2 Critical evaluation of methods 
6.2.1 Metabolomics and metabolite coverage 
For any study, limitations should be acknowledged. It should be noted that no single 
analytical method can capture the entirety of a metabolic profile [230]. Metabolite coverage 
is one of the main limitations as there are multiple extraction methods widely used in 
metabolomics. For polar metabolites the most common extraction methods are: 
methanol:water (4:1, v:v) [231], acetonitrile:water (1:1, v:v) [189] and 
chloroform:methanol:water (1:1:1, v:v:v) [232]. In this study, the observable metabolites 
were polar metabolites extracted with 50% acetonitrile in water. Any metabolite requiring a 
different extraction procedure would not be detected, such as non-polar compounds. 
Chloroform:methanol:water is typically a two stage extraction method which has the added 
benefit of extracting both polar and non-polar metabolites although this method requires 
aliquoting from two separate layers without disturbing the other layer and is prone to 
inconsistent aliquoting. This, compounded with the fact that focus of this project was on 
polar metabolites, meant this extraction method was not preferred. Between the extraction 
methods of acetonitrile:water  and methanol:water, acetonitrile:water was preferred due to 
its higher metabolite coverage [233]–[236]. It should be noted that acetonitrile:water can 
extract some mobile lipids alongside the polar metabolites. Furthermore, sonication was 
used for homogenisation of the samples which can heat up the samples during the 
homogenisation process. In order to address this problem, sonication was performed on an 
ice bath with 30 s breaks taken in between sonicator pulses. 
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This study utilised NMR as the metabolite detection method of choice. As described (Section 
1.6.5.1), NMR is inherently less sensitive compared to mass spectrometry (MS). However, 
NMR is more reproducible and self-contained as samples do not come in contact with the 
detection probe which makes it virtually impossible for sample cross-contamination during 
data acquisition to occur. It should be noted that ideally these techniques would be used 
together as complementary methods. Unfortunately, for this study this was unfeasible due 
to time and financial constraints, as it is for most studies. 
 
In this study, the scope of observable metabolites was limited to the coverage of 
acetonitrile:water extraction and observation via 700 MHz magnet NMR fitted with an 
inverse cryoprobe. This method does not capture low concentration metabolites (i.e. 
secondary metabolites) or non-polar metabolites. Identification was carried out using an in-
house library, Chenomx and online databases such as biological magnetic resonance bank 
(BMRB). The in-house library has the advantage of standards being acquired on the same 
spectrometer and so better matching between the standards and the samples can be 
achieved. The main disadvantage of the library is its smaller size compared to other libraries. 
External databases (i.e. BMRB) cover a wide range of metabolite spectra, but these spectra 
are acquired under different conditions such as: pH, temperature and magnetic field which 
makes the matching of the spectra a challenging process. Chenomx is currently the ‘gold 
standard’ software for NMR metabolite identification. However, it is better suited for the 
identification of mammalian metabolites, as is the case with most metabolite identification 
software. Although it is more favourable to establish a mosquito metabolome library, this 
would be a great undertaking that would merit a PhD on its own. 
 
6.2.2 Identification of unknowns 
In any untargeted metabolomics approach, unidentified metabolites are a challenge. 
Unidentified metabolites can be categorised as known unknowns and unknown unknowns. 
In an NMR context, a known unknown is easier to deal with than an unknown unknown. A 
known unknown is when all peaks arising from the unknown metabolite are free from 
overlap and are able to be picked out making elucidation of the structure and identification 
of the molecule a possibility. A unknown unknown is when this is not possible since the 
information to elucidate the structure of the metabolite is overlapped beyond deconvolution 
or it is simply not possible to identify all the signals arising from the unknown metabolite. It 
is sometimes possible to recover some information via statistical approaches such as ANOVA 
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or t-test as one would expect a significantly different unknown bin would have all other bins 
associated to it to be also significantly different. Although this is true in certain cases, such 
as when a great percentage of bins are identified, usually it is not the case in the majority of 
NMR metabolomics studies and it is not the case in this one. 
 
In this project, two distinctly different datasets were used (An. gambiae and Ae. aegypti) and 
within these species' datasets, only metabolite levels were fluctuating. For the An. gambiae 
dataset, only 107 out of 496 (21.57%) bins were identified, leaving 389 bins to be classed as 
unknown unknowns. For the Ae. aegypti dataset, 111 out of 517 (21.47%) bins were 
identified, leaving 406 unidentified. Excluding the possible overlaps, theoretically this can 
represent any number of compounds between 1-389 for An. gambiae and 1-406 for Ae. 
aegypti. Unfortunately, due to the large quantity of unidentified bins, the possible bin 
combinations would not be able to be deconvoluted with the significance shown by ANOVA 
or t-test. Furthermore, due to the multiple comparisons performed, a p-value adjustment 
would have to be carried out prior to making assumptions for the grouping of bins. Given the 
large number of comparisons, some bins, especially overlapping ones, may score higher than 
0.05 while other bins from the same molecule may be scoreless or vice versa. Additionally, 
similar significant differences from different molecules may be wrongly interpreted as one 
metabolite. Subsequently, to be more conservative, this approach was not considered in this 
project. 
 
Nevertheless, it is not impossible to identify the unknowns. In order to identify unknowns, a 
more natural products approach can be taken. This requires the use of various 
chromatographical methods to either isolate or simplify the complexity of a sample which 
can then be analysed using a combination of NMR and MS. Using a variety of NMR 
experiments (HSQC, HMBC, TOCSY, COSY, DEPT45 and DEPT135), almost all isolated 
compounds, or even simplified mixtures of two to five compounds, can be identified and 
verified via MS. Meanwhile, MS can identify a great deal of low concentration compounds 
which may not be detectable by NMR. 
 
6.2.3 Relative quantification over absolute quantification 
One of the core properties of a metabolomics study is the quantification of metabolites, be 
it relative or absolute. Within the most popular metabolomics platforms of NMR and MS, 
NMR is more amenable for quantification. Besides the obvious method of using a calibration 
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curve, NMR can exploit signal intensities being directly proportional to compound 
concentration, yielding absolute quantification without a calibration curve. This is typically 
done in one of two ways on 1H spectra. 
 
The first method uses an internal standard in the sample. Commonly used NMR internal 
standards include; trimethylsilylpropionate (TSP), trimethylsilylpropanesulfonate (DSS), and 
trimethylsilane (TMS). Typically, the internal standard chosen will resonate in a region where 
molecules of interest do not resonate. This allows the integration of the internal standard 
without the worry of signal overlap. Once the signals arising from the molecule of interest 
are assigned and integrated, both molar ratios of the internal standard and the molecule of 
interest can be calculated and extrapolated to absolute quantification with the additional 
knowledge of molecular weight and sample volume. 
 
The second method is perhaps the most convenient method and is known as electronic 
reference to access in vivo concentrations (ERETIC). This method requires the preparation of 
an external standard sample with known concentration. This external sample is then 
measured separately from the measurement of the molecule of interest. Benefiting from the 
consistency of NMR measurement, the spectral information of the external standard can be 
used to quantify the molecule of interest. A caveat to this method is, the external standard 
needs to be prepared in the same way as the molecule of interest and data acquisition needs 
to be performed under identical conditions if possible, or near identical with the trade-off of 
accuracy. 
 
These methods are simple and effective for pure or near pure compounds. However, 
metabolomics data is often with noise, many overlaps, and sometimes with shimming or 
baseline issues which can affect absolute quantification. Integration of non-overlapping 
samples with good integration regions is not a common occurrence in NMR metabolomics 
data, hence using a relative quantification can be done without the worry of searching for 
the perfect signal. Furthermore, relative quantification allows the use of unidentified signals 
and so the entire dataset can be used. When using an absolute quantification method, all 
unidentified metabolites need to be discarded prior to data analysis. In this project, due to 
the very low number of identified metabolites and high overlapping signals, relative 




Due to the nature of the samples, a considerable number of samples failed the QC criteria. 
As a result of this, pupae dataset comparison of knock-down strains were lower powered, 
which decreased the accuracy in the models.  
 
One of the limitations in this project was the use of only a loss of function model rather than 
being able to also analyse data from a gain of function system, for example by Cyp4g 
overexpression. An over-expression model would have provided a system to compare and 
verify the results obtained with the RNAi knockdown results. However, both Cyp4g16 and 
Cyp4g17 enzymes are already highly expressed in the wild type susceptible mosquitoes [188], 
and when overexpression was examined using the available oenocyte driver (Gareth), no 
significant increase in Cyp4g protein was observed (personal communication with Dr Gareth 
Lycett). For example, in order to increase the expression level of these enzymes two-fold, a 
Gal4 line would be required that could drive expression at a similar level to the native Cyp4g 
proteins. No such driver is available though. In contrast, RNA interference (RNAi) is 
significantly more efficient due to the fact that a single dsRNA is capable of knocking down 
many transcripts. Since over-expression was not feasible, investigation of metabolic 
consequences on CHC biosynthesis through knocking down of Cyp4g16 and Cyp4g17 was the 
only option. 
 
The wild type species used in this study were collected from different geographical locations. 
A caveat is that the resistance status and metabolic differences caused by different 
geographical backgrounds cannot be deconvoluted. In this study, it is assumed that any 
metabolic differences originating from geographical origins are negligible as a consequence 
of laboratory breeding over years (An. gambiae > 5 years and Ae. aegypti > 8 years). 
 
6.2.5 Statistics 
As a multivariate data type, metabolomics data should be analysed largely using multivariate 
statistics that can be complemented with univariate testing. There are examples in the 
literature [237] in which univariate testing is used as a way to reduce dimensionality by 
selecting significant variables. However, with multivariate data, there are a great number of 
comparisons. Subsequently, following p-value correction for multiple testing, a great deal of 
power is lost in the study. Furthermore, univariate methods are not designed to capture the 
relations between variables otherwise explained with multivariate methods. 
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In this thesis, a combination of multivariate transformations (i.e. PCA) and multivariate 
modeling (i.e. PLS-DA) have been used to analyse the differences between the groups of 
study and to select the most relevant metabolites that explain such differences. PCA, as an 
unsupervised method, poses little controversy towards its use and interpretation. Hence, 
PCA was used as a data exploration tool during the analysis and not for metabolite selection. 
 
However, supervised methods such as PLS-DA use information about the groups to maximise 
differences producing a predictive model. Although used as a technique to show differences 
between treatments, the resulting model can also be used to assign new data samples to 
groups in the data that the model was built on. The latter has not been used in this thesis. 
However, the validity of the models needs to be considered when interpreting the results. 
 
The number of variates that these models are built on can vary. Typically, use of more 
variates increases the accuracy. However, more noise associated with the data is also 
incorporated to the model, causing overfitting. Thus, it is imperative to use cross-validation 
methods to check and minimise overfitting during the model building process. The ideal 
approach uses rounds of validation and testing with different parts of the data: splitting of 
data into three parts (typically 60%, 20% and 20%): 60% used to train a model, 20% to 
validate it and the last 20%, never used to build any model, to test the model. Although the 
ideal, this approach requires a large amount of data which is unfeasible for this study. Thus, 
for this particular project, the data was split in a 70% and 30% manner as train and test data. 
Cross-validation was used to select the optimal number of variables to retain for the model 
using all the data. Data availability is a common shortcoming in biological studies and as such 
there are multiple examples in the literature in which this approach has been undertaken 
[238], [239]. 
 
Another limitation to discuss includes the choice of modelling approach. PLS-DA is the 
predominant method used to analyse metabolomics datasets due to its availability in 
different statistical packages, the ability to analyse highly collinear data and its ease of 
interpretation, relatable to original biological entities. However, it might not necessarily be 
the most adequate method [240]. Other common methods applied are random forest (RF) 
and support vector machine (SVM). Both statistical approaches are great and have their 
advantages. For example, RF is based on decision trees which are very intuitive to 
understand, and RF is a large number of decision trees created from randomly selected 
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variables (giving the name random forest). When RF models used in prediction each decision 
tree proposes a classification for the input data and the final result is generated through a 
voting process. This approach brings an inherited randomisation to the model making it more 
resistant to over-fitting of the data. On the down side, highly collinear data (such as NMR 
data) can introduce an unintentional bias during the randomised decision tree building 
process. In order to avoid such incident number of decision trees can be increased but this 
would come with a cost of computation, and harder interpretation of the model. Due to the 
nature of the model it may be more suitable for MS data where collinearity exist to a lesser 
degree. Ideally, new statistical methods, still to be developed, would address the typical 
problems in metabolomics research such as lower number of samples than variables in the 
dataset and allow for some of the above limitations to be addressed. In this thesis, PLS-DA 
was used because of all of the above advantages, coupled with relatively good results that 
can be contextualised within the literature. 
 
In this project, data acquisition was performed mainly via 1H-NMR where, depending on the 
molecular structure, a metabolite can be represented by a single peak or more. This property 
of NMR can sometimes be a limitation as well as an advantage. Multiple signals representing 
a molecule give confidence and redundancy in data. On the other hand, selecting 
important/influential features from statistical models becomes more complicated. In this 
project, a scoring system was created based on the correlation of NMR signals, termed the 
correlation reliability score (CRS). Using this scoring system, the best representative peak for 
the molecule in the analysis was selected. A caveat to this scoring system is that it is only 
useful for molecules with multiple peaks that are assigned to a molecule. This is because 
singlets will always score 100% correlation with themselves and it is virtually impossible to 
deconvolute a molecule’s NMR signature solely based on correlation in a complex mixture. 
 
6.2.6 Pathway analysis 
Metabolomics studies often search for changes in pathways, typically performed by various 
methods collectively called pathway analyses. The majority of these pathway methods, 
especially of the enrichment type, use Fisher's exact test. In a pathway analysis context, this 
test calculates the probability of a set of selected metabolites belonging to another set of 
metabolites of a pathway. The resulting probabilities are then compared to a significance 
threshold, typically α=0.05. The results deemed significant are then accepted as significantly 
changing pathways. Unfortunately, this general practice can often be misleading. Any form 
 246 
of pathway analysis based on Fisher's exact test or other network methods, such as 
betweenness centrality, can only give clues about a pathway. Furthermore, due to the highly 
dynamic nature of metabolic pathways, the quantification of a pathway down to a single 
value in order to use it in comparisons to be significantly higher or lower is not appropriate. 
Results obtained from a metabolite set enrichment analysis (MSEA) should be taken as leads 
to follow up on. If the goal of the study is to explore and discover pathways in fine detail, 
methods such as metabolic flux analysis or a combination of in vitro and in vivo biochemical 
experiments to show evidence for particular reactions would be better suited. In this project, 
MSEA was used as a lead as to which pathways might be affected under given experimental 
conditions. The final conclusions were drawn from the data presented and information 
available in the literature and not solely on MSEA results. 
 
6.3 Contributions to the field 
6.3.1 Bin selection for NMR data 
In metabolomics research, variable selection from a statistical model is a cornerstone of the 
method. In mass spectrometry platforms, this can be achieved directly from the model with 
variable selection methods (e.g. variable importance of the projection). Due to the nature of 
NMR data, a metabolite can be represented by multiple bins depending on the molecular 
structure. When a variable selection method is applied, metabolites with multiple bins often 
contribute with multiple variates. In order to simplify the data, a representative bin is 
required. Currently, there is no method to account for this systematically. In this work, a 
scoring system, CRS, was developed. CRS is calculated from the correlation of a metabolite 
bin to the remaining bins of the same metabolite. This provides a systematic and objective 
approach to select a representative bin for a metabolite with multiple bin signature (i.e. 
multiple peaks observable in the 1D 1H-NMR spectrum). 
 
6.3.2 Biomarker candidates for sex difference in An. gambiae and Ae. aegypti targeted at 
energy and energy storage mechanisms 
By comparing the metabolic profiles of male and female mosquitoes in pupal and adult 
stages, a set of metabolites were identified that were consistently distinct across different 
stages and species. These metabolites, namely glucose, propionate, lactate, and acetate, 
predominantly take part in energy and energy storage mechanisms in mosquitoes. As 
hypothesised, female mosquitoes require higher levels of energy in order to meet the high 
energy requirements for finding a blood meal, oogenesis, and oviposition. Furthermore, 
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these metabolites can be optimised to give an accurate identification of sex through 
metabolic profiling. As for application, such information can be integrated in large scale 
studies of a metabolomics nature where great numbers of mosquitoes can be collected and 
extracted rapidly, and sexing can be integrated in to the biochemical analysis. Additionally, it 
can be used as a secondary confirmation for the traditional sexing of mosquitoes or 
elucidating sample sex information for extracted legacy samples. 
 
6.3.3 Cyp4g16 and Cyp4g17 catalyse predominantly branched alkanes and 2-
methylbranched alkanes in An. gambiae. 
Prior to this study, only Cyp4g16’s decarbonylation function was shown through expression 
[75] and Cyp4g17’s function was only observed through expression in D. melanogaster [186]. 
By employing NMR metabolomics, further evidence has been raised for Cyp4g16’s and 
Cyp4g17’s function in An. gambiae. In addition, the activity of these two enzymes in relation 
to developmental stage was shown (Cyp4g16: early pupa and early adult and Cyp4g17: early 
adult). 
 
6.3.4 VK7 strain of An. gambiae show evidence of cuticular hydrocarbon resistance in 
metabolomics analysis 
VK7 strain of An. gambiae has been identified to have cuticular resistance in previous studies 
[213], [214]. In this study, supporting information of cuticular resistance through pathways 
identified in resistant and susceptible species and their similarities with the pathways 
identified in knock-down strains of An. gambiae have been shown. 
 
6.3.5 Trehalose as a biomarker candidate for pyrethroid resistant in wild type An. gambiae 
and Ae. aegypti 
Further comparison of wild type An. gambiae and Ae. aegypti has shown trehalose as a 
biomarker which is consistently in higher abundance in resistant strains across pupal and 
adult stages compared to sensitive strains. This information can be utilised as a resistance 
biomarker for quick identification of resistant species. Furthermore, metabolic systems 
relating to trehalose can be exploited as new insecticide targets such as trehalose transporter 
(TreT) and trehalase enzymes (Tre1 and Tre2). 
 
 248 
6.4 Future work 
6.4.1 Metabolomics of CHC for complementary information 
There are a several studies on the cuticular hydrocarbon composition of these knock-downs 
carried out via GC-MS, although none of these studies investigated the HC content within the 
mosquito. A metabolomics study targeting these HCs can further inform on the changes in 
the final products of Cyp4g16 and Cyp4g17. 
 
6.4.2 Mosquito metabolite library 
One of limitations in this project was the absence of a mosquito metabolomics library. In 
other fields, these libraries are extensive (e.g. HMDB [241] and livestock metabolome 
database (LMDB) [242]). Establishing a mosquito metabolome database to include 
information such as, metabolite identifications, identification method and associated data, 
location concentration ranges, associated pathways to existing databases, would greatly 
benefit entometabolomics. Since such a database will be built from ground up it is imperative 
to design this database with an API structure for easy integration with scripts and software. 
 
6.4.3 Verification of biomarkers for sexing An. gambiae and Ae. aegypti 
Using the biomarker candidates for sexing of An. gambiae and Ae. aegypti, a study should be 
carried out in order to validate and establish the concentration boundaries on field strain 
mosquitoes. 
 
6.4.4 Characterisation of Cyp4g16 and Cyp4g17 decarbonylation. 
With the growing evidence regarding Cyp4g16 and Cyp4g17 function in HC production, a 
biophysical characterisation of these enzymes would be beneficial in order to fully 
understand their roles and importance in CHC biosynthesis. A detailed pathway analysis 
could be further elucidated using a multi-omics approach combining transcriptomics and 
proteomics information. It should be noted that this multi-omics approach would be costly 
and considering the low concentrations, a different experimental design involving pooled 
cohorts could be explored. 
 
Furthermore, elucidating the molecular structures of these enzymes would contribute a 
great deal of insight to the biophysics characterisation process, especially in identifying the 
associated potential ligands. Starting with Cyp4g16 is recommended since its expression has 
shown it to be relatively easier compared with Cyp4g17 [75]. Cyp4g16 and Cyp4g17 are 
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approximately 64 KDa so an approach utilising X-ray crystallography and/or homology 
modelling would be most appropriate. 
 
6.4.5 Testing and verification of the potential resistance biomarker trehalose 
This study proposed trehalose (higher in resistant strains) as a biomarker for resistance. A 
follow up pilot study to validate the trehalose as a biomarker needs to be conducted. This 
study should be designed as a field study and aim to establish the necessary trehalose 
measurement and threshold (trehalose per body mass or trehalose ratio to another 
metabolite) for identification of resistant strains. Additionally, a broader verification of 
trehalose as a resistance biomarker should be performed on the R and S forms of An. 
gambiae. If this study requires a secondary metabolite for normalisation, three possible 
metabolites can be proposed from this thesis. Changes in these metabolites were not 
significant and not selected by the PLS-DA models as discriminating: xanthine (adults only), 
succinate (pupa only) and glutamine(both). 
 
6.5 Final remarks 
In this novel study, NMR metabolomics’ capabilities were pushed by investigating insecticide 
resistance in mosquitoes. A pipeline was built and used in the metabolic profiling of different 
sexes, knock-downs (Cyp4g16 & Cyp4g17), and different species of resistant and susceptible 
mosquitoes. This pipeline focused on analysis of polar metabolites of a relative quantitation 
nature led to the development of CRS. A tool to select a representative bin from multiple 
NMR signal, thus simplifying the analysis data. Furthermore, despite the encountered low 
sample number and identified metabolites evidence on the function of Cyp4g17 as a 
decarbonylase was shown. Additionally, sex-specific metabolic differences were reported. 
Lastly, for the first time resistant and susceptible mosquito species’ polar metabolome was 
compared presenting consistent trends between resistance statuses. 
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Appendix 1: Pattern file for Anopheles and Aedes datasets. WT and knock-down Anohpeles datasets use the same 
pattern file. Also, pupa and adult stages use the same pattern file of the same group. UNID: unidentified; NA: Not 
applicable. 
Right [ppm] Left [ppm] Anopheles bins Aedes bins 
0.8769 0.9021 UNID.1 UNID.1 
0.9316 0.9349 Isoleucine.2 Isoleucine.2 
0.9349 0.9386 UNID.3 UNID.3 
0.9412 0.9469 Isoleucine.4 Isoleucine.4 
0.9521 0.9550 UNID.5 UNID.5 
0.9526 0.9658 UNID.6 UNID.6 
0.9658 0.9824 UNID.7 UNID.7 
0.9883 1.0032 Valine.8 Valine.8 
1.0077 1.0238 Isoleucine.9 Isoleucine.9 
1.0374 1.0437 Valine.10 Valine.10 
1.0437 1.0464 UNID.11 UNID.11 
1.0464 1.0495 Propionate.12 Propionate.12 
1.0495 1.0540 Valine.13 Valine.13 
1.0540 1.0561 UNID.14 UNID.14 
1.0579 1.0600 Propionate.15 Propionate.15 
1.0600 1.0622 UNID.16 UNID.16 
1.0686 1.0726 Propionate.17 Propionate.17 
1.0838 1.1079 UNID.18 UNID.18 
1.1378 1.1396 UNID.20 UNID.20 
1.1396 1.1424 UNID.21 UNID.21 
1.1460 1.1480 UNID.22 UNID.22 
1.1480 1.1498 UNID.23 UNID.23 
1.1498 1.1513 UNID.24 UNID.24 
1.1582 1.1602 UNID.25 UNID.25 
1.1602 1.1643 UNID.26 UNID.26 
1.1643 1.1660 UNID.27 UNID.27 
1.1660 1.1706 UNID.28 UNID.28 
1.1706 1.1733 UNID.29 UNID.29 
1.1733 1.1793 UNID.30 UNID.30 
1.1793 1.1823 UNID.31 UNID.31 
1.1823 1.1903 UNID.32 UNID.32 
1.1903 1.1931 UNID.33 UNID.33 
1.1931 1.1960 UNID.34 UNID.34 
1.1960 1.2006 UNID.35 UNID.35 
1.2006 1.2050 UNID.36 UNID.36 
1.2117 1.2141 UNID.37 UNID.37 
1.2141 1.2207 UNID.38 UNID.38 
1.2207 1.2226 UNID.39 UNID.39 
1.2226 1.2249 UNID.40 UNID.40 
1.2249 1.2278 UNID.41 UNID.41 
1.2278 1.2315 UNID.42 UNID.42 
1.2315 1.2362 UNID.43 UNID.43 
1.2362 1.2409 UNID.44 UNID.44 
1.2409 1.2446 UNID.45 UNID.45 
1.2446 1.2477 UNID.46 UNID.46 
1.2584 1.3239 UNID.48 UNID.48 
1.3239 1.3278 Lactate.49 Lactate.49 
1.3278 1.3319 Threonine.50 Theronine.50 
1.3319 1.3377 Lactate.51 Lactate.51 
1.3377 1.3400 Threonine.52 Theronine.52 
1.4381 1.4448 UNID.53 UNID.53 
1.4448 1.4536 UNID.54 UNID.54 
1.4536 1.4574 UNID.55 UNID.55 
1.4574 1.4609 UNID.56 UNID.56 
1.4609 1.4684 UNID.57 UNID.57 
1.4732 1.4925 Alanine.58 Alanine.58 
1.4981 1.5369 UNID.59 UNID.59 
1.6322 1.6393 UNID.60 UNID.60 
1.6393 1.6432 UNID.61 UNID.61 
1.6432 1.6491 UNID.62 UNID.62 
1.6491 1.6529 UNID.63 UNID.63 
1.6529 1.6584 UNID.64 UNID.64 
1.6584 1.6626 UNID.65 UNID.65 
1.6626 1.6679 UNID.66 UNID.66 
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1.6679 1.6731 UNID.67 UNID.67 
1.6779 1.6856 UNID.68 UNID.68 
1.6856 1.6914 UNID.69 UNID.69 
1.6914 1.6963 UNID.70 UNID.70 
1.6963 1.7026 UNID.71 UNID.71 
1.7026 1.7077 UNID.72 UNID.72 
1.7077 1.7109 UNID.73 UNID.73 
1.7109 1.7192 UNID.74 UNID.74 
1.7192 1.7275 UNID.75 UNID.75 
1.7275 1.7312 UNID.76 UNID.76 
1.7312 1.7364 UNID.77 UNID.77 
1.7364 1.7412 UNID.78 UNID.78 
1.7414 1.7463 UNID.79 UNID.79 
1.7463 1.7503 UNID.80 UNID.80 
1.7503 1.7536 UNID.81 UNID.81 
1.7536 1.7561 UNID.82 UNID.82 
1.7561 1.7603 UNID.83 UNID.83 
1.7603 1.7646 UNID.84 UNID.84 
1.7646 1.7698 UNID.85 UNID.85 
1.7698 1.7725 UNID.86 UNID.86 
1.7725 1.7763 UNID.87 UNID.87 
1.7763 1.7822 UNID.88 UNID.88 
1.7822 1.7877 UNID.89 UNID.89 
1.7877 1.7924 UNID.90 UNID.90 
1.7924 1.7985 UNID.91 UNID.91 
1.8115 1.8158 NA UNID.92 
1.8201 1.8228 NA UNID.93 
1.8228 1.8261 NA UNID.94 
1.8261 1.8307 UNID.92 UNID.95 
1.8307 1.8351 NA UNID.96 
1.8351 1.8379 NA UNID.97 
1.8379 1.8429 NA UNID.98 
1.8429 1.8459 UNID.93 UNID.99 
1.8459 1.8504 NA UNID.100 
1.8504 1.8542 NA UNID.101 
1.8542 1.8578 NA UNID.102 
1.8578 1.8618 NA UNID.103 
1.8656 1.8691 NA UNID.104 
1.8421 1.8474 NA UNID.105 
1.8658 1.8702 UNID.94 UNID.106 
1.8749 1.8821 UNID.95 UNID.107 
1.8835 1.8888 UNID.96 UNID.108 
1.8888 1.8916 UNID.97 UNID.109 
1.8916 1.8970 UNID.98 UNID.110 
1.8970 1.9017 UNID.99 UNID.111 
1.9017 1.9112 UNID.100 UNID.112 
1.9112 1.9168 UNID.101 UNID.113 
1.9168 1.9228 Acetate.102 Acetate.114 
1.9228 1.9267 UNID.103 UNID.115 
1.9267 1.9312 UNID.104 UNID.116 
1.9312 1.9349 UNID.105 UNID.117 
1.9349 1.9423 UNID.106 UNID.118 
1.9423 1.9450 UNID.107 UNID.119 
1.9554 1.9617 UNID.108 UNID.120 
1.9711 1.9774 UNID.109 UNID.121 
1.9899 1.9977 UNID.111 UNID.123 
1.9977 2.0010 UNID.112 UNID.124 
2.0010 2.0055 UNID.113 UNID.125 
2.0055 2.0076 UNID.114 UNID.126 
2.0076 2.0099 UNID.115 UNID.127 
2.0099 2.0114 UNID.116 UNID.128 
2.0114 2.0161 UNID.117 UNID.129 
2.0161 2.0795 Glutamate.118 Glutamate.130 
2.0795 2.0833 UNID.119 UNID.131 
2.0833 2.0861 UNID.120 UNID.132 
2.0861 2.0879 UNID.121 UNID.133 
2.0879 2.0895 UNID.122 UNID.134 
2.0895 2.0912 UNID.123 UNID.135 
2.0912 2.0959 UNID.124 UNID.136 
2.0959 2.1048 UNID.125 UNID.137 
2.1092 2.1666 Glutamate.Glutamine.126 Glutamate.Glutamine.138 
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2.1666 2.1688 Propionate.127 Propionate.139 
2.1688 2.1773 Glutamine.128 Glutamine.140 
2.1773 2.1917 Propionate.129 Propionate.141 
2.1983 2.2026 Propionate.130 Propionate.142 
2.2323 2.2389 Glutamine.131 Glutamine.143 
2.2389 2.3040 Valine.132 Valine.144 
2.3091 2.3119 UNID.133 UNID.145 
2.3119 2.3169 UNID.134 UNID.146 
2.3169 2.3202 Glutamate.135 Glutamate.147 
2.3202 2.3235 UNID.136 UNID.148 
2.3235 2.3268 UNID.137 UNID.149 
2.3268 2.3654 Glutamate.138 Glutamate.150 
2.3654 2.3688 Pyruvate.139 Pyruvate.151 
2.3688 2.3730 Glutamate.140 Glutamate.152 
2.3730 2.3786 UNID.141 UNID.153 
2.3786 2.3950 Glutamate.142 Glutamate.154 
2.3950 2.4009 UNID.143 UNID.155 
2.4009 2.4132 Succinate.144 Succinate.156 
2.4132 2.4205 UNID.145 UNID.157 
2.4205 2.4242 UNID.146 UNID.158 
2.4242 2.4309 UNID.147 UNID.159 
2.4309 2.4345 UNID.148 UNID.160 
2.4345 2.4412 UNID.149 UNID.161 
2.4412 2.4453 UNID.150 UNID.162 
2.4453 2.4504 UNID.151 UNID.163 
2.4504 2.4525 UNID.152 UNID.164 
2.4525 2.4555 UNID.153 UNID.165 
2.4596 2.4624 UNID.154 UNID.166 
2.4624 2.4647 UNID.155 UNID.167 
2.4647 2.4682 UNID.156 UNID.168 
2.4700 2.4730 UNID.157 UNID.169 
2.4730 2.4781 UNID.158 UNID.170 
2.4832 2.4866 UNID.159 UNID.171 
2.4866 2.4899 UNID.160 UNID.172 
2.4955 2.5011 UNID.161 UNID.173 
2.5081 2.5128 UNID.162 UNID.174 
2.5146 2.5181 UNID.163 UNID.175 
2.5181 2.5236 UNID.164 UNID.176 
2.5236 2.5574 UNID.165 UNID.177 
2.5574 2.5625 UNID.166 UNID.178 
2.5643 2.5675 UNID.167 UNID.179 
2.5675 2.5713 UNID.168 UNID.180 
2.6343 2.6388 UNID.169 UNID.181 
2.6458 2.6495 UNID.170 UNID.182 
2.6495 2.6570 UNID.171 UNID.183 
2.6570 2.6621 UNID.172 UNID.184 
2.6621 2.6674 UNID.173 UNID.185 
2.6674 2.6791 UNID.174 UNID.186 
2.6791 2.6841 UNID.175 UNID.187 
2.6841 2.6914 UNID.176 UNID.188 
2.6985 2.7092 UNID.177 UNID.189 
2.7092 2.7105 UNID.178 UNID.190 
2.7105 2.7131 UNID.179 UNID.191 
2.7359 2.7399 UNID.180 UNID.192 
2.7399 2.7420 UNID.181 UNID.193 
2.7501 2.7593 UNID.182 UNID.194 
2.7593 2.7619 UNID.183 UNID.195 
2.7876 2.7936 NA UNID.196 
2.7972 2.8052 NA UNID.197 
2.8002 2.8050 UNID.184 UNID.198 
2.8050 2.8101 UNID.185 UNID.199 
2.8167 2.8201 UNID.186 UNID.200 
2.8258 2.8304 UNID.187 UNID.201 
2.8304 2.8334 UNID.188 UNID.202 
2.8334 2.8362 UNID.189 UNID.203 
2.8441 2.8481 UNID.190 UNID.204 
2.8481 2.8519 UNID.191 UNID.205 
2.8558 2.8602 UNID.192 UNID.206 
2.8675 2.8852 UNID.193 UNID.207 
2.9178 2.9227 UNID.194 UNID.208 
2.9227 2.9269 UNID.195 UNID.209 
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2.9382 2.9496 UNID.196 UNID.210 
2.9636 2.9731 UNID.197 UNID.211 
2.9868 2.9922 UNID.198 UNID.212 
2.9979 3.0024 UNID.199 UNID.213 
3.0024 3.0068 UNID.200 UNID.214 
3.0068 3.0131 UNID.201 UNID.215 
3.0131 3.0188 UNID.202 UNID.216 
3.0188 3.0235 UNID.203 UNID.217 
3.0235 3.0343 UNID.204 UNID.218 
3.0343 3.0411 UNID.205 UNID.219 
3.0411 3.0434 UNID.206 UNID.220 
3.0434 3.0487 Tyrosine.207 Tyrosine.221 
3.0487 3.0510 UNID.208 UNID.222 
3.0510 3.0545 UNID.209 UNID.223 
3.0545 3.0601 Tyrosine.210 Tyrosine.224 
3.0601 3.0644 UNID.211 UNID.225 
3.0644 3.0723 Tyrosine.212 Tyrosine.226 
3.0723 3.0760 UNID.213 UNID.227 
3.0760 3.0823 Tyrosine.214 Tyrosine.228 
3.0823 3.0858 UNID.215 UNID.229 
3.0885 3.0934 UNID.216 UNID.230 
3.1007 3.1050 UNID.217 UNID.231 
3.1077 3.1103 UNID.218 UNID.232 
3.1175 3.1204 UNID.219 UNID.233 
3.1204 3.1250 UNID.220 UNID.234 
3.1250 3.1284 UNID.221 UNID.235 
3.1284 3.1332 UNID.222 UNID.236 
3.1351 3.1378 UNID.223 UNID.237 
3.1378 3.1556 UNID.224 UNID.238 
3.1584 3.1779 UNID.225 UNID.239 
3.1779 3.1851 UNID.226 UNID.240 
3.1851 3.2015 Tyrosine.227 Tyrosine.241 
3.2015 3.2050 UNID.228 UNID.242 
3.2050 3.2093 UNID.229 UNID.243 
3.2093 3.2141 Tyrosine.230 Tyrosine.244 
3.2141 3.2169 UNID.231 UNID.245 
3.2169 3.2210 Tyrosine.232 Tyrosine.246 
3.2210 3.2284 UNID.233 UNID.247 
3.2284 3.2329 UNID.234 UNID.248 
3.2329 3.2359 UNID.235 UNID.249 
3.2359 3.2540 Glucose.236 Glucose.250 
3.2540 3.2563 UNID.237 UNID.251 
3.2563 3.2603 UNID.238 UNID.252 
3.2603 3.2655 Glucose.239 Glucose.253 
3.2655 3.2700 UNID.240 UNID.254 
3.2700 3.2734 UNID.241 UNID.255 
3.2734 3.2758 UNID.242 UNID.256 
3.2758 3.2789 UNID.243 UNID.257 
3.2789 3.2810 UNID.244 UNID.258 
3.2810 3.2866 UNID.245 UNID.259 
3.2866 3.2924 UNID.246 UNID.260 
3.2924 3.2983 UNID.247 UNID.261 
3.2983 3.3021 Tryptophan.248 Tryptophan.262 
3.3021 3.3053 UNID.249 UNID.263 
3.3053 3.3086 UNID.250 UNID.264 
3.3086 3.3137 Tryptophan.251 Tryptophan.265 
3.3191 3.3231 Tryptophan.252 Tryptophan.266 
3.3231 3.3265 UNID.253 UNID.267 
3.3265 3.3294 UNID.254 UNID.268 
3.3294 3.3376 Tryptophan.255 Tryptophan.269 
3.3376 3.3429 UNID.256 UNID.270 
3.3429 3.3475 UNID.257 UNID.271 
3.3475 3.3551 UNID.258 UNID.272 
3.3551 3.3595 UNID.259 UNID.273 
3.3595 3.3638 Methanol.260 Methanol.274 
3.3638 3.3702 UNID.261 UNID.275 
3.3702 3.3865 UNID.262 UNID.276 
3.3865 3.3908 UNID.263 UNID.277 
3.3908 3.3962 Glucose.264 Glucose.278 
3.3962 3.4021 UNID.265 UNID.279 
3.4021 3.4044 UNID.266 UNID.280 
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3.4044 3.4086 Glucose.267 Glucose.281 
3.4086 3.4131 UNID.268 UNID.282 
3.4131 3.4182 UNID.269 UNID.283 
3.4182 3.4235 Glucose.270 Glucose.284 
3.4235 3.4272 UNID.271 UNID.285 
3.4272 3.4287 UNID.272 UNID.286 
3.4287 3.4313 UNID.273 UNID.287 
3.4313 3.4385 Glucose.274 Glucose.288 
3.4385 3.4449 Trehalose.275 Trehalose.289 
3.4449 3.4516 Glucose.276 Glucose.290 
3.4516 3.4560 Trehalose.277 Trehalose.291 
3.4560 3.4599 Glucose.Trehalose.278 Glucose.Trehalose.292 
3.4599 3.4678 Glucose.279 Glucose.293 
3.4678 3.4714 Glucose.Trehalose.280 Glucose.Trehalose.294 
3.4714 3.4770 Glucose.281 Glucose.295 
3.4770 3.4828 Glucose.Tryptophan.282 Glucose.Tryptophan.296 
3.4828 3.4850 Glucose.283 Glucose.297 
3.4850 3.4898 Tryptophan.284 Tryptophan.298 
3.4898 3.4984 Glucose.285 Glucose.299 
3.4984 3.5071 Tryptophan.286 Tryptophan.300 
3.5071 3.5102 Glucose.287 Glucose.301 
3.5162 3.5217 UNID.288 UNID.302 
3.5262 3.5312 Glucose.289 Glucose.303 
3.5312 3.5335 UNID.290 UNID.304 
3.5335 3.5375 Glucose.291 Glucose.305 
3.5407 3.5520 Glucose.292 Glucose.306 
3.5580 3.5600 UNID.293 UNID.307 
3.5600 3.5643 UNID.294 UNID.308 
3.5643 3.5706 Glycine.295 Glycine.309 
3.5706 3.5750 UNID.296 UNID.310 
3.5750 3.5779 UNID.297 UNID.311 
3.5779 3.5838 UNID.298 UNID.312 
3.5838 3.5932 Threonine.299 Theronine.313 
3.5932 3.5968 UNID.300 UNID.314 
3.5968 3.6017 UNID.301 UNID.315 
3.6017 3.6045 UNID.302 UNID.316 
3.6045 3.6098 UNID.303 UNID.317 
3.6098 3.6188 Valine.304 Valine.318 
3.6188 3.6230 UNID.305 UNID.319 
3.6245 3.6280 UNID.306 UNID.320 
3.6280 3.6302 UNID.307 UNID.321 
3.6302 3.6333 UNID.308 UNID.322 
3.6333 3.6371 UNID.309 UNID.323 
3.6371 3.6418 UNID.310 UNID.324 
3.6418 3.6505 Trehalose.311 Trehalose.325 
3.6505 3.6559 UNID.312 UNID.326 
3.6559 3.6588 Trehalose.313 Trehalose.327 
3.6588 3.6619 UNID.314 UNID.328 
3.6619 3.6648 Trehalose.315 Trehalose.329 
3.6648 3.6693 UNID.316 UNID.330 
3.6693 3.6751 UNID.317 UNID.331 
3.6751 3.6804 UNID.318 UNID.332 
3.6804 3.6835 UNID.319 UNID.333 
3.6835 3.6874 UNID.320 UNID.334 
3.6874 3.6940 UNID.321 UNID.335 
3.6940 3.7024 UNID.322 UNID.336 
3.7024 3.7083 Glucose.323 Glucose.337 
3.7083 3.7107 UNID.324 UNID.338 
3.7107 3.7128 UNID.325 UNID.339 
3.7128 3.7164 UNID.326 UNID.340 
3.7164 3.7211 Glucose.327 Glucose.341 
3.7211 3.7268 UNID.328 UNID.342 
3.7268 3.7457 Glucose.329 Glucose.343 
3.7457 3.7506 UNID.330 UNID.344 
3.7506 3.7607 Glutamate.331 Glutamate.345 
3.7607 3.7636 Glucose.Glutamate.332 Glucose.Glutamate.346 
3.7636 3.7688 Trehalose.Glutamine.333 Trehalose.Glutamine.347 
3.7688 3.7716 Glucose.Alanine.Glutamate.334 Glucose.Alanine.Glutamate.348 
3.7716 3.7760 Trehalose.Glutamine.335 Trehalose.Glutamine.349 
3.7760 3.7792 Glutamate.336 Glutamate.350 
3.7792 3.7814 Glucose.Alanine.337 Glucose.Alanine.351 
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3.7814 3.7876 Glucose.338 Glucose.352 
3.7876 3.7898 UNID.339 UNID.353 
3.7898 3.7958 Trehalose.Alanine.340 Trehalose.Alanine.354 
3.7958 3.8000 UNID.341 UNID.355 
3.8000 3.8038 Alanine.342 Alanine.356 
3.8126 3.8157 UNID.343 UNID.357 
3.8157 3.8198 Trehalose.344 Trehalose.358 
3.8198 3.8233 Trehalose.345 Trehalose.359 
3.8233 3.8451 Glucose.Trehalose.346 Glucose.Trehalose.360 
3.8451 3.8486 Glucose.347 Glucose.361 
3.8486 3.8562 Trehalose.348 Trehalose.362 
3.8562 3.8663 Glucose.Trehalose.349 Glucose.Trehalose.363 
3.8663 3.8698 UNID.350 UNID.364 
3.8698 3.8791 Trehalose.351 Trehalose.365 
3.8825 3.8850 UNID.352 UNID.366 
3.8850 3.8881 UNID.353 UNID.367 
3.8881 3.8946 Glucose.354 Glucose.368 
3.9004 3.9049 UNID.355 UNID.369 
3.9049 3.9136 Glucose.356 Glucose.370 
3.9185 3.9228 UNID.357 UNID.371 
3.9228 3.9272 UNID.358 UNID.372 
3.9272 3.9301 UNID.359 UNID.373 
3.9330 3.9559 Tyrosine.360 Tyrosine.374 
3.9604 3.9676 UNID.361 UNID.375 
3.9747 3.9814 UNID.362 UNID.376 
3.9814 3.9836 UNID.363 UNID.377 
3.9836 3.9863 UNID.364 UNID.378 
3.9863 3.9892 UNID.365 UNID.379 
3.9892 3.9944 UNID.366 UNID.380 
3.9944 3.9964 UNID.367 UNID.381 
3.9964 3.9995 UNID.368 UNID.382 
3.9995 4.0016 UNID.369 UNID.383 
4.0016 4.0047 UNID.370 UNID.384 
4.0047 4.0070 UNID.371 UNID.385 
4.0070 4.0101 UNID.372 UNID.386 
4.0101 4.0134 UNID.373 UNID.387 
4.0134 4.0152 UNID.374 UNID.388 
4.0152 4.0173 UNID.375 UNID.389 
4.0173 4.0209 UNID.376 UNID.390 
4.0209 4.0258 UNID.377 UNID.391 
4.0258 4.0307 UNID.378 UNID.392 
4.0307 4.0344 UNID.379 UNID.393 
4.0344 4.0388 UNID.380 UNID.394 
4.0388 4.0409 UNID.381 UNID.395 
4.0409 4.0431 UNID.382 UNID.396 
4.0537 4.0766 Tryptophan.383 Tryptophan.397 
4.0961 4.1219 Lactate.384 Lactate.398 
4.1219 4.1268 UNID.385 UNID.399 
4.1268 4.1296 Lactate.386 Lactate.400 
4.1296 4.1327 UNID.387 UNID.401 
4.1327 4.1354 UNID.388 UNID.402 
4.1354 4.1372 UNID.389 UNID.403 
4.1372 4.1411 UNID.390 UNID.404 
4.1450 4.1505 UNID.391 UNID.405 
4.1566 4.1609 UNID.392 UNID.406 
4.1609 4.1647 UNID.393 UNID.407 
4.1831 4.1916 UNID.394 UNID.408 
4.1916 4.2017 UNID.395 UNID.409 
4.2237 4.2303 UNID.396 UNID.410 
4.2303 4.2356 UNID.397 UNID.411 
4.2356 4.2771 Threonine.398 Theronine.412 
4.2771 4.2830 UNID.399 UNID.413 
4.2830 4.2890 UNID.400 UNID.414 
4.2890 4.2928 UNID.401 UNID.415 
4.2928 4.2954 UNID.402 UNID.416 
4.2954 4.2987 UNID.403 UNID.417 
4.3062 4.3099 UNID.404 UNID.418 
4.3099 4.3122 UNID.405 UNID.419 
4.3122 4.3148 UNID.406 UNID.420 
4.3260 4.3321 UNID.407 UNID.421 
4.3499 4.3560 UNID.408 UNID.422 
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4.3560 4.3637 UNID.409 UNID.423 
4.3637 4.3716 UNID.410 UNID.424 
4.3716 4.3787 UNID.411 UNID.425 
4.3787 4.3854 UNID.412 UNID.426 
4.4352 4.4436 UNID.413 UNID.427 
4.4436 4.4523 UNID.414 UNID.428 
4.4584 4.4722 UNID.415 UNID.429 
4.4722 4.4851 UNID.416 UNID.430 
4.5055 4.5147 UNID.417 UNID.431 
4.5147 4.5232 UNID.418 UNID.432 
4.5622 4.5654 UNID.419 UNID.433 
4.6365 4.6577 Glucose.420 Glucose.434 
4.6577 4.6643 UNID.421 UNID.435 
4.6643 4.6720 UNID.422 UNID.436 
5.1837 5.1925 UNID.423 UNID.437 
5.1925 5.2087 Trehalose.424 Trehalose.438 
5.2326 5.2504 Glucose.425 Glucose.439 
5.3025 5.3843 UNID.426 UNID.440 
5.3843 5.3956 UNID.427 UNID.441 
5.3956 5.4019 UNID.428 UNID.442 
5.4019 5.4078 UNID.429 UNID.443 
5.4078 5.4138 UNID.430 UNID.444 
5.4138 5.4198 UNID.431 UNID.445 
5.4198 5.4294 UNID.432 UNID.446 
5.7048 5.7140 UNID.433 UNID.447 
5.8961 5.9048 UNID.434 UNID.448 
5.9048 5.9146 UNID.435 UNID.449 
5.9146 5.9225 UNID.436 UNID.450 
5.9225 5.9307 UNID.437 UNID.451 
5.9661 5.9768 UNID.438 UNID.452 
5.9768 5.9840 UNID.439 UNID.453 
5.9840 5.9899 UNID.440 UNID.454 
5.9899 5.9970 UNID.441 UNID.455 
6.0355 6.0438 UNID.442 UNID.456 
6.0438 6.0527 UNID.443 UNID.457 
6.0858 6.0931 UNID.444 UNID.458 
6.0931 6.1064 UNID.445 UNID.459 
6.1064 6.1178 UNID.446 UNID.460 
6.1401 6.1468 UNID.447 UNID.461 
6.1468 6.1555 UNID.448 UNID.462 
6.1555 6.1644 UNID.449 UNID.463 
6.5156 6.5279 Fumarate.450 Fumarate.464 
6.6968 6.7295 UNID.451 UNID.465 
6.8891 6.9202 Tyrosine.452 Tyrosine.466 
6.9719 6.9776 NA UNID.467 
6.9856 6.9901 NA UNID.468 
6.9956 7.0048 UNID.453 UNID.469 
7.0434 7.0526 UNID.454 UNID.470 
7.0526 7.0629 UNID.455 UNID.471 
7.0832 7.1003 UNID.456 UNID.472 
7.1771 7.1898 Tyrosine.457 Tyrosine.473 
7.1898 7.1989 Tyrosine.Tryptophan.458 Tyrosine.Tryptophan.474 
7.1989 7.2028 Tyrosine.459 Tyrosine.475 
7.2028 7.2080 Tyrosine.Tryptophan.460 Tyrosine.Tryptophan.476 
7.2080 7.2124 Tyrosine.461 Tyrosine.477 
7.2124 7.2191 Tryptophan.462 Tryptophan.478 
7.2525 7.2603 NA UNID.479 
7.2740 7.3022 Tryptophan.463 Tryptophan.480 
7.3062 7.3154 UNID.464 UNID.481 
7.3154 7.3243 UNID.465 UNID.482 
7.3243 7.3333 Tryptophan.466 Tryptophan.483 
7.3333 7.3396 UNID.467 UNID.484 
7.3396 7.3442 UNID.468 UNID.485 
7.3758 7.3861 UNID.469 UNID.486 
7.3861 7.3950 UNID.470 UNID.487 
7.4169 7.4269 UNID.471 UNID.488 
7.4269 7.4373 UNID.472 UNID.489 
7.4373 7.4462 UNID.473 UNID.490 
7.4462 7.4556 UNID.474 UNID.491 
7.4556 7.4671 UNID.475 UNID.492 
7.5366 7.5567 Tryptophan.476 Tryptophan.493 
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7.6911 7.7091 UNID.477 UNID.494 
7.7316 7.7519 Tryptophan.478 Tryptophan.495 
7.7717 7.7928 UNID.479 UNID.496 
7.8557 7.8731 UNID.480 UNID.497 
7.8731 7.8774 UNID.481 UNID.498 
7.8837 7.8895 Xanthine.482 Xanthine.499 
7.9521 7.9554 UNID.483 UNID.500 
7.9554 7.9605 UNID.484 UNID.501 
7.9647 7.9668 UNID.485 UNID.502 
7.9668 7.9722 UNID.486 UNID.503 
8.0027 8.0085 UNID.487 UNID.504 
8.0975 8.1157 UNID.488 UNID.505 
8.1771 8.1820 UNID.489 UNID.506 
8.2100 8.2142 UNID.490 UNID.507 
8.2337 8.2381 UNID.491 UNID.508 
8.2381 8.2446 UNID.492 UNID.509 
8.2698 8.2735 Oxypurinol.493 Oxypurinol.510 
8.2735 8.2781 UNID.494 UNID.511 
8.4316 8.4361 UNID.496 UNID.513 
8.4521 8.4658 Formate.497 Formate.514 
8.5379 8.5478 UNID.498 UNID.515 
8.5826 8.5869 UNID.499 UNID.516 
8.6076 8.6186 UNID.500 UNID.517 
 
 


































Appendix 10: Representative raw 1H NMR spectra for Ae. aegypti wild type adult grouped by sex. 
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Appendix 11: PLS-DA model assessment metrics. A: adult; Acc: accuracy; Aed: Aedes Aegypti; Aga: Anopheles 
gambiae; Av: average; Gen: genotype; KD: knock-down; NA: not applicable; P: pupa; Pre: precision; Rec: recall; 
Res: resistance; Sel: selected; Spe: species; Sta: stage WT: wild type. 
Spe Gen Sta Model Data Class Acc Pre Rec Av Acc Av pre Av rec 
Aga KD P Sex Full NA 0.4545 0.3333 0.2000 NA NA NA 
Aga KD A Sex Full NA 0.9412 0.9500 0.9500 NA NA NA 
Aga WT P Sex Full NA 0.7143 0.7500 0.5000 NA NA NA 
Aga WT A Sex Full NA 0.8750 0.8571 0.8571 NA NA NA 
Aed WT P Sex Full NA 0.9375 1.0000 0.8333 NA NA NA 
Aed WT A Sex Full NA 1.0000 1.0000 1.0000 NA NA NA 
Aga KD P 3-way  Full KD16 0.9091 0.7500 1.0000 0.7576 0.7500 0.6667 
Aga KD P 3-way Full KD17 0.6364 0.5000 0.7500 0.7576 0.7500 0.6667 
Aga KD P 3-way Full CONT 0.7273 1.0000 0.2500 0.7576 0.7500 0.6667 
Aga KD A 3-way Full KD16 0.7941 0.8333 0.4545 0.8235 0.7341 0.7126 
Aga KD A 3-way Full KD17 0.7941 0.5455 0.7500 0.8235 0.7341 0.7126 
Aga KD A 3-way Full CONT 0.8824 0.8235 0.9333 0.8235 0.7341 0.7126 
Aga KD P 2-way Full NA 0.7500 1.0000 1.0000 NA NA NA 
Aga KD A 2-way Full NA 1.0000 1.0000 1.0000 NA NA NA 
Aga WT P Res Full NA 0.6429 1.0000 0.5833 NA NA NA 
Aga WT A Res Full NA 0.8750 0.9000 0.9000 NA NA NA 
Aed WT P Res Full NA 1.0000 1.0000 1.0000 NA NA NA 
Aed WT A Res Full NA 1.0000 1.0000 1.0000 NA NA NA 
Aga KD P Sex Sel NA 0.6364 0.6667 0.6667 NA NA NA 
Aga KD A Sex Sel NA 0.9412 1.0000 0.8824 NA NA NA 
Aga WT P Sex Sel NA 0.7143 0.7273 0.8889 NA NA NA 
Aga WT A Sex Sel NA 0.9375 0.8333 0.9091 NA NA NA 
Aed WT P Sex Sel NA 1.0000 1.0000 1.0000 NA NA NA 
Aed WT A Sex Sel NA 1.0000 1.0000 1.0000 NA NA NA 
Aga KD P 3-way  Sel KD16 0.9091 1.0000 0.6667 0.6970 0.6667 0.5778 
Aga KD P 3-way Sel KD17 0.5455 0.3333 0.6667 0.6970 0.6667 0.5778 
Aga KD P 3-way Sel CONT 0.6364 0.6667 0.4000 0.6970 0.6667 0.5778 
Aga KD A 3-way Sel KD16 0.7941 0.8000 0.4000 0.7647 0.6686 0.6543 
Aga KD A 3-way Sel KD17 0.7941 0.5000 0.8571 0.7647 0.6686 0.6543 
Aga KD A 3-way Sel CONT 0.7059 0.7059 0.7059 0.7647 0.6686 0.6543 
Aga KD P 2-way Sel NA 0.7500 1.0000 0.3333 NA NA NA 
Aga KD A 2-way Sel NA 0.9000 1.0000 0.9412 NA NA NA 
Aga WT P Res Sel NA 0.8571 0.7500 0.7500 NA NA NA 
Aga WT A Res Sel NA 0.9375 0.9000 1.0000 NA NA NA 
Aed WT P Res Sel NA 0.8750 0.8000 1.0000 NA NA NA 
Aed WT A Res Sel NA 0.9167 0.8333 1.0000 NA NA NA 
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Appendix 12: t-Test results for sex comparison. AnKD: Anopheles gambiae knock-down, AnWT: Anopheles 
gambiae wild type, AeWT: Aedes Aegypti Wild type, DF: degrees of freedom, Raw pval: Raw p-value, BH pval: 
Benjamini Hochberg adjusted p-value, *: overlapping bin.  
Strain Stage Metabolite bin DF t-score Raw pval BH pval Female mean Male mean 
AnKD Pupa Propionate [17] 34.79 -1.30 2.01E-01 3.61E-01 7.30E+07 7.84E+07 
AnKD Pupa Acetate [102] 33.91 -2.31 2.70E-02 2.43E-01 2.02E+09 2.22E+09 
AnKD Pupa Tyrosine [214] 35.90 -0.37 7.11E-01 8.93E-01 2.45E+08 2.55E+08 
AnKD Pupa Methanol [260] 34.29 1.52 1.39E-01 3.12E-01 7.26E+07 6.51E+07 
AnKD Pupa Glucose [267] 34.66 0.14 8.93E-01 8.93E-01 5.08E+08 5.03E+08 
AnKD Pupa Glycine [295] 24.02 -1.82 8.15E-02 3.12E-01 1.61E+08 1.72E+08 
AnKD Pupa Tryptophan [476] 29.86 -1.14 2.62E-01 3.93E-01 2.98E+07 3.84E+07 
AnKD Pupa Oxypurinol [493] 33.23 -0.21 8.36E-01 8.93E-01 1.02E+08 1.06E+08 
AnKD Pupa Formate [497] 26.68 -1.68 1.04E-01 3.12E-01 1.14E+08 1.63E+08 
AnKD Adult Propionate [12] 92.89 -4.18 6.65E-05 7.98E-05 8.62E+07 9.71E+07 
AnKD Adult Lactate [386] 107.69 12.37 2.09E-22 1.25E-21 1.85E+08 9.12E+07 
AnKD Adult Trehalose [424] 78.35 -3.34 1.30E-03 1.30E-03 1.52E+08 2.34E+08 
AnKD Adult Tyrosine [452] 109.46 -4.95 2.76E-06 4.14E-06 6.61E+07 8.41E+07 
AnKD Adult Xanthine [482] 107.40 5.20 9.58E-07 1.92E-06 1.96E+07 1.61E+07 
AnKD Adult Oxypurinol [493] 89.84 -5.46 4.11E-07 1.23E-06 1.40E+08 1.81E+08 
AnWT Pupa Acetate [102] 44.82 -3.50 1.06E-03 1.82E-03 1.84E+09 2.15E+09 
AnWT Pupa Propionate [129] 41.81 -4.47 5.89E-05 2.35E-04 7.32E+07 8.38E+07 
AnWT Pupa Glutamate [138] 45.00 -3.52 1.01E-03 1.82E-03 3.14E+08 3.60E+08 
AnWT Pupa Pyruvate [139] 44.58 -2.41 1.99E-02 2.17E-02 2.40E+08 2.75E+08 
AnWT Pupa Glucose [270] 44.68 5.28 3.71E-06 4.00E-05 4.69E+08 3.86E+08 
AnWT Pupa Valine [304] 44.22 4.16 1.43E-04 3.43E-04 3.08E+08 2.62E+08 
AnWT Pupa Glutamine [333]* 43.76 2.73 9.09E-03 1.09E-02 1.13E+09 1.03E+09 
AnWT Pupa Alanine [342] 41.81 5.15 6.66E-06 4.00E-05 2.16E+08 1.93E+08 
AnWT Pupa Trehalose [346]* 44.86 3.26 2.11E-03 2.82E-03 7.89E+08 7.15E+08 
AnWT Pupa Lactate [384] 43.92 4.19 1.33E-04 3.43E-04 2.04E+08 1.66E+08 
AnWT Pupa Fumarate [450] 43.35 -2.17 3.57E-02 3.57E-02 2.74E+07 3.14E+07 
AnWT Pupa Formate [497] 42.88 -3.42 1.39E-03 2.09E-03 1.10E+08 1.54E+08 
AnWT Adult Propionate [12] 48.66 -3.71 5.40E-04 1.08E-03 8.26E+07 9.65E+07 
AnWT Adult Acetate [102] 44.09 -4.95 1.14E-05 3.04E-05 1.92E+09 2.25E+09 
AnWT Adult Glycine [295] 27.47 3.19 3.57E-03 4.38E-03 1.17E+09 3.86E+08 
AnWT Adult Alanine [342] 28.40 3.46 1.71E-03 2.74E-03 6.01E+08 2.58E+08 
AnWT Adult Trehalose [351] 32.92 3.07 4.29E-03 4.38E-03 8.89E+08 6.66E+08 
AnWT Adult Glucose [354] 30.10 3.08 4.38E-03 4.38E-03 2.93E+09 1.19E+09 
AnWT Adult Lactate [386] 38.83 9.02 4.54E-11 3.63E-10 2.55E+08 1.08E+08 
AnWT Adult Oxypurinol [493] 40.60 -5.80 8.65E-07 3.46E-06 1.51E+08 2.27E+08 
AeWT Pupa Isoleucine [4] 50.25 -3.47 1.09E-03 1.09E-03 5.35E+08 5.85E+08 
AeWT Pupa Acetate [114] 46.36 -9.47 2.09E-12 1.05E-11 3.60E+09 5.63E+09 
AeWT Pupa Propionate [141] 47.92 -10.95 1.23E-14 1.23E-13 6.88E+07 8.66E+07 
AeWT Pupa Glucose [284] 49.39 4.27 8.84E-05 1.10E-04 6.72E+08 5.18E+08 
AeWT Pupa Glycine [309] 47.48 6.11 1.75E-07 4.38E-07 2.96E+08 2.23E+08 
AeWT Pupa Alanine [356] 52.40 4.69 1.97E-05 2.82E-05 2.85E+08 2.50E+08 
AeWT Pupa Trehalose [362] 50.15 3.83 3.59E-04 3.99E-04 1.74E+09 1.50E+09 
AeWT Pupa Lactate [398] 48.62 4.85 1.30E-05 2.53E-05 3.01E+08 2.57E+08 
AeWT Pupa Tyrosine [466] 52.55 -4.77 1.52E-05 2.53E-05 4.04E+08 5.15E+08 
AeWT Pupa Formate [514] 41.20 -9.40 8.24E-12 2.75E-11 7.46E+07 1.34E+08 
AeWT Adult Valine [8] 34.68 8.56 4.55E-10 1.25E-09 3.90E+08 2.35E+08 
AeWT Adult Isoleucine [9] 31.37 5.30 8.67E-06 1.59E-05 1.83E+08 1.37E+08 
AeWT Adult Propionate [15] 24.83 -13.95 2.98E-13 3.28E-12 1.33E+08 2.40E+08 
AeWT Adult Acetate [114] 23.66 -12.20 1.08E-11 5.92E-11 5.74E+09 1.02E+10 
AeWT Adult Pyruvate [151] 25.44 -3.22 3.50E-03 3.85E-03 1.38E+08 1.95E+08 
AeWT Adult Methanol [274] 25.35 -3.11 4.61E-03 4.61E-03 1.32E+08 2.06E+08 
AeWT Adult Lactate [398] 38.71 5.64 1.65E-06 3.63E-06 2.56E+08 2.05E+08 
AeWT Adult Glucose [434] 38.16 3.86 4.30E-04 5.92E-04 3.77E+08 2.94E+08 
AeWT Adult Trehalose [438] 25.96 -3.73 9.55E-04 1.17E-03 1.24E+08 2.66E+08 
AeWT Adult Tryptophan [483] 35.76 3.91 3.98E-04 5.92E-04 1.33E+08 1.14E+08 




Appendix 13: Wild type An. gambiae loadings for PC1. The sub-population observed in the PCA scores plot is 




Appendix 14: An. gambiae knock-down control samples PCA scores (A: pupae, B: adults) highlighted by sex. Both 
pupa and adult controls does not show a clear separation of sex as observed in wild type An. gambiae. Ellipses 
























































































Appendix 15: Representative raw 1H NMR spectra for An. gambiae knock-down pupa grouped by genotype. KD16: 




Appendix 16: Representative raw 1H NMR spectra for An. gambiae knock-down adult grouped by genotype. KD16: 
Cyp4g16 knock-down, KD17: Cyp4g17 knock-down, CONT: Control strain. 
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Appendix 17: ANOVA, Tukey’s HSD and t-test results for knock-down comparisons. DF: degrees of freedom, Raw 
pval: Raw p-value, BH pval: Benjamini Hochberg adjusted p-value, S: stage, *: overlapping bin. 
  ANOVA Tukey's HSD 







P Valine [8] 2 8.74 8.34E-04 2.92E-03 5.35E-04 1.29E-01 4.98E-02 
P Propionate [17] 2 4.81 1.43E-02 2.50E-02 2.66E-02 9.91E-01 2.56E-02 
P Tyrosine [207] 2 0.78 4.65E-01 4.65E-01 5.41E-01 5.14E-01 9.99E-01 
P Alanine & Glutamate [334] 
2 3.00 6.26E-02 8.76E-02 2.85E-01 5.23E-02 7.36E-01 
P Trehalose [351] 2 5.91 6.17E-03 1.44E-02 5.69E-03 5.90E-01 4.06E-02 
P Glucose [425] 2 2.55 9.25E-02 1.08E-01 2.28E-01 9.24E-02 9.37E-01 
P Tryptophan [476] 2 10.07 3.52E-04 2.47E-03 5.63E-04 2.85E-03 6.59E-01 
A Valine [10] 2 12.00 1.95E-05 3.25E-05 5.71E-03 3.66E-05 4.87E-01 
A Tyrosine [207] 2 17.04 3.64E-07 1.82E-06 5.91E-01 2.44E-07 2.69E-04 
A Trehalose [311] 2 15.33 1.36E-06 3.40E-06 3.48E-02 6.75E-04 8.77E-07 
A Glucose [329] 2 11.19 3.81E-05 4.10E-05 1.13E-01 3.04E-03 2.85E-05 
A Alanine [340]* 2 11.10 4.10E-05 4.10E-05 6.31E-02 6.31E-03 2.53E-05 
t-test 






P Valine [13] 19.48 1.99 6.07E-02 1.45E-01 3.15E+08 2.68E+08  
P Propionate [17] 23.68 2.68 1.30E-02 1.12E-01 8.47E+07 7.17E+07  
P Glutamine [126]* 12.89 2.43 3.06E-02 1.12E-01 2.31E+08 1.99E+08  
P Pyruvate [139] 16.37 -0.74 4.70E-01 5.25E-01 2.03E+08 2.16E+08  
P Glutamate [331] 15.06 1.32 2.08E-01 3.81E-01 3.93E+08 3.59E+08  
P Alanine [334]* 22.25 -0.65 5.25E-01 5.25E-01 7.03E+08 7.30E+08  
P Trehalose [351] 15.19 1.98 6.61E-02 1.45E-01 6.14E+08 5.21E+08  
P Glucose [354] 23.81 0.99 3.33E-01 4.58E-01 5.36E+08 5.01E+08  
P Tryptophan [476] 20.53 0.72 4.81E-01 5.25E-01 4.61E+07 3.97E+07  
P Xanthine [482] 19.96 -2.49 2.17E-02 1.12E-01 2.37E+07 2.77E+07  
P Formate [497] 16.33 1.10 2.88E-01 4.53E-01 1.89E+08 1.49E+08  
A Propionate [15] 48.05 -3.70 5.59E-04 5.59E-04 9.47E+07 1.26E+08  
A Acetate [102] 53.66 -6.55 2.26E-08 1.81E-07 2.58E+09 3.77E+09  
A Succinate [144] 53.70 4.25 8.52E-05 1.70E-04 2.42E+08 1.73E+08  
A Tyrosine [212] 53.43 -4.14 1.23E-04 1.97E-04 8.44E+07 1.00E+08  
A Glucose [285] 31.42 4.18 2.18E-04 2.91E-04 7.35E+08 3.13E+08  
A Glycine [295] 35.72 6.51 1.49E-07 5.97E-07 5.10E+08 1.27E+08  
A Trehalose [313] 37.10 3.89 4.01E-04 4.58E-04 8.39E+08 5.18E+08  

















Appendix 21: Representative raw 1H NMR spectra for Ae. aegypti wild type adult grouped by resistance status. 
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Appendix 22: Wild type Anopheles gambiae and Aedes aegypti resistant v susceptible t-test results. Ano: 
Anopheles gambiae, Aed: Aedes Aegypti, DF: degrees of freedom, Raw pval: Raw p-value, BH pval: Benjamini 
Hochberg adjusted p-value, Res: resistant, Sus: susceptible, *: overlapping bin. 
Species Stage Metabolite bin DF t-score Raw pval BH pval Res mean Sus mean 
Ano Pupa Isoleucine [4] 41.33 -3.21 2.53E-03 2.89E-03 4.48E+08 4.94E+08 
Ano Pupa Acetate [102] 36.26 2.85 7.24E-03 7.73E-03 2.15E+09 1.88E+09 
Ano Pupa Propionate [129] 42.26 2.71 9.64E-03 9.64E-03 8.26E+07 7.53E+07 
Ano Pupa Pyruvate [139] 34.21 9.70 2.37E-11 3.79E-10 3.06E+08 2.21E+08 
Ano Pupa Tryptophan [252] 44.58 3.48 1.15E-03 1.67E-03 9.98E+07 8.06E+07 
Ano Pupa Methanol [260] 33.23 8.39 1.02E-09 8.17E-09 9.92E+07 6.86E+07 
Ano Pupa Glucose [270] 35.65 -4.58 5.54E-05 1.48E-04 3.84E+08 4.62E+08 
Ano Pupa Trehalose [275] 25.23 3.57 1.46E-03 1.95E-03 3.59E+08 2.98E+08 
Ano Pupa Glycine [295] 39.54 -3.64 7.84E-04 1.25E-03 1.68E+08 1.91E+08 
Ano Pupa Threonine [299] 38.40 -4.55 5.28E-05 1.48E-04 3.53E+08 4.34E+08 
Ano Pupa Glutamate [331] 28.67 4.04 3.61E-04 7.22E-04 4.68E+08 4.18E+08 
Ano Pupa Alanine [342] 41.11 -4.32 9.76E-05 2.23E-04 1.93E+08 2.14E+08 
Ano Pupa Lactate [384] 36.39 -4.99 1.53E-05 6.12E-05 1.60E+08 2.05E+08 
Ano Pupa Fumarate [450] 42.16 7.19 7.59E-09 4.05E-08 3.49E+07 2.53E+07 
Ano Pupa Oxypurinol [493] 43.99 3.66 6.69E-04 1.19E-03 1.39E+08 9.07E+07 
Ano Pupa Formate [497] 34.52 3.31 2.21E-03 2.72E-03 1.57E+08 1.13E+08 
Ano Adult Lactate [49] 49.71 -2.70 9.52E-03 1.07E-02 8.95E+08 1.17E+09 
Ano Adult Propionate [129] 45.86 2.82 7.01E-03 9.19E-03 5.97E+07 5.35E+07 
Ano Adult Pyruvate [139] 49.45 -5.57 1.06E-06 9.50E-06 1.38E+08 1.80E+08 
Ano Adult Succinate [144] 49.68 3.75 4.59E-04 1.03E-03 2.77E+08 2.29E+08 
Ano Adult Methanol [260] 49.98 -4.37 6.33E-05 1.90E-04 1.42E+08 1.80E+08 
Ano Adult Trehalose [315] 50.87 2.80 7.15E-03 9.19E-03 8.68E+08 6.21E+08 
Ano Adult Theronine [398] 50.48 -3.52 9.29E-04 1.67E-03 6.24E+07 6.97E+07 
Ano Adult Tyrosine [452] 31.58 -2.11 4.28E-02 4.28E-02 8.14E+07 1.03E+08 
Ano Adult Oxypurinol [493] 50.97 4.64 2.45E-05 1.10E-04 2.21E+08 1.54E+08 
Aed Pupa Alanine [58] 51.84 8.09 9.40E-11 4.70E-10 7.05E+08 5.63E+08 
Aed Pupa Pyruvate [151] 45.37 -6.89 1.44E-08 4.66E-08 2.42E+08 3.04E+08 
Aed Pupa Methanol [274] 48.25 -6.43 5.44E-08 1.09E-07 6.79E+07 8.81E+07 
Aed Pupa Glucose [284] 46.02 9.25 4.63E-12 4.63E-11 7.07E+08 4.70E+08 
Aed Pupa Glycine [309] 48.54 6.72 1.87E-08 4.66E-08 2.95E+08 2.19E+08 
Aed Pupa Trehalose [365] 50.02 4.43 5.22E-05 5.22E-05 1.03E+09 8.99E+08 
Aed Pupa Tyrosine [374] 52.79 4.41 5.09E-05 5.22E-05 6.56E+08 5.81E+08 
Aed Pupa Lactate [398] 47.24 5.23 3.74E-06 5.11E-06 3.01E+08 2.54E+08 
Aed Pupa Xanthine [499] 47.61 6.21 1.25E-07 2.08E-07 4.38E+07 3.44E+07 
Aed Pupa Oxypurinol [510] 49.62 -5.18 4.09E-06 5.11E-06 6.29E+07 8.19E+07 
Aed Adult Propionate [139] 38.05 -3.12 3.47E-03 3.82E-03 9.79E+07 1.14E+08 
Aed Adult Pyruvate [151] 35.28 -4.17 1.86E-04 4.10E-04 1.32E+08 1.99E+08 
Aed Adult Succinate [156] 33.24 -4.27 1.54E-04 4.10E-04 3.61E+08 4.42E+08 
Aed Adult Methanol [274] 36.49 -3.93 3.63E-04 6.65E-04 1.24E+08 2.10E+08 
Aed Adult Valine [318] 37.80 3.16 3.11E-03 3.80E-03 3.78E+08 2.98E+08 
Aed Adult Alanine [351*] 38.61 7.21 1.19E-08 1.30E-07 1.25E+09 1.00E+09 
Aed Adult Trehalose [362] 36.58 3.55 1.09E-03 1.71E-03 1.28E+09 1.10E+09 
Aed Adult Glucose [368] 38.29 4.58 4.84E-05 1.77E-04 9.77E+08 7.97E+08 
Aed Adult Tyrosine [374] 27.83 3.42 1.94E-03 2.67E-03 4.40E+08 3.80E+08 
Aed Adult Tryptophan [493] 39.00 2.66 1.12E-02 1.12E-02 3.85E+07 3.26E+07 
Aed Adult Oxypurinol [510] 31.14 -5.17 1.31E-05 7.20E-05 2.38E+08 3.26E+08 
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Appendix 23: Signal to noise ratio histogram calculated from all data sets used in this project. Signal region was 
defined as 1-4 ppm and noise region was defined as 10-10.5 ppm, Region integrations were normalised to the 
region range prior to Signal to noise calculation. 
Ae. aegypti wildtype An. gambiae wildtype CYP knock−down
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